<SEC-DOCUMENT>0001140361-25-006524.txt : 20250228
<SEC-HEADER>0001140361-25-006524.hdr.sgml : 20250228
<ACCEPTANCE-DATETIME>20250228161153
ACCESSION NUMBER:		0001140361-25-006524
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		22
CONFORMED PERIOD OF REPORT:	20250224
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Termination of a Material Definitive Agreement
ITEM INFORMATION:		Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
ITEM INFORMATION:		Unregistered Sales of Equity Securities
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20250228
DATE AS OF CHANGE:		20250228

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BridgeBio Pharma, Inc.
		CENTRAL INDEX KEY:			0001743881
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38959
		FILM NUMBER:		25690299

	BUSINESS ADDRESS:	
		STREET 1:		3160 PORTER DR.
		STREET 2:		SUITE 250
		CITY:			PALO ALTO
		STATE:			CA
		ZIP:			94304
		BUSINESS PHONE:		(650) 391-9740

	MAIL ADDRESS:	
		STREET 1:		3160 PORTER DR.
		STREET 2:		SUITE 250
		CITY:			PALO ALTO
		STATE:			CA
		ZIP:			94304

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BridgeBio Pharma LLC
		DATE OF NAME CHANGE:	20180618
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>ef20044715_8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:srt="http://fasb.org/srt/2024" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:country="http://xbrl.sec.gov/country/2024" xmlns:currency="http://xbrl.sec.gov/currency/2024" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:naics="http://xbrl.sec.gov/naics/2024" xmlns:sic="http://xbrl.sec.gov/sic/2024" xmlns:stpr="http://xbrl.sec.gov/stpr/2024" xmlns:exch="http://xbrl.sec.gov/exch/2024" xmlns:cef="http://xbrl.sec.gov/cef/2024" xmlns:cyd="http://xbrl.sec.gov/cyd/2024" xmlns:bbio="http://bridgebio.com/20250224" xmlns="http://www.w3.org/1999/xhtml">
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc.
         Document created using Broadridge PROfile 25.1.1.5279
         Copyright 1995 - 2025 Broadridge -->
    <meta http-equiv="Content-Type" content="text/html"/>
</head>

<body style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; background-color: #ffffff;">
<div id="DSPFiXBRLHidden" style="display: none;"><ix:header><ix:hidden><ix:nonNumeric name="dei:AmendmentFlag" id="Fact_d79fb903e3c54fba817e3cdd57c20042" contextRef="c20250224to20250224" format="ixt:fixed-false">false</ix:nonNumeric><ix:nonNumeric name="dei:EntityCentralIndexKey" id="Fact_3bd9188bd5624895b8a8160fb3e468be" contextRef="c20250224to20250224">0001743881</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:href="bbio-20250224.xsd" xlink:type="simple"/></ix:references><ix:resources><xbrli:context id="c20250224to20250224"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001743881</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2025-02-24</xbrli:startDate><xbrli:endDate>2025-02-24</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div>
<div style="line-height: initial;">
  <div><span style="font-size: 10pt;"> </span></div>

  <div>
    <hr style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"/>
    <div>
      <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 14pt; font-weight: bold;">UNITED STATES</div>

      <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 14pt; font-weight: bold;">SECURITIES AND EXCHANGE COMMISSION</div>

      <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 12pt; font-weight: bold;">WASHINGTON, D.C. 20549</div>

      <div><br/></div>

      <hr style="background-color: #000000; border-bottom: medium none; border-left: medium none; border-right: medium none; border-top: medium none; margin: 0px auto; height: 2px; width: 15%; color: #000000; text-align: center; margin-left: auto; margin-right: auto;"/>
      <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> <br/>
      </div>

      <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 18pt; font-weight: bold;">FORM <ix:nonNumeric name="dei:DocumentType" id="Fact_93772f2c96dd42139eafc2d275aab268" contextRef="c20250224to20250224">8-K</ix:nonNumeric></div>

      <div><br/></div>

      <hr style="height: 2px; width: 15%; color: #000000; background-color: #000000; text-align: center; border: none; margin-left: auto; margin-right: auto;"/>
      <div><br/>
      </div>

      <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">CURRENT REPORT</div>

      <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> </span><span style="font-size: 10pt;"><br/>
        </span></div>

      <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</div>

      <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> </span><span style="font-size: 10pt;"><br/>
        </span></div>

      <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Date of Report (Date of earliest event reported): <ix:nonNumeric name="dei:DocumentPeriodEndDate" id="Fact_d00554e814454be4a62c596c90c1716e" contextRef="c20250224to20250224" format="ixt:date-monthname-day-year-en">February 24, 2025</ix:nonNumeric></div>

      <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> <br/>
      </div>

      <div>
        <hr style="height: 2px; width: 15%; color: #000000; background-color: #000000; text-align: center; border: none; margin-left: auto; margin-right: auto;"/></div>

      <div><br/></div>

      <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 24pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityRegistrantName" id="Fact_53fbc0836e0e475d803f89efbca8fbbc" contextRef="c20250224to20250224">BridgeBio Pharma, Inc.</ix:nonNumeric><br/>
      </div>

      <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(Exact name of Registrant as Specified in Its Charter)</div>

      <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> <br/>
      </div>

      <div>
        <hr style="height: 2px; width: 15%; color: #000000; background-color: #000000; text-align: center; border: none; margin-left: auto; margin-right: auto;"/></div>

      <div><br/></div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000; border-spacing: 0;">


  <tr>

    <td style="width: 33%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" id="Fact_fcd34a5c7a7041e1a9be50d4ea6afeeb" contextRef="c20250224to20250224" format="ixt-sec:stateprovnameen">Delaware</ix:nonNumeric><br/>
              </div>
            </td>

    <td style="width: 34%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;"><ix:nonNumeric name="dei:EntityFileNumber" id="Fact_efd8787eef2548fe8b500d06160c8f08" contextRef="c20250224to20250224">001-38959</ix:nonNumeric><br/>
              </div>
            </td>

    <td style="width: 33%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" id="Fact_ffdb06dbe5164051a467e90ba686afa7" contextRef="c20250224to20250224">84-1850815</ix:nonNumeric><br/>
              </div>
            </td>

  </tr>

  <tr>

    <td style="width: 33%; vertical-align: top; font-size: 10pt; white-space: nowrap;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">(State or Other Jurisdiction of Incorporation)</div>
            </td>

    <td style="width: 34%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">(Commission File Number)</div>
            </td>

    <td style="width: 33%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">(IRS Employer Identification No.)</div>
            </td>

  </tr>


</table>
      <div style="font-size: 10pt;"><br/>
      </div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000; border-spacing: 0;">


  <tr>

    <td style="width: 49%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;"><ix:nonNumeric name="dei:EntityAddressAddressLine1" id="Fact_3377389d490b4dd7b1d0a2e72ce45dcb" contextRef="c20250224to20250224">3160 Porter Dr.</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressAddressLine2" id="Fact_e198d91a1d754c8792901fa89be20b25" contextRef="c20250224to20250224">Suite 250</ix:nonNumeric></div>
            </td>

    <td style="width: 2%; vertical-align: top; font-size: 10pt;">&#160;</td>

    <td style="width: 49%; vertical-align: bottom; font-size: 10pt;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 49%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;"><ix:nonNumeric name="dei:EntityAddressCityOrTown" id="Fact_e4ccf16e9790435fb4ffbccefde2caad" contextRef="c20250224to20250224">Palo Alto</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" id="Fact_589d8d7a34ff44688fb4d89d88603a5c" contextRef="c20250224to20250224">CA</ix:nonNumeric></div>
            </td>

    <td style="width: 2%; vertical-align: top; font-size: 10pt;">&#160;</td>

    <td style="width: 49%; vertical-align: bottom; font-size: 10pt;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;"><ix:nonNumeric name="dei:EntityAddressPostalZipCode" id="Fact_45ac14447eda4b3792b30bf59698fe8b" contextRef="c20250224to20250224">94304</ix:nonNumeric><br/>
              </div>
            </td>

  </tr>

  <tr>

    <td style="width: 49%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">(Address of Principal Executive Offices)</div>
            </td>

    <td style="width: 2%; vertical-align: top; font-size: 10pt;">&#160;</td>

    <td style="width: 49%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">(Zip Code)</div>
            </td>

  </tr>


</table>
      <div style="font-size: 10pt;"><br/>
      </div>

      <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Registrant&#8217;s Telephone Number, Including Area Code:</span><span style="font-size: 10pt;"> <span style="font-weight: bold;">(<ix:nonNumeric name="dei:CityAreaCode" id="Fact_88e7f54ab8bc4954afc5cf3f75421ce7" contextRef="c20250224to20250224">650</ix:nonNumeric><span style="font-family: 'Times New Roman';">)</span> <ix:nonNumeric name="dei:LocalPhoneNumber" id="Fact_eba4d5a19df84fec91ca4e40feaf359e" contextRef="c20250224to20250224">391-9740</ix:nonNumeric></span></span></div>

      <div style="font-size: 10pt;"><br/>
      </div>

      <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Not Applicable</div>

      <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(Former Name or Former Address, if Changed Since Last Report)</div>

      <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> <br/>
      </div>

      <div>
        <hr style="height: 2px; width: 15%; color: #000000; background-color: #000000; text-align: center; border: none; margin-left: auto; margin-right: auto;"/></div>

      <div><br/>
      </div>

      <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the
        following provisions:</div>

      <div style="font-size: 10pt;"><br/>
      </div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000; border-spacing: 0;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="dei:WrittenCommunications" id="Fact_7b0fb11ca36145daa7b9788d7dd70788" contextRef="c20250224to20250224" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>

    <td style="vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</div>
            </td>

  </tr>


</table>
      <div style="font-size: 10pt;"><br/>
      </div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000; border-spacing: 0;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="dei:SolicitingMaterial" id="Fact_027e19c6dab848fe92d74412b58b0824" contextRef="c20250224to20250224" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric><br/>
            </td>

    <td style="vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</div>
            </td>

  </tr>


</table>
      <div style="font-size: 10pt;"><br/>
      </div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000; border-spacing: 0;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="dei:PreCommencementTenderOffer" id="Fact_f5d61fd13c4b4afa8fa94cb4c73b7e14" contextRef="c20250224to20250224" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric><br/>
            </td>

    <td style="vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</div>
            </td>

  </tr>


</table>
      <div style="font-size: 10pt;"><br/>
      </div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000; border-spacing: 0;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" id="Fact_760f52d7858b471eb58d579b589bc88e" contextRef="c20250224to20250224" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric><br/>
            </td>

    <td style="vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</div>
            </td>

  </tr>


</table>
      <div style="font-size: 10pt;"><br/>
      </div>

      <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Securities registered pursuant to Section 12(b) of the Act:</div>

      <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> </span><span style="font-size: 10pt;"><br/>
        </span></div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000; border-spacing: 0;">


  <tr>

    <td style="width: 41%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">Title of each class</div>
            </td>

    <td style="width: 1%; vertical-align: top; font-size: 10pt;">&#160;</td>

    <td style="width: 10.63%; vertical-align: top; border-bottom: #000000 2px solid;">
              <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Trading</div>
              <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Symbol(s)</div>
            </td>

    <td style="width: 1%; vertical-align: top; font-size: 10pt;">&#160;</td>

    <td style="width: 46.2%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">Name of each exchange on which registered</div>
            </td>

  </tr>

  <tr>

    <td style="width: 41%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';"><ix:nonNumeric name="dei:Security12bTitle" id="Fact_9522a370899a40b3ac0a71a224a05117" contextRef="c20250224to20250224">Common Stock, par value $0.001 per share</ix:nonNumeric><br/>
              </div>
            </td>

    <td style="width: 1%; vertical-align: top; font-size: 10pt;">&#160;</td>

    <td style="width: 10.63%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';"><ix:nonNumeric name="dei:TradingSymbol" id="Fact_a0f583e34e344c77ae1fe9f00cc0c971" contextRef="c20250224to20250224">BBIO</ix:nonNumeric><br/>
              </div>
            </td>

    <td style="width: 1%; vertical-align: top; font-size: 10pt;">&#160;</td>

    <td style="width: 46.2%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';"><ix:nonNumeric name="dei:SecurityExchangeName" id="Fact_af3a50c05b3c4dae85faae4824ced06c" contextRef="c20250224to20250224" format="ixt-sec:exchnameen">The Nasdaq Global Select Market</ix:nonNumeric><br/>
              </div>
            </td>

  </tr>


</table>
      <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> </span><span style="font-size: 10pt;"><br/>
        </span></div>

      <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;&#8239;230.405 of this
        chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;&#8239;240.12b-2 of this chapter).</div>

      <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> </span><span style="font-size: 10pt;"><br/>
        </span></div>

      <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Emerging growth company <ix:nonNumeric name="dei:EntityEmergingGrowthCompany" id="Fact_a0e16efd4cbe43629552af6079645691" contextRef="c20250224to20250224" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></div>

      <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> </span><span style="font-size: 10pt;"><br/>
        </span></div>

      <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new
        or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</div>

      <div>
        <div style="font-size: 10pt;">
<div><br/></div>

          <hr style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"/></div>

      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

      </div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000; border-spacing: 0;" class="DSPFListTable">


  <tr>

    <td style="width: 54pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Item 1.01.</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">Entry into a Material Definitive Agreement.</div>
            </td>

  </tr>


</table>
      <div style="font-size: 10pt;">&#160;</div>

      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Indenture and Notes</div>

      <div style="font-size: 10pt;">&#160;</div>

      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">On February 28, 2025, BridgeBio Pharma, Inc. (&#8220;BridgeBio&#8221;) issued an aggregate of $575.0 million aggregate principal amount of its 1.75% Convertible Senior Notes due 2031
        (the &#8220;Notes&#8221;), pursuant to an Indenture dated February 28, 2025 (the &#8220;Indenture&#8221;), between BridgeBio and U.S. Bank Trust Company, National Association, as trustee (the &#8220;Trustee&#8221;), in a private offering to qualified institutional buyers (the &#8220;Note
        Offering&#8221;) pursuant to Rule 144A under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;). The Notes issued in the Note Offering include $75.0 million aggregate principal amount of Notes sold to the initial purchasers (the &#8220;Initial
        Purchasers&#8221;) pursuant to the exercise in full of the Initial Purchasers&#8217; option to purchase&#160; additional Notes.</div>

      <div style="font-size: 10pt;">&#160;</div>

      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">The Notes are senior, unsecured obligations of BridgeBio and will accrue interest payable semiannually in arrears on March 1 and September 1 of each year, beginning on
        September 1, 2025, at a rate of 1.75% per year. The Notes will mature on March 1, 2031, unless earlier converted, redeemed or repurchased. The Notes are convertible into cash, shares of BridgeBio&#8217;s common stock or a combination of cash and shares
        of BridgeBio&#8217;s common stock, at BridgeBio&#8217;s election.</div>

      <div style="font-size: 10pt;">&#160;</div>

      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">The net proceeds BridgeBio received from the Note Offering are equal to approximately $563.0 million, after deducting the Initial Purchasers&#8217; discount and estimated
        offering expenses payable by BridgeBio. BridgeBio used approximately $48.3 million to pay the cost of Repurchases (as defined below) of shares of its common stock described below. BridgeBio also used a portion of the net proceeds from the Note
        Offering to repay all outstanding borrowings under, and terminate, the Financing Agreement, dated as of January 17, 2024, with the lenders party thereto and Blue Owl Corporation, as administrative agent, as amended on February 12, 2024 and June 20,
        2024 (the &#8220;Financing Agreement&#8221;), and pay any fees related thereto. BridgeBio expects to use any remaining net proceeds from the offering for general corporate purposes.</div>

      <div style="font-size: 10pt;"><br/>
      </div>

      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">A holder of Notes may convert all or any portion of its Notes at its option at any time prior to the close of business on the business day immediately preceding December
        2, 2030 only under the following circumstances: (1) during any calendar quarter commencing after the calendar quarter ending on June 30, 2025 (and only during such calendar quarter), if the last reported sale price of BridgeBio&#8217;s common stock for
        at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the conversion
        price on each applicable trading day; (2) during the five business day period after any five consecutive trading day period (the &#8220;measurement period&#8221;) in which the &#8220;trading price&#8221; (as defined in the Indenture) per $1,000 principal amount of Notes
        for each trading day of the measurement period was less than 98% of the product of the last reported sale price of BridgeBio&#8217;s common stock and the conversion rate on each such trading day; (3) if BridgeBio calls such notes for redemption, at any
        time prior to the close of business on the second business day immediately preceding the redemption date; or (4) upon the occurrence of specified BridgeBio corporate events. On or after December 2, 2030 until the close of business on the second
        scheduled trading day immediately preceding the maturity date, a holder may convert all or any portion of its Notes at any time, regardless of the foregoing circumstances.</div>

      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"> <br/>
      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

      </div>

      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">The conversion rate will initially be 20.0773 shares of BridgeBio&#8217;s common stock per $1,000 principal amount of Notes (equivalent to an initial conversion price of
        approximately $49.81 per share of BridgeBio&#8217;s common stock). The conversion rate is subject to adjustment in some events but will not be adjusted for any accrued and unpaid interest. In addition, following certain corporate events that occur prior
        to the maturity date, BridgeBio will, in certain circumstances, increase the conversion rate for a holder who elects to convert its Notes in connection with such a corporate event.</div>

      <div style="font-size: 10pt;">&#160;</div>

      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">BridgeBio may not redeem the Notes prior to March 6, 2028. BridgeBio may redeem for cash all or any portion of the Notes, at its option, on a redemption date occurring on
        or after March 6, 2028 and on or before the 41st scheduled trading day immediately before the maturity date, if (i) the Notes are &#8220;freely tradable&#8221; (as defined in the Indenture) as of the date BridgeBio sends the related redemption notice and all
        accrued and unpaid additional interest, if any, has been paid in full as of the first interest payment date occurring on or before the date BridgeBio sends such notice; and (ii) the last reported sale price of BridgeBio&#8217;s common stock has been at
        least 130% of the conversion price then in effect for at least 20 trading days (whether or not consecutive), including the trading day immediately preceding the date on which BridgeBio provides notice of redemption, during any 30 consecutive
        trading day period ending on, and including, the trading day immediately preceding the date on which BridgeBio provides notice of redemption at a redemption price equal to 100% of the principal amount of the Notes to be redeemed, plus accrued and
        unpaid interest to, but excluding, the redemption date. If BridgeBio undergoes a fundamental change (as defined in the Indenture), holders may require BridgeBio to repurchase for cash all or any portion of their Notes at a fundamental change
        repurchase price equal to 100% of the principal amount of the Notes to be repurchased, plus any accrued and unpaid interest to, but excluding, the fundamental change repurchase date.</div>

      <div style="font-size: 10pt;">&#160;</div>

      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">The Indenture contains customary terms and covenants, including that upon certain events of default occurring and continuing, either the Trustee or the holders of not
        less than 25% in aggregate principal amount of the Notes then outstanding may declare the entire principal amount of all the Notes plus accrued special interest, if any, to be immediately due and payable.</div>

      <div style="font-size: 10pt;">&#160;</div>

      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">The Notes are BridgeBio&#8217;s general unsecured obligations and rank senior in right of payment to all of BridgeBio&#8217;s indebtedness that is expressly subordinated in right of
        payment to the Notes; equal in right of payment with all of BridgeBio&#8217;s liabilities that are not so subordinated, including BridgeBio&#8217;s 2.50% Convertible Senior Notes due 2027 and 2.25% Convertible Senior Notes due 2029; effectively junior to any
        of BridgeBio&#8217;s secured indebtedness and obligations, including its obligations under the Funding Agreement, dated as of January 17, 2024, with the purchasers and collateral agent party thereto, to the extent of the value of the assets securing such
        indebtedness; and structurally junior to all indebtedness and other liabilities (including trade payables) of BridgeBio&#8217;s subsidiaries.</div>

      <div style="font-size: 10pt;">&#160;</div>

      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">A copy of the Indenture and form of Note are filed as Exhibit 4.1 and Exhibit 4.2, respectively, to this Current Report on Form 8-K and are incorporated by reference
        herein. The foregoing description of the Indenture and Notes does not purport to be complete and is qualified in its entirety by reference to such exhibits.</div>

      <div style="font-size: 10pt;">&#160;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000; border-spacing: 0;" class="DSPFListTable">


  <tr>

    <td style="width: 54pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Item 1.02.</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="font-family: 'Times New Roman'; font-weight: bold;"> Termination of a Material Definitive Agreement.</div>
            </td>

  </tr>


</table>
      <div style="font-size: 10pt;">&#160;</div>

      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">The information provided in Item 1.01 of this Report is hereby incorporated by reference into this Item 1.02.</div>

      <div style="font-size: 10pt;">&#160;</div>

      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">BridgeBio used a portion of the net proceeds from the Note Offering to repay all outstanding borrowings under the Financing Agreement and pay any related fees thereto.&#160;
        The Financing Agreement was terminated on February 28, 2025.</div>

      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"> <br/>
      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

      </div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000; border-spacing: 0;" class="DSPFListTable">


  <tr>

    <td style="width: 54pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Item 2.03.</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">Creation of a Direct Financial Obligation under an Off-Balance Sheet Arrangement of a Registrant.</div>
            </td>

  </tr>


</table>
      <div style="font-size: 10pt;">&#160;</div>

      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">The information provided in Item 1.01 of this Report is hereby incorporated by reference into this Item 2.03.</div>

      <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman';"> </span><span style="font-size: 10pt;"><br/>
        </span></div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000; border-spacing: 0;" class="DSPFListTable">


  <tr>

    <td style="width: 54pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Item 3.02.</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">Unregistered Sale of Equity Securities.</div>
            </td>

  </tr>


</table>
      <div style="font-size: 10pt;">&#160;</div>

      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">The information provided in Item 1.01 of this Report is hereby incorporated by reference into this Item 3.02.</div>

      <div style="font-size: 10pt;">&#160;</div>

      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
        <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">BridgeBio&#8217;s offering and sale of the Notes to the Initial Purchasers was made in reliance on the exemption from registration provided by Section 4(a)(2) of the
          Securities Act. BridgeBio relied on this exemption from registration based in part on representations made by the Initial Purchasers in the purchase agreement for the Notes, including that the Initial Purchasers would only offer, sell or deliver
          the Notes to persons whom they believed to be qualified institutional buyers within the meaning of Rule 144A under the Securities Act. Any shares of the Company&#8217;s common stock that may be issued upon conversion of the Notes will be issued in
          reliance upon Section 3(a)(9) of the Securities Act as involving an exchange by the Company exclusively with its security holders. Initially, a maximum of 16,739,400 shares of BridgeBio&#8217;s common stock may be issued upon conversion of the Notes,
          based on the initial maximum conversion rate of 29.1120 shares of common stock per $1,000 principal amount of Notes, which is subject to customary anti-dilution adjustment provisions.</div>

      </div>

      <div style="font-size: 10pt;">&#160;</div>

      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">The Notes and BridgeBio&#8217;s common stock issuable upon conversion of the Notes, if any, have not been registered under the Securities Act and may not be offered or sold in
        the United States absent registration or applicable exemption from registration requirements.</div>

      <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman';"> </span><span style="font-size: 10pt;"><br/>
        </span></div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000; border-spacing: 0;" class="DSPFListTable">


  <tr>

    <td style="width: 54pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Item 8.01</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">Other Events.</div>
            </td>

  </tr>


</table>
      <div style="font-size: 10pt;">&#160;</div>

      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">On February 24, 2025, BridgeBio issued a press release announcing its intention to offer the Notes. A copy of the press release is attached hereto as Exhibit 99.1 and
        incorporated herein by reference.</div>

      <div style="font-size: 10pt;">&#160;</div>

      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">On February 25, 2025, BridgeBio issued a press release announcing the pricing of the Notes . A copy of the press release is attached hereto as Exhibit 99.2 and
        incorporated herein by reference.</div>

      <div style="font-size: 10pt;">&#160;</div>

      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Share Repurchases</div>

      <div style="font-size: 10pt;">&#160;</div>

      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">BridgeBio used approximately $48.3 million of the net proceeds from the Note Offering to repurchase shares of its common stock concurrently with the closing of the Note
        Offering on February 28, 2025 from certain purchasers of the Notes in privately negotiated transactions effected through one of the Initial Purchasers or an affiliate thereof concurrently with the pricing of the Notes (the &#8220;Repurchases&#8221;). The
        agreed to purchase price per share of common stock in the Repurchases is equal to $34.35, which was the last reported sale price per share of BridgeBio&#8217;s common stock on the Nasdaq Global Select Market on February 25, 2025. The Repurchases could
        have increased (or reduced the size of any decrease in) the market price of BridgeBio&#8217;s common stock or the Notes.</div>

      <div style="font-size: 10pt;">&#160;</div>

      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Forward-Looking Statements</div>

      <div style="font-size: 10pt;">&#160;</div>

      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">This Current Report on Form 8-K contains forward-looking statements within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act
        of 1934, as amended (the &#8220;Exchange Act&#8221;). Forward-looking statements are usually identified by the use of words such as &#8220;anticipates,&#8221; &#8220;believes,&#8221; &#8220;estimates,&#8221; &#8220;expects,&#8221; &#8220;intends,&#8221; &#8220;may,&#8221; &#8220;plans,&#8221; &#8220;projects,&#8221; &#8220;seeks,&#8221; &#8220;should,&#8221; &#8220;will,&#8221; and
        variations of such words or similar expressions. BridgeBio intends these forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in Section 27A of the Securities Act and Section 21E of the
        Exchange Act and are making this statement for purposes of complying with those safe harbor provisions. These forward-looking statements, including statements relating to the anticipated use of the net proceeds of the Note Offering and BridgeBio&#8217;s
        expectations regarding the effect of the Repurchases, reflect BridgeBio&#8217;s current views about its plans, intentions, expectations, strategies and prospects, which are based on the information currently available to BridgeBio and on assumptions it
        has made. Although BridgeBio believes that its plans, intentions, expectations, strategies and prospects as reflected in or suggested by those forward-looking statements are reasonable, BridgeBio can give no assurance that the plans, intentions,
        expectations or strategies will be attained or achieved. Furthermore, actual results may differ materially from those described in the forward-looking statements and will be affected by a number of risks, uncertainties and assumptions, including,
        but not limited to, those risks set forth in the Risk Factors section of BridgeBio&#8217;s most recent Annual Report on Form 10-K and its other SEC filings. Moreover, BridgeBio operates in a very competitive and rapidly changing environment in which new
        risks emerge from time to time. These forward-looking statements are based upon the current expectations and beliefs of BridgeBio&#8217;s management as of the date of this Current Report on Form 8-K, and are subject to certain risks and uncertainties
        that could cause actual results to differ materially from those described in the forward-looking statements. Except as required by applicable law, BridgeBio assumes no obligation to update publicly any forward-looking statements, whether as a
        result of new information, future events or otherwise.</div>

      <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman';"> </span><span style="font-size: 10pt;"><br/>
        </span></div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

      </div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000; border-spacing: 0;" class="DSPFListTable">


  <tr>

    <td style="width: 54pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Item 9.01.</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">Financial Statements and Exhibits.</div>
            </td>

  </tr>


</table>
      <div style="font-size: 10pt;">&#160;</div>

      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(d) Exhibits.</div>

      <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman';"> </span><span style="font-size: 10pt;"><br/>
        </span></div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000; border-spacing: 0;">


  <tr>

    <td style="width: 6%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">
              <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Exhibit</div>
              <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Number</div>
            </td>

    <td style="width: 2%; vertical-align: bottom; font-size: 10pt;">&#160;</td>

    <td style="width: 92%; vertical-align: bottom; font-size: 10pt;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">Description of Exhibit</div>
            </td>

  </tr>

  <tr>

    <td style="width: 6%; vertical-align: middle; font-size: 10pt;">&#160;</td>

    <td colspan="2" style="vertical-align: middle; font-size: 10pt; color: rgb(0, 0, 0);">&#160;</td>

  </tr>

  <tr>

    <td style="width: 6%; vertical-align: top; font-size: 10pt; white-space: nowrap;">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman';"><a href="ef20044715_ex4-1.htm">4.1</a></div>
            </td>

    <td style="width: 2%; vertical-align: bottom; font-size: 10pt; color: rgb(0, 0, 0);">&#160;</td>

    <td style="width: 92%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Indenture, dated as of February 28, 2025, by and between BridgeBio Pharma, Inc. and U.S. Bank Trust Company, National Association, as Trustee.</div>
            </td>

  </tr>

  <tr>

    <td style="width: 6%; vertical-align: top; font-size: 10pt; white-space: nowrap;">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman';"><a href="ef20044715_ex4-1.htm#EXHIBITA">4.2</a></div>
            </td>

    <td style="width: 2%; vertical-align: bottom; font-size: 10pt; color: rgb(0, 0, 0);">&#160;</td>

    <td style="width: 92%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Form of Global Note, representing BridgeBio Pharma, Inc.&#8217;s 1.75% Convertible Senior Notes due 2031 (included as Exhibit A to the Indenture filed as Exhibit
                4.1).</div>
            </td>

  </tr>

  <tr>

    <td style="width: 6%; vertical-align: top; font-size: 10pt; white-space: nowrap;">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman';"><a href="ef20044715_ex99-1.htm">99.1</a></div>
            </td>

    <td style="width: 2%; vertical-align: bottom; font-size: 10pt;">&#160;</td>

    <td style="width: 92%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">Press Release dated February 24, 2025.</div>
            </td>

  </tr>

  <tr>

    <td style="width: 6%; vertical-align: top; font-size: 10pt; white-space: nowrap;">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman';"><a href="ef20044715_ex99-2.htm">99.2</a></div>
            </td>

    <td style="width: 2%; vertical-align: bottom; font-size: 10pt;">&#160;</td>

    <td style="width: 92%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">Press Release dated February 25, 2025.</div>
            </td>

  </tr>

  <tr>

    <td style="width: 6%; vertical-align: top; font-size: 10pt; white-space: nowrap;" rowspan="1">104<br/>
            </td>

    <td style="width: 2%; vertical-align: bottom; font-size: 10pt;" rowspan="1">&#160;</td>

    <td style="width: 92%; vertical-align: top; font-size: 10pt;" rowspan="1">Cover Page Interactive Data File (embedded within the Inline XBRL document).<br/>
            </td>

  </tr>


</table>
      <div style="font-size: 10pt;"><br/>
      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

      </div>

      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">SIGNATURES</div>

      <div style="font-size: 10pt;">&#160;</div>

      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto
        duly authorized.</div>

      <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman';"> </span><span style="font-size: 10pt;"><br/>
        </span></div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000; border-spacing: 0;">


  <tr>

    <td style="width: 53%; vertical-align: top; font-size: 10pt;">&#160;</td>

    <td style="width: 47%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman';">BridgeBio Pharma, Inc.</div>
            </td>

  </tr>

  <tr>

    <td style="width: 53%; vertical-align: middle; font-size: 10pt;">&#160;</td>

    <td style="width: 47%; vertical-align: middle; font-size: 10pt;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 53%; vertical-align: top; font-size: 10pt; padding-bottom: 2px;">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Date: February 28, 2025</div>
            </td>

    <td style="width: 47%; vertical-align: top; font-size: 10pt; border-bottom: 2px solid rgb(0, 0, 0);">/s/ Neil Kumar, Ph.D.<br/>
            </td>

  </tr>

  <tr>

    <td style="width: 53%; vertical-align: top; font-size: 10pt;">&#160;</td>

    <td style="width: 47%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Neil Kumar, Ph.D.</div>
            </td>

  </tr>

  <tr>

    <td rowspan="1" style="width: 53%; vertical-align: top; font-size: 10pt;">&#160;</td>

    <td rowspan="1" style="width: 47%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Chief Executive Officer</div>
            </td>

  </tr>


</table>
      <div style="font-size: 10pt;"><br/>
      </div>

      <div style="font-size: 10pt;"><br/>
      </div>

      <div style="font-size: 10pt;">
        <hr style="height: 2px; color: #000000; background-color: #000000; text-align: center; border: none; margin-left: auto; margin-right: auto;"/></div>

    </div>

  </div>

  <div><span style="font-size: 10pt;"> </span></div>

</div>
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.1
<SEQUENCE>2
<FILENAME>ef20044715_ex4-1.htm
<DESCRIPTION>EXHIBIT 4.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc.
         Document created using Broadridge PROfile 25.1.1.5279
         Copyright 1995 - 2025 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <font style="font-size: 10pt;"> </font>
  <div>
    <div style="text-align: right; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 12pt; font-weight: bold;">
      <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"><font style="font-size: 10pt;">Exhibit 4.1</font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">Execution</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">BRIDGEBIO PHARMA, INC.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">AND</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION,</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">as Trustee</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">INDENTURE</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Dated as of February 28, 2025</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">1.75% Convertible Senior Notes due 2031</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <!--PROfilePageNumberReset%LCR%1%%%-->
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">TABLE OF CONTENTS</div>
    <div style="font-size: 10pt;">&#160;</div>
    <table cellspacing="0" cellpadding="0" border="0" id="zee7c6ee7ed554c5c87f9bcc966668cd2" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

        <tr>
          <td style="width: 15%; vertical-align: top; font-size: 10pt;">&#160;</td>
          <td style="width: 75%; vertical-align: top; font-size: 10pt;">&#160;</td>
          <td style="width: 10%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: right; font-family: 'Times New Roman'; font-weight: bold;">Page</div>
          </td>
        </tr>
        <tr>
          <td style="width: 15%; vertical-align: top; font-size: 10pt;" rowspan="1">&#160;</td>
          <td style="width: 75%; vertical-align: top; font-size: 10pt;" rowspan="1">&#160;</td>
          <td style="width: 10%; vertical-align: top; font-size: 10pt;" rowspan="1">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);" colspan="2">
            <div style="text-align: left; font-family: 'Times New Roman';">ARTICLE 1 DEFINITIONS</div>
          </td>
          <td style="width: 10%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: right; font-family: 'Times New Roman';">1</div>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top; font-size: 10pt;" colspan="2" rowspan="1">&#160;</td>
          <td style="width: 10%; vertical-align: top; font-size: 10pt;" rowspan="1">&#160;</td>
        </tr>
        <tr>
          <td style="width: 15%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: center; font-family: 'Times New Roman';">Section 1.01</div>
          </td>
          <td style="width: 75%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: left; font-family: 'Times New Roman';">Definitions</div>
          </td>
          <td style="width: 10%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: right; font-family: 'Times New Roman';">1</div>
          </td>
        </tr>
        <tr>
          <td style="width: 15%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: center; font-family: 'Times New Roman';">Section 1.02</div>
          </td>
          <td style="width: 75%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: left; font-family: 'Times New Roman';">References to Interest</div>
          </td>
          <td style="width: 10%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: right; font-family: 'Times New Roman';">14</div>
          </td>
        </tr>
        <tr>
          <td style="width: 15%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);" rowspan="1">&#160;</td>
          <td style="width: 75%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);" rowspan="1">&#160;</td>
          <td style="width: 10%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);" rowspan="1">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align: top; font-size: 10pt;" colspan="2">
            <div style="text-align: left; font-family: 'Times New Roman';">ARTICLE 2 ISSUE, DESCRIPTION, EXECUTION,&#160; REGISTRATION AND EXCHANGE OF NOTES</div>
          </td>
          <td style="width: 10%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: right; font-family: 'Times New Roman';">14</div>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);" colspan="2" rowspan="1">&#160;</td>
          <td style="width: 10%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);" rowspan="1">&#160;</td>
        </tr>
        <tr>
          <td style="width: 15%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: center; font-family: 'Times New Roman';">Section 2.01</div>
          </td>
          <td style="width: 75%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: left; font-family: 'Times New Roman';">Designation and Amount</div>
          </td>
          <td style="width: 10%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: right; font-family: 'Times New Roman';">14</div>
          </td>
        </tr>
        <tr>
          <td style="width: 15%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: center; font-family: 'Times New Roman';">Section 2.02</div>
          </td>
          <td style="width: 75%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: left; font-family: 'Times New Roman';">Form of Notes</div>
          </td>
          <td style="width: 10%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: right; font-family: 'Times New Roman';">15</div>
          </td>
        </tr>
        <tr>
          <td style="width: 15%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: center; font-family: 'Times New Roman';">Section 2.03</div>
          </td>
          <td style="width: 75%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: left; font-family: 'Times New Roman';">Date and Denomination of Notes; Payments of Interest and Defaulted Amounts</div>
          </td>
          <td style="width: 10%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: right; font-family: 'Times New Roman';">15</div>
          </td>
        </tr>
        <tr>
          <td style="width: 15%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: center; font-family: 'Times New Roman';">Section 2.04</div>
          </td>
          <td style="width: 75%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: left; font-family: 'Times New Roman';">Execution, Authentication and Delivery of Notes</div>
          </td>
          <td style="width: 10%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: right; font-family: 'Times New Roman';">17</div>
          </td>
        </tr>
        <tr>
          <td style="width: 15%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: center; font-family: 'Times New Roman';">Section 2.05</div>
          </td>
          <td style="width: 75%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: left; font-family: 'Times New Roman';">Exchange and Registration of Transfer of Notes; Restrictions on Transfer; Depositary</div>
          </td>
          <td style="width: 10%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: right; font-family: 'Times New Roman';">18</div>
          </td>
        </tr>
        <tr>
          <td style="width: 15%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: center; font-family: 'Times New Roman';">Section 2.06</div>
          </td>
          <td style="width: 75%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: left; font-family: 'Times New Roman';">Mutilated, Destroyed, Lost or Stolen Notes</div>
          </td>
          <td style="width: 10%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: right; font-family: 'Times New Roman';">24</div>
          </td>
        </tr>
        <tr>
          <td style="width: 15%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: center; font-family: 'Times New Roman';">Section 2.07</div>
          </td>
          <td style="width: 75%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: left; font-family: 'Times New Roman';">Temporary Notes</div>
          </td>
          <td style="width: 10%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: right; font-family: 'Times New Roman';">25</div>
          </td>
        </tr>
        <tr>
          <td style="width: 15%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: center; font-family: 'Times New Roman';">Section 2.08</div>
          </td>
          <td style="width: 75%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: left; font-family: 'Times New Roman';">Cancellation of Notes Paid, Converted, Etc</div>
          </td>
          <td style="width: 10%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: right; font-family: 'Times New Roman';">26</div>
          </td>
        </tr>
        <tr>
          <td style="width: 15%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: center; font-family: 'Times New Roman';">Section 2.09</div>
          </td>
          <td style="width: 75%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: left; font-family: 'Times New Roman';">CUSIP Numbers</div>
          </td>
          <td style="width: 10%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: right; font-family: 'Times New Roman';">26</div>
          </td>
        </tr>
        <tr>
          <td style="width: 15%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: center; font-family: 'Times New Roman';">Section 2.10</div>
          </td>
          <td style="width: 75%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: left; font-family: 'Times New Roman';">Additional Notes; Repurchases</div>
          </td>
          <td style="width: 10%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: right; font-family: 'Times New Roman';">26</div>
          </td>
        </tr>
        <tr>
          <td style="width: 15%; vertical-align: top; font-size: 10pt;" rowspan="1">&#160;</td>
          <td style="width: 75%; vertical-align: top; font-size: 10pt;" rowspan="1">&#160;</td>
          <td style="width: 10%; vertical-align: top; font-size: 10pt;" rowspan="1">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);" colspan="2">
            <div style="text-align: left; font-family: 'Times New Roman';">ARTICLE 3 SATISFACTION AND DISCHARGE</div>
          </td>
          <td style="width: 10%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: right; font-family: 'Times New Roman';">27</div>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top; font-size: 10pt;" colspan="2" rowspan="1">&#160;</td>
          <td style="width: 10%; vertical-align: top; font-size: 10pt;" rowspan="1">&#160;</td>
        </tr>
        <tr>
          <td style="width: 15%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: center; font-family: 'Times New Roman';">Section 3.01</div>
          </td>
          <td style="width: 75%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: left; font-family: 'Times New Roman';">Satisfaction and Discharge</div>
          </td>
          <td style="width: 10%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: right; font-family: 'Times New Roman';">27</div>
          </td>
        </tr>
        <tr>
          <td style="width: 15%; vertical-align: top; font-size: 10pt;" rowspan="1">&#160;</td>
          <td style="width: 75%; vertical-align: top; font-size: 10pt;" rowspan="1">&#160;</td>
          <td style="width: 10%; vertical-align: top; font-size: 10pt;" rowspan="1">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);" colspan="2">
            <div style="text-align: left; font-family: 'Times New Roman';">ARTICLE 4 PARTICULAR COVENANTS OF THE COMPANY</div>
          </td>
          <td style="width: 10%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: right; font-family: 'Times New Roman';">27</div>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top; font-size: 10pt;" colspan="2" rowspan="1">&#160;</td>
          <td style="width: 10%; vertical-align: top; font-size: 10pt;" rowspan="1">&#160;</td>
        </tr>
        <tr>
          <td style="width: 15%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: center; font-family: 'Times New Roman';">Section 4.01</div>
          </td>
          <td style="width: 75%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: left; font-family: 'Times New Roman';">Payment of Principal and Interest</div>
          </td>
          <td style="width: 10%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: right; font-family: 'Times New Roman';">27</div>
          </td>
        </tr>
        <tr>
          <td style="width: 15%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: center; font-family: 'Times New Roman';">Section 4.02</div>
          </td>
          <td style="width: 75%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: left; font-family: 'Times New Roman';">Maintenance of Office or Agency</div>
          </td>
          <td style="width: 10%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: right; font-family: 'Times New Roman';">27</div>
          </td>
        </tr>
        <tr>
          <td style="width: 15%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: center; font-family: 'Times New Roman';">Section 4.03</div>
          </td>
          <td style="width: 75%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: left; font-family: 'Times New Roman';">Appointments to Fill Vacancies in Trustee&#8217;s Office</div>
          </td>
          <td style="width: 10%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: right; font-family: 'Times New Roman';">28</div>
          </td>
        </tr>
        <tr>
          <td style="width: 15%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: center; font-family: 'Times New Roman';">Section 4.04</div>
          </td>
          <td style="width: 75%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: left; font-family: 'Times New Roman';">Provisions as to Paying Agent</div>
          </td>
          <td style="width: 10%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: right; font-family: 'Times New Roman';">28</div>
          </td>
        </tr>
        <tr>
          <td style="width: 15%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: center; font-family: 'Times New Roman';">Section 4.05</div>
          </td>
          <td style="width: 75%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: left; font-family: 'Times New Roman';">Existence</div>
          </td>
          <td style="width: 10%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: right; font-family: 'Times New Roman';">29</div>
          </td>
        </tr>
        <tr>
          <td style="width: 15%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: center; font-family: 'Times New Roman';">Section 4.06</div>
          </td>
          <td style="width: 75%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: left; font-family: 'Times New Roman';">Rule 144A Information Requirement and Annual Reports</div>
          </td>
          <td style="width: 10%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: right; font-family: 'Times New Roman';">29</div>
          </td>
        </tr>
        <tr>
          <td style="width: 15%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: center; font-family: 'Times New Roman';">Section 4.07</div>
          </td>
          <td style="width: 75%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: left; font-family: 'Times New Roman';">Stay, Extension and Usury Laws</div>
          </td>
          <td style="width: 10%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: right; font-family: 'Times New Roman';">33</div>
          </td>
        </tr>
        <tr>
          <td style="width: 15%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: center; font-family: 'Times New Roman';">Section 4.08</div>
          </td>
          <td style="width: 75%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: left; font-family: 'Times New Roman';">Compliance Certificate; Statements as to Defaults</div>
          </td>
          <td style="width: 10%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: right; font-family: 'Times New Roman';">33</div>
          </td>
        </tr>
        <tr>
          <td style="width: 15%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: center; font-family: 'Times New Roman';">Section 4.09</div>
          </td>
          <td style="width: 75%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: left; font-family: 'Times New Roman';">Further Instruments and Acts</div>
          </td>
          <td style="width: 10%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: right; font-family: 'Times New Roman';">33</div>
          </td>
        </tr>
        <tr>
          <td style="width: 15%; vertical-align: top; font-size: 10pt;" rowspan="1">&#160;</td>
          <td style="width: 75%; vertical-align: top; font-size: 10pt;" rowspan="1">&#160;</td>
          <td style="width: 10%; vertical-align: top; font-size: 10pt;" rowspan="1">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);" colspan="2">
            <div style="text-align: left; font-family: 'Times New Roman';">ARTICLE 5 LISTS OF HOLDERS AND REPORTS BY THE COMPANY AND THE TRUSTEE</div>
          </td>
          <td style="width: 10%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: right; font-family: 'Times New Roman';">33</div>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top; font-size: 10pt;" colspan="2" rowspan="1">&#160;</td>
          <td style="width: 10%; vertical-align: top; font-size: 10pt;" rowspan="1">&#160;</td>
        </tr>
        <tr>
          <td style="width: 15%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: center; font-family: 'Times New Roman';">Section 5.01</div>
          </td>
          <td style="width: 75%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: left; font-family: 'Times New Roman';">Lists of Holders</div>
          </td>
          <td style="width: 10%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: right; font-family: 'Times New Roman';">33</div>
          </td>
        </tr>
        <tr>
          <td style="width: 15%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: center; font-family: 'Times New Roman';">Section 5.02</div>
          </td>
          <td style="width: 75%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: left; font-family: 'Times New Roman';">Preservation and Disclosure of Lists</div>
          </td>
          <td style="width: 10%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: right; font-family: 'Times New Roman';">33</div>
          </td>
        </tr>

    </table>
    <div><font style="font-size: 10pt;"><br>
      </font> </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">i</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

        <tr>
          <td style="vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);" colspan="2">
            <div style="text-align: left; font-family: 'Times New Roman';">ARTICLE 6 DEFAULTS AND REMEDIES</div>
          </td>
          <td style="width: 10%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: right; font-family: 'Times New Roman';">34</div>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top; font-size: 10pt;" colspan="2" rowspan="1">&#160;</td>
          <td style="width: 10%; vertical-align: top; font-size: 10pt;" rowspan="1">&#160;</td>
        </tr>
        <tr>
          <td style="width: 15%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: center; font-family: 'Times New Roman';">Section 6.01</div>
          </td>
          <td style="width: 75%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: left; font-family: 'Times New Roman';">Events of Default</div>
          </td>
          <td style="width: 10%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: right; font-family: 'Times New Roman';">34</div>
          </td>
        </tr>
        <tr>
          <td style="width: 15%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: center; font-family: 'Times New Roman';">Section 6.02</div>
          </td>
          <td style="width: 75%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: left; font-family: 'Times New Roman';">Acceleration; Rescission and Annulment</div>
          </td>
          <td style="width: 10%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: right; font-family: 'Times New Roman';">35</div>
          </td>
        </tr>
        <tr>
          <td style="width: 15%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: center; font-family: 'Times New Roman';">Section 6.03</div>
          </td>
          <td style="width: 75%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: left; font-family: 'Times New Roman';">Additional Interest</div>
          </td>
          <td style="width: 10%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: right; font-family: 'Times New Roman';">37</div>
          </td>
        </tr>
        <tr>
          <td style="width: 15%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: center; font-family: 'Times New Roman';">Section 6.04</div>
          </td>
          <td style="width: 75%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: left; font-family: 'Times New Roman';">Payments of Notes on Default; Suit Therefor</div>
          </td>
          <td style="width: 10%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: right; font-family: 'Times New Roman';">37</div>
          </td>
        </tr>
        <tr>
          <td style="width: 15%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: center; font-family: 'Times New Roman';">Section 6.05</div>
          </td>
          <td style="width: 75%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: left; font-family: 'Times New Roman';">Application of Monies Collected by Trustee</div>
          </td>
          <td style="width: 10%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: right; font-family: 'Times New Roman';">39</div>
          </td>
        </tr>
        <tr>
          <td style="width: 15%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: center; font-family: 'Times New Roman';">Section 6.06</div>
          </td>
          <td style="width: 75%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: left; font-family: 'Times New Roman';">Proceedings by Holders</div>
          </td>
          <td style="width: 10%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: right; font-family: 'Times New Roman';">39</div>
          </td>
        </tr>
        <tr>
          <td style="width: 15%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: center; font-family: 'Times New Roman';">Section 6.07</div>
          </td>
          <td style="width: 75%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: left; font-family: 'Times New Roman';">Proceedings by Trustee</div>
          </td>
          <td style="width: 10%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: right; font-family: 'Times New Roman';">40</div>
          </td>
        </tr>
        <tr>
          <td style="width: 15%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: center; font-family: 'Times New Roman';">Section 6.08</div>
          </td>
          <td style="width: 75%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: left; font-family: 'Times New Roman';">Remedies Cumulative and Continuing</div>
          </td>
          <td style="width: 10%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: right; font-family: 'Times New Roman';">41</div>
          </td>
        </tr>
        <tr>
          <td style="width: 15%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: center; font-family: 'Times New Roman';">Section 6.09</div>
          </td>
          <td style="width: 75%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: left; font-family: 'Times New Roman';">Direction of Proceedings and Waiver of Defaults by Majority of Holders</div>
          </td>
          <td style="width: 10%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: right; font-family: 'Times New Roman';">41</div>
          </td>
        </tr>
        <tr>
          <td style="width: 15%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: center; font-family: 'Times New Roman';">Section 6.10</div>
          </td>
          <td style="width: 75%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: left; font-family: 'Times New Roman';">Notice of Defaults</div>
          </td>
          <td style="width: 10%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: right; font-family: 'Times New Roman';">42</div>
          </td>
        </tr>
        <tr>
          <td style="width: 15%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: center; font-family: 'Times New Roman';">Section 6.11</div>
          </td>
          <td style="width: 75%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: left; font-family: 'Times New Roman';">Undertaking to Pay Costs</div>
          </td>
          <td style="width: 10%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: right; font-family: 'Times New Roman';">42</div>
          </td>
        </tr>
        <tr>
          <td style="width: 15%; vertical-align: top; font-size: 10pt;" rowspan="1">&#160;</td>
          <td style="width: 75%; vertical-align: top; font-size: 10pt;" rowspan="1">&#160;</td>
          <td style="width: 10%; vertical-align: top; font-size: 10pt;" rowspan="1">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);" colspan="2">
            <div style="text-align: left; font-family: 'Times New Roman';">ARTICLE 7 CONCERNING THE TRUSTEE</div>
          </td>
          <td style="width: 10%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: right; font-family: 'Times New Roman';">42</div>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top; font-size: 10pt;" colspan="2" rowspan="1">&#160;</td>
          <td style="width: 10%; vertical-align: top; font-size: 10pt;" rowspan="1">&#160;</td>
        </tr>
        <tr>
          <td style="width: 15%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: center; font-family: 'Times New Roman';">Section 7.01</div>
          </td>
          <td style="width: 75%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: left; font-family: 'Times New Roman';">Duties and Responsibilities of Trustee</div>
          </td>
          <td style="width: 10%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: right; font-family: 'Times New Roman';">42</div>
          </td>
        </tr>
        <tr>
          <td style="width: 15%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: center; font-family: 'Times New Roman';">Section 7.02</div>
          </td>
          <td style="width: 75%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: left; font-family: 'Times New Roman';">Reliance on Documents, Opinions, Etc</div>
          </td>
          <td style="width: 10%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: right; font-family: 'Times New Roman';">44</div>
          </td>
        </tr>
        <tr>
          <td style="width: 15%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: center; font-family: 'Times New Roman';">Section 7.03</div>
          </td>
          <td style="width: 75%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: left; font-family: 'Times New Roman';">No Responsibility for Recitals, Etc</div>
          </td>
          <td style="width: 10%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: right; font-family: 'Times New Roman';">46</div>
          </td>
        </tr>
        <tr>
          <td style="width: 15%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: center; font-family: 'Times New Roman';">Section 7.04</div>
          </td>
          <td style="width: 75%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: left; font-family: 'Times New Roman';">Trustee, Paying Agents, Conversion Agents, Bid Solicitation Agent or Note Registrar May Own Notes</div>
          </td>
          <td style="width: 10%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: right; font-family: 'Times New Roman';">46</div>
          </td>
        </tr>
        <tr>
          <td style="width: 15%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: center; font-family: 'Times New Roman';">Section 7.05</div>
          </td>
          <td style="width: 75%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: left; font-family: 'Times New Roman';">Monies and Shares of Common Stock to Be Held in Trust</div>
          </td>
          <td style="width: 10%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: right; font-family: 'Times New Roman';">46</div>
          </td>
        </tr>
        <tr>
          <td style="width: 15%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: center; font-family: 'Times New Roman';">Section 7.06</div>
          </td>
          <td style="width: 75%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: left; font-family: 'Times New Roman';">Compensation and Expenses of Trustee</div>
          </td>
          <td style="width: 10%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: right; font-family: 'Times New Roman';">46</div>
          </td>
        </tr>
        <tr>
          <td style="width: 15%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: center; font-family: 'Times New Roman';">Section 7.07</div>
          </td>
          <td style="width: 75%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: left; font-family: 'Times New Roman';">Officer&#8217;s Certificate as Evidence</div>
          </td>
          <td style="width: 10%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: right; font-family: 'Times New Roman';">47</div>
          </td>
        </tr>
        <tr>
          <td style="width: 15%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: center; font-family: 'Times New Roman';">Section 7.08</div>
          </td>
          <td style="width: 75%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: left; font-family: 'Times New Roman';">Eligibility of Trustee</div>
          </td>
          <td style="width: 10%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: right; font-family: 'Times New Roman';">47</div>
          </td>
        </tr>
        <tr>
          <td style="width: 15%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: center; font-family: 'Times New Roman';">Section 7.09</div>
          </td>
          <td style="width: 75%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: left; font-family: 'Times New Roman';">Resignation or Removal of Trustee</div>
          </td>
          <td style="width: 10%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: right; font-family: 'Times New Roman';">47</div>
          </td>
        </tr>
        <tr>
          <td style="width: 15%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: center; font-family: 'Times New Roman';">Section 7.10</div>
          </td>
          <td style="width: 75%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: left; font-family: 'Times New Roman';">Acceptance by Successor Trustee</div>
          </td>
          <td style="width: 10%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: right; font-family: 'Times New Roman';">48</div>
          </td>
        </tr>
        <tr>
          <td style="width: 15%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: center; font-family: 'Times New Roman';">Section 7.11</div>
          </td>
          <td style="width: 75%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: left; font-family: 'Times New Roman';">Succession by Merger, Etc.</div>
          </td>
          <td style="width: 10%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: right; font-family: 'Times New Roman';">49</div>
          </td>
        </tr>
        <tr>
          <td style="width: 15%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: center; font-family: 'Times New Roman';">Section 7.12</div>
          </td>
          <td style="width: 75%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: left; font-family: 'Times New Roman';">Trustee&#8217;s Application for Instructions from the Company</div>
          </td>
          <td style="width: 10%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: right; font-family: 'Times New Roman';">49</div>
          </td>
        </tr>
        <tr>
          <td style="width: 15%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);" rowspan="1">&#160;</td>
          <td style="width: 75%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);" rowspan="1">&#160;</td>
          <td style="width: 10%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);" rowspan="1">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align: top; font-size: 10pt;" colspan="2">
            <div style="text-align: left; font-family: 'Times New Roman';">ARTICLE 8 CONCERNING THE HOLDERS</div>
          </td>
          <td style="width: 10%; vertical-align: top; font-size: 10pt; text-align: right;">50</td>
        </tr>
        <tr>
          <td style="vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);" colspan="2" rowspan="1">&#160;</td>
          <td style="width: 10%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);" rowspan="1">&#160;</td>
        </tr>
        <tr>
          <td style="width: 15%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: center; font-family: 'Times New Roman';">Section 8.01</div>
          </td>
          <td style="width: 75%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: left; font-family: 'Times New Roman';">Action by Holders</div>
          </td>
          <td style="width: 10%; vertical-align: top; font-size: 10pt; text-align: right;">50</td>
        </tr>
        <tr>
          <td style="width: 15%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: center; font-family: 'Times New Roman';">Section 8.02</div>
          </td>
          <td style="width: 75%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: left; font-family: 'Times New Roman';">Proof of Execution by Holders</div>
          </td>
          <td style="width: 10%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: right; font-family: 'Times New Roman';">50</div>
          </td>
        </tr>
        <tr>
          <td style="width: 15%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: center; font-family: 'Times New Roman';">Section 8.03</div>
          </td>
          <td style="width: 75%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: left; font-family: 'Times New Roman';">Who Are Deemed Absolute Owners</div>
          </td>
          <td style="width: 10%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: right; font-family: 'Times New Roman';">50</div>
          </td>
        </tr>
        <tr>
          <td style="width: 15%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: center; font-family: 'Times New Roman';">Section 8.04</div>
          </td>
          <td style="width: 75%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: left; font-family: 'Times New Roman';">Company-Owned Notes Disregarded</div>
          </td>
          <td style="width: 10%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: right; font-family: 'Times New Roman';">51</div>
          </td>
        </tr>
        <tr>
          <td style="width: 15%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: center; font-family: 'Times New Roman';">Section 8.05</div>
          </td>
          <td style="width: 75%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: left; font-family: 'Times New Roman';">Revocation of Consents; Future Holders Bound</div>
          </td>
          <td style="width: 10%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: right; font-family: 'Times New Roman';">51</div>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);" colspan="2">
            <div style="text-align: left; font-family: 'Times New Roman';">ARTICLE 9 HOLDERS&#8217; MEETINGS</div>
          </td>
          <td style="width: 10%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: right; font-family: 'Times New Roman';">51</div>
          </td>
        </tr>
        <tr>
          <td style="width: 15%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: center; font-family: 'Times New Roman';">Section 9.01</div>
          </td>
          <td style="width: 75%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: left; font-family: 'Times New Roman';">Purpose of Meetings</div>
          </td>
          <td style="width: 10%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: right; font-family: 'Times New Roman';">51</div>
          </td>
        </tr>
        <tr>
          <td style="width: 15%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: center; font-family: 'Times New Roman';">Section 9.02</div>
          </td>
          <td style="width: 75%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: left; font-family: 'Times New Roman';">Call of Meetings by Trustee</div>
          </td>
          <td style="width: 10%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: right; font-family: 'Times New Roman';">52</div>
          </td>
        </tr>
        <tr>
          <td style="width: 15%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: center; font-family: 'Times New Roman';">Section 9.03</div>
          </td>
          <td style="width: 75%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: left; font-family: 'Times New Roman';">Call of Meetings by Company or Holders</div>
          </td>
          <td style="width: 10%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: right; font-family: 'Times New Roman';">52</div>
          </td>
        </tr>
        <tr>
          <td style="width: 15%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: center; font-family: 'Times New Roman';">Section 9.04</div>
          </td>
          <td style="width: 75%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: left; font-family: 'Times New Roman';">Qualifications for Voting</div>
          </td>
          <td style="width: 10%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: right; font-family: 'Times New Roman';">52</div>
          </td>
        </tr>
        <tr>
          <td style="width: 15%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: center; font-family: 'Times New Roman';">Section 9.05</div>
          </td>
          <td style="width: 75%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: left; font-family: 'Times New Roman';">Regulations</div>
          </td>
          <td style="width: 10%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: right; font-family: 'Times New Roman';">53</div>
          </td>
        </tr>
        <tr>
          <td style="width: 15%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: center; font-family: 'Times New Roman';">Section 9.06</div>
          </td>
          <td style="width: 75%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: left; font-family: 'Times New Roman';">Voting</div>
          </td>
          <td style="width: 10%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: right; font-family: 'Times New Roman';">53</div>
          </td>
        </tr>

    </table>
    <div><font style="font-size: 10pt;"><br>
      </font> </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">ii</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

        <tr>
          <td style="width: 15%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: center; font-family: 'Times New Roman';">Section 9.07</div>
          </td>
          <td style="width: 75%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: left; font-family: 'Times New Roman';">No Delay of Rights by Meeting</div>
          </td>
          <td style="width: 10%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: right; font-family: 'Times New Roman';">53</div>
          </td>
        </tr>
        <tr>
          <td style="width: 15%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);" rowspan="1">&#160;</td>
          <td style="width: 75%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);" rowspan="1">&#160;</td>
          <td style="width: 10%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);" rowspan="1">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align: top; font-size: 10pt;" colspan="2">
            <div style="text-align: left; font-family: 'Times New Roman';">ARTICLE 10 SUPPLEMENTAL INDENTURES</div>
          </td>
          <td style="width: 10%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: right; font-family: 'Times New Roman';">54</div>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);" colspan="2" rowspan="1">&#160;</td>
          <td style="width: 10%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);" rowspan="1">&#160;</td>
        </tr>
        <tr>
          <td style="width: 15%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: center; font-family: 'Times New Roman';">Section 10.01</div>
          </td>
          <td style="width: 75%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: left; font-family: 'Times New Roman';">Supplemental Indentures Without Consent of Holders</div>
          </td>
          <td style="width: 10%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: right; font-family: 'Times New Roman';">54</div>
          </td>
        </tr>
        <tr>
          <td style="width: 15%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: center; font-family: 'Times New Roman';">Section 10.02</div>
          </td>
          <td style="width: 75%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: left; font-family: 'Times New Roman';">Supplemental Indentures with Consent of Holders</div>
          </td>
          <td style="width: 10%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: right; font-family: 'Times New Roman';">55</div>
          </td>
        </tr>
        <tr>
          <td style="width: 15%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: center; font-family: 'Times New Roman';">Section 10.03</div>
          </td>
          <td style="width: 75%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: left; font-family: 'Times New Roman';">Effect of Supplemental Indentures</div>
          </td>
          <td style="width: 10%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: right; font-family: 'Times New Roman';">56</div>
          </td>
        </tr>
        <tr>
          <td style="width: 15%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: center; font-family: 'Times New Roman';">Section 10.04</div>
          </td>
          <td style="width: 75%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: left; font-family: 'Times New Roman';">Notation on Notes</div>
          </td>
          <td style="width: 10%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: right; font-family: 'Times New Roman';">56</div>
          </td>
        </tr>
        <tr>
          <td style="width: 15%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: center; font-family: 'Times New Roman';">Section 10.05</div>
          </td>
          <td style="width: 75%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: left; font-family: 'Times New Roman';">Evidence of Compliance of Supplemental Indenture to Be Furnished Trustee</div>
          </td>
          <td style="width: 10%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: right; font-family: 'Times New Roman';">56</div>
          </td>
        </tr>
        <tr>
          <td style="width: 15%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);" rowspan="1">&#160;</td>
          <td style="width: 75%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);" rowspan="1">&#160;</td>
          <td style="width: 10%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);" rowspan="1">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align: top; font-size: 10pt;" colspan="2">
            <div style="text-align: left; font-family: 'Times New Roman';">ARTICLE 11 CONSOLIDATION, MERGER, SALE, CONVEYANCE AND LEASE</div>
          </td>
          <td style="width: 10%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: right; font-family: 'Times New Roman';">57</div>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);" colspan="2" rowspan="1">&#160;</td>
          <td style="width: 10%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);" rowspan="1">&#160;</td>
        </tr>
        <tr>
          <td style="width: 15%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: center; font-family: 'Times New Roman';">Section 11.01</div>
          </td>
          <td style="width: 75%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: left; font-family: 'Times New Roman';">Company May Consolidate, Etc. on Certain Terms</div>
          </td>
          <td style="width: 10%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: right; font-family: 'Times New Roman';">57</div>
          </td>
        </tr>
        <tr>
          <td style="width: 15%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: center; font-family: 'Times New Roman';">Section 11.02</div>
          </td>
          <td style="width: 75%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: left; font-family: 'Times New Roman';">Successor Corporation to Be Substituted</div>
          </td>
          <td style="width: 10%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: right; font-family: 'Times New Roman';">57</div>
          </td>
        </tr>
        <tr>
          <td style="width: 15%; vertical-align: top; font-size: 10pt;" rowspan="1">&#160;</td>
          <td style="width: 75%; vertical-align: top; font-size: 10pt;" rowspan="1">&#160;</td>
          <td style="width: 10%; vertical-align: top; font-size: 10pt;" rowspan="1">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);" colspan="2">
            <div style="text-align: left; font-family: 'Times New Roman';">ARTICLE 12 IMMUNITY OF INCORPORATORS, STOCKHOLDERS, OFFICERS AND DIRECTORS</div>
          </td>
          <td style="width: 10%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: right; font-family: 'Times New Roman';">58</div>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top; font-size: 10pt;" colspan="2" rowspan="1">&#160;</td>
          <td style="width: 10%; vertical-align: top; font-size: 10pt;" rowspan="1">&#160;</td>
        </tr>
        <tr>
          <td style="width: 15%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: center; font-family: 'Times New Roman';">Section 12.01</div>
          </td>
          <td style="width: 75%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: left; font-family: 'Times New Roman';">Indenture and Notes Solely Corporate Obligations</div>
          </td>
          <td style="width: 10%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: right; font-family: 'Times New Roman';">58</div>
          </td>
        </tr>
        <tr>
          <td style="width: 15%; vertical-align: top; font-size: 10pt;" rowspan="1">&#160;</td>
          <td style="width: 75%; vertical-align: top; font-size: 10pt;" rowspan="1">&#160;</td>
          <td style="width: 10%; vertical-align: top; font-size: 10pt;" rowspan="1">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);" colspan="2">
            <div style="text-align: left; font-family: 'Times New Roman';">ARTICLE 13 [INTENTIONALLY OMITTED]</div>
          </td>
          <td style="width: 10%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: right; font-family: 'Times New Roman';">58</div>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top; font-size: 10pt;" colspan="2" rowspan="1">&#160;</td>
          <td style="width: 10%; vertical-align: top; font-size: 10pt;" rowspan="1">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);" colspan="2">
            <div style="text-align: left; font-family: 'Times New Roman';">ARTICLE 14 CONVERSION OF NOTES</div>
          </td>
          <td style="width: 10%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: right; font-family: 'Times New Roman';">58</div>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top; font-size: 10pt;" colspan="2" rowspan="1">&#160;</td>
          <td style="width: 10%; vertical-align: top; font-size: 10pt;" rowspan="1">&#160;</td>
        </tr>
        <tr>
          <td style="width: 15%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: center; font-family: 'Times New Roman';">Section 14.01</div>
          </td>
          <td style="width: 75%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: left; font-family: 'Times New Roman';">Conversion Privilege</div>
          </td>
          <td style="width: 10%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: right; font-family: 'Times New Roman';">58</div>
          </td>
        </tr>
        <tr>
          <td style="width: 15%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: center; font-family: 'Times New Roman';">Section 14.02</div>
          </td>
          <td style="width: 75%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: left; font-family: 'Times New Roman';">Conversion Procedure; Settlement Upon Conversion</div>
          </td>
          <td style="width: 10%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: right; font-family: 'Times New Roman';">62</div>
          </td>
        </tr>
        <tr>
          <td style="width: 15%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: center; font-family: 'Times New Roman';">Section 14.03</div>
          </td>
          <td style="width: 75%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: left; font-family: 'Times New Roman';">Increased Conversion Rate Applicable to Certain Notes Surrendered in Connection with Make-Whole Fundamental Changes or a Notice of Redemption</div>
          </td>
          <td style="width: 10%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: right; font-family: 'Times New Roman';">67</div>
          </td>
        </tr>
        <tr>
          <td style="width: 15%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: center; font-family: 'Times New Roman';">Section 14.04</div>
          </td>
          <td style="width: 75%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: left; font-family: 'Times New Roman';">Adjustment of Conversion Rate</div>
          </td>
          <td style="width: 10%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: right; font-family: 'Times New Roman';">69</div>
          </td>
        </tr>
        <tr>
          <td style="width: 15%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: center; font-family: 'Times New Roman';">Section 14.05</div>
          </td>
          <td style="width: 75%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: left; font-family: 'Times New Roman';">Adjustments of Prices</div>
          </td>
          <td style="width: 10%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: right; font-family: 'Times New Roman';">78</div>
          </td>
        </tr>
        <tr>
          <td style="width: 15%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: center; font-family: 'Times New Roman';">Section 14.06</div>
          </td>
          <td style="width: 75%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: left; font-family: 'Times New Roman';">Shares to Be Fully Paid</div>
          </td>
          <td style="width: 10%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: right; font-family: 'Times New Roman';">78</div>
          </td>
        </tr>
        <tr>
          <td style="width: 15%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: center; font-family: 'Times New Roman';">Section 14.07</div>
          </td>
          <td style="width: 75%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: left; font-family: 'Times New Roman';">Effect of Recapitalizations, Reclassifications and Changes of the Common Stock</div>
          </td>
          <td style="width: 10%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: right; font-family: 'Times New Roman';">79</div>
          </td>
        </tr>
        <tr>
          <td style="width: 15%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: center; font-family: 'Times New Roman';">Section 14.08</div>
          </td>
          <td style="width: 75%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: left; font-family: 'Times New Roman';">Certain Covenants</div>
          </td>
          <td style="width: 10%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: right; font-family: 'Times New Roman';">81</div>
          </td>
        </tr>
        <tr>
          <td style="width: 15%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: center; font-family: 'Times New Roman';">Section 14.09</div>
          </td>
          <td style="width: 75%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: left; font-family: 'Times New Roman';">Responsibility of Trustee</div>
          </td>
          <td style="width: 10%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: right; font-family: 'Times New Roman';">81</div>
          </td>
        </tr>
        <tr>
          <td style="width: 15%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: center; font-family: 'Times New Roman';">Section 14.10</div>
          </td>
          <td style="width: 75%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: left; font-family: 'Times New Roman';">Notice to Holders Prior to Certain Actions</div>
          </td>
          <td style="width: 10%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: right; font-family: 'Times New Roman';">82</div>
          </td>
        </tr>
        <tr>
          <td style="width: 15%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: center; font-family: 'Times New Roman';">Section 14.11</div>
          </td>
          <td style="width: 75%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: left; font-family: 'Times New Roman';">Stockholder Rights Plans</div>
          </td>
          <td style="width: 10%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: right; font-family: 'Times New Roman';">82</div>
          </td>
        </tr>
        <tr>
          <td style="width: 15%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: center; font-family: 'Times New Roman';">Section 14.12</div>
          </td>
          <td style="width: 75%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: left; font-family: 'Times New Roman';">Exchange in Lieu of Conversion</div>
          </td>
          <td style="width: 10%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: right; font-family: 'Times New Roman';">83</div>
          </td>
        </tr>
        <tr>
          <td style="width: 15%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);" rowspan="1">&#160;</td>
          <td style="width: 75%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);" rowspan="1">&#160;</td>
          <td style="width: 10%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);" rowspan="1">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align: top; font-size: 10pt;" colspan="2">
            <div style="text-align: left; font-family: 'Times New Roman';">ARTICLE 15 REPURCHASE OF NOTES AT OPTION OF HOLDERS</div>
          </td>
          <td style="width: 10%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: right; font-family: 'Times New Roman';">83</div>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);" colspan="2" rowspan="1">&#160;</td>
          <td style="width: 10%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);" rowspan="1">&#160;</td>
        </tr>
        <tr>
          <td style="width: 15%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: center; font-family: 'Times New Roman';">Section 15.01</div>
          </td>
          <td style="width: 75%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: left; font-family: 'Times New Roman';">[Intentionally Omitted]</div>
          </td>
          <td style="width: 10%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: right; font-family: 'Times New Roman';">83</div>
          </td>
        </tr>
        <tr>
          <td style="width: 15%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: center; font-family: 'Times New Roman';">Section 15.02</div>
          </td>
          <td style="width: 75%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: left; font-family: 'Times New Roman';">Repurchase at Option of Holders Upon a Fundamental Change</div>
          </td>
          <td style="width: 10%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: right; font-family: 'Times New Roman';">83</div>
          </td>
        </tr>
        <tr>
          <td style="width: 15%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: center; font-family: 'Times New Roman';">Section 15.03</div>
          </td>
          <td style="width: 75%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: left; font-family: 'Times New Roman';">Withdrawal of Fundamental Change Repurchase Notice</div>
          </td>
          <td style="width: 10%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: right; font-family: 'Times New Roman';">86</div>
          </td>
        </tr>
        <tr>
          <td style="width: 15%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: center; font-family: 'Times New Roman';">Section 15.04</div>
          </td>
          <td style="width: 75%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: left; font-family: 'Times New Roman';">Deposit of Fundamental Change Repurchase Price</div>
          </td>
          <td style="width: 10%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: right; font-family: 'Times New Roman';">87</div>
          </td>
        </tr>

    </table>
    <div><font style="font-size: 10pt;"><br>
      </font> </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">iii</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

        <tr>
          <td style="width: 15%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: center; font-family: 'Times New Roman';">Section 15.05</div>
          </td>
          <td style="width: 75%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: left; font-family: 'Times New Roman';">Covenant to Comply with Applicable Laws Upon Repurchase of Notes</div>
          </td>
          <td style="width: 10%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: right; font-family: 'Times New Roman';">87</div>
          </td>
        </tr>
        <tr>
          <td style="width: 15%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);" rowspan="1">&#160;</td>
          <td style="width: 75%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);" rowspan="1">&#160;</td>
          <td style="width: 10%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);" rowspan="1">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align: top; font-size: 10pt;" colspan="2">
            <div style="text-align: left; font-family: 'Times New Roman';">ARTICLE 16 OPTIONAL REDEMPTION</div>
          </td>
          <td style="width: 10%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: right; font-family: 'Times New Roman';">88</div>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);" colspan="2" rowspan="1">&#160;</td>
          <td style="width: 10%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);" rowspan="1">&#160;</td>
        </tr>
        <tr>
          <td style="width: 15%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: center; font-family: 'Times New Roman';">Section 16.01</div>
          </td>
          <td style="width: 75%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: left; font-family: 'Times New Roman';">Optional Redemption</div>
          </td>
          <td style="width: 10%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: right; font-family: 'Times New Roman';">88</div>
          </td>
        </tr>
        <tr>
          <td style="width: 15%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: center; font-family: 'Times New Roman';">Section 16.02</div>
          </td>
          <td style="width: 75%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: left; font-family: 'Times New Roman';">Notice of Optional Redemption; Selection of Notes</div>
          </td>
          <td style="width: 10%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: right; font-family: 'Times New Roman';">88</div>
          </td>
        </tr>
        <tr>
          <td style="width: 15%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: center; font-family: 'Times New Roman';">Section 16.03</div>
          </td>
          <td style="width: 75%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: left; font-family: 'Times New Roman';">Payment of Notes Called for Redemption</div>
          </td>
          <td style="width: 10%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: right; font-family: 'Times New Roman';">90</div>
          </td>
        </tr>
        <tr>
          <td style="width: 15%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: center; font-family: 'Times New Roman';">Section 16.04</div>
          </td>
          <td style="width: 75%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: left; font-family: 'Times New Roman';">Restrictions on Redemption</div>
          </td>
          <td style="width: 10%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: right; font-family: 'Times New Roman';">90</div>
          </td>
        </tr>
        <tr>
          <td style="width: 15%; vertical-align: top; font-size: 10pt;" rowspan="1">&#160;</td>
          <td style="width: 75%; vertical-align: top; font-size: 10pt;" rowspan="1">&#160;</td>
          <td style="width: 10%; vertical-align: top; font-size: 10pt;" rowspan="1">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);" colspan="2">
            <div style="text-align: left; font-family: 'Times New Roman';">ARTICLE 17 MISCELLANEOUS PROVISIONS</div>
          </td>
          <td style="width: 10%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: right; font-family: 'Times New Roman';">91</div>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top; font-size: 10pt;" colspan="2" rowspan="1">&#160;</td>
          <td style="width: 10%; vertical-align: top; font-size: 10pt;" rowspan="1">&#160;</td>
        </tr>
        <tr>
          <td style="width: 15%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: center; font-family: 'Times New Roman';">Section 17.01</div>
          </td>
          <td style="width: 75%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: left; font-family: 'Times New Roman';">Provisions Binding on Company&#8217;s Successors</div>
          </td>
          <td style="width: 10%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255); text-align: right;">91</td>
        </tr>
        <tr>
          <td style="width: 15%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: center; font-family: 'Times New Roman';">Section 17.02</div>
          </td>
          <td style="width: 75%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: left; font-family: 'Times New Roman';">Official Acts by Successor Corporation</div>
          </td>
          <td style="width: 10%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: right; font-family: 'Times New Roman';">91</div>
          </td>
        </tr>
        <tr>
          <td style="width: 15%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: center; font-family: 'Times New Roman';">Section 17.03</div>
          </td>
          <td style="width: 75%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: left; font-family: 'Times New Roman';">Addresses for Notices, Etc</div>
          </td>
          <td style="width: 10%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255); text-align: right;">91</td>
        </tr>
        <tr>
          <td style="width: 15%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: center; font-family: 'Times New Roman';">Section 17.04</div>
          </td>
          <td style="width: 75%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: left; font-family: 'Times New Roman';">Governing Law; Jurisdiction</div>
          </td>
          <td style="width: 10%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: right; font-family: 'Times New Roman';">92</div>
          </td>
        </tr>
        <tr>
          <td style="width: 15%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: center; font-family: 'Times New Roman';">Section 17.05</div>
          </td>
          <td style="width: 75%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: left; font-family: 'Times New Roman';">Evidence of Compliance with Conditions Precedent; Certificates and Opinions of Counsel to Trustee</div>
          </td>
          <td style="width: 10%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: right; font-family: 'Times New Roman';">92</div>
          </td>
        </tr>
        <tr>
          <td style="width: 15%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: center; font-family: 'Times New Roman';">Section 17.06</div>
          </td>
          <td style="width: 75%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: left; font-family: 'Times New Roman';">Legal Holidays</div>
          </td>
          <td style="width: 10%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: right; font-family: 'Times New Roman';">93</div>
          </td>
        </tr>
        <tr>
          <td style="width: 15%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: center; font-family: 'Times New Roman';">Section 17.07</div>
          </td>
          <td style="width: 75%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: left; font-family: 'Times New Roman';">No Security Interest Created</div>
          </td>
          <td style="width: 10%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255); text-align: right;">93</td>
        </tr>
        <tr>
          <td style="width: 15%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: center; font-family: 'Times New Roman';">Section 17.08</div>
          </td>
          <td style="width: 75%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: left; font-family: 'Times New Roman';">Benefits of Indenture</div>
          </td>
          <td style="width: 10%; vertical-align: top; font-size: 10pt; text-align: right;">93</td>
        </tr>
        <tr>
          <td style="width: 15%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: center; font-family: 'Times New Roman';">Section 17.09</div>
          </td>
          <td style="width: 75%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: left; font-family: 'Times New Roman';">Table of Contents, Headings, Etc.</div>
          </td>
          <td style="width: 10%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255); text-align: right;">93</td>
        </tr>
        <tr>
          <td style="width: 15%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: center; font-family: 'Times New Roman';">Section 17.10</div>
          </td>
          <td style="width: 75%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: left; font-family: 'Times New Roman';">Authenticating Agent</div>
          </td>
          <td style="width: 10%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: right; font-family: 'Times New Roman';">93</div>
          </td>
        </tr>
        <tr>
          <td style="width: 15%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: center; font-family: 'Times New Roman';">Section 17.11</div>
          </td>
          <td style="width: 75%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: left; font-family: 'Times New Roman';">Execution in Counterparts</div>
          </td>
          <td style="width: 10%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: right; font-family: 'Times New Roman';">94</div>
          </td>
        </tr>
        <tr>
          <td style="width: 15%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: center; font-family: 'Times New Roman';">Section 17.12</div>
          </td>
          <td style="width: 75%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: left; font-family: 'Times New Roman';">Severability</div>
          </td>
          <td style="width: 10%; vertical-align: top; font-size: 10pt; text-align: right;">95</td>
        </tr>
        <tr>
          <td style="width: 15%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: center; font-family: 'Times New Roman';">Section 17.13</div>
          </td>
          <td style="width: 75%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: left; font-family: 'Times New Roman';">Waiver of Jury Trial</div>
          </td>
          <td style="width: 10%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255); text-align: right;">95</td>
        </tr>
        <tr>
          <td style="width: 15%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: center; font-family: 'Times New Roman';">Section 17.14</div>
          </td>
          <td style="width: 75%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: left; font-family: 'Times New Roman';">Force Majeure</div>
          </td>
          <td style="width: 10%; vertical-align: top; font-size: 10pt; text-align: right;">95</td>
        </tr>
        <tr>
          <td style="width: 15%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: center; font-family: 'Times New Roman';">Section 17.15</div>
          </td>
          <td style="width: 75%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: left; font-family: 'Times New Roman';">Calculations</div>
          </td>
          <td style="width: 10%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255); text-align: right;">95</td>
        </tr>
        <tr>
          <td style="width: 15%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: center; font-family: 'Times New Roman';">Section 17.16</div>
          </td>
          <td style="width: 75%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: left; font-family: 'Times New Roman';">USA PATRIOT Act</div>
          </td>
          <td style="width: 10%; vertical-align: top; font-size: 10pt; text-align: right;">95</td>
        </tr>

    </table>
    <div style="font-size: 10pt;"><br>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">iv</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <!--PROfilePageNumberReset%Num%1%%%-->
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">INDENTURE dated as of February 28, 2025 between BRIDGEBIO PHARMA, INC., a Delaware corporation, as issuer (the &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Company</font>,&#8221; as more fully set forth in <font style="font-family: 'Times New Roman';"><u>Section&#160;1.01</u></font>) and U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, as trustee (the &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Trustee</font>,&#8221; as more fully set forth in <font style="font-family: 'Times New Roman';"><u>Section&#160;1.01</u></font>).</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">W I T N E S S E T H:</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">WHEREAS</font><font style="font-size: 10pt;">, for its lawful corporate
        purposes, the Company has duly authorized the issuance of its 1.75% Convertible Senior Notes due 2031 (the &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Notes</font>&#8221;), initially in an aggregate principal amount not to exceed
        $575,000,000, and in order to provide the terms and conditions upon which the Notes are to be authenticated, issued and delivered, the Company has duly authorized the execution and delivery of this Indenture; and</font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">WHEREAS</font><font style="font-size: 10pt;">, the Form of Note, the
        certificate of authentication to be borne by each Note, the Form of Notice of Conversion, the Form of Fundamental Change Repurchase Notice and the Form of Assignment and Transfer to be borne by the Notes are to be substantially in the forms
        hereinafter provided; and</font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">WHEREAS</font><font style="font-size: 10pt;">, all acts and things
        necessary to make the Notes, when executed by the Company and authenticated and delivered by the Trustee or a duly authorized authenticating agent, as in this Indenture provided, the valid, binding and legal obligations of the Company, and this
        Indenture a valid agreement according to its terms, have been done and performed, and the execution of this Indenture and the issuance hereunder of the Notes have in all respects been duly authorized.</font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">NOW, THEREFORE, THIS INDENTURE WITNESSETH:</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">That in order to declare the terms and conditions upon which the Notes are, and are to be, authenticated, issued and delivered, and in consideration of
      the premises and of the purchase and acceptance of the Notes by the Holders thereof, the Company covenants and agrees with the Trustee for the equal and proportionate benefit of the respective Holders from time to time of the Notes (except as
      otherwise provided below), as follows:</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">ARTICLE 1<font style="font-family: 'Times New Roman';"><br>
      </font><a name="z_Toc62469660"></a>DEFINITIONS</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">Section 1.01</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><a name="z_Toc62469661"></a><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><u>Definitions</u></font><font style="font-family: 'Times New Roman'; font-style: italic;">.&#160; </font>The terms defined in this <font style="font-family: 'Times New Roman';"><u>Section&#160;1.01</u></font>
          (except as herein otherwise expressly provided or unless the context otherwise requires) for all purposes of this Indenture and of any indenture supplemental hereto shall have the respective meanings specified in this <font style="font-family: 'Times New Roman';"><u>Section&#160;1.01</u></font>.&#160; The words &#8220;herein,&#8221; &#8220;hereof,&#8221; &#8220;hereunder&#8221; and words of similar import refer to this Indenture as a whole and not to any particular Article, Section or other subdivision.&#160; The terms defined in
          this Article include the plural as well as the singular.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="font-size: 10pt; margin-left: 36pt;"><font style="font-family: 'Times New Roman';">&#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Additional Interest</font>&#8221; means all amounts, if any, payable pursuant to <font style="font-family: 'Times New Roman';"><u>Section&#160;4.06(c)</u></font>, <font style="font-family: 'Times New Roman';"><u>Section&#160;4.06(d)</u></font> and <font style="font-family: 'Times New Roman';"><u>Section&#160;6.03</u></font>, as applicable.</font></div>
    <div style="font-size: 10pt; margin-left: 36pt;">&#160;</div>
    <div style="font-size: 10pt; margin-left: 36pt;"><font style="font-family: 'Times New Roman';">&#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Additional Shares</font>&#8221; shall have the meaning specified in <font style="font-family: 'Times New Roman';"><u>Section&#160;14.03(a)</u></font>.</font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">1</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <!--PROfilePageNumberReset%Num%2%%%-->
    <div style="text-indent: 36pt; font-size: 10pt;"><font style="font-family: 'Times New Roman';">&#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Affiliate</font>&#8221; of any specified Person means any other Person directly or indirectly
        controlling or controlled by or under direct or indirect common control with such specified Person.&#160; For the purposes of this definition, &#8220;control,&#8221; when used with respect to any specified Person means the power to direct or cause the direction of
        the management and policies of such Person, directly or indirectly, whether through the ownership of voting securities, by contract or otherwise; and the terms &#8220;controlling&#8221; and &#8220;controlled&#8221; have meanings correlative to the foregoing.&#160;
        Notwithstanding anything to the contrary herein, the determination of whether one Person is an &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Affiliate</font>&#8221; of another Person for purposes of this Indenture shall be made based
        on the facts at the time such determination is made or required to be made, as the case may be, hereunder.</font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="font-size: 10pt; text-indent: 36pt;"><font style="font-family: 'Times New Roman';">&#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Bid Solicitation Agent</font>&#8221; means the Company or the Person appointed by the Company to
        solicit bids for the Trading Price of the Notes in accordance with <font style="font-family: 'Times New Roman';"><u>Section&#160;14.01(b)(i)</u></font>.&#160; The Company shall initially act as the Bid Solicitation Agent.</font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt; font-size: 10pt;"><font style="font-family: 'Times New Roman';">&#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Board of Directors</font>&#8221; means the board of directors (or the functional equivalent
        thereof) of the Company or any duly authorized committee of such board.</font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt; font-size: 10pt;"><font style="font-family: 'Times New Roman';">&#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Board Resolution</font>&#8221; means a copy of a resolution certified by the Secretary or an
        Assistant Secretary of the Company to have been duly adopted by the Board of Directors (or duly authorized committee thereof), and to be in full force and effect on the date of such certification.</font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt; font-size: 10pt;"><font style="font-family: 'Times New Roman';">&#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Business Day</font>&#8221; means, with respect to any Note, any day other than a Saturday, a
        Sunday or a day on which the Federal Reserve Bank of New York is authorized or required by law or executive order to close or be closed.</font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt; font-size: 10pt;"><font style="font-family: 'Times New Roman';">&#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Capital Stock</font>&#8221; means, for any entity, any and all shares, interests, rights to
        purchase, warrants, options, participations or other equivalents of or interests in (however designated) stock issued by that entity, but shall not include any debt securities convertible into or exchangeable for any securities otherwise
        constituting Capital Stock pursuant to this definition.</font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt; font-size: 10pt;"><font style="font-family: 'Times New Roman';">&#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Cash Settlement</font>&#8221; shall have the meaning specified in <font style="font-family: 'Times New Roman';"><u>Section&#160;14.02(a)</u></font>.</font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt; font-size: 10pt;"><font style="font-family: 'Times New Roman';">&#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Clause A Distribution</font>&#8221; shall have the meaning specified in <font style="font-family: 'Times New Roman';"><u>Section&#160;14.04(c)</u></font>.</font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt; font-size: 10pt;"><font style="font-family: 'Times New Roman';">&#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Clause B Distribution</font>&#8221; shall have the meaning specified in <font style="font-family: 'Times New Roman';"><u>Section&#160;14.04(c)</u></font>.</font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt; font-size: 10pt;"><font style="font-family: 'Times New Roman';">&#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Clause C Distribution</font>&#8221; shall have the meaning specified in <font style="font-family: 'Times New Roman';"><u>Section&#160;14.04(c)</u></font>.</font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt; font-size: 10pt;"><font style="font-family: 'Times New Roman';">&#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">close of business</font>&#8221; means 5:00 p.m. (New York City time).</font></div>
    <font style="font-size: 10pt;"><br>
    </font>
    <div style="text-indent: 36pt; font-size: 10pt;"><font style="font-family: 'Times New Roman';">&#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Combination Settlement</font>&#8221; shall have the meaning specified in <font style="font-family: 'Times New Roman';"><u>Section&#160;14.02(a)</u></font>.</font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt; font-size: 10pt;"><font style="font-family: 'Times New Roman';">&#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Commission</font>&#8221; means the U.S. Securities and Exchange Commission, as from time to time
        constituted, created under the Exchange Act, or, if at any time after the execution of this instrument such Commission is not existing and performing the duties now assigned to it under the Trust Indenture Act, then the body performing such duties
        at such time.</font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">2</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-indent: 36pt; font-size: 10pt;"><font style="font-family: 'Times New Roman';">&#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Common Equity</font>&#8221; of any Person means Capital Stock of such Person that is generally
        entitled (a) to vote in the election of directors of such Person or (b) if such Person is not a corporation, to vote or otherwise participate in the selection of the governing body, partners, managers or others that will control the management or
        policies of such Person.</font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt; font-size: 10pt;"><font style="font-family: 'Times New Roman';">&#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Common Stock</font>&#8221; means the common stock of the Company, par value $0.001 per share, at
        the date of this Indenture, subject to <font style="font-family: 'Times New Roman';"><u>Section&#160;14.07</u></font>.</font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt; font-size: 10pt;"><font style="font-family: 'Times New Roman';">&#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Company</font>&#8221; shall have the meaning specified in the first paragraph of this Indenture,
        and subject to the provisions of&#160;<font style="font-family: 'Times New Roman';"><u>Article 11</u></font>, shall include its successors and assigns.</font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt; font-size: 10pt;"><font style="font-family: 'Times New Roman';">&#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Company Order</font>&#8221; means a written order of the Company signed by any of its Officers
        and delivered to the Trustee.</font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt; font-size: 10pt;"><font style="font-family: 'Times New Roman';">&#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Conversion Agent</font>&#8221; shall have the meaning specified in <font style="font-family: 'Times New Roman';"><u>Section&#160;4.02</u></font>.</font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt; font-size: 10pt;"><font style="font-family: 'Times New Roman';">&#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Conversion Consideration</font>&#8221; shall have the meaning specified in <font style="font-family: 'Times New Roman';"><u>Section&#160;14.12(a)</u></font>.</font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt; font-size: 10pt;"><font style="font-family: 'Times New Roman';">&#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Conversion Date</font>&#8221; shall have the meaning specified in <font style="font-family: 'Times New Roman';"><u>Section&#160;14.02(c)</u></font>.</font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt; font-size: 10pt;"><font style="font-family: 'Times New Roman';">&#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Conversion Obligation</font>&#8221; shall have the meaning specified in <font style="font-family: 'Times New Roman';"><u>Section&#160;14.01(a)</u></font>.</font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt; font-size: 10pt;"><font style="font-family: 'Times New Roman';">&#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Conversion Price</font>&#8221; means as of any time, $1,000, <font style="font-family: 'Times New Roman'; font-style: italic;">divided by</font>&#160;the Conversion Rate as of such time.</font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt; font-size: 10pt;"><font style="font-family: 'Times New Roman';">&#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Conversion Rate</font>&#8221; shall have the meaning specified in <font style="font-family: 'Times New Roman';"><u>Section&#160;14.01(a)</u></font>.</font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt; font-size: 10pt;"><font style="font-family: 'Times New Roman';">&#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Corporate Trust Office</font>&#8221; means the designated office of the Trustee at which at any
        time this Indenture shall be administered, which office at the date hereof is located at U.S. Bank Trust Company, National Association, West Side Flats, Saint Paul, 60 Livingston Avenue, Saint Paul, MN 55107, Attention:&#160; BridgeBio Pharma, Inc.
        Administrator, or such other address as the Trustee may designate from time to time by notice to the Holders and the Company, or the designated corporate trust office of any successor trustee (or such other address as such successor trustee may
        designate from time to time by notice to the Holders and the Company).</font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt; font-size: 10pt;"><font style="font-family: 'Times New Roman';">&#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Custodian</font>&#8221; means the Trustee, as custodian for The Depository Trust Company, with
        respect to the Global Notes, or any successor entity thereto.</font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt; font-size: 10pt;"><font style="font-family: 'Times New Roman';">&#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Daily Conversion Value</font>&#8221; means, for each of the 40 consecutive Trading Days during
        the Observation Period, 1/40<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup> of the product of (a) the Conversion Rate on such Trading Day and (b)&#160;the Daily VWAP for such Trading Day.</font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt; font-size: 10pt;"><font style="font-family: 'Times New Roman';">&#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Daily Measurement Value</font>&#8221; means the Specified Dollar Amount (if any), <font style="font-family: 'Times New Roman'; font-style: italic;">divided by</font>&#160;40.</font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt; font-size: 10pt;"><font style="font-family: 'Times New Roman';">&#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Daily Settlement Amount</font>,&#8221; for each of the 40 consecutive Trading Days during the
        Observation Period, shall consist of:</font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">3</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(a)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">cash in an amount equal to the lesser of (i) the Daily
          Measurement Value and (ii)&#160;the Daily Conversion Value on such Trading Day; and</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(b)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">if the Daily Conversion Value on such Trading Day exceeds the
          Daily Measurement Value, a number of shares of Common Stock equal to (i) the difference between the Daily Conversion Value and the Daily Measurement Value, <font style="font-family: 'Times New Roman'; font-style: italic;">divided by</font> (ii)
          the Daily VWAP for such Trading Day.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt; font-size: 10pt;"><font style="font-family: 'Times New Roman';">&#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Daily VWAP</font>&#8221; means, for each of the 40 consecutive Trading Days during the relevant
        Observation Period, the per share volume-weighted average price as displayed under the heading &#8220;Bloomberg VWAP&#8221; on Bloomberg page &#8220;BBIO &lt;equity&gt; AQR&#8221; (or its equivalent successor if such page is not available) in respect of the period from
        the scheduled open of trading until the scheduled close of trading of the primary trading session on such Trading Day (or if such volume-weighted average price is unavailable, the market value of one share of the Common Stock on such Trading Day
        determined, using a volume-weighted average method, by a nationally recognized independent investment banking firm retained for this purpose by the Company).&#160; The &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Daily VWAP</font>&#8221;
        shall be determined without regard to after-hours trading or any other trading outside of the regular trading session trading hours.</font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt; font-size: 10pt;"><font style="font-family: 'Times New Roman';">&#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Default</font>&#8221; means any event that is, or after notice or passage of time, or both, would
        be, an Event of Default.</font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt; font-size: 10pt;"><font style="font-family: 'Times New Roman';">&#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Defaulted Amounts</font>&#8221; means any amounts on any Note (including, without limitation, the
        Redemption Price, the Fundamental Change Repurchase Price, principal and interest) that are payable but are not punctually paid or duly provided for.</font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt; font-size: 10pt;"><font style="font-family: 'Times New Roman';">&#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Default Interest</font>&#8221; shall have the meaning specified in <font style="font-family: 'Times New Roman';"><u>Section 2.03(c)</u></font>.</font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt; font-size: 10pt;"><font style="font-family: 'Times New Roman';">&#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Default Settlement Method</font>&#8221; means Combination Settlement with a Specified Dollar
        Amount of $1,000 per $1,000 principal amount of Notes; <font style="font-family: 'Times New Roman'; font-style: italic;">provided, however</font>, that the Company may, from time to time, change the Default Settlement Method by sending notice of
        the new Default Settlement Method to the Holders, Trustee and Conversion Agent; and <font style="font-family: 'Times New Roman'; font-style: italic;">provided, further</font> that the Company may, by notice to Holders, elect to irrevocably fix the
        Settlement Method, to any Settlement Method that it is then permitted to elect, including Combination Settlement with a Specified Dollar Amount per $1,000 principal amount of Notes of $1,000 or with an ability to continue to set the Specified
        Dollar Amount per $1,000 principal amount of Notes at or above any specific amount set forth in such election notice, that will apply to all Note conversions with a Conversion Date that is on or after the date the Company sends such notice. For the
        avoidance of doubt, such an irrevocable election, if made, will be effective without the need to amend this Indenture or the Notes, including pursuant to Section 10.01(m).</font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">&#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Deferred Additional Interest</font>&#8221; shall have the meaning specified in <font style="font-family: 'Times New Roman';"><u>Section 4.06(f)(i)</u></font>.</div>
    <div style="font-size: 10pt; text-indent: 36pt;">&#160;</div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">&#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Deferred Additional Interest Demand Request</font>&#8221; shall have the meaning specified in
      <font style="font-family: 'Times New Roman';"><u>Section 4.06(f)(i)</u></font>.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="font-size: 10pt; text-indent: 36pt;"><font style="font-family: 'Times New Roman';">&#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Depositary</font>&#8221; means, with respect to each Global Note, the Person specified in <font style="font-family: 'Times New Roman';"><u>Section&#160;2.05(c)</u></font> as the Depositary with respect to such Notes, until a successor shall have been appointed and become such pursuant to the applicable provisions of this Indenture, and
        thereafter, &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Depositary</font>&#8221; shall mean or include such successor.</font></div>
    <div style="text-indent: 36pt; font-size: 10pt;"><font style="font-family: 'Times New Roman';"> <br>
      </font></div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">4</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-indent: 36pt; font-size: 10pt;"><font style="font-family: 'Times New Roman';">&#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Designated Financial Institution</font>&#8221; shall have the meaning specified in <font style="font-family: 'Times New Roman';"><u>Section&#160;14.12(a)</u></font>.</font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt; font-size: 10pt;"><font style="font-family: 'Times New Roman';">&#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Distributed Property</font>&#8221; shall have the meaning specified in <font style="font-family: 'Times New Roman';"><u>Section&#160;14.04(c)</u></font>.</font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt; font-size: 10pt;"><font style="font-family: 'Times New Roman';">&#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Effective Date</font>&#8221; shall have the meaning specified in <font style="font-family: 'Times New Roman';"><u>Section&#160;14.03(c)</u></font>, except that, as used in <font style="font-family: 'Times New Roman';"><u>Section&#160;14.04</u></font>&#160;and <font style="font-family: 'Times New Roman';"><u>Section&#160;14.05</u></font>, &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Effective Date</font>&#8221; means the first date on which shares of the Common Stock trade on the applicable exchange or in the applicable market, regular way, reflecting the relevant share
        split or share combination, as applicable.&#160; For the avoidance of doubt, any alternative trading convention on the applicable exchange or market in respect of shares of the Common Stock under a separate ticker symbol or CUSIP number will not be
        considered &#8220;regular way&#8221; for this purpose.</font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt; font-size: 10pt;"><font style="font-family: 'Times New Roman';">&#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Event of Default</font>&#8221; shall have the meaning specified in <font style="font-family: 'Times New Roman';"><u>Section&#160;6.01</u></font>.</font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt; font-size: 10pt;"><font style="font-family: 'Times New Roman';">&#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Ex-Dividend&#160;Date</font>&#8221; means the first date on which shares of the Common Stock trade on
        the applicable exchange or in the applicable market, regular way, without the right to receive the issuance, dividend or distribution in question, from the Company or, if applicable, from the seller of Common Stock on such exchange or market (in
        the form of due bills or otherwise) as determined by such exchange or market.&#160; For the avoidance of doubt, any alternative trading convention on the applicable exchange or market in respect of shares of the Common Stock under a separate ticker
        symbol or CUSIP number will not be considered &#8220;regular way&#8221; for this purpose.</font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt; font-size: 10pt;"><font style="font-family: 'Times New Roman';">&#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Exchange Act</font>&#8221; means the Securities Exchange Act of 1934, as amended, and the rules
        and regulations promulgated thereunder.</font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt; font-size: 10pt;"><font style="font-family: 'Times New Roman';">&#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Exchange Election</font>&#8221; shall have the meaning specified in <font style="font-family: 'Times New Roman';"><u>Section&#160;14.12(a)</u></font>.</font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt; font-size: 10pt;"><font style="font-family: 'Times New Roman';">&#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Exempted Fundamental Change</font>&#8221; shall have the meaning specified in <font style="font-family: 'Times New Roman';"><u>Section 15.02(f)</u></font>.</font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt; font-size: 10pt;"><font style="font-family: 'Times New Roman';">&#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Form of Assignment and Transfer</font>&#8221; means the &#8220;Form of Assignment and Transfer&#8221;
        attached as Attachment 3 to the Form of Note attached hereto as Exhibit A.</font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt; font-size: 10pt;"><font style="font-family: 'Times New Roman';">&#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Form of Fundamental Change Repurchase Notice</font>&#8221; means the &#8220;Form of Fundamental Change
        Repurchase Notice&#8221; attached as Attachment 2 to the Form of Note attached hereto as Exhibit A.</font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt; font-size: 10pt;"><font style="font-family: 'Times New Roman';">&#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Form of Note</font>&#8221; means the &#8220;Form of Note&#8221; attached hereto as Exhibit A.</font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt; font-size: 10pt;"><font style="font-family: 'Times New Roman';">&#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Form of Notice of Conversion</font>&#8221; means the &#8220;Form of Notice of Conversion&#8221; attached as
        Attachment 1 to the Form of Note attached hereto as Exhibit A.</font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">5</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-indent: 36pt; font-size: 10pt;"><font style="font-family: 'Times New Roman';">&#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Freely Tradable</font>&#8221; means, with respect to any Note, that such Note would be eligible
        to be offered, sold or otherwise transferred pursuant to Rule 144 or otherwise if held by a Person that is not an Affiliate of the Company, and that has not been an Affiliate of the Company during the immediately preceding three (3) months, without
        any requirements as to volume, manner of sale, availability of current public information or notice under the Securities Act (except that, during the six (6) month period beginning on, and including, the date that is six (6) months after the Last
        Original Issue Date of such Note, any such requirement as to the availability of current public information will be disregarded if the same is satisfied at that time); <font style="font-family: 'Times New Roman'; font-style: italic;">provided</font>,
        <font style="font-family: 'Times New Roman'; font-style: italic;">however</font>, that from and after the date that is one year after the last original issue date of such Note,&#160; such Note will not be &#8220;Freely Tradable&#8221; unless such Note (x) is
        identified by an &#8220;unrestricted&#8221; CUSIP or ISIN number; and (y) is not represented by any certificate that bears the Restricted Note Legend. For the avoidance of doubt, whether a Note is deemed to be identified by a &#8220;restricted&#8221; CUSIP or ISIN number
        or to bear the Restricted Note Legend is subject to <font style="font-family: 'Times New Roman';"><u>Section 2.05(c)</u></font>.</font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt; font-size: 10pt;"><font style="font-family: 'Times New Roman';">&#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Fundamental Change</font>&#8221; shall be deemed to have occurred at the time after the Notes are
        originally issued if any of the following occurs:</font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(a)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">a &#8220;person&#8221; or &#8220;group&#8221; within the meaning of <font style="font-family: 'Times New Roman';"><u>Section</u></font>&#160;13(d) of the Exchange Act, other than the Company, its Wholly Owned Subsidiaries and the employee benefit plans of the Company and its Wholly Owned Subsidiaries, has become the
          direct or indirect &#8220;beneficial owner,&#8221; as defined in Rule&#160;13d-3&#160;under the Exchange Act, of Common Stock representing more than 50% of the voting power of the Common Stock and has filed a Schedule TO (or any successor schedule, form or report) or
          any schedule, form or report under the Exchange Act that discloses such fact, unless such beneficial ownership arises solely as a result of a revocable proxy delivered in response to a public proxy or consent solicitation made pursuant to the
          applicable rules and regulations under the Exchange Act and is not also then reportable on Schedule 13D or Schedule 13G (or any successor schedule) under the Exchange Act; <font style="font-family: 'Times New Roman'; font-style: italic;">provided</font>,
          that no person or group shall be deemed to be the beneficial owner of any securities tendered pursuant to a tender or exchange offer made by or on behalf of such &#8220;person&#8221; or &#8220;group&#8221; until such tendered securities are accepted for purchase or
          exchange under such offer;</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(b)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">the consummation of (A) any recapitalization, reclassification
          or change of the Common Stock (other than changes resulting from a subdivision or combination or solely a change in par value) as a result of which the Common Stock would be converted into, or exchanged for, stock, other securities, other
          property or assets; (B) any share exchange, consolidation or merger of the Company pursuant to which the Common Stock will be converted into cash, securities or other property or assets; or (C) any sale, lease or other transfer in one transaction
          or a series of transactions of all or substantially all of the consolidated assets of the Company and its Subsidiaries, taken as a whole, to any Person other than one or more of the Company&#8217;s direct or indirect Wholly Owned Subsidiaries; <font style="font-family: 'Times New Roman'; font-style: italic;">provided, however</font>, that a transaction described in clause (A) or clause (B) in which the holders of all classes of the Company&#8217;s Common Equity immediately prior to such
          transaction own, directly or indirectly, more than 50% of all classes of Common Equity of the continuing or surviving corporation or transferee or the parent thereof immediately after such transaction in substantially the same proportions
          (relative to each other) as such ownership immediately prior to such transaction shall not be a Fundamental Change pursuant to this clause (b);</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">6</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(c)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">the stockholders of the Company approve any plan or proposal
          for the liquidation or dissolution of the Company; or</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(d)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">the Common Stock (or other common stock underlying the Notes)
          ceases to be listed or quoted on any of The New York Stock Exchange, the Nasdaq Global Select Market or the Nasdaq Global Market (or any of their respective successors);</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">provided</font><font style="font-size: 10pt;">, <font style="font-family: 'Times New Roman'; font-style: italic;">however</font>, that a transaction or transactions described in clause (b) above shall not constitute a Fundamental Change, if at least 90% of the consideration received or to be received by the common stockholders of
        the Company, excluding cash payments for fractional shares and cash payments made in respect of dissenters&#8217; appraisal rights, in connection with such transaction or transactions consists of shares of common stock that are listed or quoted on any of
        The New York Stock Exchange, the Nasdaq Global Select Market or the Nasdaq Global Market (or any of their respective successors) or will be so listed or quoted when issued or exchanged in connection with such transaction or transactions and as a
        result of such transaction or transactions the Notes become convertible into such consideration, excluding cash payments for fractional shares and cash payments made in respect of dissenters&#8217; appraisal rights (subject to the provisions of <font style="font-family: 'Times New Roman';"><u>Section&#160;14.02(a)</u></font>).&#160; If any transaction in which the Common Stock is replaced by the securities of another entity occurs, following completion of any related Make-Whole Fundamental Change
        Period (or, in the case of a transaction that would have been a Fundamental Change or a Make-Whole Fundamental Change but for the proviso immediately following clause&#160;(d) of this definition, following the effective date of such transaction)
        references to the Company in this definition shall instead be references to such other entity.</font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt; font-size: 10pt;"><font style="font-family: 'Times New Roman';">For purposes of this definition of &#8220;Fundamental Change,&#8221; any transaction or series of related transactions that constitute a Fundamental Change pursuant to
        both clause (a) and clause (b) of this definition (determined without regard to the proviso in clause (b) of this definition) shall be deemed a Fundamental Change solely under clause (b) of this definition (subject to such proviso).</font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt; font-size: 10pt;"><font style="font-family: 'Times New Roman';">&#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Fundamental Change Company Notice</font>&#8221; shall have the meaning specified in <font style="font-family: 'Times New Roman';"><u>Section&#160;15.02(c)</u></font>.</font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt; font-size: 10pt;"><font style="font-family: 'Times New Roman';">&#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Fundamental Change Repurchase Date</font>&#8221; shall have the meaning specified in <font style="font-family: 'Times New Roman';"><u>Section&#160;15.02(a)</u></font>.</font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt; font-size: 10pt;"><font style="font-family: 'Times New Roman';">&#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Fundamental Change Repurchase Notice</font>&#8221; shall have the meaning specified in <font style="font-family: 'Times New Roman';"><u>Section&#160;15.02(b)(i)</u></font>.</font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt; font-size: 10pt;"><font style="font-family: 'Times New Roman';">&#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Fundamental Change Repurchase Price</font>&#8221; shall have the meaning specified in <font style="font-family: 'Times New Roman';"><u>Section&#160;15.02(a)</u></font>.</font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt; font-size: 10pt;"><font style="font-family: 'Times New Roman';">The terms &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">given</font>&#8221;, &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">mailed</font>&#8221;,



        &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">notify</font>&#8221; or &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">sent</font>&#8221; with respect to any notice to be given to a Holder pursuant to this Indenture, shall
        mean notice (x) given to the Depositary (or its designee) pursuant to the standing instructions from the Depositary or its designee, including by electronic mail in accordance with accepted practices or procedures at the Depositary (in the case of
        a Global Note) or (y) mailed to such Holder by first class mail, postage prepaid, at its address as it appears on the Note Register (in the case of a Physical Note), in each case, in accordance with <font style="font-family: 'Times New Roman';"><u>Section&#160;17.03</u></font>.&#160;



        Notice so &#8220;given&#8221; shall be deemed to include any notice to be &#8220;mailed&#8221; or &#8220;delivered,&#8221; as applicable, under this Indenture.</font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">7</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-indent: 36pt; font-size: 10pt;"><font style="font-family: 'Times New Roman';">&#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Global Note</font>&#8221; shall have the meaning specified in <font style="font-family: 'Times New Roman';"><u>Section&#160;2.05(b)</u></font>.</font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt; font-size: 10pt;"><font style="font-family: 'Times New Roman';">&#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Holder</font>,&#8221; as applied to any Note, or other similar terms (but excluding the term
        &#8220;beneficial holder&#8221;), means any Person in whose name at the time a particular Note is registered on the Note Register.</font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt; font-size: 10pt;"><font style="font-family: 'Times New Roman';">&#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Indenture</font>&#8221; means this instrument as originally executed or, if amended or
        supplemented as herein provided, as so amended or supplemented.</font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt; font-size: 10pt;"><font style="font-family: 'Times New Roman';">&#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Initial Purchasers</font>&#8221; means the initial purchasers set forth on Schedule 1 to the
        Purchase Agreement.</font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt; font-size: 10pt;"><font style="font-family: 'Times New Roman';">&#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Interest Payment Date</font>&#8221; means each March 1 and September 1 of each year, beginning on
        September 1, 2025 (or, if such date is not a Business Day, the next succeeding Business Day).</font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt; font-size: 10pt;"><font style="font-family: 'Times New Roman';">&#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Last Reported Sale Price</font>&#8221; of the Common Stock (or any other security for which a
        closing sale price must be determined) on any date means the closing sale price per share (or if no closing sale price is reported, the average of the bid and ask prices or, if more than one in either case, the average of the average bid and the
        average ask prices) on that date as reported in composite transactions for the principal U.S. national or regional securities exchange on which the Common Stock (or such other security) is traded.&#160; If the Common Stock (or such other security) is
        not listed for trading on a U.S. national or regional securities exchange on the relevant date, the &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Last Reported Sale Price</font>&#8221; shall be the last quoted bid price for the Common
        Stock (or such other security) in the&#160;over-the-counter&#160;market on the relevant date as reported by OTC Markets Group Inc. or a similar organization.&#160; If the Common Stock (or such other security) is not so quoted, the &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Last Reported Sale Price</font>&#8221; shall be the average of the&#160;mid-point&#160;of the last bid and ask prices for the Common Stock (or such other security) on the relevant date from each of at least three nationally
        recognized independent investment banking firms selected by the Company for this purpose.&#160; The &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Last Reported Sale Price</font>&#8221; shall be determined without regard to after-hours
        trading or any other trading outside of regular trading session hours.</font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt; font-size: 10pt;"><font style="font-family: 'Times New Roman';">&#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Make-Whole Fundamental Change</font>&#8221; means any transaction or event that constitutes a
        Fundamental Change (as defined above and determined after giving effect to any exceptions to or exclusions from such definition, but without regard to the&#160;<font style="font-family: 'Times New Roman'; font-style: italic;">proviso</font>&#160;in clause
        (b) of the definition thereof).</font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt; font-size: 10pt;"><font style="font-family: 'Times New Roman';">&#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Make-Whole Fundamental Change Period</font>&#8221; shall have the meaning specified in <font style="font-family: 'Times New Roman';"><u>Section&#160;14.03(a)</u></font>.</font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt; font-size: 10pt;"><font style="font-family: 'Times New Roman';">&#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Market Disruption Event</font>&#8221; means, for the purposes of determining amounts due upon
        conversion (a) a failure by the primary U.S. national or regional securities exchange or market on which the Common Stock is listed or admitted for trading to open for trading during its regular trading session or (b) the occurrence or existence
        prior to 1:00 p.m., New York City time, on any Scheduled Trading Day for the Common Stock for more than one half-hour period in the aggregate during regular trading hours of any suspension or limitation imposed on trading (by reason of movements in
        price exceeding limits permitted by the relevant stock exchange or otherwise) in the Common Stock or in any options contracts or futures contracts relating to the Common Stock.</font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">8</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-indent: 36pt; font-size: 10pt;"><font style="font-family: 'Times New Roman';">&#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Maturity Date</font>&#8221; means March 1, 2031.</font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt; font-size: 10pt;"><font style="font-family: 'Times New Roman';">&#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Measurement Period</font>&#8221; shall have the meaning specified in <font style="font-family: 'Times New Roman';"><u>Section&#160;14.01(b)(i)</u></font>.</font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt; font-size: 10pt;"><font style="font-family: 'Times New Roman';">&#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Merger Event</font>&#8221; shall have the meaning specified in <font style="font-family: 'Times New Roman';"><u>Section&#160;14.07(a)</u></font>.</font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt; font-size: 10pt;"><font style="font-family: 'Times New Roman';">&#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Non-Recourse Indebtedness</font>&#8221; means any indebtedness of any Significant Subsidiary for
        money borrowed that is unsecured (or secured only by the assets or equity of such Significant Subsidiary or any of such Significant Subsidiary&#8217;s Subsidiaries) and which is not guaranteed, co-issued or co-borrowed by the Company or any of the
        Company&#8217;s other Subsidiaries (other than any of such Significant Subsidiary&#8217;s Subsidiaries or holding company parent entities (other than the Company) that hold, directly or indirectly, the equity of such Significant Subsidiary and no other
        material assets) (including, for the avoidance of doubt, any secured or unsecured guarantees or co-borrowings thereof by such Significant Subsidiary&#8217;s Subsidiaries or holding company parent entities (other than the Company)).</font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt; font-size: 10pt;"><font style="font-family: 'Times New Roman';">&#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Note</font>&#8221; or &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Notes</font>&#8221;
        shall have the meaning specified in the first paragraph of the recitals of this Indenture.</font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt; font-size: 10pt;"><font style="font-family: 'Times New Roman';">&#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Note Register</font>&#8221; shall have the meaning specified in <font style="font-family: 'Times New Roman';"><u>Section&#160;2.05(a)</u></font>.</font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt; font-size: 10pt;"><font style="font-family: 'Times New Roman';">&#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Note Registrar</font>&#8221; shall have the meaning specified in <font style="font-family: 'Times New Roman';"><u>Section&#160;2.05(a)</u></font>.</font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt; font-size: 10pt;"><font style="font-family: 'Times New Roman';">&#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Notice of Conversion</font>&#8221; shall have the meaning specified in <font style="font-family: 'Times New Roman';"><u>Section&#160;14.02(b)</u></font>.</font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">&#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Notice of Election to Pay Deferred Additional Interest</font>&#8221; shall have the meaning
      specified in <font style="font-family: 'Times New Roman';"><u>Section 4.06(f)(i)</u></font>.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt; font-size: 10pt;"><font style="font-family: 'Times New Roman';">&#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Notice of Redemption</font>&#8221; shall have the meaning specified in <font style="font-family: 'Times New Roman';"><u>Section 16.02(a)</u></font>.</font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt; font-size: 10pt;"><font style="font-family: 'Times New Roman';">&#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Observation Period</font>&#8221; with respect to any Note surrendered for conversion means:&#160; (i)
        subject to clause (ii), if the relevant Conversion Date occurs prior to December 2, 2030, the 40 consecutive Trading Day period beginning on, and including, the second Trading Day immediately succeeding such Conversion Date; (ii) if the relevant
        Conversion Date occurs on or after the date of the Company&#8217;s issuance of a Notice of Redemption with respect to the Notes pursuant to <font style="font-family: 'Times New Roman';"><u>Section 16.02</u></font> and prior to the close of business on
        the second Business Day immediately preceding the relevant Redemption Date, the 40 consecutive Trading Days beginning on, and including, the 42nd Scheduled Trading Day immediately preceding such Redemption Date; and (iii) subject to clause (ii), if
        the relevant Conversion Date occurs on or after December 2, 2030, the 40 consecutive Trading Days beginning on, and including, the 41st Scheduled Trading Day immediately preceding the Maturity Date.</font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">9</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-indent: 36pt; font-size: 10pt;"><font style="font-family: 'Times New Roman';">&#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Offering Memorandum</font>&#8221; means the preliminary offering memorandum dated February 24,
        2025, as supplemented by the related pricing term sheet dated February 25, 2025, relating to the offering and sale of the Notes.</font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt; font-size: 10pt;"><font style="font-family: 'Times New Roman';">&#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Officer</font>&#8221; means, with respect to the Company, the Chairman of the Board of Directors,
        a Chief Executive Officer, a President, a Chief Financial Officer, a Chief Operating Officer, any Executive Vice President, any Senior Vice President, any Vice President, the Treasurer or any Assistant Treasurer, the Controller or any Assistant
        Controller or the Secretary or any Assistant Secretary.</font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt; font-size: 10pt;"><font style="font-family: 'Times New Roman';">&#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Officer&#8217;s Certificate</font>,&#8221; when used with respect to the Company, means a certificate
        that is delivered to the Trustee and that is signed by any Officer of the Company.&#160; Each such certificate shall include the statements provided for in <font style="font-family: 'Times New Roman';"><u>Section&#160;17.05</u></font>&#160;if and to the extent
        required by the provisions of such Section.&#160; The Officer giving an Officer&#8217;s Certificate pursuant to <font style="font-family: 'Times New Roman';"><u>Section&#160;4.08</u></font>&#160;shall be the principal executive, financial or accounting officer of the
        Company.</font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt; font-size: 10pt;"><font style="font-family: 'Times New Roman';">&#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">open of business</font>&#8221; means 9:00 a.m. (New York City time).</font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt; font-size: 10pt;"><font style="font-family: 'Times New Roman';">&#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Opinion of Counsel</font>&#8221; means an opinion in writing signed by legal counsel, who may be
        an employee of or counsel to the Company, or other counsel who is reasonably acceptable to the Trustee, which opinion may contain customary exceptions and qualifications as to the matters set forth therein, that is delivered to the Trustee.&#160; Each
        such opinion shall include the statements provided for in <font style="font-family: 'Times New Roman';"><u>Section&#160;17.05</u></font>&#160;if and to the extent required by the provisions of such <font style="font-family: 'Times New Roman';"><u>Section&#160;17.05</u></font>.</font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt; font-size: 10pt;"><font style="font-family: 'Times New Roman';">&#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Optional Redemption</font>&#8221; shall have the meaning specified in <font style="font-family: 'Times New Roman';"><u>Section 16.01</u></font>.</font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt; font-size: 10pt;"><font style="font-family: 'Times New Roman';">&#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">outstanding</font>,&#8221; when used with reference to Notes, shall, subject to the provisions of
        <font style="font-family: 'Times New Roman';"><u>Section&#160;8.04</u></font>, mean, as of any particular time, all Notes authenticated and delivered by the Trustee under this Indenture, except:</font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(a)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">Notes theretofore canceled by the Trustee or accepted by the
          Trustee for cancellation;</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(b)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">Notes, or portions thereof, that have become due and payable
          and in respect of which monies in the necessary amount shall have been deposited in trust with the Trustee or with any Paying Agent (other than the Company) or shall have been set aside and segregated in trust by the Company (if the Company shall
          act as its own Paying Agent);</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(c)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">Notes that have been paid pursuant to <font style="font-family: 'Times New Roman';"><u>Section&#160;2.06</u></font>&#160;or Notes in lieu of which, or in substitution for which, other Notes shall have been authenticated and delivered pursuant to the terms of <font style="font-family: 'Times New Roman';"><u>Section&#160;2.06</u></font>&#160;unless proof satisfactory to the Trustee is presented that any such Notes are held by protected purchasers in due course;</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(d)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">Notes converted pursuant to&#160;<font style="font-family: 'Times New Roman';"><u>Article 14</u></font>&#160;and required to be cancelled pursuant to <font style="font-family: 'Times New Roman';"><u>Section&#160;2.08</u></font>; and</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(e)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">Notes redeemed pursuant to <font style="font-family: 'Times New Roman';"><u>Article 16</u></font>.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">10</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-indent: 36pt; font-size: 10pt;"><font style="font-family: 'Times New Roman';">&#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Partial Redemption Limitation</font>&#8221; shall have the meaning specified in <font style="font-family: 'Times New Roman';"><u>Section&#160;16.02(d)</u></font>.</font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt; font-size: 10pt;"><font style="font-family: 'Times New Roman';">&#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Paying Agent</font>&#8221; shall have the meaning specified in <font style="font-family: 'Times New Roman';"><u>Section&#160;4.02</u></font>.</font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt; font-size: 10pt;"><font style="font-family: 'Times New Roman';">&#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Person</font>&#8221; means an individual, a corporation, a limited liability company, an
        association, a partnership, a joint venture, a joint stock company, a trust, an unincorporated organization or a government or an agency or a political subdivision thereof.</font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt; font-size: 10pt;"><font style="font-family: 'Times New Roman';">&#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Physical Notes</font>&#8221; means permanent certificated Notes in registered form issued in
        denominations of $1,000 principal amount and integral multiples thereof.</font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt; font-size: 10pt;"><font style="font-family: 'Times New Roman';">&#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Physical Settlement</font>&#8221; shall have the meaning specified in <font style="font-family: 'Times New Roman';"><u>Section&#160;14.02(a)</u></font>.</font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt; font-size: 10pt;"><font style="font-family: 'Times New Roman';">&#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Predecessor Note</font>&#8221; of any particular Note means every previous Note evidencing all or
        a portion of the same debt as that evidenced by such particular Note; and, for the purposes of this definition, any Note authenticated and delivered under <font style="font-family: 'Times New Roman';"><u>Section&#160;2.06</u></font>&#160;in lieu of or in
        exchange for a mutilated, lost, destroyed or stolen Note shall be deemed to evidence the same debt as the mutilated, lost, destroyed or stolen Note that it replaces.</font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt; font-size: 10pt;"><font style="font-family: 'Times New Roman';">&#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Purchase Agreement</font>&#8221; means that certain Purchase Agreement, dated as of February 25,
        2025, among the Company and Goldman Sachs &amp; Co. LLC, TD Securities (USA) LLC, Mizuho Securities USA LLC and Cantor Fitzgerald &amp; Co., as representatives of the Initial Purchasers.</font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt; font-size: 10pt;"><font style="font-family: 'Times New Roman';">&#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Record Date</font>&#8221; means, with respect to any dividend, distribution or other transaction
        or event in which the holders of Common Stock (or other applicable security) have the right to receive any cash, securities or other property or in which the Common Stock (or such other security) is exchanged for or converted into any combination
        of cash, securities or other property, the date fixed for determination of holders of the Common Stock (or such other security) entitled to receive such cash, securities or other property (whether such date is fixed by the Board of Directors, by
        statute, contract or otherwise).</font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt; font-size: 10pt;"><font style="font-family: 'Times New Roman';">&#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Redemption Date</font>&#8221; shall have the meaning specified in <font style="font-family: 'Times New Roman';"><u>Section 16.02(a)</u></font>.</font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt; font-size: 10pt;"><font style="font-family: 'Times New Roman';">&#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Redemption Notice Date</font>&#8221; shall have the meaning specified in <font style="font-family: 'Times New Roman';"><u>Section 16.01</u></font>.</font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt; font-size: 10pt;"><font style="font-family: 'Times New Roman';">&#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Redemption Price</font>&#8221; means, for any Notes to be redeemed pursuant to <font style="font-family: 'Times New Roman';"><u>Section 16.01</u></font>, 100% of the principal amount of such Notes, <font style="font-family: 'Times New Roman'; font-style: italic;">plus</font> accrued and unpaid interest, if any, to, but
        excluding, the Redemption Date (unless the Redemption Date falls after a Regular Record Date but on or prior to the immediately succeeding Interest Payment Date, in which case interest accrued to the Interest Payment Date will be paid by the
        Company to Holders of record of such Notes as of the close of business on such Regular Record Date, and the Redemption Price will be equal to 100% of the principal amount of such Notes).</font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt; font-size: 10pt;"><font style="font-family: 'Times New Roman';">&#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Reference Property</font>&#8221; shall have the meaning specified in <font style="font-family: 'Times New Roman';"><u>Section&#160;14.07(a)</u></font>.</font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">11</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-indent: 36pt; font-size: 10pt;"><font style="font-family: 'Times New Roman';">&#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Regular Record Date</font>,&#8221; with respect to any Interest Payment Date, means the February
        15 or August 15 (whether or not such day is a Business Day) immediately preceding the applicable March 1 or September 1 Interest Payment Date, respectively.</font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt; font-size: 10pt;"><font style="font-family: 'Times New Roman';">&#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Reporting Event of Default</font>&#8221; shall have the meaning specified in <font style="font-family: 'Times New Roman';"><u>Section 6.03</u></font>.</font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt; font-size: 10pt;"><font style="font-family: 'Times New Roman';">&#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Resale Restriction Termination Date</font>&#8221; shall have the meaning specified in <font style="font-family: 'Times New Roman';"><u>Section&#160;2.05(c)</u></font>.</font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt; font-size: 10pt;"><font style="font-family: 'Times New Roman';">&#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Responsible Officer</font>&#8221; means, when used with respect to the Trustee, any officer
        within the corporate trust department of the Trustee, including any vice president, assistant vice president, assistant secretary, assistant treasurer, trust officer or any other officer of the Trustee who customarily performs functions similar to
        those performed by the persons who at the time shall be such officers, respectively, or to whom any corporate trust matter is referred because of such person&#8217;s knowledge of and familiarity with the particular subject and who shall have direct
        responsibility for the administration of this Indenture.</font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt; font-size: 10pt;"><font style="font-family: 'Times New Roman';">&#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Restricted Securities</font>&#8221; shall have the meaning specified in <font style="font-family: 'Times New Roman';"><u>Section&#160;2.05(c)</u></font>.</font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt; font-size: 10pt;"><font style="font-family: 'Times New Roman';">&#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Restrictive Notes Legend</font>&#8221; shall have the meaning specified in <font style="font-family: 'Times New Roman';"><u>Section&#160;2.05(c)</u></font>.</font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt; font-size: 10pt;"><font style="font-family: 'Times New Roman';">&#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Rule 144</font>&#8221; means Rule 144 as promulgated under the Securities Act.</font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt; font-size: 10pt;"><font style="font-family: 'Times New Roman';">&#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Rule 144A</font>&#8221; means Rule 144A as promulgated under the Securities Act.</font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt; font-size: 10pt;"><font style="font-family: 'Times New Roman';">&#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Scheduled Trading Day</font>&#8221; means a day that is scheduled to be a Trading Day on the
        principal U.S. national or regional securities exchange or market on which the Common Stock is listed or admitted for trading.&#160; If the Common Stock is not so listed or admitted for trading, &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Scheduled Trading Day</font>&#8221; means a Business Day.</font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt; font-size: 10pt;"><font style="font-family: 'Times New Roman';">&#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Securities Act</font>&#8221; means the Securities Act of 1933, as amended, and the rules and
        regulations promulgated thereunder.</font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt; font-size: 10pt;"><font style="font-family: 'Times New Roman';">&#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Settlement Amount</font>&#8221; has the meaning specified in <font style="font-family: 'Times New Roman';"><u>Section&#160;14.02(a)(iv)</u></font>.</font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt; font-size: 10pt;"><font style="font-family: 'Times New Roman';">&#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Settlement Method</font>&#8221; means, with respect to any conversion of Notes, Physical
        Settlement, Cash Settlement or Combination Settlement, as elected (or deemed to have been elected) by the Company.</font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt; font-size: 10pt;"><font style="font-family: 'Times New Roman';">&#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Settlement Method Election Deadline</font>&#8221; shall have the meaning specified in <font style="font-family: 'Times New Roman';"><u>Section&#160;14.02(a)(iii)(A)</u></font>.</font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt; font-size: 10pt;"><font style="font-family: 'Times New Roman';">&#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Settlement Notice</font>&#8221; has the meaning specified in <font style="font-family: 'Times New Roman';"><u>Section&#160;14.02(a)(iii)(A)</u></font>.</font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt; font-size: 10pt;"><font style="font-family: 'Times New Roman';">&#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Significant Subsidiary</font>&#8221; means a Subsidiary of the Company that meets the definition
        of &#8220;significant subsidiary&#8221; in Article 1, Rule&#160;1-02&#160;of Regulation&#160;S-X&#160;promulgated by the Commission.</font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">12</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-indent: 36pt; font-size: 10pt;"><font style="font-family: 'Times New Roman';">&#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Specified Dollar Amount</font>&#8221; means the maximum cash amount per $1,000 principal amount
        of Notes to be received upon conversion as specified in the Settlement Notice (or deemed specified as provided in <font style="font-family: 'Times New Roman';"><u>Section&#160;14.02(a)(iii)</u></font>) related to any converted Notes.</font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt; font-size: 10pt;"><font style="font-family: 'Times New Roman';">&#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Spin-Off</font>&#8221; shall have the meaning specified in <font style="font-family: 'Times New Roman';"><u>Section&#160;14.04(c)</u></font>.</font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt; font-size: 10pt;"><font style="font-family: 'Times New Roman';">&#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Stock Price</font>&#8221; shall have the meaning specified in <font style="font-family: 'Times New Roman';"><u>Section&#160;14.03(c)</u></font>.</font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt; font-size: 10pt;"><font style="font-family: 'Times New Roman';">&#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Subsidiary</font>&#8221; means, with respect to any Person, any corporation, association,
        partnership or other business entity of which more than 50% of the total voting power of shares of Capital Stock or other interests (including partnership interests) entitled (without regard to the occurrence of any contingency) to vote in the
        election of directors, managers, general partners or trustees thereof is at the time owned or controlled, directly or indirectly, by (i) such Person; (ii) such Person and one or more Subsidiaries of such Person; or (iii) one or more Subsidiaries of
        such Person.</font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt; font-size: 10pt;"><font style="font-family: 'Times New Roman';">&#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Successor Company</font>&#8221; shall have the meaning specified in <font style="font-family: 'Times New Roman';"><u>Section&#160;11.01(a)</u></font>.</font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt; font-size: 10pt;"><font style="font-family: 'Times New Roman';">&#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Trading Day</font>&#8221; means, except for determining amounts due upon conversion as set forth
        below, a day on which (i) trading in the Common Stock (or other security for which a closing sale price must be determined) generally occurs on the Nasdaq Global Select Market or, if the Common Stock (or such other security) is not then listed on
        the Nasdaq Global Select Market, on the principal other U.S. national or regional securities exchange on which the Common Stock (or such other security) is then listed or, if the Common Stock (or such other security) is not then listed on a U.S.
        national or regional securities exchange, on the principal other market on which the Common Stock (or such other security) is then traded and (ii) a Last Reported Sale Price for the Common Stock (or closing sale price for such other security) is
        available on such securities exchange or market; <font style="font-family: 'Times New Roman'; font-style: italic;">provided </font>that if the Common Stock (or such other security) is not so listed or traded, &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Trading Day</font>&#8221; means a Business Day; and&#160;<font style="font-family: 'Times New Roman'; font-style: italic;">provided</font>, <font style="font-family: 'Times New Roman'; font-style: italic;">further</font>, that
        for purposes of determining amounts due upon conversion only, &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Trading Day</font>&#8221; means a day on which (x) there is no Market Disruption Event and (y) trading in the Common Stock
        generally occurs on the Nasdaq Global Select Market or, if the Common Stock is not then listed on the Nasdaq Global Select Market, on the principal other U.S. national or regional securities exchange on which the Common Stock is then listed or, if
        the Common Stock is not then listed on a U.S. national or regional securities exchange, on the principal other market on which the Common Stock is then listed or admitted for trading, except that if the Common Stock is not so listed or admitted for
        trading, &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Trading Day</font>&#8221; means a Business Day.</font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt; font-size: 10pt;"><font style="font-family: 'Times New Roman';">&#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Trading Price</font>&#8221; of the Notes on any date of determination means the average of the
        secondary market bid quotations obtained by the Bid Solicitation Agent for $5,000,000 principal amount of Notes at approximately 3:30 p.m., New York City time, on such determination date from three independent nationally recognized securities
        dealers the Company selects for this purpose; <font style="font-family: 'Times New Roman'; font-style: italic;">provided </font>that if three such bids cannot reasonably be obtained by the Bid Solicitation Agent but two such bids are obtained,
        then the average of the two bids shall be used, and if only one such bid can reasonably be obtained by the Bid Solicitation Agent, that one bid shall be used.&#160; If, on any determination date, the Bid Solicitation Agent cannot reasonably obtain at
        least one bid for $5,000,000 principal amount of Notes from a nationally recognized securities dealer, then the Trading Price per $1,000 principal amount of Notes on such determination date shall be deemed to be less than 98% of the product of the
        Last Reported Sale Price of the Common Stock and the Conversion Rate.&#160; Any such determination will be conclusive absent manifest error.</font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">13</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-indent: 36pt; font-size: 10pt;"><font style="font-family: 'Times New Roman';">&#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">transfer</font>&#8221; shall have the meaning specified in <font style="font-family: 'Times New Roman';"><u>Section&#160;2.05(c)</u></font>.</font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt; font-size: 10pt;"><font style="font-family: 'Times New Roman';">&#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Trigger Event</font>&#8221; shall have the meaning specified in <font style="font-family: 'Times New Roman';"><u>Section&#160;14.04(c)</u></font>.</font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt; font-size: 10pt;"><font style="font-family: 'Times New Roman';">&#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Trust Indenture Act</font>&#8221; means the Trust Indenture Act of 1939, as amended, as it was in
        force at the date of execution of this Indenture; <font style="font-family: 'Times New Roman'; font-style: italic;">provided</font>, <font style="font-family: 'Times New Roman'; font-style: italic;">however</font>, that in the event the Trust
        Indenture Act of 1939 is amended after the date hereof, the term &#8220;Trust Indenture Act&#8221; shall mean, to the extent required by such amendment, the Trust Indenture Act of 1939, as so amended.</font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt; font-size: 10pt;"><font style="font-family: 'Times New Roman';">&#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Trustee</font>&#8221; means the Person named as the &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Trustee</font>&#8221; in the first paragraph of this Indenture until a successor trustee shall have become such pursuant to the applicable provisions of this Indenture, and thereafter &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Trustee</font>&#8221; shall mean or include each Person who is then a Trustee hereunder.</font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt; font-size: 10pt;"><font style="font-family: 'Times New Roman';">&#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">unit of Reference Property</font>&#8221; shall have the meaning specified in <font style="font-family: 'Times New Roman';"><u>Section&#160;14.07(a)</u></font>.</font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt; font-size: 10pt;"><font style="font-family: 'Times New Roman';">&#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Valuation Period</font>&#8221; shall have the meaning specified in <font style="font-family: 'Times New Roman';"><u>Section&#160;14.04(c)</u></font>.</font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt; font-size: 10pt;"><font style="font-family: 'Times New Roman';">&#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Wholly Owned Subsidiary</font>&#8221; means, with respect to any Person, any Subsidiary of such
        Person, except that, solely for purposes of this definition, the reference to &#8220;more than 50%&#8221; in the definition of &#8220;Subsidiary&#8221; shall be deemed replaced by a reference to &#8220;100%,&#8221; the calculation of which shall exclude nominal amounts of the voting
        power of shares of Capital Stock or other interests in the relevant Subsidiary not held by such person to the extent required to satisfy local minority interest requirements outside of the United States.</font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">Section 1.02</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><u>References to Interest</u></font><font style="font-family: 'Times New Roman'; font-style: italic;">.&#160; </font>Unless the context otherwise requires, any reference to interest on, or in respect of, any Note in this Indenture
          shall be deemed to include Additional Interest and Deferred Additional Interest if, in such context, Additional Interest or Deferred Additional Interest is, was or would be payable pursuant to any of <font style="font-family: 'Times New Roman';"><u>Section&#160;4.06(c)</u></font>,
          <font style="font-family: 'Times New Roman';"><u>Section&#160;4.06(d)</u></font>, <font style="font-family: 'Times New Roman';"><u>Section 4.06(f)</u></font> and <font style="font-family: 'Times New Roman';"><u>Section&#160;6.03</u></font>.&#160; Unless the
          context otherwise requires, any express mention of Additional Interest, Deferred Additional Interest, or interest in any provision hereof shall not be construed as excluding Additional Interest, Deferred Additional Interest, or interest in those
          provisions hereof where such express mention is not made.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">ARTICLE 2<font style="font-family: 'Times New Roman';"><br>
      </font><a name="z_Toc62469663"></a>ISSUE, DESCRIPTION, EXECUTION,<font style="font-family: 'Times New Roman';"><br>
      </font>REGISTRATION AND EXCHANGE OF NOTES</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">Section 2.01</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><u>Designation and Amount</u></font><font style="font-family: 'Times New Roman'; font-style: italic;">.&#160; </font>The Notes shall be designated as the &#8220;1.75% Convertible Senior Notes due 2031.&#8221; The aggregate principal amount of
          Notes that may be authenticated and delivered under this Indenture is initially limited to $575,000,000, subject to <font style="font-family: 'Times New Roman';"><u>Section&#160;2.10</u></font>&#160;and except for Notes authenticated and delivered upon
          registration or transfer of, or in exchange for, or in lieu of other Notes to the extent expressly permitted hereunder.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">14</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">Section 2.02</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><a name="z_Toc62469665"></a><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><u>Form of Notes</u></font><font style="font-family: 'Times New Roman'; font-style: italic;">.&#160; </font>The Notes and the Trustee&#8217;s certificate of authentication to be borne by such Notes shall be
          substantially in the respective forms set forth in Exhibit A, the terms and provisions of which shall constitute, and are hereby expressly incorporated in and made a part of this Indenture.&#160; To the extent applicable, the Company and the Trustee,
          by their execution and delivery of this Indenture, expressly agree to such terms and provisions and to be bound thereby.&#160; In the case of any conflict between this Indenture and a Note, the provisions of this Indenture shall control and govern to
          the extent of such conflict.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Any Global Note may be endorsed with or have incorporated in the text thereof such legends or recitals or changes not inconsistent with the provisions of
      this Indenture as may be required by the Custodian or the Depositary, or as may be required to comply with any applicable law or any regulation thereunder or with the rules and regulations of any securities exchange or automated quotation system upon
      which the Notes may be listed or traded or designated for issuance or to conform with any usage with respect thereto, or to indicate any special limitations or restrictions to which any particular Notes are subject.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Any of the Notes may have such letters, numbers or other marks of identification and such notations, legends or endorsements as the Officer executing the
      same may approve (execution thereof to be conclusive evidence of such approval) and as are not inconsistent with the provisions of this Indenture, or as may be required to comply with any law or with any rule or regulation made pursuant thereto or
      with any rule or regulation of any securities exchange or automated quotation system on which the Notes may be listed or designated for issuance, or to conform to usage or to indicate any special limitations or restrictions to which any particular
      Notes are subject.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Each Global Note shall represent such principal amount of the outstanding Notes as shall be specified therein and shall provide that it shall represent
      the aggregate principal amount of outstanding Notes from time to time endorsed thereon and that the aggregate principal amount of outstanding Notes represented thereby may from time to time be increased or reduced to reflect redemptions, repurchases,
      cancellations, conversions, transfers or exchanges permitted hereby.&#160; Any endorsement of a Global Note to reflect the amount of any increase or decrease in the amount of outstanding Notes represented thereby shall be made by the Trustee or the
      Custodian, at the direction of the Trustee, in such manner and upon instructions given by the Holder of such Notes in accordance with this Indenture.&#160; Payment of principal (including the Redemption Price and the Fundamental Change Repurchase Price,
      if applicable) of, and accrued and unpaid interest on, a Global Note shall be made to the Holder of such Note on the date of payment, unless a record date or other means of determining Holders eligible to receive payment is provided for herein.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">Section 2.03</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><u>Date and Denomination of Notes; Payments of Interest and Defaulted Amounts</u></font>.&#160; (a)&#160; The Notes shall be issuable in registered form without coupons in minimum denominations of $1,000 principal amount and integral
          multiples thereof.&#160; Each Note shall be dated the date of its authentication and shall bear interest from the date specified on the face of such Note.&#160; Accrued interest on the Notes shall be computed on the basis of a&#160;360-day&#160;year composed of
          twelve&#160;30-day&#160;months and, for partial months, on the basis of the number of days actually elapsed in a&#160;30-day&#160;month.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">15</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(b)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">The Person in whose
          name any Note (or its Predecessor Note) is registered on the Note Register at the close of business on any Regular Record Date with respect to any Interest Payment Date shall be entitled to receive the interest payable on such Interest Payment
          Date.&#160; The principal amount of any Note (x) in the case of any Physical Note, shall be payable at the office or agency of the Company designated by the Company for such purposes in the contiguous United States, which shall initially be the
          Corporate Trust Office and (y) in the case of any Global Note, shall be payable by wire transfer of immediately available funds to the account of the Depositary or its nominee.&#160; The Company shall pay or cause the Paying Agent to pay interest (i)
          on any Physical Notes (A) to Holders holding Physical Notes having an aggregate principal amount of $5,000,000 or less, by check mailed to the Holders of these Notes at their address as it appears in the Note Register and (B) to Holders holding
          Physical Notes having an aggregate principal amount of more than $5,000,000, either by check mailed to each such Holder or, upon written application by such a Holder to the Note Registrar not later than the relevant Regular Record Date, by wire
          transfer in immediately available funds to that Holder&#8217;s account within the United States if such Holder has provided the Company, the Trustee or the Paying Agent (if other than the Trustee) with the requisite information necessary to make such
          wire transfer, which application shall remain in effect until the Holder notifies, in writing, the Note Registrar to the contrary or (ii) on any Global Note by wire transfer of immediately available funds to the account of the Depositary or its
          nominee.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(c)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">Any Defaulted
          Amounts shall forthwith cease to be payable to the Holder on the relevant payment date but shall accrue interest (&#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Default Interest</font>&#8221;) per annum at the rate borne by the
          Notes, subject to the enforceability thereof under applicable law, from, and including, such relevant payment date, and such Defaulted Amounts together with such interest thereon shall be paid by the Company, at its election in each case, as
          provided in clause (i) or (ii) below:</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div>
      <div>
        <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; margin-left: 36pt; text-indent: 27pt;"><font style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(i) &#160; &#160; &#160; &#160;&#160; </font><font style="font-size: 10pt;">The Company may elect to make payment of any Defaulted Amounts to the Persons in whose names the Notes (or their respective Predecessor Notes) are registered at the close of business on a special record date for the
            payment of such Defaulted Amounts, which shall be fixed in the following manner.&#160; The Company shall notify the Trustee in writing of the amount of the Defaulted Amounts proposed to be paid on each Note and the date of the proposed payment
            (which shall be not less than 25 days after the receipt by the Trustee of such notice, unless the Trustee shall consent to an earlier date), and at the same time the Company shall deposit with the Trustee an amount of money equal to the
            aggregate amount to be paid in respect of such Defaulted Amounts or shall make arrangements satisfactory to the Trustee for such deposit on or prior to the date of the proposed payment, such money when deposited to be held in trust for the
            benefit of the Persons entitled to such Defaulted Amounts as in this clause provided.&#160; Thereupon the Company shall fix a special record date for the payment of such Defaulted Amounts which shall be not more than 15 days and not less than 10
            days prior to the date of the proposed payment, and not less than 10 days after the receipt by the Trustee of the notice of the proposed payment (unless the Trustee shall consent to an earlier date).&#160; The Company shall promptly notify the
            Trustee in writing of such special record date and the Trustee, in the name and at the expense of the Company, shall cause notice of the proposed payment of such Defaulted Amounts and the special record date therefor to be delivered to each
            Holder not less than 10 days prior to such special record date; provided that the Trustee has received such notice at least two Business Days prior to the date such notice is to be sent (or such shorter period as shall be acceptable to the
            Trustee).&#160; Notice of the proposed payment of such Defaulted Amounts and the special record date therefor having been so delivered, such Defaulted Amounts shall be paid to the Persons in whose names the Notes (or their respective Predecessor
            Notes) are registered at the close of business on such special record date and shall no longer be payable pursuant to the following clause (ii) of this <font style="font-family: 'Times New Roman';"><u>Section&#160;2.03(c)</u></font>. The Trustee
            shall have no responsibility whatsoever for the calculation of the Defaulted Amounts.</font></div>
        <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman';"> <font style="font-size: 10pt;"><br>
          </font></div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
          <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">16</font></div>
          <div style="page-break-after: always;" class="BRPFPageBreak">
            <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
        </div>
      </div>
    </div>
    <div>
      <div>
        <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; margin-left: 36pt; text-indent: 27pt;"><font style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-size: 10pt;">The Company may make payment of any Defaulted Amounts in any other lawful manner not inconsistent with the requirements of any securities exchange or automated quotation system on which the Notes may be listed or
            designated for issuance, and upon such notice as may be required by such exchange or automated quotation system, if, after notice given by the Company to the Trustee of the proposed payment pursuant to this clause, such manner of payment shall
            be deemed practicable by the Trustee.</font></div>
      </div>
    </div>
    <div style="text-indent: 36pt; font-size: 10pt;"><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"> <br>
      </font></div>
    <div style="text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(d)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">If the first date on
          which any Additional Interest begins to accrue on a Global Note is on or after the fifth (5th) Business Day before a Regular Record Date and before the next Interest Payment Date, then, notwithstanding anything to the contrary in this Indenture
          or the Notes, the amount thereof accruing in respect of the period from, and including, such first date to, but excluding, such Interest Payment Date will not be payable on such Interest Payment Date but will instead be deemed to accrue (without
          duplication) entirely on such Interest Payment Date (and, for the avoidance of doubt, no interest will accrue as a result of the related delay).</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">Section 2.04</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><u>Execution, Authentication and Delivery of Notes</u></font><font style="font-family: 'Times New Roman'; font-style: italic;">.&#160; </font>The Notes shall be signed in the name and on behalf of the Company by the manual, facsimile
          or other electronic signature of one of the Officers of the Company.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">At any time and from time to time after the execution and delivery of this Indenture, the Company may deliver Notes executed by the Company to the
      Trustee for authentication, together with a Company Order (such Company Order to include the terms of the Notes) for the authentication and delivery of such Notes, and the Trustee in accordance with such Company Order shall authenticate and deliver
      such Notes, without any further action by the Company hereunder; provided that, subject to <font style="font-family: 'Times New Roman';"><u>Section&#160;17.05</u></font>, the Trustee shall be entitled to receive an Officer&#8217;s Certificate and an Opinion of
      Counsel of the Company with respect to the issuance, authentication and delivery of such Notes.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Only such Notes as shall bear thereon a certificate of authentication substantially in the form set forth on the Form of Note attached as Exhibit A
      hereto, executed manually by an authorized signatory of the Trustee (or an authenticating agent appointed by the Trustee as provided by <font style="font-family: 'Times New Roman';"><u>Section&#160;17.10</u></font>), shall be entitled to the benefits of
      this Indenture or be valid or obligatory for any purpose.&#160; Such certificate by the Trustee (or such an authenticating agent) upon any Note executed by the Company shall be conclusive evidence that the Note so authenticated has been duly authenticated
      and delivered hereunder and that the Holder is entitled to the benefits of this Indenture.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">17</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">In case any Officer of the Company who shall have signed any of the Notes shall cease to be such Officer before the Notes so signed shall have been
      authenticated and delivered by the Trustee, or disposed of by the Company, such Notes nevertheless may be authenticated and delivered or disposed of as though the person who signed such Notes had not ceased to be such Officer of the Company; and any
      Note may be signed on behalf of the Company by such persons as, at the actual date of the execution of such Note, shall be the Officers of the Company, although at the date of the execution of this Indenture any such person was not such an Officer.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">Section 2.05</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><u>Exchange and Registration of Transfer of Notes; Restrictions on Transfer; Depositary</u></font><font style="font-family: 'Times New Roman'; font-style: italic;">.&#160; </font>(a)&#160; The Company shall cause to be kept at the
          Corporate Trust Office a register (the register maintained in such office or in any other office or agency of the Company designated pursuant to <font style="font-family: 'Times New Roman';"><u>Section&#160;4.02</u></font>, the &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Note Register</font>&#8221;) in which, subject to such reasonable regulations as it may prescribe, the Company shall provide for the registration of Notes and of transfers of Notes.&#160; Such
          register shall be in written form or in any form capable of being converted into written form within a reasonable period of time.&#160; The Trustee is hereby initially appointed the &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Note



            Registrar</font>&#8221; for the purpose of registering Notes and transfers of Notes as herein provided.&#160; The Company may appoint one or more&#160;co-Note&#160;Registrars in accordance with <font style="font-family: 'Times New Roman';"><u>Section&#160;4.02</u></font>.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Upon surrender for registration of transfer of any Note to the Note Registrar or any&#160;co-Note&#160;Registrar, and satisfaction of the requirements for such
      transfer set forth in this <font style="font-family: 'Times New Roman';"><u>Section&#160;2.05</u></font>, the Company shall execute, and the Trustee shall authenticate and deliver, in the name of the designated transferee or transferees, one or more new
      Notes of any authorized denominations and of a like aggregate principal amount and bearing such restrictive legends as may be required by this Indenture.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Notes may be exchanged for other Notes of any authorized denominations and of a like aggregate principal amount, upon surrender of the Notes to be
      exchanged at any such office or agency maintained by the Company pursuant to <font style="font-family: 'Times New Roman';"><u>Section&#160;4.02</u></font>.&#160; Whenever any Notes are so surrendered for exchange, the Company shall execute, and the Trustee
      shall authenticate and deliver, the Notes that the Holder making the exchange is entitled to receive, bearing registration numbers not contemporaneously outstanding.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">All Notes presented or surrendered for registration of transfer or for exchange, redemption, repurchase or conversion shall (if so required by the
      Company, the Trustee, the Note Registrar or any&#160;co-Note&#160;Registrar) be duly endorsed, or be accompanied by a written instrument or instruments of transfer in form satisfactory to the Company and duly executed, by the Holder thereof or
      its&#160;attorney-in-fact&#160;duly authorized in writing.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">No service charge shall be imposed by the Company, the Trustee, the Note Registrar, any&#160;co-Note&#160;Registrar or the Paying Agent for any exchange or
      registration of transfer of Notes, but the Company and Trustee may require a Holder to pay a sum sufficient to cover any documentary, stamp or similar issue or transfer tax required in connection therewith as a result of the name of the Holder of new
      Notes issued upon such exchange or registration of transfer being different from the name of the Holder of the old Notes surrendered for exchange or registration of transfer.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">18</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">None of the Company, the Trustee, the Note Registrar or any&#160;co-Note&#160;Registrar shall be required to exchange for other Notes or register a transfer of (i)
      any Notes surrendered for conversion or, if a portion of any Note is surrendered for conversion, such portion thereof surrendered for conversion, (ii) any Notes, or a portion of any Note, surrendered for repurchase (and not withdrawn) in accordance
      with&#160;<font style="font-family: 'Times New Roman';"><u>Article 15</u></font> or (iii) any Notes selected for redemption in accordance with <font style="font-family: 'Times New Roman';"><u>Article 16</u></font>, except the unredeemed portion of any
      Note being redeemed in part.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">All Notes issued upon any registration of transfer or exchange of Notes in accordance with this Indenture shall be the valid obligations of the Company,
      evidencing the same debt, and entitled to the same benefits under this Indenture as the Notes surrendered upon such registration of transfer or exchange.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(b)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160; &#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">So long as the
          Notes are eligible for book-entry settlement with the Depositary, unless otherwise required by law, subject to the fourth paragraph from the end of <font style="font-family: 'Times New Roman';"><u>Section&#160;2.05(c)</u></font> all Notes shall be
          represented by one or more Notes in global form (each, a &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Global Note</font>&#8221;) registered in the name of the Depositary or the nominee of the Depositary.&#160; Each Global Note shall
          bear the legend required on a Global Note set forth in&#160;<font style="font-family: 'Times New Roman';"><u>Exhibit A</u></font>&#160;hereto.&#160; The transfer and exchange of beneficial interests in a Global Note that does not involve the issuance of a
          Physical Note shall be effected through the Depositary (but not the Trustee or the Custodian) in accordance with this Indenture (including the restrictions on transfer set forth herein) and the procedures of the Depositary therefor.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(c)</font><font style="font-size: 10pt;">&#160;&#160; &#160; &#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">Every Note that
          bears or is required under this <font style="font-family: 'Times New Roman';"><u>Section&#160;2.05(c)</u></font> to bear the Restrictive Notes Legend (together with any Common Stock issued upon conversion of the Notes that is required to bear the
          legend set forth in <font style="font-family: 'Times New Roman';"><u>Section&#160;2.05(d)</u></font>, collectively, the &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Restricted Securities</font>&#8221;) shall be subject to the
          restrictions on transfer set forth in this <font style="font-family: 'Times New Roman';"><u>Section&#160;2.05(c)</u></font> (including the Restrictive Notes Legend set forth below), unless such restrictions on transfer shall be eliminated or
          otherwise waived by written consent of the Company, and the Holder of each such Restricted Security, by such Holder&#8217;s acceptance thereof, agrees to be bound by all such restrictions on transfer.&#160; As used in this <font style="font-family: 'Times New Roman';"><u>Section&#160;2.05(c)</u></font> and <font style="font-family: 'Times New Roman';"><u>Section&#160;2.05(d)</u></font>, the term &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">transfer</font>&#8221; encompasses any sale,
          pledge, transfer or other disposition whatsoever of any Restricted Security.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Until the date (the &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Resale Restriction Termination Date</font>&#8221;) that is the later of
      (1) the date that is one year after the last date of original issuance of the Notes, or such shorter period of time as permitted by Rule 144 or any successor provision thereto, and (2) such later date, if any, as may be required by applicable law,
      any certificate evidencing such Note (and all securities issued in exchange therefor or substitution thereof, other than Common Stock, if any, issued upon conversion thereof, which shall bear the legend set forth in <font style="font-family: 'Times New Roman';"><u>Section&#160;2.05(d)</u></font>, if applicable) shall bear a legend in substantially the following form (the &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Restrictive Notes Legend</font>&#8221;) (unless such Notes have been
      transferred pursuant to a registration statement that has become or been declared effective under the Securities Act and that continues to be effective at the time of such transfer, or sold pursuant to the exemption from registration provided by Rule
      144 or any similar provision then in force under the Securities Act, or unless otherwise agreed by the Company in writing, with notice thereof to the Trustee):</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">19</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">THIS SECURITY AND THE COMMON STOCK, IF ANY, ISSUABLE UPON CONVERSION OF THIS SECURITY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS
      AMENDED (THE &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">SECURITIES ACT</font>&#8221;), AND MAY NOT BE OFFERED, SOLD, PLEDGED OR OTHERWISE TRANSFERRED EXCEPT IN ACCORDANCE WITH THE FOLLOWING SENTENCE.&#160; BY ITS ACQUISITION HEREOF OR OF
      A BENEFICIAL INTEREST HEREIN, THE ACQUIRER:</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div>
      <div>
        <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: 36pt;"><font style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(1)&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-size: 10pt;">REPRESENTS THAT IT AND ANY ACCOUNT FOR WHICH IT IS ACTING IS A &#8220;QUALIFIED INSTITUTIONAL BUYER&#8221; (WITHIN THE MEANING OF RULE 144A UNDER THE SECURITIES ACT) AND THAT IT EXERCISES SOLE INVESTMENT DISCRETION WITH RESPECT TO EACH SUCH ACCOUNT,
            AND</font></div>
        <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman';"> <font style="font-size: 10pt;"><br>
          </font></div>
      </div>
    </div>
    <div>
      <div>
        <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-indent: 36pt;"><font style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(2)&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-size: 10pt;">AGREES FOR THE BENEFIT OF BRIDGEBIO PHARMA, INC. (THE &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">COMPANY</font>&#8221;) THAT IT WILL NOT OFFER, SELL, PLEDGE OR OTHERWISE TRANSFER THIS SECURITY AND THE COMMON STOCK, IF
            ANY, ISSUABLE UPON CONVERSION OF THIS SECURITY, IF ANY OR ANY BENEFICIAL INTEREST HEREIN OR THEREIN PRIOR TO THE DATE THAT IS THE LATER OF (X) ONE YEAR AFTER THE LAST ORIGINAL ISSUE DATE HEREOF OR SUCH SHORTER PERIOD OF TIME AS PERMITTED BY
            RULE 144 UNDER THE SECURITIES ACT OR ANY SUCCESSOR PROVISION THERETO AND (Y) SUCH LATER DATE, IF ANY, AS MAY BE REQUIRED BY APPLICABLE LAW, EXCEPT:</font></div>
        <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman';"> <font style="font-size: 10pt;"><br>
          </font></div>
      </div>
    </div>
    <div>
      <div>
        <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; margin-left: 63pt;"><font style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(A)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-size: 10pt;">TO THE COMPANY OR ANY SUBSIDIARY THEREOF, OR</font></div>
        <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman';"> <font style="font-size: 10pt;"><br>
          </font></div>
      </div>
    </div>
    <div>
      <div>
        <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; margin-left: 36pt; text-indent: 27pt;"><font style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(B)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-size: 10pt;">PURSUANT TO A REGISTRATION STATEMENT WHICH HAS BECOME EFFECTIVE UNDER THE SECURITIES ACT, OR</font></div>
        <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman';"> <font style="font-size: 10pt;"><br>
          </font></div>
      </div>
    </div>
    <div>
      <div>
        <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; margin-left: 36pt; text-indent: 27pt;"><font style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(C)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-size: 10pt;">TO A QUALIFIED INSTITUTIONAL BUYER IN COMPLIANCE WITH RULE 144A UNDER THE SECURITIES ACT, OR</font></div>
        <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman';"> <font style="font-size: 10pt;"><br>
          </font></div>
      </div>
    </div>
    <div>
      <div>
        <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; margin-left: 36pt; text-indent: 27pt;"><font style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(D) &#160; &#160; &#160;&#160; </font><font style="font-size: 10pt;">PURSUANT TO AN EXEMPTION FROM REGISTRATION PROVIDED BY RULE 144 UNDER THE SECURITIES ACT OR ANY OTHER AVAILABLE EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT.</font></div>
      </div>
    </div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"> <font style="font-size: 10pt;"><br>
      </font></div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">PRIOR TO THE REGISTRATION OF ANY TRANSFER IN ACCORDANCE WITH CLAUSE (2)(D) ABOVE, THE COMPANY AND THE TRUSTEE RESERVE THE RIGHT TO REQUIRE THE DELIVERY
      OF SUCH LEGAL OPINIONS, CERTIFICATIONS OR OTHER EVIDENCE AS MAY REASONABLY BE REQUIRED IN ORDER TO DETERMINE THAT THE PROPOSED TRANSFER IS BEING MADE IN COMPLIANCE WITH THE SECURITIES ACT AND APPLICABLE STATE SECURITIES LAWS.&#160; NO REPRESENTATION IS
      MADE AS TO THE AVAILABILITY OF ANY EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">20</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">No transfer of any Note prior to the Resale Restriction Termination Date will be registered by the Note Registrar unless the applicable box on the Form
      of Assignment and Transfer has been checked.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Any Note (or security issued in exchange or substitution therefor) (i) as to which such restrictions on transfer shall have expired in accordance with
      their terms, (ii) that has been transferred pursuant to a registration statement that has become effective or been declared effective under the Securities Act and that continues to be effective at the time of such transfer or (iii) that has been sold
      pursuant to the exemption from registration provided by Rule 144 or any similar provision then in force under the Securities Act, may, upon surrender of such Note for exchange to the Note Registrar in accordance with the provisions of this <font style="font-family: 'Times New Roman';"><u>Section&#160;2.05</u></font>, be exchanged for a new Note or Notes, of like tenor and aggregate principal amount, which shall not bear the Restrictive Notes Legend required by this <font style="font-family: 'Times New Roman';"><u>Section&#160;2.05(c)</u></font> and shall not be assigned a restricted CUSIP number.&#160; The Company shall be entitled to instruct the Custodian in writing to so surrender any Global Note as to which any of the conditions set forth
      in clause (i) through (iii) of the immediately preceding sentence have been satisfied, and, upon such instruction, the Custodian shall so surrender such Global Note for exchange; and any new Global Note so exchanged therefor shall not bear the
      Restrictive Notes Legend specified in this <font style="font-family: 'Times New Roman';"><u>Section&#160;2.05(c)</u></font> and shall not be assigned a restricted CUSIP number.&#160; The Company shall promptly notify the Trustee upon the occurrence of the
      Resale Restriction Termination Date and promptly after a registration statement, if any, with respect to the Notes or any Common Stock issued upon conversion of the Notes has been declared effective under the Securities Act. Upon notice of the Resale
      Restriction Termination Date in accordance with the immediately preceding sentence, the legend set forth above shall be deemed removed from the Note, with no further action required by the Company, the Trustee, or, if applicable, the Depositary; at
      such time, such Note will be deemed to be identified by the &#8220;unrestricted&#8221; CUSIP and ISIN numbers provided in the certificate representing such Note; <font style="font-family: 'Times New Roman'; font-style: italic;">provided</font>, <font style="font-family: 'Times New Roman'; font-style: italic;">however</font>, that if such Note is a Global Note and the Depositary requires a mandatory exchange or other procedure to cause such Global Note to be identified by &#8220;unrestricted&#8221; CUSIP
      and ISIN numbers in the facilities of such Depositary, then (x) the Company will effect such exchange or procedure as soon as reasonably practicable; and (y) for purposes of <font style="font-family: 'Times New Roman';"><u>Section 4.06</u></font>
      and the definition of Freely Tradable, such Global Note will not be deemed to be identified by &#8220;unrestricted&#8221; CUSIP and ISIN numbers until such time as such exchange or procedure is effected.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Notwithstanding any other provisions of this Indenture (other than the provisions set forth in this <font style="font-family: 'Times New Roman';"><u>Section&#160;2.05(c)</u></font>),



      a Global Note may not be transferred as a whole or in part except (i) by the Depositary to a nominee of the Depositary or by a nominee of the Depositary to the Depositary or another nominee of the Depositary or by the Depositary or any such nominee
      to a successor Depositary or a nominee of such successor Depositary and (ii) for exchange of a Global Note or a portion thereof for one or more Physical Notes in accordance with the second immediately succeeding paragraph.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">The Depositary shall be a clearing agency registered under the Exchange Act.&#160; The Company initially appoints The Depository Trust Company to act as
      Depositary with respect to each Global Note.&#160; Initially, each Global Note shall be issued to the Depositary, registered in the name of Cede&#160;&amp; Co., as the nominee of the Depositary, and deposited with the Trustee as custodian for Cede&#160;&amp; Co.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">21</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">If (i) the Depositary notifies the Company at any time that the Depositary is unwilling or unable to continue as depositary for the Global Notes and a
      successor depositary is not appointed within 90 days, (ii) the Depositary ceases to be registered as a clearing agency under the Exchange Act and a successor depositary is not appointed within 90 days or (iii) an Event of Default with respect to the
      Notes has occurred and is continuing and, subject to the Depositary&#8217;s applicable procedures, a beneficial owner of any Note requests that its beneficial interest therein be issued as a Physical Note, the Company shall execute, and the Trustee, upon
      receipt of an Officer&#8217;s Certificate and a Company Order for the authentication and delivery of Notes, shall authenticate and deliver (x) in the case of clause (iii), a Physical Note to such beneficial owner in a principal amount equal to the
      principal amount of such Note corresponding to such beneficial owner&#8217;s beneficial interest and (y) in the case of clause (i) or (ii), Physical Notes to each beneficial owner of the related Global Notes (or a portion thereof) in an aggregate principal
      amount equal to the aggregate principal amount of such Global Notes in exchange for such Global Notes, and upon delivery of the Global Notes to the Trustee such Global Notes shall be canceled.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Physical Notes issued in exchange for all or a part of the Global Note pursuant to this <font style="font-family: 'Times New Roman';"><u>Section&#160;2.05(c)</u></font>
      shall be registered in such names and in such authorized denominations as the Depositary, pursuant to instructions from its direct or indirect participants or otherwise, or, in the case of clause (iii) of the immediately preceding paragraph, the
      relevant beneficial owner, shall instruct the Trustee.&#160; Upon execution and authentication, the Trustee shall deliver such Physical Notes to the Persons in whose names such Physical Notes are so registered.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">At such time as all interests in a Global Note have been converted, canceled, repurchased upon a Fundamental Change, redeemed or transferred, such Global
      Note shall be, upon receipt thereof, canceled by the Trustee in accordance with standing procedures and existing instructions between the Depositary and the Custodian.&#160; At any time prior to such cancellation, if any interest in a Global Note is
      exchanged for Physical Notes, converted, canceled, repurchased upon a Fundamental Change, redeemed or transferred to a transferee who receives Physical Notes therefor or any Physical Note is exchanged or transferred for part of such Global Note, the
      principal amount of such Global Note shall, in accordance with the standing procedures and instructions existing between the Depositary and the Custodian, be appropriately reduced or increased, as the case may be, and an endorsement shall be made on
      such Global Note, by the Trustee or the Custodian, at the direction of the Trustee, to reflect such reduction or increase.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">None of the Company, the Trustee or any agent of the Company or the Trustee shall have any responsibility or liability for any act or omission of the
      Depositary or for the payment of amounts to owners of beneficial interest in a Global Note, for any aspect of the records relating to or payments made on account of those interests by the Depositary, or for maintaining, supervising or reviewing any
      records of the Depositary relating to those interests.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">22</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(d)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">Until the Resale
          Restriction Termination Date, any stock certificate representing Common Stock issued upon conversion of a Note shall bear a legend in substantially the following form (unless such Common Stock has been transferred pursuant to a registration
          statement that has become or been declared effective under the Securities Act and that continues to be effective at the time of such transfer, or pursuant to the exemption from registration provided by Rule 144 or any similar provision then in
          force under the Securities Act, or such Common Stock has been issued upon conversion of a Note that has been transferred pursuant to a registration statement that has become or been declared effective under the Securities Act and that continues
          to be effective at the time of such transfer, or pursuant to the exemption from registration provided by Rule 144 or any similar provision then in force under the Securities Act, or unless otherwise agreed by the Company with written notice
          thereof to the Trustee and any transfer agent for the Common Stock):</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">THIS SECURITY HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">SECURITIES



        ACT</font>&#8221;), AND MAY NOT BE OFFERED, SOLD, PLEDGED OR OTHERWISE TRANSFERRED EXCEPT IN ACCORDANCE WITH THE FOLLOWING SENTENCE.&#160; BY ITS ACQUISITION HEREOF OR OF A BENEFICIAL INTEREST HEREIN, THE ACQUIRER:</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div>
      <div>
        <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; margin-left: 36pt; text-indent: 27pt;"><font style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(1)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-size: 10pt;">REPRESENTS THAT IT AND ANY ACCOUNT FOR WHICH IT IS ACTING IS A &#8220;QUALIFIED INSTITUTIONAL BUYER&#8221; (WITHIN THE MEANING OF RULE 144A UNDER THE SECURITIES ACT) AND THAT IT EXERCISES SOLE INVESTMENT DISCRETION WITH RESPECT TO
            EACH SUCH ACCOUNT, AND</font></div>
        <div style="text-align: left; text-indent: 72pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';"> <font style="font-size: 10pt;"><br>
          </font></div>
      </div>
    </div>
    <div>
      <div>
        <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; margin-left: 36pt; text-indent: 27pt;"><font style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(2)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-size: 10pt;">AGREES FOR THE BENEFIT OF BRIDGEBIO PHARMA, INC. (THE &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">COMPANY</font>&#8221;) THAT IT WILL NOT OFFER, SELL, PLEDGE OR OTHERWISE TRANSFER THIS SECURITY OR ANY
            BENEFICIAL INTEREST HEREIN PRIOR TO THE DATE THAT IS THE LATER OF (X) ONE YEAR AFTER THE LAST ORIGINAL ISSUE DATE OF THE SERIES OF NOTES UPON THE CONVERSION OF WHICH THIS SECURITY WAS ISSUED OR SUCH SHORTER PERIOD OF TIME AS PERMITTED BY RULE
            144 UNDER THE SECURITIES ACT OR ANY SUCCESSOR PROVISION THERETO AND (Y) SUCH LATER DATE, IF ANY, AS MAY BE REQUIRED BY APPLICABLE LAW, EXCEPT:</font></div>
        <div style="text-align: left; text-indent: 72pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';"> <font style="font-size: 10pt;"><br>
          </font></div>
      </div>
    </div>
    <div>
      <div>
        <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; margin-left: 63pt; text-indent: 36pt;"><font style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(A)&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-size: 10pt;">TO THE COMPANY OR ANY SUBSIDIARY THEREOF, OR</font></div>
        <div style="text-align: left; text-indent: 72pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';"> <font style="font-size: 10pt;"><br>
          </font></div>
      </div>
    </div>
    <div>
      <div>
        <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; margin-left: 63pt; text-indent: 36pt;"><font style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(B)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-size: 10pt;">PURSUANT TO A REGISTRATION STATEMENT WHICH HAS BECOME EFFECTIVE UNDER THE SECURITIES ACT, OR</font></div>
        <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman';"> <font style="font-size: 10pt;"><br>
          </font></div>
      </div>
    </div>
    <div>
      <div>
        <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; margin-left: 63pt; text-indent: 36pt;"><font style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(C)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-size: 10pt;">TO A QUALIFIED INSTITUTIONAL BUYER IN COMPLIANCE WITH RULE 144A UNDER THE SECURITIES ACT, OR</font></div>
        <div style="text-align: left; text-indent: 72pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';"> <font style="font-size: 10pt;"><br>
          </font></div>
      </div>
    </div>
    <div>
      <div>
        <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; margin-left: 63pt; text-indent: 36pt;"><font style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(D)&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-size: 10pt;">PURSUANT TO AN EXEMPTION FROM REGISTRATION PROVIDED BY RULE 144 UNDER THE SECURITIES ACT OR ANY OTHER AVAILABLE EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT.</font></div>
        <div style="text-align: left; text-indent: 72pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';"> <font style="font-size: 10pt;"><br>
          </font></div>
      </div>
    </div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">PRIOR TO THE REGISTRATION OF ANY TRANSFER IN ACCORDANCE WITH CLAUSE (2)(D) ABOVE, THE COMPANY AND THE TRANSFER AGENT FOR THE COMPANY&#8217;S COMMON STOCK
      RESERVE THE RIGHT TO REQUIRE THE DELIVERY OF SUCH LEGAL OPINIONS, CERTIFICATIONS OR OTHER EVIDENCE AS MAY REASONABLY BE REQUIRED IN ORDER TO DETERMINE THAT THE PROPOSED TRANSFER IS BEING MADE IN COMPLIANCE WITH THE SECURITIES ACT AND APPLICABLE STATE
      SECURITIES LAWS.&#160; NO REPRESENTATION IS MADE AS TO THE AVAILABILITY OF ANY EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">23</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Any such Common Stock (i) as to which such restrictions on transfer shall have expired in accordance with their terms, (ii) that has been transferred
      pursuant to a registration statement that has become or been declared effective under the Securities Act and that continues to be effective at the time of such transfer or (iii) that has been sold pursuant to the exemption from registration provided
      by Rule 144 or any similar provision then in force under the Securities Act, may, upon surrender of the certificates representing such shares of Common Stock for exchange in accordance with the procedures of the transfer agent for the Common Stock,
      be exchanged for a new certificate or certificates for a like aggregate number of shares of Common Stock, which shall not bear the restrictive legend required by this <font style="font-family: 'Times New Roman';"><u>Section&#160;2.05(d)</u></font>.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">The Trustee shall have no obligation or duty to monitor, determine or inquire as to compliance with any restrictions on transfer imposed under this
      Indenture or under applicable law with respect to any transfer of any interest in any Note (including any transfers between or among Depositary participants or beneficial owners of interests in any Global Note) other than to require delivery of such
      certificates and other documentation or evidence as are expressly required by, and to do so if and when expressly required by the terms of, this Indenture, and to examine the same to determine substantial compliance as to form with the express
      requirements hereof.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(e)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">Any Note or Common
          Stock issued upon the conversion or exchange of a Note that is repurchased or owned by the Company or any Affiliate of the Company (or any Person who was an Affiliate of the Company at any time during the three months immediately preceding) may
          not be resold by the Company or such Affiliate (or such Person, as the case may be) unless registered under the Securities Act or resold pursuant to an exemption from the registration requirements of the Securities Act in a transaction that
          results in such Note or Common Stock, as the case may be, no longer being a &#8220;restricted security&#8221; (as defined under Rule 144).</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">Section 2.06</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><u>Mutilated, Destroyed, Lost or Stolen Notes</u></font>.&#160; In case any Note shall become mutilated or be destroyed, lost or stolen, the Company in its discretion may execute, and upon receipt of a Company Order the Trustee or an
          authenticating agent appointed by the Trustee shall authenticate and deliver, a new Note, bearing a registration number not contemporaneously outstanding, in exchange and substitution for the mutilated Note, or in lieu of and in substitution for
          the Note so destroyed, lost or stolen.&#160; In every case the applicant for a substituted Note shall furnish to the Company, to the Trustee and, if applicable, to such authenticating agent such security or indemnity as may be required by them to save
          each of them harmless from any loss, liability, cost or expense caused by or connected with such substitution, and, in every case of destruction, loss or theft, the applicant shall also furnish to the Company, to the Trustee and, if applicable,
          to such authenticating agent evidence to their satisfaction of the destruction, loss or theft of such Note and of the ownership thereof.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">24</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">The Trustee or such authenticating agent may authenticate any such substituted Note and deliver the same upon the receipt of such security or indemnity
      as the Trustee, the Company and, if applicable, such authenticating agent may require.&#160; No service charge shall be imposed by the Company, the Trustee, the Note Registrar, any&#160;co-Note&#160;Registrar or the Paying Agent upon the issuance of any substitute
      Note, but the Company may require a Holder to pay a sum sufficient to cover any documentary, stamp or similar issue or transfer tax required in connection therewith as a result of the name of the Holder of the new substitute Note being different from
      the name of the Holder of the old Note that became mutilated or was destroyed, lost or stolen.&#160; In case any Note that has matured or is about to mature or has been surrendered for required repurchase or is about to be converted in accordance with&#160;<font style="font-family: 'Times New Roman';"><u>Article 14</u></font>&#160;shall become mutilated or be destroyed, lost or stolen, the Company may, in its sole discretion, instead of issuing a substitute Note, pay or authorize the payment of or convert or
      authorize the conversion of the same (without surrender thereof except in the case of a mutilated Note), as the case may be, if the applicant for such payment or conversion shall furnish to the Company, to the Trustee and, if applicable, to such
      authenticating agent such security or indemnity as may be required by them to save each of them harmless for any loss, liability, cost or expense caused by or connected with such substitution, and, in every case of destruction, loss or theft,
      evidence satisfactory to the Company, the Trustee and, if applicable, any Paying Agent or Conversion Agent evidence of their satisfaction of the destruction, loss or theft of such Note and of the ownership thereof.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Every substitute Note issued pursuant to the provisions of this <font style="font-family: 'Times New Roman';"><u>Section&#160;2.06</u></font>&#160;by virtue of
      the fact that any Note is destroyed, lost or stolen shall constitute an additional contractual obligation of the Company, whether or not the destroyed, lost or stolen Note shall be found at any time, and shall be entitled to all the benefits of (but
      shall be subject to all the limitations set forth in) this Indenture equally and proportionately with any and all other Notes duly issued hereunder.&#160; To the extent permitted by law, all Notes shall be held and owned upon the express condition that
      the foregoing provisions are exclusive with respect to the replacement, payment, redemption, conversion or repurchase of mutilated, destroyed, lost or stolen Notes and shall preclude any and all other rights or remedies notwithstanding any law or
      statute existing or hereafter enacted to the contrary with respect to the replacement, payment, redemption, conversion or repurchase of negotiable instruments or other securities without their surrender.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">Section 2.07</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><u>Temporary Notes</u></font><font style="font-family: 'Times New Roman'; font-style: italic;">.&#160; </font>Pending the preparation of Physical Notes, the Company may execute and the Trustee or an authenticating agent appointed by
          the Trustee shall, upon receipt of a Company Order, authenticate and deliver temporary Notes (printed or lithographed).&#160; Temporary Notes shall be issuable in any authorized denomination, and substantially in the form of the Physical Notes but
          with such omissions, insertions and variations as may be appropriate for temporary Notes, all as may be determined by the Company.&#160; Every such temporary Note shall be executed by the Company and authenticated by the Trustee or such authenticating
          agent upon the same conditions and in substantially the same manner, and with the same effect, as the Physical Notes.&#160; Without unreasonable delay, the Company shall execute and deliver to the Trustee or such authenticating agent Physical Notes
          (other than any Global Note) and thereupon any or all temporary Notes (other than any Global Note) may be surrendered in exchange therefor, at each office or agency maintained by the Company pursuant to <font style="font-family: 'Times New Roman';"><u>Section&#160;4.02</u></font>&#160;and the Trustee or such authenticating agent shall authenticate and deliver in exchange for such temporary Notes an equal aggregate principal amount of Physical Notes.&#160; Such exchange shall be made by the
          Company at its own expense and without any charge therefor.&#160; Until so exchanged, the temporary Notes shall in all respects be entitled to the same benefits and subject to the same limitations under this Indenture as Physical Notes authenticated
          and delivered hereunder.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">25</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">Section 2.08</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><a name="z_Toc62469671"></a><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><u>Cancellation of Notes Paid, Converted, Etc</u></font>.&#160; The Company shall cause all Notes surrendered for the purpose of payment at maturity, redemption, registration of transfer or exchange or
          conversion (other than any Notes exchanged pursuant to <font style="font-family: 'Times New Roman';"><u>Section&#160;14.12</u></font>), if surrendered to any Person that the Company controls, to be delivered to the Trustee for cancellation.&#160; All
          Notes delivered to the Trustee shall be canceled promptly by it.&#160; No Notes shall be authenticated in exchange for any Notes surrendered to the Trustee for cancellation.&#160; The Trustee shall dispose of canceled Notes in accordance with its customary
          procedures and, after such disposition, shall deliver a certificate of such disposition to the Company, at the Company&#8217;s written request in a Company Order.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">Section 2.09</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><u>CUSIP Numbers</u></font>.&#160; The Company in issuing the Notes may use &#8220;CUSIP&#8221; numbers (if then generally in use), and, if so, the Trustee shall use &#8220;CUSIP&#8221; numbers in all notices issued to Holders as a convenience to such
          Holders; <font style="font-family: 'Times New Roman'; font-style: italic;">provided </font>that the Trustee shall have no liability for any defect in the &#8220;CUSIP&#8221; numbers as they appear on any Note, notice or elsewhere, and, <font style="font-family: 'Times New Roman'; font-style: italic;">provided, further, </font>that any such notice may state that no representation is made as to the correctness of such numbers either as printed on the Notes or on such notice and that
          reliance may be placed only on the other identification numbers printed on the Notes.&#160; The Company shall promptly notify the Trustee in writing of any change in the &#8220;CUSIP&#8221; numbers.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">Section 2.10</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><u>Additional Notes; Repurchases</u></font>.&#160; The Company may, without the consent of, or notice to, the Holders and notwithstanding <font style="font-family: 'Times New Roman';"><u>Section&#160;2.01</u></font>, reopen this Indenture
          and issue additional Notes hereunder with the same terms as the Notes initially issued hereunder (other than differences in the issue date, the issue price, interest accrued prior to the issue date of such additional Notes and, if applicable,
          restrictions on transfer in respect of such additional Notes) in an unlimited aggregate principal amount; <font style="font-family: 'Times New Roman'; font-style: italic;">provided </font>that if any such additional Notes are not fungible with
          the Notes initially issued hereunder for U.S. federal income tax or securities law purposes, such additional Notes shall have one or more separate CUSIP numbers.&#160; Prior to the issuance of any such additional Notes, the Company shall deliver to
          the Trustee a Company Order, an Officer&#8217;s Certificate and an Opinion of Counsel, such Officer&#8217;s Certificate and Opinion of Counsel to cover such matters, in addition to those required by <font style="font-family: 'Times New Roman';"><u>Section&#160;17.05</u></font>,
          as the Trustee shall reasonably request.&#160; In addition, subject to applicable law, the Company or its Subsidiaries may directly or indirectly&#160; repurchase Notes in the open market or otherwise, whether through private or public tender or exchange
          offers, cash-settled swaps or other cash-settled derivatives.&#160; The Company may, at its option and to the extent permitted by applicable law, reissue, resell or surrender to the Trustee for cancellation any Notes that the Company may repurchase,
          in the case of a reissuance or resale, so long as such Notes do not constitute Restricted Securities upon such reissuance or resale. Any Notes that the Company or its Subsidiaries may repurchase will be considered outstanding for all purposes
          herein (other than, at any time when such Notes are held by the Company, any of its Subsidiaries or Affiliates or any subsidiary of any of the Company&#8217;s Affiliates, for the purpose of determining whether Holders of the requisite aggregate
          principal amount of the Notes have concurred in any direction, consent, waiver or other action under this Indenture) unless and until such time the Company surrenders the Notes to the Trustee for cancellation and, upon receipt of a Company Order,
          the Trustee will cancel all the Notes so surrendered.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">26</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">ARTICLE 3<font style="font-family: 'Times New Roman';"><br>
      </font><a name="z_Toc62469674"></a>SATISFACTION AND DISCHARGE</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">Section 3.01</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><a name="z_Toc62469675"></a><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><u>Satisfaction and Discharge</u></font>.&#160; (a) This Indenture and the Notes shall cease to be of further effect when (i) all Notes theretofore authenticated and delivered (other than (x) Notes which have
          been destroyed, lost or stolen and which have been replaced, paid or converted as provided in <font style="font-family: 'Times New Roman';"><u>Section&#160;2.06</u></font>&#160;and (y) Notes for whose payment money has heretofore been deposited in trust
          or segregated and held in trust by the Company and thereafter repaid to the Company or discharged from such trust, as provided in <font style="font-family: 'Times New Roman';"><u>Section&#160;4.04(d)</u></font>) have been delivered to the Trustee for
          cancellation; or (ii) the Company has deposited with the Trustee or delivered to Holders, as applicable, after the Notes have become due and payable, whether on the Maturity Date, any Redemption Date, any Fundamental Change Repurchase Date, upon
          conversion or otherwise, cash, shares of Common Stock or a combination thereof, as applicable, solely to satisfy the Company&#8217;s Conversion Obligation, sufficient to pay all of the outstanding Notes and all other sums due and payable under this
          Indenture or the Notes by the Company; and (b) the Trustee upon request of the Company contained in an Officer&#8217;s Certificate and at the expense of the Company, shall execute such instruments reasonably requested by the Company acknowledging
          satisfaction and discharge of this Indenture and the Notes, when the Company has delivered to the Trustee an Officer&#8217;s Certificate and an Opinion of Counsel, each stating that all conditions precedent herein provided for relating to the
          satisfaction and discharge of this Indenture and the Notes have been complied with.&#160; Notwithstanding the satisfaction and discharge of this Indenture, the obligations of the Company to the Trustee under <font style="font-family: 'Times New Roman';"><u>Section&#160;7.06</u></font>&#160;shall survive.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">ARTICLE 4<font style="font-family: 'Times New Roman';"><br>
      </font><a name="z_Toc62469676"></a>PARTICULAR COVENANTS OF THE COMPANY</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">Section 4.01</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><u>Payment of Principal and Interest</u></font><font style="font-family: 'Times New Roman'; font-style: italic;">.&#160; </font>The Company covenants and agrees that it will cause to be paid the principal (including the Redemption
          Price and the Fundamental Change Repurchase Price, if applicable) of, and accrued and unpaid interest on, each of the Notes at the places, at the respective times and in the manner provided herein and in the Notes.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">Section 4.02</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><u>Maintenance of Office or Agency</u></font>.&#160; The Company will maintain in the contiguous United States, an office or agency where the Notes may be surrendered for registration of transfer or exchange or for presentation for
          payment or repurchase (&#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Paying Agent</font>&#8221;) or for conversion (&#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Conversion Agent</font>&#8221;) and where notices and
          demands to or upon the Company in respect of the Notes and this Indenture may be served.&#160; The Company will give prompt written notice to the Trustee of the location, and any change in the location, of such office or agency.&#160; If at any time the
          Company shall fail to maintain any such required office or agency or shall fail to furnish the Trustee with the address thereof, such presentations, surrenders, notices and demands may be made or served at the Corporate Trust Office or the office
          or agency of the Trustee in the contiguous United States.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">The Company may also from time to time designate as&#160;co-Note&#160;Registrars one or more other offices or agencies where the Notes may be presented or
      surrendered for any or all such purposes and may from time to time rescind such designations; <font style="font-family: 'Times New Roman'; font-style: italic;">provided </font>that no such designation or rescission shall in any manner relieve the
      Company of its obligation to maintain an office or agency in the contiguous United States, for such purposes.&#160; The Company will give prompt written notice to the Trustee of any such designation or rescission and of any change in the location of any
      such other office or agency.&#160; The terms &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Paying Agent</font>&#8221; and &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Conversion Agent</font>&#8221; include any such additional
      or other offices or agencies, as applicable.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">27</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">The Company hereby initially designates the Trustee as the Paying Agent, Note Registrar, Custodian and Conversion Agent and the Corporate Trust Office as
      the office or agency in the contiguous United States, where Notes may be surrendered for registration of transfer or exchange or for presentation for payment or repurchase or for conversion and where notices and demands to or upon the Company in
      respect of the Notes and this Indenture may be served; provided that the Corporate Trust Office shall not be a place for service of legal process for the Company.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">Section 4.03</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><u>Appointments to Fill Vacancies in Trustee&#8217;s Office</u></font>.&#160; The Company, whenever necessary to avoid or fill a vacancy in the office of Trustee, will appoint, in the manner provided in <font style="font-family: 'Times New Roman';"><u>Section&#160;7.09</u></font>, a Trustee, so that there shall at all times be a Trustee hereunder.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">Section 4.04</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><a name="z_Toc62469680"></a><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><u>Provisions as to Paying Agent</u></font><font style="font-family: 'Times New Roman'; font-style: italic;">.&#160; </font>(a) If the Company shall appoint a Paying Agent other than the Trustee, the Company
          will cause such Paying Agent to execute and deliver to the Trustee an instrument in which such agent shall agree with the Trustee, subject to the provisions of this <font style="font-family: 'Times New Roman';"><u>Section&#160;4.04</u></font>:</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div>
      <div>
        <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; margin-left: 36pt; text-indent: 27pt;"><font style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-size: 10pt;">that it will hold all sums held by it as such agent for the payment of the principal (including the Redemption Price and the Fundamental Change Repurchase Price, if applicable) of, and accrued and unpaid interest on,
            the Notes in trust for the benefit of the Holders of the Notes;</font></div>
      </div>
    </div>
    <div>
      <div>
        <div style="text-align: left; text-indent: 72pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><font style="text-align: left; margin-left: 72pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';"> <br>
          </font></div>
        <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; margin-left: 36pt; text-indent: 27pt;"><font style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-size: 10pt;">that it will give the Trustee prompt notice of any failure by the Company to make any payment of the principal (including the Redemption Price and the Fundamental Change Repurchase Price, if applicable) of, and accrued
            and unpaid interest on, the Notes when the same shall be due and payable; and</font></div>
        <div style="text-align: left; text-indent: 72pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';"> <font style="font-size: 10pt;"><br>
          </font></div>
      </div>
    </div>
    <div>
      <div>
        <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; margin-left: 36pt; text-indent: 27pt;"><font style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(iii) &#160; &#160; &#160;&#160; </font><font style="font-size: 10pt;">that at any time during the continuance of an Event of Default, upon request of the Trustee, it will forthwith pay to the Trustee all sums so held in trust.</font></div>
        <div style="text-align: left; text-indent: 72pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';"> <font style="font-size: 10pt;"><br>
          </font></div>
      </div>
    </div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">The Company shall, on or before each due date of the principal (including the Redemption Price and the Fundamental Change Repurchase Price, if
      applicable) of, or accrued and unpaid interest on, the Notes, deposit with the Paying Agent a sum sufficient to pay such principal (including the Redemption Price and the Fundamental Change Repurchase Price, if applicable) or accrued and unpaid
      interest, and (unless such Paying Agent is the Trustee) the Company will promptly notify the Trustee in writing of any failure to take such action; <font style="font-family: 'Times New Roman'; font-style: italic;">provided </font>that if such
      deposit is made on the due date, such deposit must be received by the Paying Agent by 11:00&#160;a.m., New York City time, on such date.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">28</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(b)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">If the Company
          shall act as its own Paying Agent, it will, on or before each due date of the principal (including the Redemption Price and the Fundamental Change Repurchase Price, if applicable) of, and accrued and unpaid interest on, the Notes, set aside,
          segregate and hold in trust for the benefit of the Holders of the Notes a sum sufficient to pay such principal (including the Redemption Price and the Fundamental Change Repurchase Price, if applicable) and accrued and unpaid interest so becoming
          due and will promptly notify the Trustee in writing of any failure to take such action and of any failure by the Company to make any payment of the principal (including the Redemption Price and the Fundamental Change Repurchase Price, if
          applicable) of, or accrued and unpaid interest on, the Notes when the same shall become due and payable.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(c)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">Anything in this <font style="font-family: 'Times New Roman';"><u>Section&#160;4.04</u></font>&#160;to the contrary notwithstanding, the Company may, at any time, for the purpose of obtaining a satisfaction and discharge of this Indenture, or for any other reason, pay, cause
          to be paid or deliver to the Trustee all sums or amounts held in trust by the Company or any Paying Agent hereunder as required by this <font style="font-family: 'Times New Roman';"><u>Section&#160;4.04</u></font>, such sums or amounts to be held by
          the Trustee upon the trusts herein contained and upon such payment or delivery by the Company or any Paying Agent to the Trustee, the Company or such Paying Agent shall be released from all further liability but only with respect to such sums or
          amounts. Upon the occurrence of any event specified in <font style="font-family: 'Times New Roman';"><u>Section 6.01(h)</u></font> or <font style="font-family: 'Times New Roman';"><u>Section 6.01(i)</u></font>, the Trustee shall automatically
          become the Paying Agent.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(d)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">Subject to
          applicable escheatment laws, any money and shares of Common Stock deposited with the Trustee or any Paying Agent, or then held by the Company, in trust for the payment of the principal (including the Redemption Price and the Fundamental Change
          Repurchase Price, if applicable) of, accrued and unpaid interest on and the consideration due upon conversion of any Note and remaining unclaimed for two years after such principal (including the Redemption Price and the Fundamental Change
          Repurchase Price, if applicable), interest or consideration due upon conversion has become due and payable shall be paid to the Company on request of the Company contained in an Officer&#8217;s Certificate, or (if then held by the Company) shall be
          discharged from such trust; and the Holder of such Note shall thereafter, as an unsecured general creditor, look only to the Company for payment thereof, and all liability of the Trustee or such Paying Agent with respect to such trust money and
          shares of Common Stock, and all liability of the Company as trustee thereof, shall thereupon cease.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">Section 4.05</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><a name="z_Toc62469681"></a><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><u>Existence</u></font><font style="font-family: 'Times New Roman'; font-style: italic;">.&#160; </font>Subject to&#160;<font style="font-family: 'Times New Roman';"><u>Article 11</u></font>, the Company shall do
          or cause to be done all things necessary to preserve and keep in full force and effect its corporate existence.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">Section 4.06</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><u>Rule 144A Information Requirement and Annual Reports</u></font><font style="font-family: 'Times New Roman'; font-style: italic;">.&#160; </font>(a) At any time the Company is not subject to Section&#160;13 or 15(d) of the Exchange Act,
          the Company shall, so long as any of the Notes or any shares of Common Stock issuable upon conversion thereof shall, at such time, constitute &#8220;restricted securities&#8221; within the meaning of Rule 144(a)(3) under the Securities Act, promptly provide
          to the Trustee and, upon written request, any Holder, beneficial owner or prospective purchaser of such Notes or any shares of Common Stock issuable upon conversion of such Notes, the information required to be delivered pursuant to Rule
          144A(d)(4) under the Securities Act to facilitate the resale of such Notes or shares of Common Stock pursuant to Rule 144A.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">29</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(b)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">The Company shall
          file with the Trustee, within 15 days after the same are required to be filed with the Commission, copies of any annual or quarterly reports (on Form&#160;10-K&#160;or Form&#160;10-Q&#160;or any respective successor form) that the Company is required to file with
          the Commission pursuant to Section&#160;13 or 15(d) of the Exchange Act (excluding any such information, documents or reports, or portions thereof, subject to confidential treatment and any correspondence with the Commission, and giving effect to any
          grace period provided by Rule&#160;12b-25&#160;under the Exchange Act (or any successor thereto)).&#160; Any such document or report that the Company files with the Commission via the Commission&#8217;s EDGAR system (or any successor system) shall be deemed to be
          filed with the Trustee for purposes of this <font style="font-family: 'Times New Roman';"><u>Section&#160;4.06(b)</u></font> at the time such documents are filed via the EDGAR system (or such successor), it being understood that the Trustee shall
          have no responsibility to determine if any documents have been filed.&#160; Delivery of the reports, information and documents described in this subsection (b) to the Trustee is for informational purposes only, and the information and the Trustee&#8217;s
          receipt of such shall not constitute actual or constructive notice of any information contained therein or determinable from information contained therein, including the Company&#8217;s compliance with any of its covenants hereunder (as to which the
          Trustee is entitled to conclusively rely on an Officer&#8217;s Certificate). The Trustee shall have no liability or responsibility for the filing, timeliness, or content of such reports. The Trustee shall not be obligated to monitor or confirm, on a
          continuing basis or otherwise, the Company&#8217;s compliance with the covenants or with respect to any reports or other documents filed with the Commission or posted to any website or participate in any conference calls.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">The &#8220;grace periods&#8221; referred to in the preceding paragraph with respect to any report will include the maximum period afforded by Rule 12b-25 (or any
      successor rule thereto) under the Exchange Act regardless of whether the Company files, or indicates in the related Form 12b-25 (or any successor form thereto) that Company expects to or will file, such report before the expiration of such maximum
      period.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(c)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">If, at any time
          during the&#160;six-month&#160;period beginning on, and including, the date that is six months after the last date of original issuance of the Notes (including any Notes issued pursuant to the Initial Purchasers&#8217; option to purchase additional Notes as set
          forth in the Purchase Agreement), the Company fails to timely file any document or report that it is required to file with the Commission pursuant to <font style="font-family: 'Times New Roman';"><u>Section</u></font>&#160;13 or 15(d) of the Exchange
          Act, as applicable (after giving effect to all applicable grace periods thereunder and other than reports on Form 8-K), or the Notes are not otherwise Freely Tradable, the Company shall pay Additional Interest on the Notes.&#160; The &#8220;grace periods&#8221;
          referred to in the preceding sentence with respect to any report will include the maximum period afforded by Rule 12b-25 (or any successor rule thereto) under the Exchange Act regardless of whether the Company files, or indicates in the related
          Form 12b-25 (or any successor form thereto) that Company expects to or will file, such report before the expiration of such maximum period.&#160; Such Additional Interest shall accrue on the Notes at the rate of 0.50% per annum of the principal amount
          of the Notes outstanding for each day during such period for which the Company&#8217;s failure to file has occurred and is continuing or the Notes are not otherwise Freely Tradable.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">As used in this <font style="font-family: 'Times New Roman';"><u>Section&#160;4.06(c)</u></font>, documents or reports that the Company is required to &#8220;file&#8221;
      with the Commission pursuant to Section&#160;13 or 15(d) of the Exchange Act does not include documents or reports that the Company furnishes to the Commission pursuant to Section&#160;13 or 15(d) of the Exchange Act.&#160; For purposes of this <font style="font-family: 'Times New Roman';"><u>Section 4.06(c)</u></font>, the phrase &#8220;restrictions pursuant to U.S. securities laws or the terms of this Indenture or the Notes&#8221; shall not include, for the avoidance of doubt, the assignment of a
      restricted CUSIP number or the existence of the Restrictive Notes Legend on Notes in compliance with <font style="font-family: 'Times New Roman';"><u>Section&#160;2.05(c)</u></font>, in either case, during the&#160;six-month&#160;period described in this <font style="font-family: 'Times New Roman';"><u>Section&#160;4.06(c)</u></font>.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">30</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(d)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">If, and for so long
          as, the Restrictive Notes Legend on the Notes specified in <font style="font-family: 'Times New Roman';"><u>Section 2.05(c)</u></font> has not been removed, the Notes are assigned a restricted CUSIP number or the Notes are not otherwise Freely
          Tradable as of the 380th day after the last date of original issuance of the Notes (including any Notes issued pursuant to the Initial Purchasers&#8217; option to purchase additional Notes as set forth in the Purchase Agreement), the Company shall pay
          Additional Interest on the Notes at a rate equal to 0.50% per annum of the principal amount of Notes outstanding until the Restrictive Notes Legend on the Notes has been removed in accordance with<font style="font-family: 'Times New Roman';"><u>
              Section 2.05(c)</u></font>, the Notes are assigned an unrestricted CUSIP number and the Notes are Freely Tradable.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(e)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">Additional Interest
          will be payable in arrears on each Interest Payment Date following accrual in the same manner as regular interest on the Notes.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(f)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(i) Notwithstanding
          anything in this Indenture or the Notes to the contrary, Additional Interest that accrues on the Notes pursuant to <font style="font-family: 'Times New Roman';"><u>Section 4.06(d)</u></font> occurring on or after such date will not be payable on
          any Interest Payment Date, unless (x) a Holder or beneficial owner of a Note (in the case of a beneficial owner subject to the satisfactory verification of a beneficial owner&#8217;s identity and ownership) has delivered to the Company (with a copy to
          the Trustee), before the Regular Record Date immediately before such Interest Payment Date, a written notice (a &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Deferred Additional Interest Demand Request</font>&#8221;) demanding
          payment of Additional Interest; or (y) the Company, in its sole and absolute discretion, elects, by sending notice of such election (a &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Notice of Election to Pay Deferred Additional
            Interest</font>&#8221;) to Holders (with a copy to the Trustee) before such Regular Record Date, to pay such Additional Interest on such Interest Payment Date (any such accrued and unpaid Additional Interest that, in compliance with the foregoing, is
          not paid on such Interest Payment Date, &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Deferred Additional Interest</font>&#8221;).</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: left; text-indent: 24.5pt; font-family: 'Times New Roman'; font-size: 10pt;">(ii) Without further action by the Company or any other Person, interest will automatically accrue on any Deferred Additional Interest from, and
      including, the applicable Interest Payment Date at a rate per annum equal to the rate per annum at which regular interest accrues to, but excluding, the date on which such Deferred Additional Interest, together with any interest thereon, is paid.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: left; text-indent: 24.5pt; font-family: 'Times New Roman'; font-size: 10pt;">(iii) Once any accrued and unpaid Additional Interest becomes payable on an Interest Payment Date, whether as a result of the delivery of a written
      notice pursuant to <font style="font-family: 'Times New Roman';"><u>Section 4.06(f)(i)</u></font> or, if earlier, the Company&#8217;s election to pay the same, Additional Interest will thereafter not be subject to deferral pursuant to <font style="font-family: 'Times New Roman';"><u>Section 4.06(f)(i)</u></font>. For the avoidance of doubt, the failure to pay any accrued and unpaid Additional Interest on an Interest Payment Date will not constitute a Default or an Event of Default
      under this Indenture or the Notes if such payment is deferred in accordance with <font style="font-family: 'Times New Roman';"><u>Section 4.06(f)(i)</u></font>. Each reference in this Indenture or the Notes to any accrued interest (including in the
      definitions of the Redemption Price and Fundamental Change Repurchase Price for any Note) or to any accrued Additional Interest includes, to the extent applicable, and without duplication, any Deferred Additional Interest, together with accrued and
      unpaid interest thereon.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">31</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: left; text-indent: 24.5pt; font-family: 'Times New Roman'; font-size: 10pt;">(iv) Notwithstanding to the contrary in this Indenture or the Notes, if (1) any unpaid Deferred Additional Interest exists on any Notes as of the close
      of business on the Regular Record Date immediately preceding the Maturity Date; (2) no Holder or beneficial owner of a Note has delivered a Deferred Additional Interest Demand Request in the manner described in <font style="font-family: 'Times New Roman';"><u>Section 4.06(f)(i)</u></font> before such Regular Record Date; and (3) the Company has not sent a Notice of Election to Pay Deferred Additional Interest in the manner described in <font style="font-family: 'Times New Roman';"><u>Section



          4.06(f)(i)</u></font> before such Regular Record Date, then Deferred Additional Interest on each Note then outstanding will cease to accrue, and all Deferred Additional Interest, together with interest thereon, on such Note will be deemed to be
      extinguished on the following date: (a) if such Note is to be converted, the Conversion Date for such conversion (it being understood, for the avoidance of doubt, that the conversion consideration therefor need not include, and the amount referred to
      in the fifth sentence of <font style="font-family: 'Times New Roman';"><u>Section 14.02(h)</u></font> below need not include, the payment of any such Deferred Additional Interest or any interest thereon); and (b) in all other cases, the later of (x)
      the Maturity Date; and (y) the first date on which the Company has repaid the principal of, and accrued and unpaid interest (other than such Deferred Additional Interest and any interest thereon) on, such Note in full.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(g)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">The Additional
          Interest that is payable in accordance with <font style="font-family: 'Times New Roman';"><u>Section 4.06(c)</u></font> or <font style="font-family: 'Times New Roman';"><u>Section&#160;4.06(d)</u></font> shall be in addition to, and not in lieu of,
          any Additional Interest that may be payable as a result of the Company&#8217;s election pursuant to <font style="font-family: 'Times New Roman';"><u>Section&#160;6.03</u></font>.&#160; In no event shall Additional Interest (excluding interest that accrues on
          Deferred Additional Interest) that may accrue as a result of the Company&#8217;s failure to comply with its obligations to timely file any document or report that the Company is required to file with the Commission pursuant to Section&#160;13 or 15(d) of
          the Exchange Act, as applicable (after giving effect to all applicable grace periods thereunder and other than reports on Form 8-K), as set forth in <font style="font-family: 'Times New Roman';"><u>Section&#160;4.06(c)</u></font>, together with any
          Additional Interest that may accrue at the Company&#8217;s election as the remedy for a Reporting Event of Default, accrue at a rate in excess of 0.50% per annum pursuant to this Indenture, regardless of the number of events or circumstances giving
          rise to the requirement to pay such Additional Interest.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(h)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">If Additional
          Interest is payable by the Company pursuant to <font style="font-family: 'Times New Roman';"><u>Section&#160;4.06(c)</u></font> or <font style="font-family: 'Times New Roman';"><u>Section&#160;4.06(d)</u></font>, the Company shall deliver to the Trustee
          an Officer&#8217;s Certificate to that effect stating (i) the amount of such Additional Interest that is payable and (ii) the date on which such Additional Interest is payable.&#160; Unless and until a Responsible Officer of the Trustee receives at the
          Corporate Trust Office such a certificate, the Trustee may assume without inquiry that no such Additional Interest is payable.&#160; If the Company has paid Additional Interest directly to the Persons entitled to it, the Company shall deliver to the
          Trustee an Officer&#8217;s Certificate setting forth the particulars of such payment. The Trustee shall have no duty to verify the Company&#8217;s determination as to whether Additional Interest is due or the Company&#8217;s calculations as to the amount of
          Additional Interest, and may assume without inquiry that no Additional Interest is payable or has been deferred until written notice of such Additional Interest being payable has been provided to the Trustee by the Company.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">32</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">Section 4.07</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><u>Stay, Extension and Usury Laws</u></font>.&#160; The Company covenants (to the extent that it may lawfully do so) that it shall not at any time insist upon, plead, or in any manner whatsoever claim or take the benefit or advantage
          of, any stay, extension or usury law or other law that would prohibit or forgive the Company from paying all or any portion of the principal of or interest on the Notes as contemplated herein, wherever enacted, now or at any time hereafter in
          force, or that may affect the covenants or the performance of this Indenture; and the Company (to the extent it may lawfully do so) hereby expressly waives all benefit or advantage of any such law, and covenants that it will not, by resort to any
          such law, hinder, delay or impede the execution of any power herein granted to the Trustee, but will suffer and permit the execution of every such power as though no such law had been enacted.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">Section 4.08</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><u>Compliance Certificate; Statements as to Defaults</u></font><font style="font-family: 'Times New Roman'; font-style: italic;">.&#160; </font>The Company shall deliver to the Trustee within 120 days after the end of each fiscal
          year of the Company (beginning with the fiscal year ending on December&#160;31, 2025) an Officer&#8217;s Certificate stating whether the signers thereof have knowledge of any Event of Default or Default that occurred during the previous year and, if so,
          specifying each such Event of Default or Default and the nature thereof.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">In addition, the Company shall deliver to the Trustee, within 30 days after the Company obtains knowledge of the occurrence of any Event of Default or
      Default, an Officer&#8217;s Certificate setting forth the details of such Event of Default or Default, its status and the action that the Company is taking or proposing to take in respect thereof; <font style="font-family: 'Times New Roman'; font-style: italic;">provided </font>that the Company is not required to deliver such Officer&#8217;s Certificate if the event that would constitute a Default or Event of Default has been cured or waived before the date the Company is required to deliver such
      Officer&#8217;s Certificate.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">Section 4.09</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><a name="z_Toc62469685"></a><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><u>Further Instruments and Acts</u></font>.&#160; Upon request of the Trustee, the Company will execute and deliver such further instruments and do such further acts as may be reasonably necessary or proper
          to carry out more effectively the purposes of this Indenture.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">ARTICLE 5<font style="font-family: 'Times New Roman';"><br>
      </font><a name="z_Toc62469686"></a>LISTS OF HOLDERS AND REPORTS BY THE COMPANY AND THE TRUSTEE</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">Section 5.01</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><a name="z_Toc62469687"></a><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><u>Lists of Holders</u></font>.&#160; The Company covenants and agrees that it will furnish or cause to be furnished to the Trustee, semi-annually, not more than 15 days after each March 1 and September 1 in
          each year beginning with September 1, 2025, and at such other times as the Trustee may request in writing, within 30 days after receipt by the Company of any such request (or such lesser time as the Trustee may reasonably request in order to
          enable it to timely provide any notice to be provided by it hereunder), a list in such form as the Trustee may reasonably require of the names and addresses of the Holders as of a date not more than 15 days (or such other date as the Trustee may
          reasonably request in order to so provide any such notices) prior to the time such information is furnished, except that no such list need be furnished so long as the Trustee is acting as Note Registrar.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">Section 5.02</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><u>Preservation and Disclosure of Lists</u></font>.&#160; The Trustee shall preserve, in as current a form as is reasonably practicable, all information as to the names and addresses of the Holders contained in the most recent list
          furnished to it as provided in <font style="font-family: 'Times New Roman';"><u>Section&#160;5.01</u></font>&#160;or maintained by the Trustee in its capacity as Note Registrar, if so acting.&#160; The Trustee may destroy any list furnished to it as provided
          in <font style="font-family: 'Times New Roman';"><u>Section&#160;5.01</u></font>&#160;upon receipt of a new list so furnished.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">33</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">ARTICLE 6<font style="font-family: 'Times New Roman';"><br>
      </font><a name="z_Toc62469689"></a>DEFAULTS AND REMEDIES</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">Section 6.01</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><u>Events of Default</u></font>.&#160; Each of the following events shall be an &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Event of Default</font>&#8221; with respect to the Notes:</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(a)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">default in any
          payment of interest on any Note when due and payable, and the default continues for a period of 30 days;</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(b)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">default in the
          payment of principal of any Note when due and payable on the Maturity Date, upon Optional Redemption, upon any required repurchase, upon declaration of acceleration or otherwise;</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(c)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">failure by the
          Company to comply with its obligation to convert the Notes in accordance with this Indenture upon exercise of a Holder&#8217;s conversion right and such failure continues for three (3) Business Days;</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(d)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">failure by the
          Company to issue a Fundamental Change Company Notice in accordance with <font style="font-family: 'Times New Roman';"><u>Section&#160;15.02(c)</u></font>, a notice of a Make-Whole Fundamental Change in accordance with <font style="font-family: 'Times New Roman';"><u>Section&#160;14.03(b)</u></font> or notice of a specified corporate transaction in accordance with <font style="font-family: 'Times New Roman';"><u>Section&#160;14.01(b)(ii)</u></font> or&#160;<font style="font-family: 'Times New Roman';"><u>14.01(b)(iii)</u></font>, in each case when due and, except with respect to any notice of a specified corporate transaction in accordance with <font style="font-family: 'Times New Roman';"><u>Section&#160;14.01(b)(ii)</u></font>, such
          failure continues for three (3) Business Days;</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(e)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">failure by the
          Company to comply with its obligations under&#160;<font style="font-family: 'Times New Roman';"><u>Article 11</u></font>;</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(f)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">failure by the
          Company for 60 days after written notice from the Trustee or the Holders of at least 25% in principal amount of the Notes then outstanding has been received by the Company to comply with any of its other agreements contained in the Notes or this
          Indenture;</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(g)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">default by the
          Company or any Significant Subsidiary of the Company with respect to any mortgage, agreement or other instrument under which there may be outstanding, or by which there may be secured or evidenced, any indebtedness for money borrowed in excess of
          $75,000,000 (or its foreign currency equivalent) in the aggregate of the Company and/or any such Significant Subsidiary (other than Non-Recourse Indebtedness), whether such indebtedness now exists or shall hereafter be created (i) resulting in
          such indebtedness becoming or being declared due and payable prior to its stated maturity date or (ii) constituting a failure to pay the principal of any such debt when due and payable (after the expiration of all applicable grace periods) at its
          stated maturity, upon required repurchase, upon declaration of acceleration or otherwise, and in the cases of clauses (i) and (ii), such acceleration shall not have been rescinded or annulled or such failure to pay or default shall not have been
          cured or waived, or such indebtedness is not paid or discharged, as the case may be, within 30 days after written notice to the Company by the Trustee or to the Company and the Trustee by Holders of at least 25% in aggregate principal amount of
          Notes then outstanding in accordance with this Indenture;</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">34</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(h)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">the Company or any
          Significant Subsidiary shall commence a voluntary case or other proceeding seeking liquidation, reorganization or other relief with respect to the Company or any such Significant Subsidiary or the Company or Significant Subsidiary&#8217;s debts under
          any bankruptcy, insolvency or other similar law now or hereafter in effect or seeking the appointment of a trustee, receiver, liquidator, custodian or other similar official of the Company or any such Significant Subsidiary or any substantial
          part of the Company or Significant Subsidiary&#8217;s property, or shall consent to any such relief or to the appointment of or taking possession by any such official in an involuntary case or other proceeding commenced against the Company or
          Significant Subsidiary, or shall make a general assignment for the benefit of creditors; provided that no such voluntary case, other proceeding, other relief, appointment, consent or general assignment by a Significant Subsidiary shall be deemed
          to be an Event of Default under this clause (h), if, (x) in the Company&#8217;s judgment, a principal reason for the occurrence of any such voluntary case, other proceeding, other relief, appointment, consent or general assignment is because of, or
          directly related to, the occurrence of an &#8220;event of default&#8221; (or similar term) under Non-Recourse Indebtedness, or an acceleration of such Non-Recourse Indebtedness by the lenders thereof, and the Company provides written notice of such event and
          the determination of such principal reason to Holders of the Notes and the Trustee, and (y) at the time of commencement of such voluntary case, other proceeding, other relief, appointment, consent or general assignment, such Significant
          Subsidiary shall have less than $75,000,000 in the aggregate in indebtedness for borrowed money that is not Non-Recourse Indebtedness; or</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(i)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">an involuntary case
          or other proceeding shall be commenced against the Company or any Significant Subsidiary seeking liquidation, reorganization or other relief with respect to the Company or such Significant Subsidiary or its debts under any bankruptcy, insolvency
          or other similar law now or hereafter in effect or seeking the appointment of a trustee, receiver, liquidator, custodian or other similar official of the Company or such Significant Subsidiary or any substantial part of the Company or Significant
          Subsidiary&#8217;s property, and such involuntary case or other proceeding shall remain undismissed and unstayed for a period of 60 consecutive days; provided that no such involuntary case or proceeding in respect of a Significant Subsidiary shall be
          deemed to be an Event of Default under this clause (i) if, (x) in the Company&#8217;s judgment, a principal reason for the occurrence of any such involuntary case or proceeding is because of, or directly related to, the occurrence of an &#8220;event of
          default&#8221; (or similar term) under Non-Recourse Indebtedness, or an acceleration of such non-recourse indebtedness by the lenders thereof, and the Company provides written notice of such event and the determination of such principal reason to
          Holders of the Notes and the Trustee, and (y) at the time of commencement of such involuntary case or proceeding, such Significant Subsidiary shall have less than $75,000,000 in the aggregate in indebtedness for borrowed money that is not
          Non-Recourse Indebtedness.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">Section 6.02</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><u>Acceleration; Rescission and Annulment</u></font><font style="font-family: 'Times New Roman'; font-style: italic;">.&#160; </font>If one or more Events of Default shall have occurred and be continuing (whatever the reason for such
          Event of Default and whether it shall be voluntary or involuntary or be effected by operation of law or pursuant to any judgment, decree or order of any court or any order, rule or regulation of any administrative or governmental body), then, and
          in each and every such case (other than an Event of Default specified in <font style="font-family: 'Times New Roman';"><u>Section&#160;6.01(h)</u></font> or <font style="font-family: 'Times New Roman';"><u>Section&#160;6.01(i)</u></font> with respect to
          the Company), unless the principal of all of the Notes shall have already become due and payable, either the Trustee or the Holders of at least 25% in aggregate principal amount of the Notes then outstanding determined in accordance with <font style="font-family: 'Times New Roman';"><u>Section&#160;8.04</u></font>, by notice in writing to the Company (and to the Trustee if given by Holders), may declare 100% of the principal of, and accrued and unpaid interest on, all outstanding Notes to
          be due and payable immediately, and upon any such declaration the same shall become and shall automatically be immediately due and payable, anything contained in this Indenture or in the Notes to the contrary notwithstanding.&#160; For the avoidance
          of doubt, if such Event of Default is not continuing at the time such notice is provided (that is, such Event of Default has been cured or waived as of such time), then such notice will not be effective to cause such amounts to become due and
          payable immediately.&#160; If an Event of Default specified in <font style="font-family: 'Times New Roman';"><u>Section&#160;6.01(h)</u></font> or <font style="font-family: 'Times New Roman';"><u>Section&#160;6.01(i)</u></font> with respect to the Company
          occurs and is continuing, 100% of the principal of, and accrued and unpaid interest, if any, on, all Notes shall become and shall automatically be immediately due and payable.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">35</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">The immediately preceding paragraph, however, is subject to the conditions that if, at any time after the principal of the Notes shall have been so
      declared due and payable, and before any judgment or decree for the payment of the monies due shall have been obtained or entered as hereinafter provided, and if (1) rescission would not conflict with any judgment or decree of a court of competent
      jurisdiction and (2) any and all existing Events of Default (including, for the avoidance of doubt, the failure to pay interest, if any, due and payable on any Defaulted Amounts) under this Indenture, other than the nonpayment of the principal of and
      accrued and unpaid interest, if any, on Notes that shall have become due solely by such acceleration, shall have been cured or waived pursuant to <font style="font-family: 'Times New Roman';"><u>Section&#160;6.09</u></font>, then and in every such case
      the Holders of a majority in aggregate principal amount of the Notes then outstanding, by written notice to the Company and to the Trustee, may waive all Defaults or Events of Default with respect to the Notes and rescind and annul such declaration
      and its consequences and such Default shall cease to exist, and any Event of Default arising therefrom shall be deemed to have been cured for every purpose of this Indenture; but no such waiver or rescission and annulment shall extend to or shall
      affect any subsequent Default or Event of Default, or shall impair any right consequent thereon.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">For the avoidance of doubt, and without limiting the manner in which any Default can be cured, (a) a Default consisting of a failure to send a notice in
      accordance with this Indenture will be cured upon the sending of such notice; (b) a Default in making any payment on (or delivering any other consideration in respect of) any Note will be cured upon the delivery, in accordance with this Indenture, of
      such payment (or other consideration) together, if applicable, with Default Interest thereon; and (c) a Default that is or, after notice, passage of time or both, would be a Reporting Event of Default will be cured upon the filing of the relevant
      report(s) giving rise to such Reporting Event of Default. In addition, for the avoidance of doubt, if a Default that is not an Event of Default is cured or waived before such Default would have constituted an Event of Default, then no Event of
      Default will result from such Default.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">36</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">Section 6.03</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><a name="z_Toc62469692"></a><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><u>Additional Interest</u></font><font style="font-family: 'Times New Roman'; font-style: italic;">.&#160; </font>Notwithstanding anything in this Indenture or in the Notes to the contrary, to the extent the
          Company elects, the sole remedy for an Event of Default relating to the Company&#8217;s failure to comply with its obligations as set forth in <font style="font-family: 'Times New Roman';"><u>Section&#160;4.06(b)</u></font> (a &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Reporting Event of Default</font>&#8221;) shall, for the first 365 days, after the occurrence of such an Event of Default, consist exclusively of the right to receive Additional Interest on the Notes at a rate
          equal to (x) 0.25% per annum of the principal amount of the Notes outstanding for each day that such Event of Default is continuing during the first 180 days after the occurrence of such Event of Default and (y) 0.50% per annum of the principal
          amount of the Notes outstanding for each day that such Event of Default is continuing during the subsequent&#160;185-day&#160;period.&#160; Subject to the last paragraph of this <font style="font-family: 'Times New Roman';"><u>Section&#160;6.03</u></font>,
          Additional Interest payable pursuant to this <font style="font-family: 'Times New Roman';"><u>Section&#160;6.03</u></font>&#160;shall be in addition to, not in lieu of, any Additional Interest payable pursuant to <font style="font-family: 'Times New Roman';"><u>Section&#160;4.06(c)</u></font> or <font style="font-family: 'Times New Roman';"><u>Section&#160;4.06(d)</u></font>.&#160; If the Company so elects, such Additional Interest shall be payable in the same manner and on the same dates as the stated
          interest payable on the Notes.&#160; On the 366th day after such Event of Default (if <font style="font-family: 'Times New Roman';"><u>a </u></font>Reporting Event of Default is not cured or waived prior to such 366th day), the Notes shall be
          immediately subject to acceleration as provided in <font style="font-family: 'Times New Roman';"><u>Section&#160;6.02</u></font>.&#160; The provisions of this paragraph will not affect the rights of Holders in the event of the occurrence of any Event of
          Default other than a Reporting Event of Default.&#160; In the event the Company does not elect to pay Additional Interest following an Event of Default in accordance with this <font style="font-family: 'Times New Roman';"><u>Section&#160;6.03</u></font>&#160;or



          the Company elected to make such payment but does not pay the Additional Interest when due, the Notes shall be immediately subject to acceleration as provided in <font style="font-family: 'Times New Roman';"><u>Section&#160;6.02</u></font>.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">In order to elect to pay Additional Interest as the sole remedy during the first 365 days after the occurrence of a Reporting Event of Default, the
      Company must notify all Holders of the Notes, the Trustee and the Paying Agent of such election prior to the beginning of such&#160;365-day&#160;period.&#160; Upon the failure to timely give such notice, the Notes shall be immediately subject to acceleration as
      provided in <font style="font-family: 'Times New Roman';"><u>Section&#160;6.02</u></font>.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">In no event shall Additional Interest payable at the Company&#8217;s election as the remedy for a Reporting Event of Default, together with any Additional
      Interest (excluding interest that accrues on Deferred Additional Interest) that may accrue as a result of the Company&#8217;s failure to timely file any document or report that the Company is required to file with the Commission pursuant to Section&#160;13 or
      15(d) of the Exchange Act, as applicable (after giving effect to all applicable grace periods under the Exchange Act and other than reports on Form&#160;8-K), pursuant to <font style="font-family: 'Times New Roman';"><u>Section&#160;4.06(c)</u></font>, accrue
      at a rate in excess of 0.50% per annum pursuant to this Indenture, regardless of the number of events or circumstances giving rise to the requirement to pay such Additional Interest.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">Section 6.04</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><a name="z_Toc62469693"></a><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><u>Payments of Notes on Default; Suit Therefor</u></font>.&#160; If an Event of Default described in clause (a) or (b) of <font style="font-family: 'Times New Roman';"><u>Section&#160;6.01</u></font>&#160;shall have
          occurred and be continuing, the Company shall, upon demand of the Trustee, pay to the Trustee, for the benefit of the Holders of the Notes, the whole amount then due and payable on the Notes for principal and interest, if any, with interest on
          any overdue principal and interest, if any, at the rate borne by the Notes at such time and, in addition thereto, such further amount as shall be sufficient to cover any amounts due to the Trustee under <font style="font-family: 'Times New Roman';"><u>Section&#160;7.06</u></font>.&#160; If the Company shall fail to pay such amounts forthwith upon such demand, the Trustee, in its own name and as trustee of an express trust, may institute a judicial proceeding for the collection of the sums
          so due and unpaid, may prosecute such proceeding to judgment or final decree and may enforce the same against the Company or any other obligor upon the Notes and collect the moneys adjudged or decreed to be payable in the manner provided by law
          out of the property of the Company or any other obligor upon the Notes, wherever situated.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">37</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">In the event there shall be pending proceedings for the bankruptcy or for the reorganization of the Company or any other obligor on the Notes under Title
      11 of the United States Code, or any other applicable law, or in case a receiver, assignee or trustee in bankruptcy or reorganization, liquidator, sequestrator or similar official shall have been appointed for or taken possession of the Company or
      such other obligor, the property of the Company or such other obligor, or in the event of any other judicial proceedings relative to the Company or such other obligor upon the Notes, or to the creditors or property of the Company or such other
      obligor, the Trustee, irrespective of whether the principal of the Notes shall then be due and payable as therein expressed or by declaration or otherwise and irrespective of whether the Trustee shall have made any demand pursuant to the provisions
      of this <font style="font-family: 'Times New Roman';"><u>Section&#160;6.04</u></font>, shall be entitled and empowered, by intervention in such proceedings or otherwise, to file and prove a claim or claims for the whole amount of principal and accrued
      and unpaid interest, if any, in respect of the Notes, and, in case of any judicial proceedings, to file such proofs of claim and other papers or documents and to take such other actions as it may deem necessary or advisable in order to have the
      claims of the Trustee (including any claim for the reasonable compensation, expenses, disbursements and advances of the Trustee, its agents and counsel) and of the Holders allowed in such judicial proceedings relative to the Company or any other
      obligor on the Notes, its or their creditors, or its or their property, and to collect and receive any monies or other property payable or deliverable on any such claims, and to distribute the same after the deduction of any amounts due to the
      Trustee under <font style="font-family: 'Times New Roman';"><u>Section&#160;7.06</u></font>; and any receiver, assignee or trustee in bankruptcy or reorganization, liquidator, custodian or similar official is hereby authorized by each of the Holders to
      make such payments to the Trustee, as administrative expenses, and, in the event that the Trustee shall consent to the making of such payments directly to the Holders, to pay to the Trustee any amount due it for reasonable compensation, expenses,
      advances and disbursements, including agents and counsel fees, and including any other amounts due to the Trustee under <font style="font-family: 'Times New Roman';"><u>Section&#160;7.06</u></font>, incurred by it up to the date of such distribution.&#160; To
      the extent that such payment of reasonable compensation, expenses, advances and disbursements out of the estate in any such proceedings shall be denied for any reason, payment of the same shall be secured by a lien on, and shall be paid out of, any
      and all distributions, dividends, monies, securities and other property that the Holders of the Notes may be entitled to receive in such proceedings, whether in liquidation or under any plan of reorganization or arrangement or otherwise.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Nothing herein contained shall be deemed to authorize the Trustee to authorize or consent to or accept or adopt on behalf of any Holder any plan of
      reorganization, arrangement, adjustment or composition affecting such Holder or the rights of any Holder thereof, or to authorize the Trustee to vote in respect of the claim of any Holder in any such proceeding.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">All rights of action and of asserting claims under this Indenture, or under any of the Notes, may be enforced by the Trustee without the possession of
      any of the Notes, or the production thereof at any trial or other proceeding relative thereto, and any such suit or proceeding instituted by the Trustee shall be brought in its own name as trustee of an express trust, and any recovery of judgment
      shall, after provision for the payment of the reasonable compensation, expenses, disbursements and advances of the Trustee, its agents and counsel, be for the ratable benefit of the Holders of the Notes.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">In any proceedings brought by the Trustee (and in any proceedings involving the interpretation of any provision of this Indenture to which the Trustee
      shall be a party) the Trustee shall be held to represent all the Holders of the Notes, and it shall not be necessary to make any Holders of the Notes parties to any such proceedings.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">38</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">In case the Trustee shall have proceeded to enforce any right under this Indenture and such proceedings shall have been discontinued or abandoned because
      of any waiver pursuant to <font style="font-family: 'Times New Roman';"><u>Section&#160;6.09</u></font>&#160;or any rescission and annulment pursuant to <font style="font-family: 'Times New Roman';"><u>Section&#160;6.02</u></font>&#160;or for any other reason or shall
      have been determined adversely to the Trustee, then and in every such case the Company, the Holders and the Trustee shall, subject to any determination in such proceeding, be restored respectively to their several positions and rights hereunder, and
      all rights, remedies and powers of the Company, the Holders and the Trustee shall continue as though no such proceeding had been instituted.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">Section 6.05</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><u>Application of Monies or Property Collected by Trustee</u></font>.&#160; Any monies or property collected by the Trustee pursuant to this&#160;<font style="font-family: 'Times New Roman';"><u>Article 6</u></font>&#160;with respect to the
          Notes shall be applied in the following order, at the date or dates fixed by the Trustee for the distribution of such monies or property, upon presentation of the several Notes, and stamping thereon the payment, if only partially paid, and upon
          surrender thereof, if fully paid:</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">First</font><font style="font-size: 10pt;">, to the payment of all
        amounts due the Trustee (acting in any capacity hereunder) hereunder, including its agent and counsel under <font style="font-family: 'Times New Roman';"><u>Section&#160;7.06</u></font>;</font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Second</font><font style="font-size: 10pt;">, in case the principal of
        the outstanding Notes shall not have become due and be unpaid, to the payment of interest on, and any cash due upon conversion of, the Notes in default in the order of the date due of the payments of such interest and cash due upon conversion, as
        the case may be, with interest (to the extent that such interest has been collected by the Trustee) upon such overdue payments at the rate borne by the Notes at such time, such payments to be made ratably to the Persons entitled thereto;</font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Third</font><font style="font-size: 10pt;">, in case the principal of
        the outstanding Notes shall have become due, by declaration or otherwise, and be unpaid to the payment of the whole amount (including, if applicable, the payment of the Redemption Price and the Fundamental Change Repurchase Price and any cash due
        upon conversion) then owing and unpaid upon the Notes for principal and interest, if any, with interest on the overdue principal and, to the extent that such interest has been collected by the Trustee, upon overdue installments of interest at the
        rate borne by the Notes at such time, and in case such monies shall be insufficient to pay in full the whole amounts so due and unpaid upon the Notes, then to the payment of such principal (including, if applicable, the Redemption Price and the
        Fundamental Change Repurchase Price and any cash due upon conversion) and interest without preference or priority of principal over interest, or of interest over principal or of any installment of interest over any other installment of interest, or
        of any Note over any other Note, ratably to the aggregate of such principal (including, if applicable, the Redemption Price and the Fundamental Change Repurchase Price and any cash due upon conversion) and accrued and unpaid interest; and</font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Fourth</font><font style="font-size: 10pt;">, to the payment of the
        remainder, if any, to the Company.</font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">Section 6.06</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><u>Proceedings by Holders</u></font><font style="font-family: 'Times New Roman'; font-style: italic;">.&#160; </font>Except to enforce the right to receive payment of principal (including, if applicable, the Redemption Price and the
          Fundamental Change Repurchase Price) or interest when due, or the right to receive payment or delivery of the consideration due upon conversion, no Holder of any Note shall have any right by virtue of or by availing of any provision of this
          Indenture or the Notes to institute any suit, action or proceeding in equity or at law upon or under or with respect to this Indenture, or for the appointment of a receiver, trustee, liquidator, custodian or other similar official, or for any
          other remedy hereunder, unless:</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">39</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(a)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">such Holder
          previously shall have given to the Trustee written notice of an Event of Default and of the continuance thereof, as herein provided;</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(b)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">Holders of at least
          25% in aggregate principal amount of the Notes then outstanding shall have made written request upon the Trustee to institute such action, suit or proceeding in its own name as Trustee hereunder;</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(c)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">such Holders shall
          have offered to the Trustee such security or indemnity satisfactory to it against any loss, liability or expense to be incurred therein or thereby;</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(d)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">the Trustee for 60
          days after its receipt of such notice, request and offer of such security or indemnity, shall have neglected or refused to institute any such action, suit or proceeding; and</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(e)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">no direction that,
          in the opinion of the Trustee, is inconsistent with such written request shall have been given to the Trustee by the Holders of a majority of the aggregate principal amount of the Notes then outstanding within such&#160;60-day&#160;period pursuant to <font style="font-family: 'Times New Roman';"><u>Section&#160;6.09</u></font>,</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">it being understood and intended, and being expressly covenanted by the taker and Holder of every Note with every other taker and Holder and the Trustee that no one or more
      Holders shall have any right in any manner whatever by virtue of or by availing of any provision of this Indenture to affect, disturb or prejudice the rights of any other Holder, or to obtain or seek to obtain priority over or preference to any other
      such Holder (it being understood that the Trustee does not have an affirmative duty to ascertain whether or not such actions or forbearances are unduly prejudicial to any other Holder), or to enforce any right under this Indenture, except in the
      manner herein provided and for the equal, ratable and common benefit of all Holders (except as otherwise provided herein).&#160; For the protection and enforcement of this <font style="font-family: 'Times New Roman';"><u>Section&#160;6.06</u></font>, each and
      every Holder and the Trustee shall be entitled to such relief as can be given either at law or in equity.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Notwithstanding any other provision of this Indenture and any provision of any Note, each Holder shall have the right to receive payment or delivery, as
      the case may be, of (x) the principal (including the Redemption Price and the Fundamental Change Repurchase Price, if applicable) of, (y) accrued and unpaid interest, if any, on, and (z) the consideration due upon conversion of, such Note, on or
      after the respective due dates expressed or provided for in such Note or in this Indenture, or to institute suit for the enforcement of any such payment or delivery, as the case may be.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">Section 6.07</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><a name="z_Toc62469696"></a><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><u>Proceedings by Trustee</u></font>.&#160; In case of an Event of Default, the Trustee may in its discretion proceed to protect and enforce the rights vested in it by this Indenture by such appropriate
          judicial proceedings as are necessary to protect and enforce any of such rights, either by suit in equity or by action at law or by proceeding in bankruptcy or otherwise, whether for the specific enforcement of any covenant or agreement contained
          in this Indenture or in aid of the exercise of any power granted in this Indenture, or to enforce any other legal or equitable right vested in the Trustee by this Indenture or by law.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">40</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">Section 6.08</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><a name="z_Toc62469697"></a><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><u>Remedies Cumulative and Continuing</u></font>.&#160; Except as provided in the last paragraph of <font style="font-family: 'Times New Roman';"><u>Section&#160;2.06</u></font>, all powers and remedies given by
          this <font style="font-family: 'Times New Roman';"><u>Article 6</u></font> to the Trustee or to the Holders shall, to the extent permitted by law, be deemed cumulative and not exclusive of any thereof or of any other powers and remedies
          available to the Trustee or the Holders of the Notes, by judicial proceedings or otherwise, to enforce the performance or observance of the covenants and agreements contained in this Indenture, and no delay or omission of the Trustee or of any
          Holder of any of the Notes to exercise any right or power accruing upon any Default or Event of Default shall impair any such right or power, or shall be construed to be a waiver of any such Default or Event of Default or any acquiescence
          therein; and, subject to the provisions of <font style="font-family: 'Times New Roman';"><u>Section&#160;6.06</u></font>, every power and remedy given by this <font style="font-family: 'Times New Roman';"><u>Article 6</u></font> or by law to the
          Trustee or to the Holders may be exercised from time to time, and as often as shall be deemed expedient, by the Trustee or by the Holders.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">Section 6.09</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><u>Direction of Proceedings and Waiver of Defaults by Majority of Holders</u></font><font style="font-family: 'Times New Roman'; font-style: italic;">.&#160; </font>Subject to the Trustee&#8217;s right to receive security or indemnity from
          the relevant Holders as described herein, the Holders of a majority of the aggregate principal amount of the Notes at the time outstanding determined in accordance with <font style="font-family: 'Times New Roman';"><u>Section&#160;8.04</u></font>&#160;shall



          have the right to direct the time, method and place of conducting any proceeding for any remedy available to the Trustee or exercising any trust or power conferred on the Trustee with respect to the Notes; <font style="font-family: 'Times New Roman'; font-style: italic;">provided</font>, <font style="font-family: 'Times New Roman'; font-style: italic;">however</font>, that (a) such direction shall not be in conflict with any rule of law or with this Indenture, and (b) the Trustee
          may take any other action deemed proper by the Trustee that is not inconsistent with such direction.&#160; The Trustee may refuse to follow any direction that it determines is in conflict with any rule of law or with this Indenture or is unduly
          prejudicial to the rights of any other Holder or that would involve the Trustee in personal liability.&#160; The Holders of a majority in aggregate principal amount of the Notes at the time outstanding determined in accordance with <font style="font-family: 'Times New Roman';"><u>Section&#160;8.04</u></font>&#160;may on behalf of the Holders of all of the Notes waive any past Default or Event of Default hereunder and its consequences except any continuing defaults relating to (i) a
          default in the payment of accrued and unpaid interest, if any, on, or the principal (including any Redemption Price and any Fundamental Change Repurchase Price) of, the Notes when due that has not been cured pursuant to the provisions of <font style="font-family: 'Times New Roman';"><u>Section&#160;6.01</u></font>, (ii) a failure by the Company to pay or deliver, as the case may be, the consideration due upon conversion of the Notes or (iii) a default in respect of a covenant or provision
          hereof which under&#160;<font style="font-family: 'Times New Roman';"><u>Article 10</u></font>&#160;cannot be modified or amended without the consent of each Holder of an outstanding Note affected.&#160; Upon any such waiver the Company, the Trustee and the
          Holders of the Notes shall be restored to their former positions and rights hereunder; but no such waiver shall extend to any subsequent or other Default or Event of Default or impair any right consequent thereon.&#160; Whenever any Default or Event
          of Default hereunder shall have been waived as permitted by this <font style="font-family: 'Times New Roman';"><u>Section&#160;6.09</u></font>, said Default or Event of Default shall for all purposes of the Notes and this Indenture be deemed to have
          been cured and to be not continuing; but no such waiver shall extend to any subsequent or other Default or Event of Default or impair any right consequent thereon.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">41</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">Section 6.10</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><a name="z_Toc62469699"></a><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><u>Notice of Defaults</u></font>.&#160; The Trustee shall, within 90 days after the occurrence and continuance of a Default of which a Responsible Officer has actual knowledge, deliver to all Holders notice
          of all Defaults known to a Responsible Officer, unless such Defaults shall have been cured or waived before the giving of such notice; <font style="font-family: 'Times New Roman'; font-style: italic;">provided </font>that, except in the case of
          a Default in the payment of the principal of (including the Redemption Price and the Fundamental Change Repurchase Price, if applicable), or accrued and unpaid interest on, any of the Notes or a Default in the payment or delivery of the
          consideration due upon conversion, the Trustee shall be protected in withholding such notice if it in good faith determines that the withholding of such notice is in the interests of the Holders. For the avoidance of doubt, the Trustee will not
          be required to deliver such notice if such Default or Event of Default is cured or waived.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">Section 6.11</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><a name="z_Toc62469700"></a><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><u>Undertaking to Pay Costs</u></font>.&#160; All parties to this Indenture agree, and each Holder of any Note by its acceptance thereof shall be deemed to have agreed, that any court may, in its discretion,
          require, in any suit for the enforcement of any right or remedy under this Indenture, or in any suit against the Trustee for any action taken or omitted by it as Trustee, the filing by any party litigant in such suit of an undertaking to pay the
          costs of such suit and that such court may in its discretion assess reasonable costs, including reasonable attorneys&#8217; fees and expenses, against any party litigant in such suit, having due regard to the merits and good faith of the claims or
          defenses made by such party litigant; <font style="font-family: 'Times New Roman'; font-style: italic;">provided </font>that the provisions of this <font style="font-family: 'Times New Roman';"><u>Section&#160;6.11</u></font> (to the extent
          permitted by law) shall not apply to any suit instituted by the Trustee, to any suit instituted by any Holder, or group of Holders, holding in the aggregate more than 10% in principal amount of the Notes at the time outstanding determined in
          accordance with <font style="font-family: 'Times New Roman';"><u>Section&#160;8.04</u></font>, or to any suit instituted by any Holder for the enforcement of the payment of the principal of or accrued and unpaid interest, if any, on any Note
          (including, but not limited to, the Redemption Price and the Fundamental Change Repurchase Price, if applicable) on or after the due date expressed or provided for in such Note or to any suit for the enforcement of the right to convert any Note,
          or receive the consideration due upon conversion, in accordance with the provisions of&#160;<font style="font-family: 'Times New Roman';"><u>Article 14</u></font>.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">ARTICLE 7<font style="font-family: 'Times New Roman';"><br>
      </font><a name="z_Toc62469701"></a>CONCERNING THE TRUSTEE</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">Section 7.01</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><u>Duties and Responsibilities of Trustee</u></font>.&#160; The Trustee, prior to the occurrence of an Event of Default and after the curing or waiver of all Events of Default that may have occurred for which a Responsible Officer has
          actual knowledge or written notice, undertakes to perform such duties and only such duties as are specifically set forth in this Indenture.&#160; In the event an Event of Default has occurred and is continuing, the Trustee shall exercise such of the
          rights and powers vested in it by this Indenture, and use the same degree of care and skill in its exercise, as a prudent person would exercise or use under the circumstances in the conduct of such person&#8217;s own affairs; <font style="font-family: 'Times New Roman'; font-style: italic;">provided </font>that if an Event of Default occurs and is continuing, the Trustee will be under no obligation to exercise any of the rights or powers under this Indenture at the request or direction of
          any of the Holders unless such Holders have offered, and, if requested, provided to the Trustee indemnity or security satisfactory to it against any loss, liability or expense that might be incurred by it in compliance with such request or
          direction.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">No provision of this Indenture shall be construed to relieve the Trustee from liability for its own grossly negligent action, its own grossly negligent
      failure to act or its own willful misconduct, except that:</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">42</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(a)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">prior to the
          occurrence of an Event of Default and after the curing or waiving of all Events of Default that may have occurred:</font></font></div>
    <div style="font-size: 10pt; margin-left: 36pt; text-indent: 27pt;">&#160;</div>
    <div>
      <div>
        <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; margin-left: 36pt; text-indent: 27pt;"><font style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-size: 10pt;">the duties and obligations of the Trustee shall be determined solely by the express provisions of this Indenture, and the Trustee shall not be liable except for the performance of such duties and obligations as are
            specifically set forth in this Indenture and no implied covenants or obligations shall be read into this Indenture against the Trustee; and</font></div>
        <div style="text-align: left; text-indent: 72pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';"> <font style="font-size: 10pt;"><br>
          </font></div>
      </div>
    </div>
    <div>
      <div>
        <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; margin-left: 36pt; text-indent: 27pt;"><font style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-size: 10pt;">in the absence of gross negligence or willful misconduct on the part of the Trustee, the Trustee may, as to the truth of the statements and the correctness of the opinions expressed therein, conclusively rely upon any
            certificates or opinions furnished to the Trustee and conforming to the requirements of this Indenture; but, in the case of any such certificates or opinions that by any provisions hereof are specifically required to be furnished to the
            Trustee, the Trustee shall be under a duty to examine the same to determine whether or not they conform to the requirements of this Indenture (but need not confirm or investigate the accuracy of any mathematical calculations or other facts
            stated therein);</font></div>
      </div>
    </div>
    <div style="text-indent: 36pt; font-size: 10pt;"><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"> <br>
      </font></div>
    <div style="text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(b)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">the Trustee shall
          not be liable for any error of judgment made in good faith by a Responsible Officer or Officers of the Trustee, unless it shall be proved that the Trustee was grossly negligent in ascertaining the pertinent facts;</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(c)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">the Trustee shall
          not be liable with respect to any action taken or omitted to be taken by it in good faith in accordance with the direction of the Holders of not less than a majority of the aggregate principal amount of the Notes at the time outstanding
          determined as provided in <font style="font-family: 'Times New Roman';"><u>Section&#160;8.04</u></font>&#160;relating to the time, method and place of conducting any proceeding for any remedy available to the Trustee, or exercising any trust or power
          conferred upon the Trustee, under this Indenture;</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(d)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">whether or not
          therein provided, every provision of this Indenture relating to the conduct or affecting the liability of, or affording protection to, the Trustee shall be subject to the provisions of this Section;</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(e)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">the Trustee shall
          not be liable in respect of any payment (as to the correctness of amount, entitlement to receive or any other matters relating to payment) or notice effected by the Company or any Paying Agent or any records maintained by any&#160;co-Note&#160;Registrar
          with respect to the Notes;</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(f)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">if any party fails
          to deliver a notice relating to an event the fact of which, pursuant to this Indenture, requires notice to be sent to the Trustee, the Trustee may conclusively rely on its failure to receive such notice as reason to act as if no such event
          occurred, unless a Responsible Officer of the Trustee had actual knowledge of such event;</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(g)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">in the absence of
          written investment direction from the Company, all cash received by the Trustee shall be placed in a non-interest bearing trust account, and in no event shall the Trustee be liable for the selection of investments or for investment losses
          incurred thereon or for losses incurred as a result of the liquidation of any such investment prior to its maturity date or the failure of the party directing such investments prior to its maturity date or the failure of the party directing such
          investment to provide timely written investment direction, and the Trustee shall have no obligation to invest or reinvest any amounts held hereunder in the absence of such written investment direction from the Company; and</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">43</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(h)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">in the event that
          the Trustee is also acting as Custodian, Note Registrar, Paying Agent, Conversion Agent, Bid Solicitation Agent or transfer agent hereunder, the rights and protections afforded to the Trustee pursuant to this&#160;<font style="font-family: 'Times New Roman';"><u>Article 7</u></font>&#160;shall also be afforded to such Custodian, Note Registrar, Paying Agent, Conversion Agent, Bid Solicitation Agent or transfer agent.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">None of the provisions contained in this Indenture or the Notes shall require the Trustee to expend or risk its own funds or otherwise incur personal
      financial liability in the performance of any of its duties or in the exercise of any of its rights or powers.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">Section 7.02</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><u>Reliance on Documents, Opinions, Etc</u></font>.&#160; Except as otherwise provided in <font style="font-family: 'Times New Roman';"><u>Section&#160;7.01</u></font>:</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(a)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">the Trustee may
          conclusively rely and shall be fully protected in acting or refraining from acting upon any resolution, certificate, statement, instrument, opinion, report, notice, request, consent, order, bond, note, coupon or other paper or document believed
          by it in good faith to be genuine and to have been signed or presented by the proper party or parties;</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(b)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">any request,
          direction, order or demand of the Company mentioned herein shall be sufficiently evidenced by an Officer&#8217;s Certificate (unless other evidence in respect thereof be herein specifically prescribed); and any Board Resolution may be evidenced to the
          Trustee by a copy thereof certified by the Secretary or an Assistant Secretary of the Company;</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(c)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">whenever in the
          administration of this Indenture, the Trustee shall deem it desirable that a matter be proved or established prior to taking, suffering or omitting any action hereunder, the Trustee (unless other evidence be herein specifically prescribed) may,
          in the absence of gross negligence or willful misconduct on its part, conclusively rely upon an Officer&#8217;s Certificate;</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(d)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">the Trustee may
          consult with counsel of its selection, and require an Opinion of Counsel and any advice of such counsel or Opinion of Counsel shall be full and complete authorization and protection in respect of any action taken or omitted by it hereunder in
          good faith and in accordance with such advice or Opinion of Counsel;</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(e)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">the Trustee shall
          not be bound to make any investigation into the facts or matters stated in any resolution, certificate, statement, instrument, opinion, report, notice, request, direction, consent, order, bond, debenture or other paper or document, but the
          Trustee, in its discretion, may make such further inquiry or investigation into such facts or matters as it may see fit, and, if the Trustee shall determine to make such further inquiry or investigation, it shall be entitled to examine the books,
          records and premises of the Company, personally or by agent or attorney at the expense of the Company and shall incur no liability of any kind by reason of such inquiry or investigation;</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">44</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(f)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">the Trustee may
          execute any of the trusts or powers hereunder or perform any duties hereunder either directly or by or through agents, custodians, nominees or attorneys and the Trustee shall not be responsible for any action, inaction, misconduct or negligence
          on the part of any agent, custodian, nominee or attorney appointed by it with due care hereunder;</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(g)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">the permissive
          rights of the Trustee enumerated herein shall not be construed as duties;</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(h)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">the Trustee may
          request that the Company deliver an Officer&#8217;s Certificate setting forth the names of the individuals and/or titles of officers authorized at such times to take specified actions pursuant to this Indenture, which Officer&#8217;s Certificate may be
          signed by any Person authorized to sign an Officer&#8217;s Certificate, including any Person specified as so authorized in any such certificate previously delivered and not superseded;</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(i)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">neither the Trustee
          nor any of its directors, officers, employees, agents, or affiliates shall be responsible for nor have any duty to monitor the performance or any action of the Company, or any of their respective directors, members, officers, agents, affiliates,
          or employees, nor shall it have any liability in connection with the malfeasance or nonfeasance by such party.&#160; The Trustee shall not be responsible for any inaccuracy in the information obtained from the Company or for any inaccuracy or omission
          in the records which may result from such information or any failure by the Trustee to perform its duties or set forth herein as a result of any inaccuracy or incompleteness;</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(j)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">the Trustee shall
          have no obligation to pursue any action that is not in accordance with applicable law;</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">(k) the Trustee shall be under no obligation to exercise any of the rights or powers vested in it by this Indenture at the request or direction of any of
      the Holders pursuant to this Indenture, unless such Holders shall have offered (and if requested, provided) to the Trustee security or indemnity satisfactory to the Trustee against the costs, expenses and liabilities which might be incurred by it in
      compliance with such request or direction;</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">(l) the Trustee shall not be liable for any action taken, suffered, or omitted to be taken by it in good faith and reasonably believed by it to be
      authorized or within the discretion or rights or powers conferred upon it by this Indenture; and</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">(m) the Trustee shall not be obligated to take possession of any Common Stock, whether upon conversion or in connection with any discharge of this
      Indenture pursuant to Article 3 hereof, but shall satisfy its obligation as Conversion Agent by working through the stock transfer agent of the Company from time to time as directed by the Company.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">In no event shall the Trustee be liable for any special, indirect, punitive, or consequential loss or damage of any kind whatsoever (including but not
      limited to lost profits), even if the Trustee has been advised of the likelihood of such loss or damage and regardless of the form of action.&#160; The Trustee shall not be charged with knowledge of any Default or Event of Default with respect to the
      Notes, unless either (1) a Responsible Officer shall have actual knowledge of such Default or Event of Default or (2) written notice of such Default or Event of Default shall have been actually received by a Responsible Officer of the Trustee.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">45</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">Section 7.03</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><u>No Responsibility for Recitals, Etc</u></font>.&#160; The recitals contained herein and in the Notes (except in the Trustee&#8217;s certificate of authentication) shall be taken as the statements of the Company, and the Trustee assumes
          no responsibility for the correctness of the same.&#160; The Trustee makes no representations as to the validity or sufficiency of this Indenture or of the Notes.&#160; The Trustee shall not be accountable for the use or application by the Company of any
          Notes or the proceeds of any Notes authenticated and delivered by the Trustee in conformity with the provisions of this Indenture.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">Section 7.04</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><u>Trustee, Paying Agents, Conversion Agents, Bid Solicitation Agent or Note Registrar May Own Notes</u></font>.&#160; The Trustee, any Paying Agent, any Conversion Agent, Bid Solicitation Agent (if other than the Company or any
          Affiliate thereof) or Note Registrar, in its individual or any other capacity, may become the owner or pledgee of Notes with the same rights it would have if it were not the Trustee, Paying Agent, Conversion Agent, Bid Solicitation Agent or Note
          Registrar.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">Section 7.05</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><u>Monies and Shares of Common Stock to Be Held in Trust</u></font>.&#160; All monies and shares of Common Stock received by the Trustee shall, until used or applied as herein provided, be held in trust for the purposes for which they
          were received.&#160; Money and shares of Common Stock held by the Trustee in trust hereunder need not be segregated from other funds except to the extent required by law.&#160; The Trustee shall be under no liability for interest on any money or shares of
          Common Stock received by it hereunder except as may be agreed from time to time by the Company and the Trustee.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">Section 7.06</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><u>Compensation and Expenses of Trustee</u></font>.&#160; The Company covenants and agrees to pay to the Trustee, in each capacity under this Indenture, from time to time and the Trustee shall receive such compensation for all
          services rendered by it hereunder in any capacity (which shall not be limited by any provision of law in regard to the compensation of a trustee of an express trust) as mutually agreed to in writing between the Trustee and the Company, and the
          Company will pay or reimburse the Trustee upon its request for all reasonable expenses, disbursements and advances reasonably incurred or made by the Trustee in accordance with any of the provisions of this Indenture in any capacity thereunder
          (including the reasonable compensation and the expenses and disbursements of its agents and counsel and of all Persons not regularly in its employ) except any such expense, disbursement or advance as shall have been caused by its gross negligence
          or willful misconduct as finally adjudicated by a court of competent jurisdiction.&#160; The Company also covenants to indemnify the Trustee or any predecessor Trustee in any capacity under this Indenture and any other document or transaction entered
          into in connection herewith and its agents and any authenticating agent for, and to hold them harmless against, any loss, claim, damage, liability or expense incurred without gross negligence or willful misconduct, as finally adjudicated by a
          court of competent jurisdiction on the part of the Trustee, its officers, directors, agents or employees, or such agent or authenticating agent, as the case may be, and arising out of or in connection with the acceptance or administration of this
          Indenture or in any other capacity hereunder, including the costs and expenses of defending themselves against any claim of liability in the premises and enforcement of this <font style="font-family: 'Times New Roman';"><u>Section&#160;7.06</u></font>.&#160;



          The obligations of the Company under this <font style="font-family: 'Times New Roman';"><u>Section&#160;7.06</u></font>&#160;to compensate or indemnify the Trustee and to pay or reimburse the Trustee for expenses, disbursements and advances shall be
          secured by a senior lien to which the Notes are hereby made subordinate on all money or property held or collected by the Trustee, except, subject to the effect of <font style="font-family: 'Times New Roman';"><u>Section&#160;6.05</u></font>, funds
          held in trust herewith for the benefit of the Holders of particular Notes.&#160; The Trustee&#8217;s right to receive payment of any amounts due under this <font style="font-family: 'Times New Roman';"><u>Section&#160;7.06</u></font>&#160;shall not be subordinate to
          any other liability or indebtedness of the Company.&#160; The obligation of the Company under this <font style="font-family: 'Times New Roman';"><u>Section&#160;7.06</u></font>&#160;shall survive the satisfaction and discharge of this Indenture and the earlier
          resignation or removal of the Trustee.&#160; The Company need not pay for any settlement made without its consent, which consent shall not be unreasonably withheld.&#160; The indemnification provided in this <font style="font-family: 'Times New Roman';"><u>Section&#160;7.06</u></font>&#160;shall



          extend to the officers, directors, agents and employees of the Trustee.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">46</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Without prejudice to any other rights available to the Trustee under applicable law, when the Trustee and its agents and any authenticating agent incur
      expenses or render services after an Event of Default specified in <font style="font-family: 'Times New Roman';"><u>Section&#160;6.01(h)</u></font> or <font style="font-family: 'Times New Roman';"><u>Section&#160;6.01(i)</u></font> occurs, the expenses and
      the compensation for the services are intended to constitute expenses of administration under any bankruptcy, insolvency or similar laws.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">Section 7.07</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><u>Officer&#8217;s Certificate as Evidence</u></font>.&#160; Except as otherwise provided in <font style="font-family: 'Times New Roman';"><u>Section&#160;7.01</u></font>, whenever in the administration of the provisions of this Indenture the
          Trustee shall deem it necessary or desirable that a matter be proved or established prior to taking or omitting any action hereunder, such matter (unless other evidence in respect thereof be herein specifically prescribed) may, in the absence of
          gross negligence or willful misconduct on the part of the Trustee, be deemed to be conclusively proved and established by an Officer&#8217;s Certificate delivered to the Trustee, and such Officer&#8217;s Certificate, in the absence of gross negligence or
          willful misconduct on the part of the Trustee, shall be full warrant to the Trustee for any action taken or omitted by it under the provisions of this Indenture upon the faith thereof.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">Section 7.08</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><u>Eligibility of Trustee</u></font>.&#160; There shall at all times be a Trustee hereunder which shall be a Person that is eligible pursuant to the Trust Indenture Act (as if the Trust Indenture Act were applicable hereto) to act as
          such and has a combined capital and surplus of at least $50,000,000.&#160; If such Person publishes reports of condition at least annually, pursuant to law or to the requirements of any supervising or examining authority, then for the purposes of this
          Section, the combined capital and surplus of such Person shall be deemed to be its combined capital and surplus as set forth in its most recent report of condition so published.&#160; If at any time the Trustee shall cease to be eligible in accordance
          with the provisions of this Section, it shall resign immediately in the manner and with the effect hereinafter specified in this&#160;<font style="font-family: 'Times New Roman';"><u>Article 7</u></font>.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">Section 7.09</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><a name="z_Toc62469710"></a><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><u>Resignation or Removal of Trustee</u></font>.&#160; (a) The Trustee may at any time resign by giving written notice of such resignation to the Company and by delivering notice thereof to the Holders.&#160; Upon
          receiving such notice of resignation, the Company shall promptly appoint a successor trustee by written instrument, in duplicate, executed by order of the Board of Directors, one copy of which instrument shall be delivered to the resigning
          Trustee and one copy to the successor trustee.&#160; If no successor trustee shall have been so appointed and have accepted appointment within 45 days after the giving of such notice of resignation to the Holders, the resigning Trustee may, upon ten
          Business Days&#8217; notice to the Company and the Holders, petition any court of competent jurisdiction, at the expense of the Company, for the appointment of a successor trustee, or any Holder who has been a bona fide holder of a Note or Notes for at
          least six months (or since the date of this Indenture) may, subject to the provisions of <font style="font-family: 'Times New Roman';"><u>Section&#160;6.11</u></font>, on behalf of himself or herself and all others similarly situated, petition any
          such court for the appointment of a successor trustee.&#160; Such court may thereupon, after such notice, if any, as it may deem proper and prescribe, appoint a successor trustee.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">47</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(b)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">In case at any time
          any of the following shall occur:</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div>
      <div>
        <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; margin-left: 36pt; text-indent: 27pt;"><font style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(i) &#160; &#160; &#160; &#160;&#160; </font><font style="font-size: 10pt;">the Trustee shall cease to be eligible in accordance with the provisions of <font style="font-family: 'Times New Roman';"><u>Section&#160;7.08</u></font>&#160;and shall fail to resign after written request therefor by the
            Company or by any such Holder, or</font></div>
        <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman';"> <font style="font-size: 10pt;"><br>
          </font></div>
      </div>
    </div>
    <div>
      <div>
        <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; margin-left: 36pt; text-indent: 27pt;"><font style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(ii) &#160; &#160; &#160; &#160; </font><font style="font-size: 10pt;">the Trustee shall become incapable of acting, or shall be adjudged a bankrupt or insolvent, or a receiver of the Trustee or of its property shall be appointed, or any public officer shall take charge or control of the
            Trustee or of its property or affairs for the purpose of rehabilitation, conservation or liquidation, then, in either case, the Company may by a Board Resolution remove the Trustee and appoint a successor trustee by written instrument, in
            duplicate, executed by order of the Board of Directors, one copy of which instrument shall be delivered to the Trustee so removed, upon 30 days&#8217; advance written notice, and one copy to the successor trustee, or, subject to the provisions of <font style="font-family: 'Times New Roman';"><u>Section&#160;6.11</u></font>, any Holder who has been a bona fide holder of a Note or Notes for at least six months (or since the date of this Indenture) may, on behalf of himself or herself and all
            others similarly situated, petition any court of competent jurisdiction for the removal of the Trustee and the appointment of a successor trustee.&#160; Such court may thereupon, after such notice, if any, as it may deem proper and prescribe, remove
            the Trustee and appoint a successor trustee.</font></div>
        <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman';"> <font style="font-size: 10pt;"><br>
          </font></div>
      </div>
    </div>
    <div style="text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(c)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">The Holders of a
          majority in aggregate principal amount of the Notes at the time outstanding, as determined in accordance with <font style="font-family: 'Times New Roman';"><u>Section&#160;8.04</u></font>, may at any time remove the Trustee upon 30 days&#8217; advance
          written notice and nominate a successor trustee that shall be deemed appointed as successor trustee unless within ten days after notice to the Company of such nomination the Company objects thereto, in which case the Trustee so removed or any
          Holder, upon the terms and conditions and otherwise as in <font style="font-family: 'Times New Roman';"><u>Section&#160;7.09(a)</u></font> provided, may petition any court of competent jurisdiction for an appointment of a successor trustee.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(d)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">Any resignation or
          removal of the Trustee and appointment of a successor trustee pursuant to any of the provisions of this <font style="font-family: 'Times New Roman';"><u>Section&#160;7.09</u></font>&#160;shall become effective upon acceptance of appointment by the
          successor trustee as provided in <font style="font-family: 'Times New Roman';"><u>Section&#160;7.10</u></font>.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">Section 7.10</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><u>Acceptance by Successor Trustee</u></font>.&#160; Any successor trustee appointed as provided in <font style="font-family: 'Times New Roman';"><u>Section&#160;7.09</u></font>&#160;shall execute, acknowledge and deliver to the Company and to
          its predecessor trustee an instrument accepting such appointment hereunder, and thereupon the resignation or removal of the predecessor trustee shall become effective and such successor trustee, without any further act, deed or conveyance, shall
          become vested with all the rights, powers, duties and obligations of its predecessor hereunder, with like effect as if originally named as Trustee herein; but, nevertheless, on the written request of the Company or of the successor trustee, the
          trustee ceasing to act shall, upon payment of any amounts then due it pursuant to the provisions of <font style="font-family: 'Times New Roman';"><u>Section&#160;7.06</u></font>, execute and deliver an instrument transferring to such successor
          trustee all the rights and powers of the trustee so ceasing to act.&#160; Upon request of any such successor trustee, the Company shall execute any and all instruments in writing for more fully and certainly vesting in and confirming to such successor
          trustee all such rights and powers.&#160; Any trustee ceasing to act shall, nevertheless, retain a senior lien to which the Notes are hereby made subordinate on all money or property held or collected by such trustee as such, except for funds held in
          trust for the benefit of Holders of particular Notes, to secure any amounts then due it pursuant to the provisions of <font style="font-family: 'Times New Roman';"><u>Section&#160;7.06</u></font>.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">48</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">No successor trustee shall accept appointment as provided in this <font style="font-family: 'Times New Roman';"><u>Section&#160;7.10</u></font>&#160;unless at the
      time of such acceptance such successor trustee shall be eligible under the provisions of <font style="font-family: 'Times New Roman';"><u>Section&#160;7.08</u></font>.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Upon acceptance of appointment by a successor trustee as provided in this <font style="font-family: 'Times New Roman';"><u>Section&#160;7.10</u></font>, each
      of the Company and the successor trustee, at the written direction and at the expense of the Company shall deliver or cause to be delivered notice of the succession of such trustee hereunder to the Holders.&#160; If the Company fails to deliver such
      notice within ten days after acceptance of appointment by the successor trustee, the successor trustee shall cause such notice to be delivered at the expense of the Company.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">Section 7.11</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><a name="z_Toc62469712"></a><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><u>Succession by Merger, Etc.</u></font> Any corporation or other entity into which the Trustee may be merged or converted or with which it may be consolidated, or any corporation or other entity
          resulting from any merger, conversion or consolidation to which the Trustee shall be a party, or any corporation or other entity succeeding to all or substantially all of the corporate trust business of the Trustee (including the administration
          of this Indenture), shall be the successor to the Trustee hereunder without the execution or filing of any paper or any further act on the part of any of the parties hereto; <font style="font-family: 'Times New Roman'; font-style: italic;">provided



          </font>that in the case of any corporation or other entity succeeding to all or substantially all of the corporate trust business of the Trustee such corporation or other entity shall be eligible under the provisions of <font style="font-family: 'Times New Roman';"><u>Section&#160;7.08</u></font>.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">In case at the time such successor to the Trustee shall succeed to the trusts created by this Indenture, any of the Notes shall have been authenticated
      but not delivered, any such successor to the Trustee may adopt the certificate of authentication of any predecessor trustee or authenticating agent appointed by such predecessor trustee, and deliver such Notes so authenticated; and in case at that
      time any of the Notes shall not have been authenticated, any successor to the Trustee or an authenticating agent appointed by such successor trustee may authenticate such Notes either in the name of any predecessor trustee hereunder or in the name of
      the successor trustee; and in all such cases such certificates shall have the full force which it is anywhere in the Notes or in this Indenture provided that the certificate of the Trustee shall have; <font style="font-family: 'Times New Roman'; font-style: italic;">provided</font>, <font style="font-family: 'Times New Roman'; font-style: italic;">however</font>, that the right to adopt the certificate of authentication of any predecessor trustee or to authenticate Notes in the name of
      any predecessor trustee shall apply only to its successor or successors by merger, conversion or consolidation.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">Section 7.12</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><a name="z_Toc62469713"></a><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><u>Trustee&#8217;s Application for Instructions from the Company</u></font>.&#160; Any application by the Trustee for written instructions from the Company (other than with regard to any action proposed to be taken
          or omitted to be taken by the Trustee that affects the rights of the Holders of the Notes under this Indenture) may, at the option of the Trustee, set forth in writing any action proposed to be taken or omitted by the Trustee under this Indenture
          and the date on and/or after which such action shall be taken or such omission shall be effective.&#160; The Trustee shall not be liable to the Company for any action taken by, or omission of, the Trustee in accordance with a proposal included in such
          application on or after the date specified in such application (which date shall not be less than three Business Days after the date notice to the Company is deemed to be received pursuant to <font style="font-family: 'Times New Roman';"><u>Section



              17.03</u></font>, unless any such officer shall have consented in writing to any earlier date), unless, prior to taking any such action (or the effective date in the case of any omission), the Trustee shall have received written instructions
          in accordance with this Indenture in response to such application specifying the action to be taken or omitted.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">49</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">ARTICLE 8<font style="font-family: 'Times New Roman';"><br>
      </font><a name="z_Toc62469714"></a>CONCERNING THE HOLDERS</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">Section 8.01</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><a name="z_Toc62469715"></a><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><u>Action by Holders</u></font>.&#160; Whenever in this Indenture it is provided that the Holders of a specified percentage of the aggregate principal amount of the Notes may take any action (including the
          making of any demand or request, the giving of any notice, consent or waiver or the taking of any other action), the fact that at the time of taking any such action, the Holders of such specified percentage have joined therein may be evidenced
          (a) by any instrument or any number of instruments of similar tenor executed by Holders in person or by agent or proxy appointed in writing, or (b) by the record of the Holders voting in favor thereof at any meeting of Holders duly called and
          held in accordance with the provisions of&#160;<font style="font-family: 'Times New Roman';"><u>Article 9</u></font>, or (c) by a combination of such instrument or instruments and any such record of such a meeting of Holders.&#160; Whenever the Company or
          the Trustee solicits the taking of any action by the Holders of the Notes, the Company or the Trustee may, but shall not be required to, fix in advance of such solicitation, a date as the record date for determining Holders entitled to take such
          action.&#160; The record date if one is selected shall be not more than fifteen days prior to the date of commencement of solicitation of such action.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">Section 8.02</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><u>Proof of Execution by Holders</u></font>.&#160; Subject to the provisions of <font style="font-family: 'Times New Roman';"><u>Section&#160;7.01</u></font>, <font style="font-family: 'Times New Roman';"><u>Section&#160;7.02</u></font>&#160;and <font style="font-family: 'Times New Roman';"><u>Section&#160;9.05</u></font>, proof of the execution of any instrument or writing by a Holder or its agent or proxy shall be sufficient if made in accordance with such reasonable rules and regulations as
          may be prescribed by the Trustee or in such manner as shall be satisfactory to the Trustee.&#160; The holding of Notes shall be proved by the Note Register or by a certificate of the Note Registrar.&#160; The record of any Holders&#8217; meeting shall be proved
          in the manner provided in <font style="font-family: 'Times New Roman';"><u>Section&#160;9.06</u></font>.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">Section 8.03</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><a name="z_Toc62469717"></a><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><u>Who Are Deemed Absolute Owners</u></font>.&#160; The Company, the Trustee, any authenticating agent, any Paying Agent, any Conversion Agent and any Note Registrar may deem the Person in whose name a Note
          shall be registered upon the Note Register to be, and may treat it as, the absolute owner of such Note (whether or not such Note shall be overdue and notwithstanding any notation of ownership or other writing thereon made by any Person other than
          the Company or any Note Registrar) for the purpose of receiving payment of or on account of the principal (including any Redemption Price and any Fundamental Change Repurchase Price) of and (subject to <font style="font-family: 'Times New Roman';"><u>Section&#160;2.03</u></font>) accrued and unpaid interest on such Note, for conversion of such Note and for all other purposes under this Indenture; and neither the Company nor the Trustee nor any Paying Agent nor any Conversion Agent
          nor any Note Registrar shall be affected by any notice to the contrary.&#160; The sole registered holder of a Global Note shall be the Depositary or its nominee.&#160; All such payments or deliveries so made to any Holder for the time being, or upon its
          order, shall be valid, and, to the extent of the sums or shares of Common Stock so paid or delivered, effectual to satisfy and discharge the liability for monies payable or shares deliverable upon any such Note.&#160; Notwithstanding anything to the
          contrary in this Indenture or the Notes following an Event of Default, any holder of a beneficial interest in a Global Note may directly enforce against the Company, without the consent, solicitation, proxy, authorization or any other action of
          the Depositary or any other Person, such holder&#8217;s right to exchange such beneficial interest for a Note in certificated form in accordance with the provisions of this Indenture.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">50</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">Section 8.04</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><u>Company-Owned Notes Disregarded</u></font>.&#160; In determining whether the Holders of the requisite aggregate principal amount of Notes have concurred in any direction, consent, waiver or other action under this Indenture, Notes
          that are owned by the Company, by any Subsidiary thereof or by any Affiliate of the Company or any Subsidiary thereof shall be disregarded and deemed not to be outstanding for the purpose of any such determination; <font style="font-family: 'Times New Roman'; font-style: italic;">provided </font>that for the purposes of determining whether the Trustee shall be protected in relying on any such direction, consent, waiver or other action only Notes that a Responsible Officer
          actually knows are so owned shall be so disregarded.&#160; Notes so owned that have been pledged in good faith may be regarded as outstanding for the purposes of this <font style="font-family: 'Times New Roman';"><u>Section&#160;8.04</u></font>&#160;if the
          pledgee shall establish to the satisfaction of the Trustee the pledgee&#8217;s right to so act with respect to such Notes and that the pledgee is not the Company, a Subsidiary thereof or an Affiliate of the Company or a Subsidiary thereof.&#160; In the case
          of a dispute as to such right, any decision or indecision by the Trustee taken upon the advice of counsel shall be full protection to the Trustee.&#160; Upon request of the Trustee, the Company shall furnish to the Trustee promptly an Officer&#8217;s
          Certificate listing and identifying all Notes, if any, known by the Company to be owned or held by or for the account of any of the above described Persons; and, subject to <font style="font-family: 'Times New Roman';"><u>Section&#160;7.01</u></font>,
          the Trustee shall be entitled to accept such Officer&#8217;s Certificate as conclusive evidence of the facts therein set forth and of the fact that all Notes not listed therein are outstanding for the purpose of any such determination.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">Section 8.05</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><u>Revocation of Consents; Future Holders Bound</u></font>.&#160; At any time prior to (but not after) the evidencing to the Trustee, as provided in <font style="font-family: 'Times New Roman';"><u>Section&#160;8.01</u></font>, of the
          taking of any action by the Holders of the percentage of the aggregate principal amount of the Notes specified in this Indenture in connection with such action, any Holder of a Note that is shown by the evidence to be included in the Notes the
          Holders of which have consented to such action may, by filing written notice with the Trustee at its Corporate Trust Office and upon proof of holding as provided in <font style="font-family: 'Times New Roman';"><u>Section&#160;8.02</u></font>, revoke
          such action so far as concerns such Note.&#160; Except as aforesaid, any such action taken by the Holder of any Note shall be conclusive and binding upon such Holder and upon all future Holders and owners of such Note and of any Notes issued in
          exchange or substitution therefor or upon registration of transfer thereof, irrespective of whether any notation in regard thereto is made upon such Note or any Note issued in exchange or substitution therefor or upon registration of transfer
          thereof.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">ARTICLE 9<font style="font-family: 'Times New Roman';"><br>
      </font><a name="z_Toc62469720"></a>HOLDERS&#8217; MEETINGS</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">Section 9.01</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><u>Purpose of Meetings</u></font>.&#160; A meeting of Holders may be called at any time and from time to time pursuant to the provisions of this&#160;<font style="font-family: 'Times New Roman';"><u>Article 9</u></font>&#160;for any of the
          following purposes:</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">51</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(a)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">to give any notice
          to the Company or to the Trustee or to give any directions to the Trustee permitted under this Indenture, or to consent to the waiving of any Default or Event of Default hereunder (in each case, as permitted under this Indenture) and its
          consequences, or to take any other action authorized to be taken by Holders pursuant to any of the provisions of&#160;<font style="font-family: 'Times New Roman';"><u>Article 6</u></font>;</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(b)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">to remove the
          Trustee and nominate a successor trustee pursuant to the provisions of&#160;<font style="font-family: 'Times New Roman';"><u>Article 7</u></font>;</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(c)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">to consent to the
          execution of an indenture or indentures supplemental hereto pursuant to the provisions of <font style="font-family: 'Times New Roman';"><u>Section&#160;10.02</u></font>; or</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(d)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">to take any other
          action authorized to be taken by or on behalf of the Holders of any specified aggregate principal amount of the Notes under any other provision of this Indenture or under applicable law.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">Section 9.02</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><u>Call of Meetings by Trustee</u></font>.&#160; The Trustee may at any time call a meeting of Holders to take any action specified in <font style="font-family: 'Times New Roman';"><u>Section&#160;9.01</u></font>, to be held at such time
          and at such place as the Trustee shall determine.&#160; Notice of every meeting of the Holders, setting forth the time and the place of such meeting and in general terms the action proposed to be taken at such meeting and the establishment of any
          record date pursuant to <font style="font-family: 'Times New Roman';"><u>Section&#160;8.01</u></font>, shall be delivered to Holders of such Notes.&#160; Such notice shall also be delivered to the Company.&#160; Such notices shall be delivered not less than 20
          nor more than 90 days prior to the date fixed for the meeting.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Any meeting of Holders shall be valid without notice if the Holders of all Notes then outstanding are present in person or by proxy or if notice is
      waived before or after the meeting by the Holders of all Notes then outstanding, and if the Company and the Trustee are either present by duly authorized representatives or have, before or after the meeting, waived notice.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">Section 9.03</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><u>Call of Meetings by Company or Holders</u></font>.&#160; In case at any time the Company, pursuant to a Board Resolution, or the Holders of at least 10% of the aggregate principal amount of the Notes then outstanding, shall have
          requested the Trustee to call a meeting of Holders, by written request setting forth in reasonable detail the action proposed to be taken at the meeting, and the Trustee shall not have delivered the notice of such meeting within 20 days after
          receipt of such request, then the Company or such Holders may determine the time and the place for such meeting and may call such meeting to take any action authorized in <font style="font-family: 'Times New Roman';"><u>Section&#160;9.01</u></font>,
          by delivering notice thereof as provided in <font style="font-family: 'Times New Roman';"><u>Section&#160;9.02</u></font>.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">Section 9.04</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><a name="z_Toc62469724"></a><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><u>Qualifications for Voting</u></font>.&#160; To be entitled to vote at any meeting of Holders a Person shall (a) be a Holder of one or more Notes on the record date pertaining to such meeting or (b) be a
          Person appointed by an instrument in writing as proxy by a Holder of one or more Notes on the record date pertaining to such meeting.&#160; The only Persons who shall be entitled to be present or to speak at any meeting of Holders shall be the Persons
          entitled to vote at such meeting and their counsel and any representatives of the Trustee and its counsel and any representatives of the Company and its counsel.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">52</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">Section 9.05</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><u>Regulations</u></font>.&#160; Notwithstanding any other provisions of this Indenture, the Trustee may make such reasonable regulations as it may deem advisable for any meeting of Holders, in regard to proof of the holding of Notes
          and of the appointment of proxies, and in regard to the appointment and duties of inspectors of votes, the submission and examination of proxies, certificates and other evidence of the right to vote, and such other matters concerning the conduct
          of the meeting as it shall think fit.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">The Trustee shall, by an instrument in writing, appoint a temporary chairman of the meeting, unless the meeting shall have been called by the Company or
      by Holders as provided in <font style="font-family: 'Times New Roman';"><u>Section&#160;9.03</u></font>, in which case the Company or the Holders calling the meeting, as the case may be, shall in like manner appoint a temporary chairman.&#160; A permanent
      chairman and a permanent secretary of the meeting shall be elected by vote of the Holders of a majority in aggregate principal amount of the outstanding Notes represented at the meeting and entitled to vote at the meeting.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Subject to the provisions of <font style="font-family: 'Times New Roman';"><u>Section&#160;8.04</u></font>, at any meeting of Holders each Holder or
      proxyholder shall be entitled to one vote for each $1,000 principal amount of Notes held or represented by him or her; <font style="font-family: 'Times New Roman'; font-style: italic;">provided</font>, <font style="font-family: 'Times New Roman'; font-style: italic;">however</font>, that no vote shall be cast or counted at any meeting in respect of any Note challenged as not outstanding and ruled by the chairman of the meeting to be not outstanding.&#160; The chairman of the meeting shall have
      no right to vote other than by virtue of Notes held by it or instruments in writing as aforesaid duly designating it as the proxy to vote on behalf of other Holders.&#160; Any meeting of Holders duly called pursuant to the provisions of <font style="font-family: 'Times New Roman';"><u>Section&#160;9.02</u></font>&#160;or <font style="font-family: 'Times New Roman';"><u>Section&#160;9.03</u></font>&#160;may be adjourned from time to time by the Holders of a majority of the aggregate principal amount of
      Notes represented at the meeting, whether or not constituting a quorum, and the meeting may be held as so adjourned without further notice.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">Section 9.06</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><a name="z_Toc62469726"></a><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><u>Voting</u></font>.&#160; The vote upon any resolution submitted to any meeting of Holders shall be by written ballot on which shall be subscribed the signatures of the Holders or of their representatives
          by proxy and the outstanding aggregate principal amount of the Notes held or represented by them.&#160; The permanent chairman of the meeting shall appoint two inspectors of votes who shall count all votes cast at the meeting for or against any
          resolution and who shall make and file with the secretary of the meeting their verified written reports in duplicate of all votes cast at the meeting.&#160; A record in duplicate of the proceedings of each meeting of Holders shall be prepared by the
          secretary of the meeting and there shall be attached to said record the original reports of the inspectors of votes on any vote by ballot taken thereat and affidavits by one or more Persons having knowledge of the facts setting forth a copy of
          the notice of the meeting and showing that said notice was delivered as provided in <font style="font-family: 'Times New Roman';"><u>Section&#160;9.02</u></font>.&#160; The record shall show the aggregate principal amount of the Notes voting in favor of
          or against any resolution.&#160; The record shall be signed and verified by the affidavits of the permanent chairman and secretary of the meeting and one of the duplicates shall be delivered to the Company and the other to the Trustee to be preserved
          by the Trustee, the latter to have attached thereto the ballots voted at the meeting.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Any record so signed and verified shall be conclusive evidence of the matters therein stated.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">Section 9.07</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><a name="z_Toc62469727"></a><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><u>No Delay of Rights by Meeting</u></font><font style="font-family: 'Times New Roman'; font-style: italic;">.&#160; </font>Nothing contained in this&#160;<font style="font-family: 'Times New Roman';"><u>Article
              9</u></font>&#160;shall be deemed or construed to authorize or permit, by reason of any call of a meeting of Holders or any rights expressly or impliedly conferred hereunder to make such call, any hindrance or delay in the exercise of any right or
          rights conferred upon or reserved to the Trustee or to the Holders under any of the provisions of this Indenture or of the Notes.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">53</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">ARTICLE 10<font style="font-family: 'Times New Roman';"><br>
      </font><a name="z_Toc62469728"></a>SUPPLEMENTAL INDENTURES</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">Section 10.01</font><font style="font-size: 10pt;">&#160;&#160; <font style="font-family: 'Times New Roman';"><a name="z_Toc62469729"></a><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><u>Supplemental Indentures Without Consent of Holders</u></font><font style="font-family: 'Times New Roman'; font-style: italic;">.&#160; </font>The Company and the Trustee, at the Company&#8217;s expense, may
          from time to time and at any time enter into an indenture or indentures supplemental hereto for one or more of the following purposes:</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(a)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">to cure any
          ambiguity, omission, defect or inconsistency;</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(b)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">to provide for the
          assumption by a Successor Company of the obligations of the Company under this Indenture pursuant to&#160;<font style="font-family: 'Times New Roman';"><u>Article 11</u></font>;</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(c)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">to add guarantees
          with respect to the Notes;</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(d)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">to secure the Notes;</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(e)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">to add to the
          covenants or Events of Default of the Company for the benefit of the Holders or surrender any right or power conferred upon the Company;</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(f)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">to make any change
          that does not adversely affect the rights of any Holder in any material respect;</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(g)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">in connection with
          any Merger Event, to provide that the notes are convertible into Reference Property, subject to the provisions of <font style="font-family: 'Times New Roman';"><u>Section&#160;14.02</u></font>, and make such related changes to the terms of the Notes
          to the extent expressly required by <font style="font-family: 'Times New Roman';"><u>Section&#160;14.07</u></font>;</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(h)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">to conform the
          provisions of this Indenture or the Notes to the &#8220;Description of notes&#8221; section of the Offering Memorandum;</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(i)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">to comply with the
          rules of any applicable Depositary, including The Depository Trust Company, so long as such amendment does not adversely affect the rights of any Holder;</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(j)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">to appoint a
          successor trustee with respect to the Notes;</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(k)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">to increase the
          Conversion Rate as provided in this Indenture;</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(l)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">to provide for the
          acceptance of appointment by a successor Trustee, security registrar, Paying Agent, Bid Solicitation Agent or Conversion Agent to facilitate the administration of the trusts under this Indenture by more than one trustee; or</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(m)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">to irrevocably elect
          a Settlement Method or a Specified Dollar Amount, or eliminate the Company&#8217;s right to elect a Settlement Method; provided, however, that no such election or elimination will affect any Settlement Method theretofore elected (or deemed to be
          elected) with respect to any Note pursuant to&#160;<font style="font-family: 'Times New Roman';"><u>Article 14</u></font>.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">54</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Upon the written request of the Company, the Trustee is hereby authorized to join with the Company in the execution of any such supplemental indenture
      and to make any further appropriate agreements and stipulations that may be therein contained, but the Trustee shall not be obligated to, but may in its discretion, enter into any supplemental indenture that affects the Trustee&#8217;s own rights, duties
      or immunities under this Indenture or otherwise.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Any supplemental indenture authorized by the provisions of this <font style="font-family: 'Times New Roman';"><u>Section&#160;10.01</u></font>&#160;may be
      executed by the Company and the Trustee without the consent of the Holders of any of the Notes at the time outstanding, notwithstanding any of the provisions of <font style="font-family: 'Times New Roman';"><u>Section&#160;10.02</u></font>.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">Section 10.02</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><a name="z_Toc62469730"></a><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><u>Supplemental Indentures with Consent of Holders</u></font><font style="font-family: 'Times New Roman'; font-style: italic;">.&#160; </font>With the consent (evidenced as provided in <font style="font-family: 'Times New Roman';"><u>Article 8</u></font>) of the Holders of at least a majority of the aggregate principal amount of the Notes then outstanding (determined in accordance with <font style="font-family: 'Times New Roman';"><u>Article



              8</u></font> and including, without limitation, consents obtained in connection with a repurchase of, or tender or exchange offer for, Notes), the Company and the Trustee, at the Company&#8217;s expense, may from time to time and at any time enter
          into an indenture or indentures supplemental hereto for the purpose of adding any provisions to or changing in any manner or eliminating any of the provisions of this Indenture, the Notes or any supplemental indenture or of modifying in any
          manner the rights of the Holders; <font style="font-family: 'Times New Roman'; font-style: italic;">provided</font>, <font style="font-family: 'Times New Roman'; font-style: italic;">however</font>, that, without the consent of each Holder of
          an outstanding Note affected, no such supplemental indenture shall:</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(a)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">reduce the
          principal amount of Notes whose Holders must consent to an amendment;</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(b)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">reduce the rate of
          or extend the stated time for payment of interest on any Note;</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(c)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">reduce the
          principal of or extend the Maturity Date of any Note;</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(d)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">except as required
          by this Indenture, make any change that adversely affects the conversion rights of any Notes;</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(e)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">reduce the
          Redemption Price or the Fundamental Change Repurchase Price of any Note or amend or modify in any manner adverse to the Holders the Company&#8217;s obligation to make such payments, whether through an amendment or waiver of provisions in the covenants,
          definitions or otherwise;</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(f)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">make any Note
          payable in a currency, or at a place of payment, other than that stated in the Note;</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(g)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">change the ranking
          of the Notes; or</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(h)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">make any change in
          this&#160;<font style="font-family: 'Times New Roman';"><u>Article 10</u></font>&#160;that requires each Holder&#8217;s consent or in the waiver provisions in <font style="font-family: 'Times New Roman';"><u>Section&#160;6.02</u></font>&#160;or <font style="font-family: 'Times New Roman';"><u>Section&#160;6.09</u></font>.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Upon the written request of the Company, and upon the filing with the Trustee of evidence of the consent of Holders as aforesaid and subject to <font style="font-family: 'Times New Roman';"><u>Section&#160;10.05</u></font>, the Trustee shall join with the Company in the execution of such supplemental indenture unless such supplemental indenture affects the Trustee&#8217;s own rights, duties or immunities
      under this Indenture or otherwise, in which case the Trustee may in its discretion, but shall not be obligated to, enter into such supplemental indenture.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">55</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Holders do not need under this <font style="font-family: 'Times New Roman';"><u>Section&#160;10.02</u></font>&#160;to approve the particular form of any proposed
      supplemental indenture.&#160; It shall be sufficient if such Holders approve the substance thereof.&#160; After any such supplemental indenture becomes effective, the Company shall deliver to the Holders (with a copy to the Trustee) a notice briefly describing
      such supplemental indenture.&#160; However, the failure to give such notice to all the Holders (with a copy to the Trustee), or any defect in the notice, will not impair or affect the validity of the supplemental indenture.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">Section 10.03</font><font style="font-size: 10pt;">&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><u>Effect of Supplemental Indentures</u></font><font style="font-family: 'Times New Roman'; font-style: italic;">.&#160; </font>Upon the execution of any supplemental indenture pursuant to the provisions of this&#160;<font style="font-family: 'Times New Roman';"><u>Article 10</u></font>, this Indenture shall be and be deemed to be modified and amended in accordance therewith and the respective rights, limitation of rights, obligations, duties and immunities under
          this Indenture of the Trustee, the Company and the Holders shall thereafter be determined, exercised and enforced hereunder subject in all respects to such modifications and amendments and all the terms and conditions of any such supplemental
          indenture shall be and be deemed to be part of the terms and conditions of this Indenture for any and all purposes.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">Section 10.04</font><font style="font-size: 10pt;">&#160;&#160; <font style="font-family: 'Times New Roman';"><a name="z_Toc62469732"></a><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><u>Notation on Notes</u></font><font style="font-family: 'Times New Roman'; font-style: italic;">.&#160; </font>Notes authenticated and delivered after the execution of any supplemental indenture pursuant to
          the provisions of this&#160;<font style="font-family: 'Times New Roman';"><u>Article 10</u></font>&#160;may, at the Company&#8217;s expense, bear a notation as to any matter provided for in such supplemental indenture.&#160; If the Company or the Trustee shall so
          determine, new Notes so modified as to conform, in the opinion of the Company, to any modification of this Indenture contained in any such supplemental indenture may, at the Company&#8217;s expense, be prepared and executed by the Company,
          authenticated, upon receipt of a Company Order, by the Trustee (or an authenticating agent duly appointed by the Trustee pursuant to <font style="font-family: 'Times New Roman';"><u>Section&#160;17.10</u></font>) and delivered in exchange for the
          Notes then outstanding, upon surrender of such Notes then outstanding.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">Section 10.05</font><font style="font-size: 10pt;">&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><u>Evidence of Compliance of Supplemental Indenture to Be Furnished Trustee</u></font><font style="font-family: 'Times New Roman'; font-style: italic;">.&#160; </font>In addition to the documents required by <font style="font-family: 'Times New Roman';"><u>Section&#160;17.05</u></font>, the Trustee shall receive an Officer&#8217;s Certificate and an Opinion of Counsel as conclusive evidence that any supplemental indenture executed pursuant hereto complies with the
          requirements of this&#160;<font style="font-family: 'Times New Roman';"><u>Article 10</u></font>&#160;and is permitted or authorized by this Indenture; such Opinion of Counsel to include a customary legal opinion stating that such supplemental indenture is
          the valid and binding obligation of the Company, subject to customary exceptions and qualifications.&#160; The Trustee shall have no responsibility for determining whether any amendment or supplemental indenture will or may have an adverse effect on
          any Holder.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">56</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">ARTICLE 11<font style="font-family: 'Times New Roman';"><br>
      </font><a name="z_Toc62469734"></a>CONSOLIDATION, MERGER, SALE, CONVEYANCE AND LEASE</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">Section 11.01</font><font style="font-size: 10pt;">&#160;&#160; <font style="font-family: 'Times New Roman';"><a name="z_Toc62469735"></a><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><u>Company May Consolidate, Etc. on Certain Terms</u></font>.&#160; Subject to the provisions of <font style="font-family: 'Times New Roman';"><u>Section&#160;11.02</u></font>, the Company shall not consolidate
          with, merge with or into, or sell, convey, transfer or lease all or substantially all of the properties and assets of the Company to another Person (other than any such sale, conveyance, transfer or lease to one or more of the Company&#8217;s Wholly
          Owned Subsidiaries but, for the avoidance of doubt, in the case of any such sale, conveyance, transfer or lease, the transferee will not succeed to the transferor, and the transferor will not be discharged from its obligations, under this
          Indenture and the Notes) unless:</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(a)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">the resulting,
          surviving or transferee Person (the &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Successor Company</font>&#8221;), if not the Company, shall be a corporation organized and existing under the laws of the United States of America,
          any State thereof or the District of Columbia, and the Successor Company (if not the Company) shall expressly assume, by supplemental indenture all of the obligations of the Company under the Notes and this Indenture; and</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(b)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">immediately after
          giving effect to such transaction, no Default or Event of Default shall have occurred and be continuing under this Indenture.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">For purposes of this <font style="font-family: 'Times New Roman';"><u>Section&#160;11.01</u></font>, the sale, conveyance, transfer or lease of all or
      substantially all of the properties and assets of one or more Subsidiaries of the Company to another Person, which properties and assets, if held by the Company instead of such Subsidiaries, would constitute all or substantially all of the properties
      and assets of the Company on a consolidated basis, shall be deemed to be the sale, conveyance, transfer or lease of all or substantially all of the properties and assets of the Company to another Person.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">Section 11.02</font><font style="font-size: 10pt;">&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><u>Successor Corporation to Be Substituted</u></font><font style="font-family: 'Times New Roman'; font-style: italic;">.&#160; </font>In case of any such consolidation, merger, sale, conveyance, transfer or lease and upon the
          assumption by the Successor Company, by supplemental indenture, executed and delivered to the Trustee and satisfactory in form to the Trustee, of the due and punctual payment of the principal of and accrued and unpaid interest on all of the
          Notes, the due and punctual delivery or payment, as the case may be, of any consideration due upon conversion of the Notes and the due and punctual performance of all of the covenants and conditions of this Indenture to be performed by the
          Company, such Successor Company (if not the Company) shall succeed to and, except in the case of a lease of all or substantially all of the Company&#8217;s properties and assets, shall be substituted for the Company, with the same effect as if it had
          been named herein as the party of the first part, and may thereafter exercise every right and power of the Company under this Indenture.&#160; Such Successor Company thereupon may cause to be signed, and may issue either in its own name or in the name
          of the Company any or all of the Notes issuable hereunder which theretofore shall not have been signed by the Company and delivered to the Trustee; and, upon the order of such Successor Company instead of the Company and subject to all the terms,
          conditions and limitations in this Indenture prescribed, the Trustee shall authenticate and shall deliver, or cause to be authenticated and delivered, any Notes that previously shall have been signed and delivered by the Officers of the Company
          to the Trustee for authentication, and any Notes that such Successor Company thereafter shall cause to be signed and delivered to the Trustee for that purpose.&#160; All the Notes so issued shall in all respects have the same legal rank and benefit
          under this Indenture as the Notes theretofore or thereafter issued in accordance with the terms of this Indenture as though all of such Notes had been issued at the date of the execution hereof.&#160; In the event of any such consolidation, merger,
          sale, conveyance or transfer (but not in the case of a lease), upon compliance with this&#160;<font style="font-family: 'Times New Roman';"><u>Article 11</u></font>&#160;the Person named as the &#8220;Company&#8221; in the first paragraph of this Indenture (or any
          successor that shall thereafter have become such in the manner prescribed in this&#160;<font style="font-family: 'Times New Roman';"><u>Article 11</u></font>) may be dissolved, wound up and liquidated at any time thereafter and, except in the case of
          a lease, such Person shall be released from its liabilities as obligor and maker of the Notes and from its obligations under this Indenture and the Notes.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">57</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">In case of any such consolidation, merger, sale, conveyance, transfer or lease, such changes in phraseology and form (but not in substance) may be made
      in the Notes thereafter to be issued as may be appropriate.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">ARTICLE 12<font style="font-family: 'Times New Roman';"><br>
      </font><a name="z_Toc62469737"></a>IMMUNITY OF INCORPORATORS, STOCKHOLDERS, OFFICERS AND DIRECTORS</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">Section 12.01</font><font style="font-size: 10pt;">&#160;&#160; <font style="font-family: 'Times New Roman';"><a name="z_Toc62469738"></a><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><u>Indenture and Notes Solely Corporate Obligations</u></font><font style="font-family: 'Times New Roman'; font-style: italic;">.&#160; </font>No recourse for the payment of the principal of or accrued and
          unpaid interest on any Note, nor for any claim based thereon or otherwise in respect thereof, and no recourse under or upon any obligation, covenant or agreement of the Company in this Indenture or in any supplemental indenture or in any Note,
          nor because of the creation of any indebtedness represented thereby, shall be had against any incorporator, stockholder, employee, agent, Officer or director or Subsidiary, as such, past, present or future, of the Company or of any successor
          corporation, either directly or through the Company or any successor corporation, whether by virtue of any constitution, statute or rule of law, or by the enforcement of any assessment or penalty or otherwise; it being expressly understood that
          all such liability is hereby expressly waived and released as a condition of, and as a consideration for, the execution of this Indenture and the issue of the Notes.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">ARTICLE 13<font style="font-family: 'Times New Roman';"><br>
      </font><a name="z_Toc62469739"></a>[INTENTIONALLY OMITTED]</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">ARTICLE 14<font style="font-family: 'Times New Roman';"><br>
      </font><a name="z_Toc62469740"></a>CONVERSION OF NOTES</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">Section 14.01</font><font style="font-size: 10pt;">&#160;&#160; <font style="font-family: 'Times New Roman';"><a name="z_Toc62469741"></a><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><u>Conversion Privilege</u></font>.&#160; (a) Subject to and upon compliance with the provisions of this&#160;<font style="font-family: 'Times New Roman';"><u>Article 14</u></font>, each Holder of a Note shall
          have the right, at such Holder&#8217;s option, to convert all or any portion (if the portion to be converted is $1,000 principal amount or an integral multiple thereof) of such Note (i) subject to satisfaction of the conditions described in <font style="font-family: 'Times New Roman';"><u>Section&#160;14.01(b)</u></font>, at any time prior to the close of business on the Business Day immediately preceding December 2, 2030 under the circumstances and during the periods set forth in <font style="font-family: 'Times New Roman';"><u>Section&#160;14.01(b)</u></font>, and (ii) regardless of the conditions described in <font style="font-family: 'Times New Roman';"><u>Section&#160;14.01(b)</u></font>, on or after December 2, 2030 and prior to
          the close of business on the second Scheduled Trading Day immediately preceding the Maturity Date, in each case, at an initial conversion rate of 20.0773 shares of Common Stock (subject to adjustment as provided in this&#160;<font style="font-family: 'Times New Roman';"><u>Article 14</u></font>, the &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Conversion Rate</font>&#8221;) per $1,000 principal amount of Notes (subject to, and in accordance with, the settlement provisions of
          <font style="font-family: 'Times New Roman';"><u>Section&#160;14.02</u></font>, the &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Conversion Obligation</font>&#8221;).</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">58</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">(b) (i) Prior to the close of business on the Business Day immediately preceding December 2, 2030, a Holder may surrender all or any portion of its Notes
      for conversion at any time during the five Business Day period immediately after any five consecutive Trading Day period (the &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Measurement Period</font>&#8221;) in which the Trading Price per
      $1,000 principal amount of Notes, as determined following a request by a Holder of Notes in accordance with this&#160;<font style="font-family: 'Times New Roman';"><u>subsection (b)(i)</u></font>, for each Trading Day of the Measurement Period was less
      than 98% of the product of the Last Reported Sale Price of the Common Stock on each such Trading Day and the Conversion Rate on each such Trading Day.&#160; The Trading Prices shall be determined by the Bid Solicitation Agent pursuant to this&#160;<font style="font-family: 'Times New Roman';"><u>subsection (b)(i)</u></font> and the definition of Trading Price set forth in this Indenture.&#160; The Bid Solicitation Agent (if other than the Company) shall have no obligation to determine the Trading Price
      per $1,000 principal amount of Notes unless the Company has requested such determination, and the Company shall have no obligation to make such request (or, if the Company is acting as Bid Solicitation Agent, the Company shall have no obligation to
      determine the Trading Price per $1,000 principal amount of Notes) unless a Holder of at least $3,000,000 aggregate principal amount of Notes provides the Company with reasonable evidence that the Trading Price per $1,000 principal amount of Notes on
      any Trading Day would be less than 98% of the product of the Last Reported Sale Price of the Common Stock on such Trading Day and the Conversion Rate on such Trading Day, at which time the Company shall instruct the Bid Solicitation Agent (if other
      than the Company) to determine, or if the Company is acting as Bid Solicitation Agent, the Company shall determine, the Trading Price per $1,000 principal amount of Notes beginning on the next Trading Day and on each successive Trading Day until the
      Trading Price per $1,000 principal amount of Notes is greater than or equal to 98% of the product of the Last Reported Sale Price of the Common Stock and the Conversion Rate and the Company will instruct three (3) independent nationally recognized
      securities dealers to deliver bids to the Bid Solicitation Agent.&#160; If (x) the Company is not acting as Bid Solicitation Agent, and the Company does not, when the Company is required to, instruct the Bid Solicitation Agent to determine the Trading
      Price per $1,000 principal amount of Notes when obligated as provided in the preceding sentence, or if the Company instructs the Bid Solicitation Agent to obtain bids and the Bid Solicitation Agent fails to make such determination, or (y) the Company
      is acting as Bid Solicitation Agent and the Company fails to make such determination when obligated as provided in the preceding sentence, then, in either case, the Trading Price per $1,000 principal amount of Notes shall be deemed to be less than
      98% of the product of the Last Reported Sale Price of the Common Stock and the Conversion Rate on each Trading Day of such failure.&#160; If the Trading Price condition set forth above has been met, the Company shall so notify the Holders, the Trustee and
      the Conversion Agent (if other than the Trustee).&#160; If, at any time after the Trading Price condition set forth above has been met, the Trading Price per $1,000 principal amount of Notes is greater than or equal to 98% of the product of the Last
      Reported Sale Price of the Common Stock and the Conversion Rate for such date, the Company shall so notify in writing the Holders of the Notes, the Trustee and the Conversion Agent (if other than the Trustee) and thereafter neither the Company nor
      the Bid Solicitation Agent (if other than the Company) shall be required to solicit bids (or determine the Trading Price of the Notes as set forth in this Indenture) again until a new Holder request is made as provided in this&#160;<font style="font-family: 'Times New Roman';"><u>subsection (b)(i)</u></font>.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div>
      <div>
        <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; margin-left: 63pt;"><font style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-size: 10pt;">If the Company elects to:</font></div>
        <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman';"> <font style="font-size: 10pt;"><br>
          </font></div>
      </div>
    </div>
    <div>
      <div>
        <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; margin-left: 63pt; text-indent: 36pt;"><font style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(A) &#160; &#160;&#160; </font><font style="font-size: 10pt;">distribute to all or substantially all holders of the Common Stock any rights, options or warrants (other than in connection with a stockholder rights plan prior to the separation of such rights from the Common Stock)
            entitling them, for a period of not more than 60 calendar days after the announcement date of such distribution, to subscribe for or purchase shares of the Common Stock at a price per share that is less than the average of the Last Reported
            Sale Prices of the Common Stock for the 10 consecutive Trading Day period ending on, and including, the Trading Day immediately preceding the date of announcement of such distribution; or</font></div>
        <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman';"> <font style="font-size: 10pt;"><br>
          </font></div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
          <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">59</font></div>
          <div style="page-break-after: always;" class="BRPFPageBreak">
            <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
        </div>
      </div>
    </div>
    <div>
      <div>
        <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; margin-left: 63pt; text-indent: 36pt;"><font style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(B)&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-size: 10pt;">distribute to all or substantially all holders of the Common Stock the Company&#8217;s assets, securities or rights to purchase securities of the Company (other than in connection with a stockholder rights plan prior to
            separation of such rights from the Common Stock), which distribution has a per share value, as reasonably determined by the Company in good faith and in commercially reasonable manner, exceeding 10% of the Last Reported Sale Price of the Common
            Stock on the Trading Day preceding the date of announcement for such distribution,</font></div>
        <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman';"> <font style="font-size: 10pt;"><br>
          </font></div>
      </div>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">then, in either case, the Company shall notify all Holders of the Notes, the Trustee and the Conversion Agent (if other than the Trustee) at least 45 Scheduled Trading Days
      prior to the&#160;Ex-Dividend&#160;Date for such distribution (or, if later in the case of any such separation of rights issued pursuant to a stockholder rights plan, as soon as reasonably practicable after the Company becomes aware that such separation or
      triggering event has occurred or will occur); <font style="font-family: 'Times New Roman'; font-style: italic;">provided</font>, <font style="font-family: 'Times New Roman'; font-style: italic;">however</font>, that if the Company is then otherwise
      permitted to settle conversions of Notes by Physical Settlement (and, for the avoidance of doubt, has not irrevocably elected another Settlement Method for conversions of Notes), then the Company may instead elect to provide such notice at least ten
      Scheduled Trading Days prior to such Ex-Dividend Date, in which case the Company shall be required to settle all conversions of Notes with a Conversion Date occurring during the period on or after the date the Company provides such notice and before
      such Ex-Dividend Date (or, if earlier, the date the Company announces that such issuance or distribution will not take place) by Physical Settlement, and the Company shall describe the same in such notice.&#160; Once the Company has given such notice, a
      Holder may surrender all or any portion of its Notes for conversion at any time until the earlier of (1) the close of business on the Business Day immediately preceding the&#160;Ex-Dividend&#160;Date for such distribution and (2) the Company&#8217;s announcement
      that such distribution will not take place, in each case, even if the Notes are not otherwise convertible at such time; <font style="font-family: 'Times New Roman'; font-style: italic;">provided </font>that Holders may not convert their Notes
      pursuant to this&#160;<font style="font-family: 'Times New Roman';"><u>subsection (b)(ii)</u></font> if they participate, at the same time and upon the same terms as holders of the Common Stock and solely as a result of holding the Notes, in any of the
      transactions described in clause (A) or (B) of this&#160;<font style="font-family: 'Times New Roman';"><u>subsection (b)(ii)</u></font> without having to convert their Notes as if they held a number of shares of Common Stock equal to the applicable
      Conversion Rate as of the record date for such issuance or distribution, <font style="font-family: 'Times New Roman'; font-style: italic;">multiplied by</font>&#160;the principal amount (expressed in thousands) of Notes held by such Holder.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">60</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <!--PROfilePageNumberReset%Num%61%%%-->
    <div>
      <div>
        <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; margin-left: 36pt; text-indent: 27pt;"><font style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(iii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-size: 10pt;">If a transaction or event that constitutes a Fundamental Change or a Make-Whole Fundamental Change occurs, regardless of whether a Holder has the right to require the Company to repurchase the Notes pursuant to <font style="font-family: 'Times New Roman';"><u>Section&#160;15.02</u></font>, or if the Company is a party to a consolidation, merger, binding share exchange, or transfer or lease of all or substantially all of its assets that occurs, in each case,
            pursuant to which the Common Stock would be converted into cash, securities or other assets (other than a merger effected solely to change the Company&#8217;s jurisdiction of incorporation solely within the United States that (x) does not otherwise
            constitute a Fundamental Change or a Make-Whole Fundamental Change and (y) results in a reclassification, conversion, or exchange of outstanding shares of the Common Stock solely into shares of common stock of the surviving entity and such
            common stock becomes the sole Reference Property for the Notes), all or any portion of a Holder&#8217;s Notes may be surrendered for conversion at any time from or after the effective date of such transaction until the earlier of (x) 35 Scheduled
            Trading Days after the effective date of such transaction (or, if the Company gives notice after the effective date of such transaction, until 35 Trading Days after the date the Company gives notice) or, if such transaction also constitutes a
            Fundamental Change (other than an Exempted Fundamental Change), until close of business on the Business Day immediately preceding the related Fundamental Change Repurchase Date and (y) the second Scheduled Trading Day immediately preceding the
            Maturity Date.&#160; The Company shall notify Holders, the Trustee and the Conversion Agent (if other than the Trustee) as promptly as practicable following the effective date of such transaction, but in no event later than five Business Days after
            the effective date of such transaction.</font></div>
        <div style="text-align: left; text-indent: 72pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';"> <font style="font-size: 10pt;"><br>
          </font></div>
      </div>
    </div>
    <div>
      <div>
        <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; margin-left: 36pt; text-indent: 27pt;"><font style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(iv)&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-size: 10pt;">Prior to the close of business on the Business Day immediately preceding December 2, 2030, a Holder may surrender all or any portion of its Notes for conversion at any time during any calendar quarter commencing after
            the calendar quarter ending on June&#160;30, 2025 (and only during such calendar quarter), if the Last Reported Sale Price of the Common Stock for at least 20 Trading Days (whether or not consecutive) during the period of 30 consecutive Trading Days
            ending on, and including, the last Trading Day of the immediately preceding calendar quarter is greater than or equal to 130% of the Conversion Price on each applicable Trading Day.</font></div>
        <div style="text-align: left; text-indent: 72pt; color: rgb(0, 0, 0); font-family: 'Times New Roman';"> <font style="font-size: 10pt;"><br>
          </font></div>
      </div>
    </div>
    <div>
      <div>
        <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; margin-left: 36pt; text-indent: 27pt;"><font style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(v) &#160; &#160; &#160;&#160; </font><font style="font-size: 10pt;">If the Company calls any Note for redemption pursuant to <font style="font-family: 'Times New Roman';"><u>Article 16</u></font>, then a Holder of the Note called for redemption may surrender such Note (or a portion
            thereof) called for redemption for conversion at any time prior to the close of business on the second Business Day prior to the applicable Redemption Date, even if the Notes are not otherwise convertible at such time.&#160; After that time, the
            right to convert such Note called for redemption pursuant to this subsection (b)(v) shall expire, unless the Company defaults in the payment of the Redemption Price, in which case a Holder of such Note called for redemption may convert such
            Note (or a portion thereof) called for redemption until the Redemption Price has been paid or duly provided for.&#160; If the Company elects to redeem less than all of the outstanding Notes pursuant to Article 16, and the Holder of any Note (or any
            owner of a beneficial interest in any Global Note) is reasonably not able to determine, before the close of business on the 42nd Scheduled Trading Day immediately before the relevant Redemption Date, whether such Note or beneficial interest, as
            applicable, is to be redeemed pursuant to such redemption (and, as a result thereof, convertible in accordance with the provisions of this Indenture), then such Holder or owner, as applicable, shall be entitled to convert such Note or
            beneficial interest, as applicable, at any time before the close of business on the Business Day prior to such Redemption Date, unless the Company defaults in the payment of the Redemption Price, in which case such Holder or owner, as
            applicable, shall be entitled to convert all or any portion of such Note (or any such beneficial interest in any Global Note), as applicable, until the Redemption Price has been paid or duly provided for, and each such conversion shall be
            deemed to be of a Note called for redemption for the purposes of this subsection (b)(v), <font style="font-family: 'Times New Roman';"><u>Article 16</u></font> and <font style="font-family: 'Times New Roman';"><u>Section 14.03</u></font>.</font></div>
        <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"> <br>
        </div>
      </div>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">61</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div>
      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><font style="font-size: 10pt;"><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">Section 14.02</font></font>&#160;&#160; C<u>onversion Procedure; Settlement Upon Conversion</u></font><font style="font-size: 10pt;">.</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(a)</font><font style="font-size: 10pt;">&#160;&#160; &#160; &#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">Subject


            to this <font style="font-family: 'Times New Roman';"><u>Section 14.02</u></font>, <font style="font-family: 'Times New Roman';"><u>Section 14.03(b)</u></font> and <font style="font-family: 'Times New Roman';"><u>Section 14.07(a)</u></font>,
            upon conversion of any Note, the Company shall satisfy its Conversion Obligation by paying or delivering, as the case may be, to the converting Holder, in respect of each $1,000 principal amount of Notes being converted, cash (&#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Cash Settlement</font>&#8221;), shares of Common Stock, together with cash, if applicable, in lieu of delivering any fractional share of Common Stock in accordance with subsection (j) of
            this <font style="font-family: 'Times New Roman';"><u>Section 14.02</u></font> (&#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Physical Settlement</font>&#8221;) or a combination of cash and shares of Common Stock, together with
            cash, if applicable, in lieu of delivering any fractional share of Common Stock in accordance with subsection (j) of this <font style="font-family: 'Times New Roman';"><u>Section 14.02</u></font> (&#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Combination Settlement</font>&#8221;), at its election, as set forth in this <font style="font-family: 'Times New Roman';"><u>Section 14.02</u></font>.</font></font></div>
      <div style="text-align: left; text-indent: 36pt; margin-left: 36pt;">&#160;</div>
      <div style="text-align: left; margin-left: 36pt; text-indent: 27pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(i)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">All conversions for which the relevant Conversion Date occurs on or after the date of the Company&#8217;s issuance of a Notice of Redemption with respect to any Notes selected for redemption in respect of such Notice of
            Redemption and prior to the close of business on the second Business Day before the related Redemption Date shall be settled using the same Settlement Method, and all conversions for which the relevant Conversion Date occurs on or after
            December 2, 2030, shall be settled using the same Settlement Method.</font></font></div>
      <div style="font-size: 10pt; margin-left: 36pt; text-indent: 27pt;">&#160;</div>
      <div style="text-align: left; margin-left: 36pt; text-indent: 27pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(ii)</font><font style="font-size: 10pt;">&#160;&#160; &#160;&#160; &#160; &#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">Except for any conversions for which the relevant Conversion Date occurs after the date of the Company&#8217;s issuance of a Notice of Redemption with respect to the Notes but prior to the close of business on the second
            Business Day before the related Redemption Date with respect to any Notes selected for redemption in respect of such Notice of Redemption, and any conversions for which the relevant Conversion Date occurs on or after December 2, 2030, and
            except to the extent the Company has irrevocably elected P<font style="font-family: 'Times New Roman';">hysical Settlement pursuant to <u>Section 14.01(b)(ii)</u></font> in a notice as described in such Section or previously made an
            irrevocable e<font style="font-family: 'Times New Roman';">lection with respect to all subsequent conversions of Notes in accordance with <u>Section 14.02(a)(iii)</u></font>, the Company shall use the same Settlement Method for all conversions
            with the same Conversion Date, but the Company shall not have any obligation to use the same Settlement Method with respect to conversions with different Conversion Dates.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">62</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: left; margin-left: 36pt; text-indent: 27pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(iii)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(A) If, in respect of any Conversion Date (or any conversions for which the relevant Conversion Date occurs after the Company&#8217;s issuance of a Notice of Redemption with respect to the Notes but prior to the close of
            business on the second Business Day before the related Redemption Date with respect to any Notes selected for redemption in respect of such Notice of Redemption, or for which the relevant Conversion Date occurs on or after December 2, 2030),
            the Company elects to deliver a notice (the &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Settlement Notice</font>&#8221;) of the relevant Settlement Method in respect of such Conversion Date (or such period, as the case may be),
            the Company shall deliver such Settlement Notice to converting Holders, the Trustee and the Conversion Agent no later than the close of business on the Trading Day immediately following the relevant Conversion Date (or, in the case of any
            conversions (x) for which the relevant Conversion Date occurs (1) after the date of issuance of a Notice of Redemption with respect to the Notes and prior to the close of business on the second Business Day before the related Redemption Date
            with respect to any Notes selected for redemption in respect of such Notice of Redemption, in such Notice of Redemption (and, in the case of a partial redemption, in a notice sent on the relevant Redemption Notice Date to all Holders of Notes
            not called for redemption) or (2) on or after December 2, 2030, no later than December 2, 2030 or (y) for which the Company has irrevocably selected Physical Settlement pursuant to <font style="font-family: 'Times New Roman';"><u>Section
                14.01(b)(ii)</u></font> in a notice as described in such Section (in each case, the &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Settlement Method Election Deadline</font>&#8221;).&#160; If the Company does not elect a Settlement
            Method prior to the deadline set forth in the immediately preceding sentence with respect to any conversion, the Company shall be deemed to have elected the Default Settlement Method with respect to such conversion. Such Settlement Notice shall
            specify the relevant Settlement Method and in the case of an election of Combination Settlement, the relevant Settlement Notice shall indicate the Specified Dollar Amount per $1,000 principal amount of Notes.&#160; If the Company delivers a
            Settlement Notice electing Combination Settlement in respect of its Conversion Obligation but does not indicate a Specified Dollar Amount per $1,000 principal amount of Notes to be converted in such Settlement Notice, the Specified Dollar
            Amount per $1,000 principal amount of Notes shall be deemed to be $1,000.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; margin-left: 63pt; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(B)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">If the Company changes the Default Settlement Method or elects to irrevocably fix the Settlement Method, in either case, to Combination Settlement with an ability to continue to set the Specified Dollar Amount per $1,000
            principal amount of Notes at or above a specified amount, the Company shall, after the date of such change or election, as the case may be, inform Holders converting their Notes, the Trustee and the Conversion Agent (if other than the Trustee)
            in writing of such Specified Dollar Amount in respect of the relevant conversion or conversions no later than the relevant Settlement Method Election Deadline for such conversion or conversions, or, if the Company does not timely inform the
            Holders, the Trustee and the Conversion Agent of the Specified Dollar Amount, such Specified Dollar Amount shall be the specific amount set forth in the change or election notice or, if no specific amount was set forth in the change or election
            notice, such Specified Dollar Amount shall be deemed to be $1,000 per $1,000 principal amount of Notes.&#160; If the Company changes the Default Settlement Method or irrevocably fixes the Settlement Method, then the Company shall concurrently either
            post the Default Settlement Method or fixed Settlement Method, as applicable, on the Company&#8217;s website or disclose the same in a current report on Form 8-K (or any successor form) that is filed with the Commission. Notwithstanding the
            foregoing, no such change in the Default Settlement Method or irrevocable election will affect any Settlement Method theretofore elected (or deemed to be elected) with respect to any Conversion Date pursuant to this Section 14.02.</font></font></div>
      <div style="font-size: 10pt; margin-left: 63pt;">&#160;</div>
      <div style="text-align: left; margin-left: 36pt; text-indent: 27pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(iv)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">The cash, shares of Common Stock or combination of cash and shares of Common Stock in respect of any conversion of Notes (the &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Settlement Amount</font>&#8221;)
            shall be computed as follows:</font></font></div>
      <div style="font-size: 10pt; margin-left: 63pt;">&#160;</div>
      <div style="text-align: left; margin-left: 63pt; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(A)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">if the Company elects to satisfy its Conversion Obligation in respect of such conversion by Physical Settlement, the Company shall deliver to the converting Holder in respect of each $1,000 principal amount of Notes being
            converted a number of shares of Common Stock equal to the Conversion Rate in effect on the Conversion Date;</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">63</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: left; margin-left: 63pt; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(B)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">if the Company elects to satisfy its Conversion Obligation in respect of such conversion by Cash Settlement, the Company shall pay to the converting Holder in respect of each $1,000 principal amount of Notes being
            converted cash in an amount equal to the sum of the Daily Conversion Values for each of the 40 consecutive Trading Days during the related Observation Period; and</font></font></div>
      <div style="font-size: 10pt; margin-left: 63pt; text-indent: 36pt;">&#160;</div>
      <div style="text-align: left; margin-left: 63pt; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(C)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">if the Company elects (or is deemed to have elected) to satisfy its Conversion Obligation in respect of such conversion by Combination Settlement, the Company shall pay or deliver, as the case may be, to the converting
            Holder in respect of each $1,000 principal amount of Notes being converted, a Settlement Amount equal to the sum of the Daily Settlement Amounts for each of the 40 consecutive Trading Days during the related Observation Period.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; margin-left: 36pt; text-indent: 27pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(v)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">The Daily Settlement Amounts (if applicable) and the Daily Conversion Values (if applicable) shall be determined by the Company promptly following the last day of the Observation Period.&#160; Promptly after such determination
            of the Daily Settlement Amounts or the Daily Conversion Values, as the case may be, and the amount of cash payable in lieu of delivering any fractional share of Common Stock, the Company shall notify the Trustee and the Conversion Agent (if
            other than the Trustee) of the Daily Settlement Amounts or the Daily Conversion Values, as the case may be, and the amount of cash payable in lieu of delivering fractional shares of Common Stock.&#160; The Trustee and the Conversion Agent (if other
            than the Trustee) shall have no responsibility for any such determination.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(b)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">Subject


            to <font style="font-family: 'Times New Roman';"><u>Section 14.02(e)</u></font>, before any Holder of a Note shall be entitled to convert a Note as set forth above, such Holder shall (i) in the case of a Global Note, comply with the applicable
            procedures of the Depositary in effect at that time and, if required, pay funds equal to interest payable on the next Interest Payment Date to which such Holder is not entitled as set forth in <font style="font-family: 'Times New Roman';"><u>Section


                14.02(h)</u></font> and (ii) in the case of a Physical Note (1) complete, manually sign and deliver an irrevocable notice to the Conversion Agent as set forth in the Form of Notice of Conversion (or a facsimile, PDF or other electronic
            transmission thereof) (a notice pursuant to the applicable procedure of the Depositary or a notice as set forth in the Form of Notice of Conversion, a &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Notice of Conversion</font>&#8221;
            which notice shall be irrevocable, in either case) at the office of the Conversion Agent and state in writing therein the principal amount of Notes to be converted and the name or names (with addresses) in which such Holder wishes the
            certificate or certificates for any shares of Common Stock to be delivered upon settlement of the Conversion Obligation to be registered, (2) surrender such Notes, duly endorsed to the Company or in blank (and accompanied by appropriate
            endorsement and transfer documents), at the office of the Conversion Agent, (3) if required, furnish appropriate endorsements and transfer documents and (4) if required, pay funds equal to interest payable on the next Interest Payment Date to
            which such Holder is not entitled as set forth in <font style="font-family: 'Times New Roman';"><u>Section 14.02(h)</u></font>.&#160; The Trustee (and if different, the Conversion Agent) shall notify the Company of any conversion pursuant to this <font style="font-family: 'Times New Roman';"><u>Article 14</u></font> on the Conversion Date for such conversion.&#160; No Notes may be surrendered for conversion by a Holder thereof if such Holder has also delivered a Fundamental Change Repurchase
            Notice to the Company in respect of such Notes and has not validly withdrawn such Fundamental Change Repurchase Notice in accordance with <font style="font-family: 'Times New Roman';"><u>Section 15.03</u></font>.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">64</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">If more than one Note shall be surrendered for conversion at one time by the same Holder, the Conversion Obligation with respect to such Notes shall be
        computed on the basis of the aggregate principal amount of the Notes (or specified portions thereof to the extent permitted thereby) so surrendered.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(c)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160; &#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">A
            Note shall be deemed to have been converted immediately prior to the close of business on the date (the &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Conversion Date</font>&#8221;) that the Holder has complied with the
            requirements set forth in subsection (b) above.&#160; Except as set forth in <font style="font-family: 'Times New Roman';"><u>Section 14.03(b)</u></font> and <font style="font-family: 'Times New Roman';"><u>Section 14.07(a)</u></font>, the Company
            shall pay or deliver, as the case may be, the consideration due in respect of the Conversion Obligation on the second Business Day immediately following the relevant Conversion Date, if the Company elects Physical Settlement, or on the second
            Business Day immediately following the last Trading Day of the Observation Period, in the case of any other Settlement Method.&#160; If any shares of Common Stock are due to a converting Holder, the Company shall issue or cause to be issued, and
            deliver (if applicable) to the Conversion Agent or to such Holder, or such Holder&#8217;s nominee or nominees, the full number of shares of Common Stock to which such Holder shall be entitled, in book-entry format through the Depositary, in
            satisfaction of the Company&#8217;s Conversion Obligation.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(d)</font><font style="font-size: 10pt;">&#160;&#160; &#160; &#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">In


            case any Note shall be surrendered for partial conversion, the Company shall execute and the Trustee shall authenticate and deliver to or upon the written order of the Holder of the Note so surrendered a new Note or Notes in authorized
            denominations in an aggregate principal amount equal to the unconverted portion of the surrendered Note, without payment of any service charge by the converting Holder but, if required by the Company or Trustee, with payment of a sum sufficient
            to cover any documentary, stamp or similar issue or transfer tax or similar governmental charge required by law or that may be imposed in connection therewith as a result of the name of the Holder of the new Notes issued upon such conversion
            being different from the name of the Holder of the old Notes surrendered for such conversion.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(e)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">If


            a Holder submits a Note for conversion, the Company shall pay any documentary, stamp or similar issue or transfer tax due on the issue or delivery of any shares of Common Stock upon conversion, unless the tax is due because the Holder requests
            such shares to be issued in a name other than the Holder&#8217;s name, in which case the Holder shall pay that tax.&#160; The Conversion Agent may refuse to deliver the certificates representing the shares of Common Stock being issued in a name other than
            the Holder&#8217;s name until the Trustee receives a sum sufficient to pay any tax that is due by such Holder in accordance with the immediately preceding sentence.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(f)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">Except


            as provided in <font style="font-family: 'Times New Roman';"><u>Section 14.04</u></font>, no adjustment shall be made for dividends on any shares of Common Stock issued upon the conversion of any Note as provided in this <font style="font-family: 'Times New Roman';"><u>Article 14</u></font>.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(g)</font><font style="font-size: 10pt;">&#160;&#160; &#160; &#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">Upon


            the conversion of an interest in a Global Note, the Trustee, or the Custodian at the direction of the Trustee, shall make a notation on such Global Note as to the reduction in the principal amount represented thereby.&#160; The Company shall notify
            the Trustee in writing of any conversion of Notes effected through any Conversion Agent other than the Trustee.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">65</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(h)</font><font style="font-size: 10pt;">&#160;&#160;&#160; &#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">Upon


            conversion, a Holder shall not receive any separate cash payment for accrued and unpaid interest, if any, except as set forth below.&#160; The Company&#8217;s settlement of the full Conversion Obligation shall be deemed to satisfy in full its obligation
            to pay the principal amount of the Note and accrued and unpaid interest, if any, to, but not including, the relevant Conversion Date.&#160; As a result, accrued and unpaid interest, if any, to, but not including, the relevant Conversion Date shall
            be deemed to be paid in full rather than cancelled, extinguished or forfeited.&#160; Upon a conversion of Notes into a combination of cash and shares of Common Stock, accrued and unpaid interest will be deemed to be paid first out of the cash paid
            upon such conversion.&#160; Notwithstanding the foregoing, if Notes are converted after the close of business on a Regular Record Date, Holders of such Notes as of the close of business on such Regular Record Date will receive the full amount of
            interest payable on such Notes on the corresponding Interest Payment Date notwithstanding the conversion.&#160; Notes surrendered for conversion during the period from the close of business on any Regular Record Date to the open of business on the
            immediately following Interest Payment Date must be accompanied by funds equal to the amount of interest payable on the Notes so converted; <font style="font-family: 'Times New Roman'; font-style: italic;">provided </font>that no such payment
            shall be required (1) for conversions following the close of business on the Regular Record Date immediately preceding the Maturity Date; (2) if the Company has specified a Redemption Date that is after a Regular Record Date and on or prior to
            the second Business Day immediately following the corresponding Interest Payment Date; (3) if the Company has specified a Fundamental Change Repurchase Date that is after a Regular Record Date and on or prior to the Business Day immediately
            following the corresponding Interest Payment Date; or (4) to the extent of any Defaulted Amounts, if any Defaulted Amounts exists at the time of conversion with respect to such Note.&#160; Therefore, for the avoidance of doubt, all Holders of record
            at the close of business on the Regular Record Date immediately preceding the Maturity Date, or a Fundamental Change Repurchase Date or Redemption Date referred to the proviso above shall receive the full interest payment due on the Maturity
            Date in cash regardless of whether their Notes have been converted following such Regular Record Date.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(i)</font><font style="font-size: 10pt;">&#160;&#160;&#160; &#160; &#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">The


            Person in whose name the shares of Common Stock shall be issuable upon conversion shall become the stockholder of record as of the close of business on the relevant Conversion Date (if the Company elects to satisfy the related Conversion
            Obligation by Physical Settlement) or the last Trading Day of the relevant Observation Period (if the Company elects to satisfy the related Conversion Obligation by Combination Settlement), as the case may be.&#160; Upon a conversion of Notes, such
            Person shall no longer be a Holder of such Notes surrendered for conversion.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(j)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">The


            Company shall not issue any fractional share of Common Stock upon conversion of the Notes and shall instead pay cash in lieu of delivering any fractional share of Common Stock issuable upon conversion based on the Daily VWAP for the relevant
            Conversion Date (in the case of Physical Settlement) or based on the Daily VWAP for the last Trading Day of the relevant Observation Period (in the case of Combination Settlement).&#160; For each Note surrendered for conversion, if the Company has
            elected (or is deemed to have elected) Combination Settlement, the full number of shares that shall be issued upon conversion thereof shall be computed on the basis of the aggregate Daily Settlement Amounts for the relevant Observation Period
            and any fractional shares remaining after such computation shall be paid in cash.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">66</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">Section 14.03&#160;&#160; <u>Increased Conversion Rate Applicable to Certain
            Notes Surrendered in Connection with Make-Whole Fundamental Changes or a Notice of Redemption</u></font><font style="font-size: 10pt;">.&#160; ix) If (i) the Effective Date of a Make-Whole Fundamental Change occurs prior to the Maturity Date or (ii)
          the Company delivers a Notice of Redemption with respect to any or all of the Notes as provided for under <font style="font-family: 'Times New Roman';"><u>Section 16.02</u></font> and, in each case, a Holder elects to convert its Notes in
          connection with such Make-Whole Fundamental Change or Notice of Redemption, as applicable, the Company shall, under the circumstances described below, increase the Conversion Rate for the Notes so surrendered for conversion by a number of
          additional shares of Common Stock (the &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Additional Shares</font>&#8221;), as described below.&#160; A conversion of Notes shall be deemed for these purposes to be &#8220;in connection with&#8221; a
          Make-Whole Fundamental Change pursuant to clause (i) above if the relevant Conversion Date occurs during the period beginning on, and including, the Effective Date of the Make-Whole Fundamental Change up to, and including, the Business Day
          immediately prior to the related Fundamental Change Repurchase Date (or, in the case of an Exempted Fundamental Change or Make-Whole Fundamental Change that would have been a Fundamental Change but for the proviso in clause (b) of the definition
          thereof, the 35th Trading Day immediately following the Effective Date of such Make-Whole Fundamental Change) (such period, the &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Make-Whole Fundamental Change Period</font>&#8221;). A
          conversion of Notes shall be deemed for these purposes to be &#8220;in connection with&#8221; such Notice of Redemption pursuant to clause (ii) above if the relevant Conversion Date with respect to the Notes called (or deemed called) for redemption occurs
          during the period from, and including, the applicable Redemption Notice Date to, and including, the close of business on the second Business Day immediately preceding the related Redemption Date.&#160; For the avoidance of doubt, the Company shall
          increase the Conversion Rate in connection with a Notice of Redemption only with respect to conversions of Notes called (or deemed called as contemplated by <font style="font-family: 'Times New Roman';"><u>Section 14.01(b)(v)</u></font>) for
          redemption, and not of Notes not called for redemption.&#160; Accordingly, if the Company elects to redeem less than all of the outstanding Notes as described under Article 16, Holders of the Notes not called for redemption shall not be entitled to an
          increased Conversion Rate for conversions of such Notes, except in the limited circumstances set forth under <font style="font-family: 'Times New Roman';"><u>Section 14.01(b)(v)</u></font>.</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(b)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">Upon


            surrender of Notes for conversion in connection with a Make-Whole Fundamental Change or Notice of Redemption, the Company shall, at its option, satisfy the related Conversion Obligation by Physical Settlement, Cash Settlement or Combination
            Settlement in accordance with <font style="font-family: 'Times New Roman';"><u>Section 14.02</u></font>; <font style="font-family: 'Times New Roman'; font-style: italic;">provided</font>, <font style="font-family: 'Times New Roman'; font-style: italic;">however</font>, that if, at the effective time of a Make-Whole Fundamental Change described in clause (b) of the definition of Fundamental Change, the Reference Property following such Make-Whole Fundamental Change is
            composed entirely of cash, for any conversion of Notes following the Effective Date of such Make-Whole Fundamental Change, the Conversion Obligation shall be calculated based solely on the Stock Price for the transaction and shall be deemed to
            be an amount of cash per $1,000 principal amount of converted Notes equal to the Conversion Rate (including any increase to reflect the Additional Shares), <font style="font-family: 'Times New Roman'; font-style: italic;">multiplied by</font>
            such Stock Price.&#160; In such event, the Conversion Obligation shall be determined and paid to Holders in cash on the second Business Day following the Conversion Date.&#160; The Company shall notify the Holders, the Trustee and the Conversion Agent of
            the Effective Date of any Make-Whole Fundamental Change no later than five Business Days after such Effective Date.</font></font></div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt;"><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"> <br>
          </font></font></div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">67</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(c)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">The


            number of Additional Shares, if any, by which the Conversion Rate shall be increased for conversions in connection with a Make-Whole Fundamental Change or a Notice of Redemption shall be determined by reference to the table below, based on the
            date on which the Make-Whole Fundamental Change occurs or becomes effective of the Redemption Notice Date, as the case may be (the &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Effective Date</font>&#8221;), and the price paid (or
            deemed to be paid) per share of the Common Stock in the Make-Whole Fundamental Change or with respect to the redemption, as the case may be (the &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Stock Price</font>&#8221;).&#160; If the
            holders of the Common Stock receive in exchange for their Common Stock only cash in a Make-Whole Fundamental Change described in clause (b) of the definition of Fundamental Change, the Stock Price shall be the cash amount paid per share.&#160;
            Otherwise, the Stock Price shall be the average of the Last Reported Sale Prices of the Common Stock over the five consecutive Trading Day period ending on, and including, the Trading Day immediately preceding the applicable Effective Date of
            the Make-Whole Fundamental Change or the Redemption Notice Date, as the case may be.&#160; In the event that a conversion in connection with a Notice of Redemption would also be deemed to be in connection with a Make-Whole Fundamental Change, a
            Holder of the Notes to be converted will be entitled to a single increase to the Conversion Rate with respect to the first to occur of the applicable Redemption Notice Date or the Effective Date of the applicable Make-Whole Fundamental Change,
            and the later event will be deemed not to have occurred for purposes of such conversion.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(d)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">The


            Stock Prices set forth in the column headings of the table below shall be adjusted as of any date on which the Conversion Rate of the Notes is otherwise adjusted.&#160; The adjusted Stock Prices shall equal the Stock Prices applicable immediately
            prior to such adjustment, <font style="font-family: 'Times New Roman'; font-style: italic;">multiplied by</font> a fraction, the numerator of which is the Conversion Rate immediately prior to such adjustment giving rise to the Stock Price
            adjustment and the denominator of which is the Conversion Rate as so adjusted.&#160; The number of Additional Shares set forth in the table below shall be adjusted in the same manner and at the same time as the Conversion Rate as set forth in <font style="font-family: 'Times New Roman';"><u>Section 14.04</u></font>.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">The following table sets forth the number of Additional Shares by which the Conversion Rate shall be increased per $1,000 principal amount of Notes
        pursuant to this <font style="font-family: 'Times New Roman';"><u>Section 14.03</u></font> for each Stock Price and Effective Date set forth below:</div>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" border="0" class="cfttable" id="z64187fc747cb41b89e326e09d7999fce" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">

          <tr>
            <td valign="bottom" style="vertical-align: top; padding-bottom: 2px; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; font-size: 10pt;">&#160;</td>
            <td valign="bottom" colspan="54" style="vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">
              <div>
                <div style="text-align: center; font-family: 'Times New Roman'; font-weight: bold;">Stock Price</div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; font-size: 10pt;">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: top; width: 16%; background-color: rgb(204, 238, 255); font-size: 10pt; border-bottom: 2px solid rgb(0, 0, 0);">
              <div>
                <div style="text-align: left; font-family: 'Times New Roman'; font-weight: bold; text-indent: -9pt; margin-left: 9pt;">Effective Date</div>
              </div>
            </td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); font-size: 10pt;">
              <div>
                <div style="font-family: 'Times New Roman'; font-weight: bold;">$</div>
              </div>
            </td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 3%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); font-size: 10pt;">
              <div>
                <div style="font-family: 'Times New Roman'; font-weight: bold;">34.35</div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); font-size: 10pt;">
              <div>
                <div style="font-family: 'Times New Roman'; font-weight: bold;">$</div>
              </div>
            </td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 3%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); font-size: 10pt;">
              <div>
                <div style="font-family: 'Times New Roman'; font-weight: bold;">40.00</div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); font-size: 10pt;">
              <div>
                <div style="font-family: 'Times New Roman'; font-weight: bold;">$</div>
              </div>
            </td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 3%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); font-size: 10pt;">
              <div>
                <div style="font-family: 'Times New Roman'; font-weight: bold;">45.00</div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); font-size: 10pt;">
              <div>
                <div style="font-family: 'Times New Roman'; font-weight: bold;">$</div>
              </div>
            </td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 3%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); font-size: 10pt;">
              <div>
                <div style="font-family: 'Times New Roman'; font-weight: bold;">49.81</div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); font-size: 10pt;">
              <div>
                <div style="font-family: 'Times New Roman'; font-weight: bold;">$</div>
              </div>
            </td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 3%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); font-size: 10pt;">
              <div>
                <div style="font-family: 'Times New Roman'; font-weight: bold;">55.00</div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); font-size: 10pt;">
              <div>
                <div style="font-family: 'Times New Roman'; font-weight: bold;">$</div>
              </div>
            </td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 3%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); font-size: 10pt;">
              <div>
                <div style="font-family: 'Times New Roman'; font-weight: bold;">60.00</div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); font-size: 10pt;">
              <div>
                <div style="font-family: 'Times New Roman'; font-weight: bold;">$</div>
              </div>
            </td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 3%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); font-size: 10pt;">
              <div>
                <div style="font-family: 'Times New Roman'; font-weight: bold;">64.75</div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); font-size: 10pt;">
              <div>
                <div style="font-family: 'Times New Roman'; font-weight: bold;">$</div>
              </div>
            </td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 3%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); font-size: 10pt;">
              <div>
                <div style="font-family: 'Times New Roman'; font-weight: bold;">80.00</div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); font-size: 10pt;">
              <div>
                <div style="font-family: 'Times New Roman'; font-weight: bold;">$</div>
              </div>
            </td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 3%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); font-size: 10pt;">
              <div>
                <div style="font-family: 'Times New Roman'; font-weight: bold;">100.00</div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); font-size: 10pt;">
              <div>
                <div style="font-family: 'Times New Roman'; font-weight: bold;">$</div>
              </div>
            </td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 3%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); font-size: 10pt;">
              <div>
                <div style="font-family: 'Times New Roman'; font-weight: bold;">150.00</div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); font-size: 10pt;">
              <div>
                <div style="font-family: 'Times New Roman'; font-weight: bold;">$</div>
              </div>
            </td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 3%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); font-size: 10pt;">
              <div>
                <div style="font-family: 'Times New Roman'; font-weight: bold;">200.00</div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); font-size: 10pt;">
              <div>
                <div style="font-family: 'Times New Roman'; font-weight: bold;">$</div>
              </div>
            </td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 3%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); font-size: 10pt;">
              <div>
                <div style="font-family: 'Times New Roman'; font-weight: bold;">250.00</div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); font-size: 10pt;">
              <div>
                <div style="font-family: 'Times New Roman'; font-weight: bold;">$</div>
              </div>
            </td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 3%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); font-size: 10pt;">
              <div>
                <div style="font-family: 'Times New Roman'; font-weight: bold;">300.00</div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); font-size: 10pt;">
              <div>
                <div style="font-family: 'Times New Roman'; font-weight: bold;">$</div>
              </div>
            </td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 3%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); font-size: 10pt;">
              <div>
                <div style="font-family: 'Times New Roman'; font-weight: bold;">375.00</div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; width: 16%; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman'; text-indent: -9pt; margin-left: 9pt;">February 28, 2025</div>
            </td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 3%; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">9.0347</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 3%; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">7.1300</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 3%; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">5.8964</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 3%; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">4.9803</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 3%; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">4.2035</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 3%; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">3.6072</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 3%; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">3.1446</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 3%; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">2.1098</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 3%; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">1.3384</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 3%; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">0.5136</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 3%; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">0.2164</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 3%; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">0.0876</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 3%; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">0.0289</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 3%; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">0.0000</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; width: 16%; background-color: rgb(204, 238, 255); font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman'; text-indent: -9pt; margin-left: 9pt;">March 1, 2026&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
            </td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 3%; background-color: rgb(204, 238, 255); font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">9.0347</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 3%; background-color: rgb(204, 238, 255); font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">7.0900</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 3%; background-color: rgb(204, 238, 255); font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">5.8933</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 3%; background-color: rgb(204, 238, 255); font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">4.9255</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 3%; background-color: rgb(204, 238, 255); font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">4.1122</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 3%; background-color: rgb(204, 238, 255); font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">3.4937</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 3%; background-color: rgb(204, 238, 255); font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">3.0179</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 3%; background-color: rgb(204, 238, 255); font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">1.9709</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 3%; background-color: rgb(204, 238, 255); font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">1.2120</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 3%; background-color: rgb(204, 238, 255); font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">0.4347</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 3%; background-color: rgb(204, 238, 255); font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">0.1704</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 3%; background-color: rgb(204, 238, 255); font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">0.0619</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 3%; background-color: rgb(204, 238, 255); font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">0.0162</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 3%; background-color: rgb(204, 238, 255); font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">0.0000</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; width: 16%; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman'; text-indent: -9pt; margin-left: 9pt;">March 1, 2027&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
            </td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 3%; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">9.0347</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 3%; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">7.0500</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 3%; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">5.7653</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 3%; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">4.7492</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 3%; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">3.9055</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 3%; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">3.2718</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 3%; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">2.7901</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 3%; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">1.7538</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 3%; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">1.0316</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 3%; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">0.3360</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 3%; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">0.1183</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 3%; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">0.0353</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 3%; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">0.0043</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 3%; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">0.0000</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; width: 16%; background-color: rgb(204, 238, 255); font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman'; text-indent: -9pt; margin-left: 9pt;">March 1, 2028&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
            </td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 3%; background-color: rgb(204, 238, 255); font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">9.0347</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 3%; background-color: rgb(204, 238, 255); font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">7.0005</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 3%; background-color: rgb(204, 238, 255); font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">5.5118</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 3%; background-color: rgb(204, 238, 255); font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">4.4455</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 3%; background-color: rgb(204, 238, 255); font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">3.5751</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 3%; background-color: rgb(204, 238, 255); font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">2.9332</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 3%; background-color: rgb(204, 238, 255); font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">2.4536</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 3%; background-color: rgb(204, 238, 255); font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">1.4558</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 3%; background-color: rgb(204, 238, 255); font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">0.8010</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 3%; background-color: rgb(204, 238, 255); font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">0.2259</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 3%; background-color: rgb(204, 238, 255); font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">0.0670</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 3%; background-color: rgb(204, 238, 255); font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">0.0139</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 3%; background-color: rgb(204, 238, 255); font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">0.0000</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 3%; background-color: rgb(204, 238, 255); font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">0.0000</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; width: 16%; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman'; text-indent: -9pt; margin-left: 9pt;">March 1, 2029&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
            </td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 3%; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">9.0347</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 3%; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">6.6553</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 3%; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">5.0538</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 3%; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">3.9341</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 3%; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">3.0453</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 3%; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">2.4095</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 3%; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">1.9490</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 3%; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">1.0463</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 3%; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">0.5146</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 3%; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">0.1157</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 3%; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">0.0246</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 3%; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">0.0000</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 3%; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">0.0000</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 3%; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">0.0000</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; width: 16%; background-color: rgb(204, 238, 255); font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman'; text-indent: -9pt; margin-left: 9pt;">March 1, 2030&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
            </td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 3%; background-color: rgb(204, 238, 255); font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">9.0347</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 3%; background-color: rgb(204, 238, 255); font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">5.9815</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 3%; background-color: rgb(204, 238, 255); font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">4.2024</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 3%; background-color: rgb(204, 238, 255); font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">3.0179</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 3%; background-color: rgb(204, 238, 255); font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">2.1355</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 3%; background-color: rgb(204, 238, 255); font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">1.5502</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 3%; background-color: rgb(204, 238, 255); font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">1.1585</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 3%; background-color: rgb(204, 238, 255); font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">0.4970</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 3%; background-color: rgb(204, 238, 255); font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">0.1975</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 3%; background-color: rgb(204, 238, 255); font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">0.0317</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 3%; background-color: rgb(204, 238, 255); font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">0.0025</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 3%; background-color: rgb(204, 238, 255); font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">0.0000</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 3%; background-color: rgb(204, 238, 255); font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">0.0000</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 3%; background-color: rgb(204, 238, 255); font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">0.0000</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt;">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; width: 16%; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman'; text-indent: -9pt; margin-left: 9pt;">March 1, 2031&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
            </td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 3%; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">9.0347</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 3%; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">4.9227</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 3%; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">2.1449</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 3%; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">0.0000</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 3%; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">0.0000</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 3%; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">0.0000</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 3%; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">0.0000</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 3%; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">0.0000</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 3%; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">0.0000</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 3%; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">0.0000</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 3%; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">0.0000</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 3%; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">0.0000</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 3%; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">0.0000</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 3%; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">0.0000</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-size: 10pt;">&#160;</td>
          </tr>

      </table>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(e)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">The


            exact Stock Price and Effective Date may not be set forth in the table above, in which case:</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; margin-left: 36pt; text-indent: 27pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(i)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">if the Stock Price is between two Stock Prices in the table above or the Effective Date is between two Effective Dates in the table, the number of Additional Shares by which the conversion rate shall be increased shall be
            determined by a straight-line interpolation between the number of Additional Shares set forth for the higher and lower Stock Prices and the earlier and later Effective Dates, as applicable, based on a 365-day year;</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">68</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: left; margin-left: 36pt; text-indent: 27pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(ii)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">if the Stock Price is greater than $375.00 per share (subject to adjustment in the same manner as the Stock Prices set forth in the column headings of the table above pursuant to <font style="font-family: 'Times New Roman';"><u>subsection (d)</u></font> above), no Additional Shares shall be added to the Conversion Rate; and</font></font></div>
      <div style="font-size: 10pt; margin-left: 36pt; text-indent: 27pt;">&#160;</div>
      <div style="text-align: left; margin-left: 36pt; text-indent: 27pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(iii)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">if the Stock Price is less than $34.35 per share (subject to adjustment in the same manner as the Stock Prices set forth in the column headings of the table above pursuant to <font style="font-family: 'Times New Roman';"><u>subsection


                (d)</u></font> above), no Additional Shares shall be added to the Conversion Rate.</font></font></div>
      <div style="font-size: 10pt; margin-left: 36pt; text-indent: 27pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Notwithstanding the foregoing, in no event shall the Conversion Rate per $1,000 principal amount of Notes exceed 29.1120 shares of Common Stock,
        subject to adjustment in the same manner as the Conversion Rate pursuant to <font style="font-family: 'Times New Roman';"><u>Section 14.04</u></font>.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(f)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">Nothing


            in this <font style="font-family: 'Times New Roman';"><u>Section 14.03</u></font> shall prevent an adjustment to the Conversion Rate that would otherwise be required pursuant to <font style="font-family: 'Times New Roman';"><u>Section 14.04</u></font>
            in respect of a Make-Whole Fundamental Change.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">Section 14.04&#160;&#160; <u>Adjustment of Conversion Rate</u></font><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">.&#160; </font><font style="font-size: 10pt;">The Conversion Rate shall be adjusted from time to time by the Company if any of the following events occurs, except that the
          Company shall not make any adjustments to the Conversion Rate if Holders of the Notes participate (other than in the case of (x) a share split or share combination or (y) a tender or exchange offer), at the same time and upon the same terms as
          holders of the Common Stock and solely as a result of holding the Notes, in any of the transactions described in this <font style="font-family: 'Times New Roman';"><u>Section 14.04</u></font>, without having to convert their Notes, as if they
          held a number of shares of Common Stock equal to the Conversion Rate, <font style="font-family: 'Times New Roman'; font-style: italic;">multiplied by</font> the principal amount (expressed in thousands) of Notes held by such Holder.</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(a)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">If


            the Company exclusively issues shares of Common Stock as a dividend or distribution on shares of the Common Stock, or if the Company effects a share split or share combination, the Conversion Rate shall be adjusted based on the following
            formula:</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: center; font-size: 10pt;"><img src="image00008.jpg"></div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">where,</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left;">
        <div>
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="zf4307e00f96b43dc900a3c7bc7ef5f98">

              <tr>
                <td style="width: 5%; vertical-align: top;"><font style="font-size: 10pt; font-family: 'Times New Roman';">CR</font><font style="font-size: 10pt;"><sub style="vertical-align: bottom; line-height: 1; font-size: smaller;">0</sub></font></td>
                <td style="width: 3%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">=</td>
                <td style="width: 92%; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">the Conversion Rate in effect immediately prior to the open of business on the Ex-Dividend Date of such dividend or
                  distribution, or immediately prior to the open of business on the Effective Date of such share split or share combination, as applicable;</td>
              </tr>

          </table>
        </div>
      </div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left;">
        <div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="zfff1b2a5166d44d7b87776ebfbbd4291">

              <tr>
                <td style="width: 5%; vertical-align: top;"><font style="font-size: 10pt; font-family: 'Times New Roman';">CR</font><font style="font-size: 10pt;"><sub style="vertical-align: bottom; line-height: 1; font-size: smaller;">1</sub></font></td>
                <td style="width: 3%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">=</td>
                <td style="width: 92%; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">the Conversion Rate in effect immediately after the open of business on such Ex-Dividend Date or Effective Date, as applicable;</td>
              </tr>

          </table>
        </div>
      </div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left;">
        <div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z9704294c62714deca29f2e3d6c89f59d">

              <tr>
                <td style="width: 5%; vertical-align: top;"><font style="font-size: 10pt; font-family: 'Times New Roman';">OS</font><font style="font-size: 10pt;"><sub style="vertical-align: bottom; line-height: 1; font-size: smaller;">0</sub></font></td>
                <td style="width: 3%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">=</td>
                <td style="width: 92%; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">the number of shares of Common Stock outstanding immediately prior to the open of business on such Ex-Dividend Date or Effective
                  Date, as applicable (before giving effect to any such dividend, distribution, split or combination); and</td>
              </tr>

          </table>
        </div>
      </div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">69</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: left;">
        <div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z37acb5c32baa42ccb342ad6f8201503b">

              <tr>
                <td style="width: 31.5pt; vertical-align: top;"><font style="font-size: 10pt; font-family: 'Times New Roman';">OS</font><font style="font-size: 10pt;"><sub style="vertical-align: bottom; line-height: 1; font-size: smaller;">1</sub></font></td>
                <td style="width: 22.5pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">=</td>
                <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">the number of shares of Common Stock outstanding immediately after giving effect to such dividend, distribution, share split or
                  share combination.</td>
              </tr>

          </table>
        </div>
      </div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Any adjustment made under this <font style="font-family: 'Times New Roman';"><u>Section 14.04(a)</u></font> shall become effective immediately after
        the open of business on the Ex-Dividend Date for such dividend or distribution, or immediately after the open of business on the Effective Date for such share split or share combination, as applicable.&#160; If any dividend or distribution of the type
        described in this <font style="font-family: 'Times New Roman';"><u>Section 14.04(a)</u></font> is declared but not so paid or made, the Conversion Rate shall be immediately readjusted, effective as of the date the Board of Directors determines not
        to pay such dividend or distribution, to the Conversion Rate that would then be in effect if such dividend or distribution had not been declared.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(b)</font><font style="font-size: 10pt;">&#160; &#160; &#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">If


            the Company distributes to all or substantially all holders of the Common Stock any rights, options or warrants (other than pursuant to a stockholder rights plan) entitling them, for a period of not more than 60 calendar days after the
            announcement date of such distribution, to subscribe for or purchase shares of the Common Stock at a price per share that is less than the average of the Last Reported Sale Prices of the Common Stock for the 10 consecutive Trading Day period
            ending on, and including, the Trading Day immediately preceding the date of announcement of such distribution, the Conversion Rate shall be increased based on the following formula:</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: center; font-size: 10pt;"><img src="image00007.jpg"></div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">where,</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left;">
        <div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z13d323194e6d4489a97a00da17630a90">

              <tr>
                <td style="width: 5%; vertical-align: top;"><font style="font-size: 10pt; font-family: 'Times New Roman';">CR</font><font style="font-size: 10pt;"><sub style="vertical-align: bottom; line-height: 1; font-size: smaller;">0</sub></font></td>
                <td style="width: 3%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">=</td>
                <td style="width: 92%; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">the Conversion Rate in effect immediately prior to the open of business on the Ex-Dividend Date for such distribution;</td>
              </tr>

          </table>
        </div>
      </div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left;">
        <div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z40ea9836f17e49689c265bc90d4edecc">

              <tr>
                <td style="width: 5%; vertical-align: top;"><font style="font-size: 10pt; font-family: 'Times New Roman';">CR</font><font style="font-size: 10pt;"><sub style="vertical-align: bottom; line-height: 1; font-size: smaller;">1</sub></font></td>
                <td style="width: 3%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">=</td>
                <td style="width: 92%; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">the Conversion Rate in effect immediately after the open of business on such Ex-Dividend Date;</td>
              </tr>

          </table>
        </div>
      </div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left;">
        <div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="zcba5f0e1f8544425b489b2b039ca9712">

              <tr>
                <td style="width: 5%; vertical-align: top;"><font style="font-size: 10pt; font-family: 'Times New Roman';">OS</font><font style="font-size: 10pt;"><sub style="vertical-align: bottom; line-height: 1; font-size: smaller;">0</sub></font></td>
                <td style="width: 3%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">=</td>
                <td style="width: 92%; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">the number of shares of Common Stock outstanding immediately prior to the open of business on such Ex-Dividend Date;</td>
              </tr>

          </table>
        </div>
      </div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left;">
        <div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="zbd9418df5f99426bab0bbe1d0a72f396">

              <tr>
                <td style="width: 5%; vertical-align: top;"><font style="font-size: 10pt; font-family: 'Times New Roman';">X</font><font style="font-size: 10pt;"> <br>
                  </font></td>
                <td style="width: 3%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">=</td>
                <td style="width: 92%; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">the total number of shares of Common Stock distributable pursuant to such rights, options or warrants; and</td>
              </tr>

          </table>
        </div>
      </div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left;">
        <div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="zb88e1b66a8da42658a49ab294d00cd23">

              <tr>
                <td style="width: 5%; vertical-align: top;"><font style="font-size: 10pt; font-family: 'Times New Roman';">Y</font><font style="font-size: 10pt;"> <br>
                  </font></td>
                <td style="width: 3%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">=</td>
                <td style="width: 92%; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">the number of shares of Common Stock equal to the aggregate price payable to exercise such rights, options or warrants, <font style="font-family: 'Times New Roman'; font-style: italic;">divided by</font> the average of the Last Reported Sale Prices of the Common Stock over the 10 consecutive Trading Day period ending on, and including, the Trading Day
                  immediately preceding the date of announcement of the distribution of such rights, options or warrants.</td>
              </tr>

          </table>
        </div>
      </div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Any increase made under this <font style="font-family: 'Times New Roman';"><u>Section 14.04(b)</u></font> shall be made successively whenever any such
        rights, options or warrants are distributed and shall become effective immediately after the open of business on the Ex-Dividend Date for such distribution.&#160; To the extent that shares of the Common Stock are not delivered after the expiration of
        such rights, options or warrants, the Conversion Rate shall be decreased to the Conversion Rate that would then be in effect had the increase with respect to the distribution of such rights, options or warrants been made on the basis of delivery of
        only the number of shares of Common Stock actually delivered.&#160; If such rights, options or warrants are not so distributed, the Conversion Rate shall be decreased to the Conversion Rate that would then be in effect if such Ex-Dividend Date for such
        distribution had not occurred.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">70</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">For purposes of this <font style="font-family: 'Times New Roman';"><u>Section 14.04(b)</u></font> and for the purpose of <font style="font-family: 'Times New Roman';"><u>Section 14.01(b)(ii)(A)</u></font>, in determining whether any rights, options or warrants entitle the holders of Common Stock to subscribe for or purchase shares of the Common Stock at less than such average of the Last
        Reported Sale Prices of the Common Stock for the 10 consecutive Trading Day period ending on, and including, the Trading Day immediately preceding the date of announcement of such distribution, and in determining the aggregate offering price of
        such shares of Common Stock, there shall be taken into account any consideration received by the Company for such rights, options or warrants and any amount payable on exercise or conversion thereof, the value of such consideration, if other than
        cash, to be determined by the Company in good faith and in a commercially reasonable manner.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(c)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">If


            the Company distributes shares of its Capital Stock, evidences of its indebtedness, other assets or property of the Company or rights, options or warrants to acquire its Capital Stock or other securities, to all or substantially all holders of
            the Common Stock, excluding (i) dividends, distributions or issuances (including share splits) as to which an adjustment was effected pursuant to <font style="font-family: 'Times New Roman';"><u>Section 14.04(a)</u></font> or <font style="font-family: 'Times New Roman';"><u>Section 14.04(b)</u></font>, (ii) except as otherwise provided in <font style="font-family: 'Times New Roman';"><u>Section 14.11</u></font>, rights issued pursuant to any stockholder rights plan of
            the Company then in effect, (iii) distributions of Reference Property in exchange for, or upon conversion of, Common Stock in a Merger Event, (iv) dividends or distributions paid exclusively in cash as to which the provisions set forth in <font style="font-family: 'Times New Roman';"><u>Section 14.04(d)</u></font> shall apply, and (v) Spin-Offs as to which the provisions set forth below in this <font style="font-family: 'Times New Roman';"><u>Section 14.04(c)</u></font> shall apply
            (any of such shares of Capital Stock, evidences of indebtedness, other assets or property or rights, options or warrants to acquire Capital Stock or other securities, the &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Distributed


              Property</font>&#8221;), then the Conversion Rate shall be increased based on the following formula:</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: center; font-size: 10pt;"><img src="image00006.jpg"></div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">where,</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left;">
        <div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="zf4c68a8de43c45bf8e1ea081cc705aa8">

              <tr>
                <td style="width: 5%; vertical-align: top;"><font style="font-size: 10pt; font-family: 'Times New Roman';">CR</font><font style="font-size: 10pt;"><sub style="vertical-align: bottom; line-height: 1; font-size: smaller;">0</sub></font></td>
                <td style="width: 3%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">=</td>
                <td style="width: 92%; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">the Conversion Rate in effect immediately prior to the open of business on the Ex-Dividend Date for such distribution;</td>
              </tr>

          </table>
        </div>
      </div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left;">
        <div>
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="zd87e834eb83e4f2081ae496fcdf7948a">

              <tr>
                <td style="width: 5%; vertical-align: top;"><font style="font-size: 10pt; font-family: 'Times New Roman';">CR</font><font style="font-size: 10pt;"><sub style="vertical-align: bottom; line-height: 1; font-size: smaller;">1</sub></font></td>
                <td style="width: 3%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">=</td>
                <td style="width: 92%; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">the Conversion Rate in effect immediately after the open of business on such Ex-Dividend Date;</td>
              </tr>

          </table>
        </div>
      </div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left;">
        <div>
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z5bb0d92f532e48b899fd41ac150c7902">

              <tr>
                <td style="width: 5%; vertical-align: top;"><font style="font-size: 10pt; font-family: 'Times New Roman';">SP</font><font style="font-size: 10pt;"><sub style="vertical-align: bottom; line-height: 1; font-size: smaller;">0</sub></font></td>
                <td style="width: 3%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">=</td>
                <td style="width: 92%; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">the average of the Last Reported Sale Prices of the Common Stock over the 10 consecutive Trading Day period ending on, and
                  including, the Trading Day immediately preceding the Ex-Dividend Date for such distribution; and</td>
              </tr>

          </table>
        </div>
      </div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left;">
        <div>
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z6a31b26f995a487e97790251311bd2dd">

              <tr>
                <td style="width: 5%; vertical-align: top;"><font style="font-size: 10pt; font-family: 'Times New Roman';">FMV</font><font style="font-size: 10pt;"><br>
                  </font></td>
                <td style="width: 3%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">=</td>
                <td style="width: 92%; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">the fair market value (as determined by the Company in good faith and in a commercially reasonable manner) of the Distributed
                  Property with respect to each outstanding share of the Common Stock on the Ex-Dividend Date for such distribution.</td>
              </tr>

          </table>
        </div>
      </div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">71</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Any increase made under the portion of this <font style="font-family: 'Times New Roman';"><u>Section 14.04(c)</u></font> above shall become effective
        immediately after the open of business on the Ex-Dividend Date for such distribution.&#160; If such distribution is not so paid or made, the Conversion Rate shall be decreased to the Conversion Rate that would then be in effect if such distribution had
        not been declared.&#160; Notwithstanding the foregoing, if &#8220;FMV&#8221; (as defined above) is equal to or greater than &#8220;SP<sub style="vertical-align: bottom; line-height: 1; font-size: smaller;">0</sub>&#8221; (as defined above), in lieu of the foregoing increase, each Holder of a Note shall receive, in respect of each $1,000
        principal amount thereof, at the same time and upon the same terms as holders of the Common Stock receive the Distributed Property, the amount and kind of Distributed Property such Holder would have received if such Holder owned a number of shares
        of Common Stock equal to the Conversion Rate in effect on the Ex-Dividend Date for the distribution.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">With respect to an adjustment pursuant to this <font style="font-family: 'Times New Roman';"><u>Section 14.04(c)</u></font> where there has been a
        payment of a dividend or other distribution on the Common Stock of shares of Capital Stock of any class or series, or similar equity interest, of or relating to a Subsidiary or other business unit of the Company, that are, or, when issued, will be,
        listed or admitted for trading on a U.S. national securities exchange (a &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Spin-Off</font>&#8221;), the Conversion Rate shall be increased based on the following formula:</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: center; font-size: 10pt;"><img src="image00009.jpg"></div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">where,</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left;">
        <div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="za97c0241c376436aa2b441bd674e3f51">

              <tr>
                <td style="width: 5%; vertical-align: top;"><font style="font-size: 10pt; font-family: 'Times New Roman';">CR</font><font style="font-size: 10pt;"><sub style="vertical-align: bottom; line-height: 1; font-size: smaller;">0</sub></font></td>
                <td style="width: 3%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">=</td>
                <td style="width: 92%; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">the Conversion Rate in effect immediately prior to the end of the Valuation Period;</td>
              </tr>

          </table>
        </div>
      </div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left;">
        <div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="ze85d5e3cbba54287ba60b2551e0048f6">

              <tr>
                <td style="width: 5%; vertical-align: top;"><font style="font-size: 10pt; font-family: 'Times New Roman';">CR</font><font style="font-size: 10pt;"><sub style="vertical-align: bottom; line-height: 1; font-size: smaller;">1</sub></font></td>
                <td style="width: 3%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">=</td>
                <td style="width: 92%; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">the Conversion Rate in effect immediately after the end of the Valuation Period;</td>
              </tr>

          </table>
        </div>
      </div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left;">
        <div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="za007461b0b7d4ff6a1701577f316e220">

              <tr>
                <td style="width: 5%; vertical-align: top;"><font style="font-size: 10pt; font-family: 'Times New Roman';">FMV</font><font style="font-size: 10pt;"><sub style="vertical-align: bottom; line-height: 1; font-size: smaller;">0</sub></font></td>
                <td style="width: 3%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">=</td>
                <td style="width: 92%; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">the average of the Last Reported Sale Prices of the Capital Stock or similar equity interest distributed to holders of the
                  Common Stock applicable to one share of the Common Stock (determined by reference to the definition of Last Reported Sale Price as set forth in <font style="font-family: 'Times New Roman';"><u>Section 1.01</u></font> as if references
                  therein to Common Stock were to such Capital Stock or similar equity interest) over the first 10 consecutive Trading Day period after, and including, the Ex-Dividend Date of the Spin-Off (the &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Valuation Period</font>&#8221;); and</td>
              </tr>

          </table>
        </div>
      </div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left;">
        <div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z3c9e7b8d7225432395357d7de6bf1094">

              <tr>
                <td style="width: 5%; vertical-align: top;"><font style="font-size: 10pt; font-family: 'Times New Roman';">MP</font><font style="font-size: 10pt;"><sub style="vertical-align: bottom; line-height: 1; font-size: smaller;">0</sub></font></td>
                <td style="width: 3%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">=</td>
                <td style="width: 92%; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">the average of the Last Reported Sale Prices of the Common Stock over the Valuation Period.</td>
              </tr>

          </table>
        </div>
      </div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">72</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">The increase to the Conversion Rate under the preceding paragraph shall occur at the close of business on the last Trading Day of the Valuation Period;
        <font style="font-family: 'Times New Roman'; font-style: italic;">provided </font>that (x) in respect of any conversion of Notes for which Physical Settlement is applicable, if the relevant Conversion Date occurs during the Valuation Period, the
        reference to &#8220;10&#8221; in the preceding paragraph shall be deemed to be replaced with such lesser number of Trading Days as have elapsed from, and including, the Ex-Dividend Date of such Spin-Off to, and including, the Conversion Date in determining the
        Conversion Rate and (y) in respect of any conversion of Notes for which Cash Settlement or Combination Settlement is applicable, for any Trading Day that falls within the relevant Observation Period for such conversion and within the Valuation
        Period, the reference to &#8220;10&#8221; in the preceding paragraph shall be deemed to be replaced with such lesser number of Trading Days as have elapsed from, and including, the Ex-Dividend Date of such Spin-Off to, and including, such Trading Day in
        determining the Conversion Rate as of such Trading Day of such Observation Period.&#160; If any dividend or distribution that constitutes a Spin-Off is declared but not so paid or made, the Conversion Rate shall be immediately decreased, effective as of
        the date the Board of Directors determines not to pay or make such dividend or distribution, to the Conversion Rate that would then be in effect if such dividend or distribution had not been declared or announced.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">For purposes of this <font style="font-family: 'Times New Roman';"><u>Section 14.04(c)</u></font> and (subject in all respect to <font style="font-family: 'Times New Roman';"><u>Section 14.11</u></font>), rights, options or warrants distributed by the Company to all holders of the Common Stock entitling them to subscribe for or purchase shares of the Company&#8217;s Capital Stock,
        including Common Stock (either initially or under certain circumstances), which rights, options or warrants, until the occurrence of a specified event or events (&#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Trigger Event</font>&#8221;):&#160;


        (i) are deemed to be transferred with such shares of the Common Stock; (ii) are not exercisable; and (iii) are also issued in respect of future issuances of the Common Stock, shall be deemed not to have been distributed for purposes of this <font style="font-family: 'Times New Roman';"><u>Section 14.04(c)</u></font> (and no adjustment to the Conversion Rate under this <font style="font-family: 'Times New Roman';"><u>Section 14.04(c)</u></font> will be required) until the occurrence of
        the earliest Trigger Event, whereupon such rights, options or warrants shall be deemed to have been distributed and an appropriate adjustment (if any is required) to the Conversion Rate shall be made under this <font style="font-family: 'Times New Roman';"><u>Section 14.04(c)</u></font>.&#160; If any such right, option or warrant, including any such existing rights, options or warrants distributed prior to the date of this Indenture, are subject to events, upon the occurrence of which such
        rights, options or warrants become exercisable to purchase different securities, evidences of indebtedness or other assets, then the date of the occurrence of any and each such event shall be deemed to be the date of distribution and Ex-Dividend
        Date with respect to new rights, options or warrants with such rights (in which case the existing rights, options or warrants shall be deemed to terminate and expire on such date without exercise by any of the holders thereof).&#160; In addition, in the
        event of any distribution (or deemed distribution) of rights, options or warrants, or any Trigger Event or other event (of the type described in the immediately preceding sentence) with respect thereto that was counted for purposes of calculating a
        distribution amount for which an adjustment to the Conversion Rate under this <font style="font-family: 'Times New Roman';"><u>Section 14.04(c)</u></font> was made, (1) in the case of any such rights, options or warrants that shall all have been
        redeemed or purchased without exercise by any holders thereof, upon such final redemption or purchase (x) the Conversion Rate shall be readjusted as if such rights, options or warrants had not been issued and (y) the Conversion Rate shall then
        again be readjusted to give effect to such distribution, deemed distribution or Trigger Event, as the case may be, as though it were a cash distribution, equal to the per share redemption or purchase price received by a holder or holders of Common
        Stock with respect to such rights, options or warrants (assuming such holder had retained such rights, options or warrants), made to all holders of Common Stock as of the date of such redemption or purchase, and (2) in the case of such rights,
        options or warrants that shall have expired or been terminated without exercise by any holders thereof, the Conversion Rate shall be readjusted as if such rights, options and warrants had not been issued.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">For purposes of <font style="font-family: 'Times New Roman';"><u>Section 14.04(a)</u></font>, <font style="font-family: 'Times New Roman';"><u>Section


            14.04(b)</u></font> and this <font style="font-family: 'Times New Roman';"><u>Section 14.04(c)</u></font>, if any dividend or distribution to which this <font style="font-family: 'Times New Roman';"><u>Section 14.04(c)</u></font> is
        applicable also includes one or both of:</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">73</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: left; margin-left: 63pt; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(A)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">a dividend or distribution of shares of Common Stock to which <font style="font-family: 'Times New Roman';"><u>Section 14.04(a)</u></font> is applicable (the &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Clause A Distribution</font>&#8221;); or</font></font></div>
      <div style="font-size: 10pt; margin-left: 63pt; text-indent: 36pt;">&#160;</div>
      <div style="text-align: left; margin-left: 63pt; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(B)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">a dividend or distribution of rights, options or warrants to which <font style="font-family: 'Times New Roman';"><u>Section 14.04(b)</u></font> is applicable (the &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Clause B Distribution</font>&#8221;), then, in either case, (1) such dividend or distribution, other than the Clause A Distribution and the Clause B Distribution, shall be deemed to be a dividend or distribution to which this <font style="font-family: 'Times New Roman';"><u>Section 14.04(c)</u></font> is applicable (the &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Clause C Distribution</font>&#8221;) and any Conversion Rate adjustment required by this <font style="font-family: 'Times New Roman';"><u>Section 14.04(c)</u></font> with respect to such Clause C Distribution shall then be made, and (2) the Clause A Distribution and Clause B Distribution shall be deemed to immediately follow the Clause
            C Distribution and any Conversion Rate adjustment required by <font style="font-family: 'Times New Roman';"><u>Section 14.04(a)</u></font> and <font style="font-family: 'Times New Roman';"><u>Section 14.04(b)</u></font> with respect thereto
            shall then be made, except that, if determined by the Company (I) the &#8220;Ex-Dividend Date&#8221; of the Clause A Distribution and the Clause B Distribution shall be deemed to be the Ex-Dividend Date of the Clause C Distribution and (II) any shares of
            Common Stock included in the Clause A Distribution or Clause B Distribution shall be deemed not to be &#8220;outstanding immediately prior to the open of business on such Ex-Dividend Date or Effective Date&#8221; within the meaning of <font style="font-family: 'Times New Roman';"><u>Section 14.04(a)</u></font> or &#8220;outstanding immediately prior to the open of business on such Ex-Dividend Date&#8221; within the meaning of <font style="font-family: 'Times New Roman';"><u>Section
                14.04(b)</u></font>.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(d)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">If


            the Company makes any cash dividend or distribution to all or substantially all holders of the Common Stock, the Conversion Rate shall be adjusted based on the following formula:</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: center; font-size: 10pt;"><img src="image00010.jpg"></div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">where,</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left;">
        <div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z5b61628e47614f499a907e01089b7f61">

              <tr>
                <td style="width: 5%; vertical-align: top;"><font style="font-size: 10pt; font-family: 'Times New Roman';">CR</font><font style="font-size: 10pt;"><sub style="vertical-align: bottom; line-height: 1; font-size: smaller;">0</sub></font></td>
                <td style="width: 3%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">=</td>
                <td style="width: 92%; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">the Conversion Rate in effect immediately prior to the open of business on the Ex-Dividend Date for such dividend or
                  distribution;</td>
              </tr>

          </table>
        </div>
      </div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left;">
        <div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z902dcd626c7c46c09b22d917284f8214">

              <tr>
                <td style="width: 5%; vertical-align: top;"><font style="font-size: 10pt; font-family: 'Times New Roman';">CR</font><font style="font-size: 10pt;"><sub style="vertical-align: bottom; line-height: 1; font-size: smaller;">1</sub></font></td>
                <td style="width: 3%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">=</td>
                <td style="width: 92%; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">the Conversion Rate in effect immediately after the open of business on the Ex-Dividend Date for such dividend or distribution;</td>
              </tr>

          </table>
        </div>
      </div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left;">
        <div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z1f96db73e9664e4690a6ad06f215b86c">

              <tr>
                <td style="width: 5%; vertical-align: top;"><font style="font-size: 10pt; font-family: 'Times New Roman';">SP</font><font style="font-size: 10pt;"><sub style="vertical-align: bottom; line-height: 1; font-size: smaller;">0</sub></font></td>
                <td style="width: 3%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">=</td>
                <td style="width: 92%; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">the Last Reported Sale Price of the Common Stock on the Trading Day immediately preceding the Ex-Dividend Date for such dividend
                  or distribution; and</td>
              </tr>

          </table>
        </div>
      </div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left;">
        <div>
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z3f0e8af1cced48458c4966347ac7eb5b">

              <tr>
                <td style="width: 5%; vertical-align: top;"><font style="font-size: 10pt; font-family: 'Times New Roman';">C</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></td>
                <td style="width: 3%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">=</td>
                <td style="width: 92%; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">the amount in cash per share the Company distributes to all or substantially all holders of the Common Stock.</td>
              </tr>

          </table>
        </div>
      </div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Any increase pursuant to this <font style="font-family: 'Times New Roman';"><u>Section 14.04(d)</u></font> shall become effective immediately after
        the open of business on the Ex-Dividend Date for such dividend or distribution.&#160; If such dividend or distribution is not so paid, the Conversion Rate shall be decreased, effective as of the date the Board of Directors determines not to make or pay
        such dividend or distribution, to be the Conversion Rate that would then be in effect if such dividend or distribution had not been declared.&#160; Notwithstanding the foregoing, if &#8220;C&#8221; (as defined above) is equal to or greater than &#8220;SP<sub style="vertical-align: bottom; line-height: 1; font-size: smaller;">0</sub>&#8221; (as
        defined above), in lieu of the foregoing increase, each Holder of a Note shall receive, for each $1,000 principal amount of Notes it holds, at the same time and upon the same terms as holders of shares of the Common Stock, the amount of cash that
        such Holder would have received if such Holder owned a number of shares of Common Stock equal to the Conversion Rate on the Ex-Dividend Date for such cash dividend or distribution.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">74</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(e)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">If the Company or any of its Subsidiaries make a payment in respect of a tender or exchange offer for the Common Stock that is subject to the then-applicable tender offer rules under the Exchange Act (other than any odd-lot tender offer),
            to the extent that the cash and value of any other consideration included in the payment per share of the Common Stock exceeds the average of the Last Reported Sale Prices of the Common Stock over the 10 consecutive Trading Day period
            commencing on, and including, the Trading Day next succeeding the last date on which tenders or exchanges may be made pursuant to such tender or exchange offer, the Conversion Rate shall be increased based on the following formula:</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: center; font-size: 10pt;"><img src="image00011.jpg"></div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">where,</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left;">
        <div>
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z59e4f5303f73471d98a3b5c160dc754c">

              <tr>
                <td style="width: 5%; vertical-align: top;"><font style="font-size: 10pt; font-family: 'Times New Roman';">CR</font><font style="font-size: 10pt;"><sub style="vertical-align: bottom; line-height: 1; font-size: smaller;">0</sub></font></td>
                <td style="width: 3%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">=</td>
                <td style="width: 92%; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">the Conversion Rate in effect immediately prior to the close of business on the 10th Trading Day immediately following, and
                  including, the Trading Day next succeeding the date such tender or exchange offer expires;</td>
              </tr>

          </table>
        </div>
      </div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left;">
        <div>
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z75cb1e7fd21f4edc8885039968aba188">

              <tr>
                <td style="width: 5%; vertical-align: top;"><font style="font-size: 10pt; font-family: 'Times New Roman';">CR</font><font style="font-size: 10pt;"><sub style="vertical-align: bottom; line-height: 1; font-size: smaller;">1</sub></font></td>
                <td style="width: 3%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">=</td>
                <td style="width: 92%; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">the Conversion Rate in effect immediately after the close of business on the 10th Trading Day immediately following, and
                  including, the Trading Day next succeeding the date such tender or exchange offer expires;</td>
              </tr>

          </table>
        </div>
      </div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left;">
        <div>
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z8ebf05293b72407cb8d51b0b62f0d27e">

              <tr>
                <td style="width: 5%; vertical-align: top;"><font style="font-size: 10pt; font-family: 'Times New Roman';">AC</font></td>
                <td style="width: 3%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">=</td>
                <td style="width: 92%; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">the aggregate value of all cash and any other consideration (as determined by the Company in good faith and in a commercially
                  reasonable manner) paid or payable for shares of Common Stock purchased in such tender or exchange offer;</td>
              </tr>

          </table>
        </div>
      </div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left;">
        <div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z68c7a6c1bbee4ab39d42d4eb35aa31b1">

              <tr>
                <td style="width: 5%; vertical-align: top;"><font style="font-size: 10pt; font-family: 'Times New Roman';">OS</font><font style="font-size: 10pt;"><sub style="vertical-align: bottom; line-height: 1; font-size: smaller;">0</sub></font></td>
                <td style="width: 3%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">=</td>
                <td style="width: 92%; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">the number of shares of Common Stock outstanding immediately prior to the date such tender or exchange offer expires (prior to
                  giving effect to the purchase of all shares of Common Stock accepted for purchase or exchange in such tender or exchange offer);</td>
              </tr>

          </table>
        </div>
      </div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left;">
        <div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="ze7c0ed7bbc8949b6b0234e891f4ab6a8">

              <tr>
                <td style="width: 5%; vertical-align: top;"><font style="font-size: 10pt; font-family: 'Times New Roman';">OS</font><font style="font-size: 10pt;"><sub style="vertical-align: bottom; line-height: 1; font-size: smaller;">1</sub></font></td>
                <td style="width: 3%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">=</td>
                <td style="width: 92%; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">the number of shares of Common Stock outstanding immediately after the date such tender or exchange offer expires (after giving
                  effect to the purchase of all shares of Common Stock accepted for purchase or exchange in such tender or exchange offer); and</td>
              </tr>

          </table>
        </div>
      </div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left;">
        <div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z34c96b84923c47f18d6dd3b68f07d56b">

              <tr>
                <td style="width: 5%; vertical-align: top;"><font style="font-size: 10pt; font-family: 'Times New Roman';">SP</font><font style="font-size: 10pt;"><sub style="vertical-align: bottom; line-height: 1; font-size: smaller;">1</sub></font></td>
                <td style="width: 3%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">=</td>
                <td style="width: 92%; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">the average of the Last Reported Sale Prices of the Common Stock over the 10 consecutive Trading Day period commencing on, and
                  including, the Trading Day next succeeding the date such tender or exchange offer expires.</td>
              </tr>

          </table>
        </div>
      </div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">75</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">The increase to the Conversion Rate under this <font style="font-family: 'Times New Roman';"><u>Section 14.04(e)</u></font> shall occur at the close
        of business on the 10th Trading Day immediately following, and including, the Trading Day next succeeding the date such tender or exchange offer expires; <font style="font-family: 'Times New Roman'; font-style: italic;">provided </font>that (x)
        in respect of any conversion of Notes for which Physical Settlement is applicable, if the relevant Conversion Date occurs during the 10 Trading Days immediately following, and including, the Trading Day next succeeding the expiration date of any
        tender or exchange offer, references to &#8220;10&#8221; or &#8220;10th&#8221; in the preceding paragraph shall be deemed replaced with such lesser number of Trading Days as have elapsed from, and including, the Trading Day next succeeding the date that such tender or
        exchange offer expires to, and including, the Conversion Date in determining the Conversion Rate and (y) in respect of any conversion of Notes for which Cash Settlement or Combination Settlement is applicable, for any Trading Day that falls within
        the relevant Observation Period for such conversion and within the 10 Trading Days immediately following, and including, the Trading Day next succeeding the expiration date of any tender or exchange offer, references to &#8220;10&#8221; or &#8220;10th&#8221; in the
        preceding paragraph shall be deemed replaced with such lesser number of Trading Days as have elapsed from, and including, the Trading Day next succeeding the expiration date of such tender or exchange offer to, and including, such Trading Day in
        determining the Conversion Rate as of such Trading Day of such Observation Period.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">If the Company or one of its Subsidiaries is obligated to purchase shares of Common Stock pursuant to any such tender or exchange offer described in
        this <font style="font-family: 'Times New Roman';"><u>Section 14.04(e)</u></font> but the Company or such Subsidiary is permanently prevented by applicable law from effecting any such purchase or all such purchases are rescinded, the Conversion
        Rate shall be readjusted to be the Conversion Rate that would then be in effect if such tender or exchange offer had not been made or had been made only in respect of the purchases that have been made.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(f)</font><font style="font-size: 10pt;">&#160;&#160; &#160; &#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">Notwithstanding


            this <font style="font-family: 'Times New Roman';"><u>Section 14.04</u></font> or any other provision of this Indenture or the Notes, if a Conversion Rate adjustment becomes effective on any Ex-Dividend Date, and a Holder that has converted
            its Notes on or after such Ex-Dividend Date and on or prior to the related Record Date would be treated as the record holder of the shares of Common Stock as of the related Conversion Date as described under <font style="font-family: 'Times New Roman';"><u>Section 14.02(i)</u></font> based on an adjusted Conversion Rate for such Ex-Dividend Date, then, notwithstanding the Conversion Rate adjustment provisions in this <font style="font-family: 'Times New Roman';"><u>Section
                14.04</u></font>, the Conversion Rate adjustment relating to such Ex-Dividend Date shall not be made for such converting Holder.&#160; Instead, such Holder shall be treated as if such Holder were the record owner of the shares of Common Stock on
            an unadjusted basis and participate in the related dividend, distribution or other event giving rise to such adjustment.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(g)</font><font style="font-size: 10pt;">&#160; &#160; &#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">Except


            as stated herein, the Company shall not adjust the Conversion Rate for the issuance of shares of the Common Stock or any securities convertible into or exchangeable for shares of the Common Stock or the right to purchase shares of the Common
            Stock or such convertible or exchangeable securities.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(h)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">In


            addition to those adjustments required by clauses (a), (b), (c), (d) and (e) of this <font style="font-family: 'Times New Roman';"><u>Section 14.04</u></font>, and subject to applicable exchange listing rules, the Company from time to time may
            increase the Conversion Rate by any amount for a period of at least 20 Business Days if the Company determines that such increase would be in the Company&#8217;s best interest.&#160; In addition, subject to applicable exchange listing rules, the Company
            may (but is not required to) increase the Conversion Rate to avoid or diminish any income tax to holders of Common Stock or rights to purchase Common Stock in connection with a dividend or distribution of shares of Common Stock (or rights to
            acquire shares of Common Stock) or similar event.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">76</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(i)</font><font style="font-size: 10pt;">&#160; &#160; &#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">Notwithstanding


            anything to the contrary in this <font style="font-family: 'Times New Roman';"><u>Article 14</u></font>, the Conversion Rate shall not be adjusted:</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; margin-left: 36pt; text-indent: 27pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(i)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160; &#160;&#160; &#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">upon the issuance of any shares of Common Stock at a price below the Conversion Price or otherwise, other than any such issuance described in clause (a), (b) or (c) of this <font style="font-family: 'Times New Roman';"><u>Section


                14.04;</u></font></font></font></div>
      <div style="font-size: 10pt; margin-left: 36pt; text-indent: 27pt;">&#160;</div>
      <div style="text-align: left; margin-left: 36pt; text-indent: 27pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(ii)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">upon the issuance of any shares of Common Stock pursuant to any present or future plan providing for the reinvestment of dividends or interest payable on the Company&#8217;s securities and the investment of additional optional
            amounts in shares of Common Stock under any plan;</font></font></div>
      <div style="font-size: 10pt; margin-left: 36pt; text-indent: 27pt;">&#160;</div>
      <div style="text-align: left; margin-left: 36pt; text-indent: 27pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(iii)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">upon the issuance of any shares of Common Stock or options or rights to purchase those shares pursuant to any present or future employee, director or consultant benefit or incentive plan or program (including pursuant to
            any evergreen plan) of or assumed by the Company or any of the Company&#8217;s Subsidiaries;</font></font></div>
      <div style="font-size: 10pt; margin-left: 36pt; text-indent: 27pt;">&#160;</div>
      <div style="text-align: left; margin-left: 36pt; text-indent: 27pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(iv)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">upon the issuance of any shares of the Common Stock pursuant to any option, warrant, right or exercisable, exchangeable or convertible security not described in clause (iii) of this subsection and outstanding as of the
            date the Notes were first issued;</font></font></div>
      <div style="font-size: 10pt; margin-left: 36pt; text-indent: 27pt;">&#160;</div>
      <div style="text-align: left; margin-left: 36pt; text-indent: 27pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(v)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">for a third-party tender offer by any party other than a tender offer by one or more of the Company&#8217;s Subsidiaries as described in clause (e) of this <font style="font-family: 'Times New Roman';"><u>Section 14.04;</u></font></font></font></div>
      <div style="font-size: 10pt; margin-left: 36pt; text-indent: 27pt;">&#160;</div>
      <div style="text-align: left; margin-left: 36pt; text-indent: 27pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(vi)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">upon the repurchase of any shares of Common Stock pursuant to an open market share purchase program or other buy-back transaction, including structured or derivative transactions such as accelerated share repurchase
            transactions or similar forward derivatives, or other buy-back transaction, that is not a tender offer or exchange offer of the kind described under clause (e) of this <font style="font-family: 'Times New Roman';"><u>Section 14.04;</u></font></font></font></div>
      <div style="font-size: 10pt; margin-left: 36pt; text-indent: 27pt;">&#160;</div>
      <div style="text-align: left; margin-left: 36pt; text-indent: 27pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(vii)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">solely for a change in the par value (or lack of par value) of the Common Stock; or</font></font></div>
      <div style="font-size: 10pt; margin-left: 36pt; text-indent: 27pt;">&#160;</div>
      <div style="text-align: left; margin-left: 36pt; text-indent: 27pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(viii)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">for accrued and unpaid interest, if any.</font></font></div>
      <div style="font-size: 10pt; margin-left: 36pt; text-indent: 27pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(j)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160; &#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">All


            calculations and other determinations under this <font style="font-family: 'Times New Roman';"><u>Article 14</u></font> shall be made by the Company and shall be made to the nearest one-ten thousandth (1/10,000th) of a share.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(k)</font><font style="font-size: 10pt;">&#160;&#160; &#160; &#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">If


            an adjustment to the Conversion Rate otherwise required by this <font style="font-family: 'Times New Roman';"><u>Section 14.04</u></font> would result in a change of less than 1% to the Conversion Rate, then, notwithstanding the foregoing, the
            Company may, at its election, defer and carry forward such adjustment, except that all such deferred adjustments must be given effect immediately upon the earliest to occur of the following:&#160; (i) when all such deferred adjustments would result
            in an aggregate change of at least 1% to the Conversion Rate, (ii) on the Conversion Date for any Notes (in the case of Physical Settlement), (iii) on each Trading Day of any Observation Period related to any conversion of Notes (in the case of
            Cash Settlement or Combination Settlement), (iv) on any date on which the Company delivers a Notice of Redemption, (v) on the effective date of any Fundamental Change and/or Make-Whole Fundamental Change, and (vi) December 2, 2030, in each
            case, unless the adjustment has already been made.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">77</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(l)</font><font style="font-size: 10pt;">&#160; &#160; &#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">Whenever


            the Conversion Rate is adjusted as herein provided, the Company shall promptly file with the Trustee (and the Conversion Agent if not the Trustee) an Officer&#8217;s Certificate setting forth the Conversion Rate after such adjustment and setting
            forth a brief statement of the facts requiring such adjustment.&#160; Unless and until a Responsible Officer of the Trustee and the Conversion Agent shall have received such Officer&#8217;s Certificate, the Trustee and the Conversion Agent shall not be
            deemed to have knowledge of any adjustment of the Conversion Rate and may assume without inquiry that the last Conversion Rate of which it has knowledge is still in effect.&#160; Promptly after delivery of such certificate, the Company shall prepare
            a notice of such adjustment of the Conversion Rate setting forth the adjusted Conversion Rate and the date on which each adjustment becomes effective and shall deliver such notice of such adjustment of the Conversion Rate to each Holder.&#160;
            Failure to deliver such notice shall not affect the legality or validity of any such adjustment.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(m)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">For


            purposes of this <font style="font-family: 'Times New Roman';"><u>Section 14.04</u></font>, the number of shares of Common Stock at any time outstanding shall not include shares of Common Stock held in the treasury of the Company so long as
            the Company does not pay any dividend or make any distribution on shares of Common Stock held in the treasury of the Company, but shall include shares of Common Stock issuable in respect of scrip certificates issued in lieu of fractions of
            shares of Common Stock.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">Section 14.05 &#160; <u>Adjustments of Prices</u></font><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">.&#160; </font><font style="font-size: 10pt;">Whenever any provision of this Indenture requires the Company to calculate the Last Reported Sale Prices, the Daily VWAPs, the
          Daily Conversion Values or the Daily Settlement Amounts over a span of multiple days (including, without limitation, an Observation Period and the period for determining the Stock Price for purposes of a Make-Whole Fundamental Change or a Notice
          of Redemption), the Company shall make appropriate adjustments in good faith and in a commercially reasonable manner to each to account for any adjustment to the Conversion Rate that becomes effective, or any event requiring an adjustment to the
          Conversion Rate where the Ex-Dividend Date, Effective Date or expiration date, as the case may be, of the event occurs at any time during the period when the Last Reported Sale Prices, the Daily VWAPs, the Daily Conversion Values or the Daily
          Settlement Amounts are to be calculated.</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">For the avoidance of doubt, the adjustments made pursuant to the foregoing paragraph shall be made, solely to the extent the Company determines in good
        faith and in a commercially reasonable manner that any such adjustment is appropriate, without duplication of any adjustment made pursuant to <font style="font-family: 'Times New Roman';"><u>Section 14.04</u></font>.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">Section 14.06 &#160; <u>Shares to Be Fully Paid</u></font><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">.&#160; </font><font style="font-size: 10pt;">The Company shall provide, free from preemptive rights, out of its authorized but unissued shares or shares held in treasury,
          sufficient shares of Common Stock to provide for conversion of the Notes from time to time as such Notes are presented for conversion (assuming delivery of the maximum number of Additional Shares pursuant to <font style="font-family: 'Times New Roman';"><u>Section 14.03</u></font> and that at the time of computation of such number of shares, all such Notes would be converted by a single Holder and that Physical Settlement were applicable).</font></div>
      <div style="font-size: 10pt;">&#160;
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
          <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">78</font></div>
          <div style="page-break-after: always;" class="BRPFPageBreak">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        </div>
      </div>
      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">Section 14.07 &#160; </font><u>Effect of Recapitalizations, Reclassifications and Changes of the Common Stock</u></font><font style="font-size: 10pt;">.</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(a)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">In


            the case of:</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; margin-left: 36pt; text-indent: 27pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(i)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">any recapitalization, reclassification or change of the Common Stock (other than a change to par value, or from par value to no par value, or changes resulting from a subdivision or combination),</font></font></div>
      <div style="font-size: 10pt; margin-left: 36pt; text-indent: 27pt;">&#160;</div>
      <div style="text-align: left; margin-left: 36pt; text-indent: 27pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(ii)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">any consolidation, merger, combination or similar transaction involving the Company,</font></font></div>
      <div style="font-size: 10pt; margin-left: 36pt; text-indent: 27pt;">&#160;</div>
      <div style="text-align: left; margin-left: 36pt; text-indent: 27pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(iii)</font><font style="font-size: 10pt;">&#160; &#160; &#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">any sale, lease or other transfer to a third party of the consolidated assets of the Company and the Company&#8217;s Subsidiaries substantially as an entirety or</font></font></div>
      <div style="font-size: 10pt; margin-left: 36pt; text-indent: 27pt;">&#160;</div>
      <div style="text-align: left; margin-left: 36pt; text-indent: 27pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(iv)</font><font style="font-size: 10pt;">&#160;&#160;&#160; &#160; &#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">any statutory share exchange,</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">in each case, as a result of which the Common Stock would be converted into, or exchanged for, stock, other securities, other property or assets (including cash or any
        combination thereof) (any such event, a &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Merger Event</font>&#8221;), then, at and after the effective time of such Merger Event, the right to convert each $1,000 principal amount of Notes
        shall be changed into a right to convert such principal amount of Notes into the kind and amount of shares of stock, other securities or other property or assets (including cash or any combination thereof) that a holder of a number of shares of
        Common Stock equal to the Conversion Rate immediately prior to such Merger Event would have owned or been entitled to receive (the &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Reference Property</font>,&#8221; with each &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">unit of Reference Property</font>&#8221; meaning the kind and amount of Reference Property that a holder of one share of Common Stock is entitled to receive on account of such Merger Event
        (without giving effect to any arrangement not to issue or deliver a fractional portion of any security or other property)) upon such Merger Event and, prior to or at the effective time of such Merger Event, the Company or the successor or
        purchasing Person, as the case may be, shall execute with the Trustee a supplemental indenture permitted under <font style="font-family: 'Times New Roman';"><u>Section 10.01(g)</u></font> providing for such change in the right to convert each
        $1,000 principal amount of Notes; <font style="font-family: 'Times New Roman'; font-style: italic;">provided</font>, <font style="font-family: 'Times New Roman'; font-style: italic;">however</font>, that at and after the effective time of the
        Merger Event (A) the Company or the successor or acquiring company, as the case may be, shall continue to have the right to determine the form of consideration to be paid or delivered, as the case may be, upon conversion of Notes in accordance with
        <font style="font-family: 'Times New Roman';"><u>Section 14.02</u></font> and (B) (I) any amount payable in cash upon conversion of the Notes in accordance with <font style="font-family: 'Times New Roman';"><u>Section 14.02</u></font> shall
        continue to be payable in cash, (II) any shares of Common Stock that the Company would have been required to deliver upon conversion of the Notes in accordance with <font style="font-family: 'Times New Roman';"><u>Section 14.02</u></font> shall
        instead be deliverable in the amount and type of Reference Property that a holder of that number of shares of Common Stock would have received in such Merger Event, (III) for purposes of the provisions of Article 16, each reference to any number of
        shares of Common Stock in such provisions (or in any related definitions) will instead be deemed to be a reference to the same number of units of Reference Property and (IV) the Daily VWAP shall be calculated based on the value of a unit of
        Reference Property.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">79</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">If the Merger Event causes the Common Stock to be converted into, or exchanged for, the right to receive more than a single type of consideration
        (determined based in part upon any form of stockholder election), then the Reference Property into which the Notes will be convertible will be deemed to be (i) the weighted average of the types and amounts of consideration received by the holders
        of Common Stock that affirmatively make such an election or (ii) if no holders of Common Stock make such an election, the weighted average of the types and amounts of consideration actually received by the holders of Common Stock. The Company shall
        notify Holders, the Trustee and the Conversion Agent (if other than the Trustee) of such weighted average as soon as practicable after such determination is made.&#160; If the holders of the Common Stock receive only cash in such Merger Event, then for
        all conversions for which the relevant Conversion Date occurs after the effective date of such Merger Event (A) the consideration due upon conversion of each $1,000 principal amount of Notes shall be solely cash in an amount equal to the Conversion
        Rate in effect on the Conversion Date (as may be increased by any Additional Shares pursuant to <font style="font-family: 'Times New Roman';"><u>Section 14.03</u></font>), <font style="font-family: 'Times New Roman'; font-style: italic;">multiplied


          by</font> the price paid per share of Common Stock in such Merger Event and (B) the Company shall satisfy the Conversion Obligation by paying cash to converting Holders on the second Business Day immediately following the relevant Conversion
        Date.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">If the Reference Property in respect of any Merger Event includes, in whole or in part, common equity, the supplemental indenture described in the
        second immediately preceding paragraph providing that the Notes will convertible into Reference Property (other than cash) shall also provide for anti-dilution and other adjustments that shall be as nearly equivalent as is possible to the
        adjustments provided for in this <font style="font-family: 'Times New Roman';"><u>Article 14</u></font> with respect to the portion of Reference Property constituting such common equity.&#160; If, in the case of any Merger Event, the Reference Property
        includes shares of stock, securities or other property or assets (including any combination thereof), other than cash and/or cash equivalents, of a Person other than the Company or the successor or purchasing corporation, as the case may be, in
        such Merger Event, then such supplemental indenture shall also be executed by such other Person, if such Person is an Affiliate of the Company or the successor or purchasing corporation, and shall contain such additional provisions to protect the
        interests of the Holders as the Company shall in good faith reasonably consider necessary by reason of the foregoing, including the provisions providing for the purchase rights set forth in <font style="font-family: 'Times New Roman';"><u>Article
            15</u></font>.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(b)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">When


            the Company executes a supplemental indenture pursuant to <font style="font-family: 'Times New Roman';"><u>subsection (a)</u></font> of this <font style="font-family: 'Times New Roman';"><u>Section 14.07</u></font>, the Company shall promptly
            file with the Trustee an Officer&#8217;s Certificate briefly stating the reasons therefor, the kind or amount of cash, securities or property or asset that will comprise a unit of Reference Property after any such Merger Event, any adjustment to be
            made with respect thereto and that all conditions precedent have been complied with, and shall promptly deliver or cause to be delivered notice thereof to all Holders.&#160; The Company shall cause notice of the execution of such supplemental
            indenture to be delivered to each Holder within 20 days after execution thereof.&#160; Failure to deliver such notice shall not affect the legality or validity of such supplemental indenture.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(c)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">The


            Company shall not become a party to any Merger Event unless its terms are consistent with this <font style="font-family: 'Times New Roman';"><u>Section 14.07</u></font>.&#160; None of the foregoing provisions shall affect the right of a holder of
            Notes to convert its Notes into cash, shares of Common Stock or a combination of cash and shares of Common Stock, as applicable, as set forth in <font style="font-family: 'Times New Roman';"><u>Section 14.01</u></font> and <font style="font-family: 'Times New Roman';"><u>Section 14.02</u></font> prior to the effective date of such Merger Event.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">80</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(d)</font><font style="font-size: 10pt;">&#160; &#160; &#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">The


            above provisions of this Section shall similarly apply to successive Merger Events.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">Section


            14.08&#160;&#160; </font><u>Certain Covenants</u></font><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">.&#160; </font><font style="font-size: 10pt;">(a) The Company covenants that all shares of Common Stock issued upon
          conversion of Notes will be fully paid and non-assessable by the Company and free from all taxes, liens and charges with respect to the issue thereof.</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(b)</font><font style="font-size: 10pt;">&#160; &#160; &#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">The


            Company covenants that, if any shares of Common Stock to be provided for the purpose of conversion of Notes hereunder require registration with or approval of any governmental authority under any federal or state law before such shares of
            Common Stock may be validly issued upon conversion, the Company will, to the extent then permitted by the rules and interpretations of the Commission, secure such registration or approval, as the case may be.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(c)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">The


            Company further covenants that if at any time the Common Stock shall be listed on any national securities exchange or automated quotation system the Company will list and keep listed, so long as the Common Stock shall be so listed on such
            exchange or automated quotation system, any Common Stock issuable upon conversion of the Notes.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">Section


            14.09 &#160; </font><u>Responsibility of Trustee</u></font><font style="font-size: 10pt;">.&#160; The Trustee and any other Conversion Agent shall not at any time be under any duty or responsibility to any Holder to determine the Conversion Rate (or any
          adjustment thereto) or whether any facts exist that may require any adjustment (including any increase) of the Conversion Rate, or with respect to the nature or extent or calculation of any such adjustment when made, or with respect to the method
          employed, or herein or in any supplemental indenture provided to be employed, in making the same.&#160; The Trustee and any other Conversion Agent shall not be accountable with respect to the validity or value (or the kind or amount) of any shares of
          Common Stock, or of any securities, property or cash that may at any time be issued or delivered upon the conversion of any Note; and the Trustee and any other Conversion Agent make no representations with respect thereto.&#160; Neither the Trustee
          nor any Conversion Agent shall be responsible for any failure of the Company to issue, transfer or deliver any shares of Common Stock or stock certificates or other securities or property or cash upon the surrender of any Note for the purpose of
          conversion or to comply with any of the duties, responsibilities or covenants of the Company contained in this <font style="font-family: 'Times New Roman';"><u>Article 14</u></font>.&#160; Without limiting the generality of the foregoing, neither the
          Trustee nor any Conversion Agent shall be under any responsibility to determine the correctness of any provisions contained in any supplemental indenture entered into pursuant to <font style="font-family: 'Times New Roman';"><u>Section 14.07</u></font>
          relating either to the kind or amount of shares of stock or securities or property (including cash) receivable by Holders upon the conversion of their Notes after any event referred to in such Section<font style="font-family: 'Times New Roman';"><u>
              14.07</u></font> or to any adjustment to be made with respect thereto, but, subject to the provisions of Section<font style="font-family: 'Times New Roman';"><u> 7.01</u></font>, may accept (without any independent investigation) as
          conclusive evidence of the correctness of any such provisions, and shall be protected in relying upon, the Officer&#8217;s Certificate (which the Company shall be obligated to file with the Trustee prior to the execution of any such supplemental
          indenture) with respect thereto.&#160; Neither the Trustee nor the Conversion Agent shall be responsible for determining whether any event contemplated by <font style="font-family: 'Times New Roman';"><u>Section 14.01(b)</u></font> has occurred that
          makes the Notes eligible for conversion or no longer eligible therefor until the Company has delivered to the Trustee and the Conversion Agent the notices referred to in <font style="font-family: 'Times New Roman';"><u>Section 14.01(b)</u></font>
          with respect to the commencement or termination of such conversion rights, on which notices the Trustee and the Conversion Agent may conclusively rely, and the Company agrees to deliver such notices to the Trustee and the Conversion Agent
          immediately after the occurrence of any such event or at such other times as shall be provided for in <font style="font-family: 'Times New Roman';"><u>Section 14.01(b)</u></font>. Neither the Trustee nor the Conversion Agent shall have any
          obligation to make any calculation or to determine whether the Notes may be surrendered for conversion pursuant to this Indenture, or to notify the Company or the Depositary or any of the Holders if the Notes have become convertible pursuant to
          the terms of this Indenture, or to otherwise independently determine or verify if any Fundamental Change, Make-Whole Fundamental Change, Share Exchange Event, Trigger Event, or any other event has occurred or notify the Holders of any such event.
          Neither the Trustee nor Conversion Agent shall have the responsibility for any act or omission of any Designated Financial Institution.</font></div>
      <br>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">81</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">Section 14.10&#160;&#160; Notice to Holders Prior to Certain Actions</font><font style="font-size: 10pt;">.&#160; In case of any:</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(a)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">action


            by the Company or one of its Subsidiaries that would require an adjustment in the Conversion Rate pursuant to <font style="font-family: 'Times New Roman';"><u>Section 14.04</u></font> or <font style="font-family: 'Times New Roman';"><u>Section


                14.11</u></font>; or</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(b)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">voluntary


            or involuntary dissolution, liquidation or winding-up of the Company; then, in each case (unless notice of such event is otherwise required pursuant to another provision of this Indenture), the Company shall cause to be filed with the Trustee
            and the Conversion Agent (if other than the Trustee) and to be delivered to each Holder, as promptly as possible but in any event at least 10 days prior to the applicable date hereinafter specified, a notice stating (i) the date on which a
            record is to be taken for the purpose of such action by the Company or, if a record is not to be taken, the date as of which the holders of Common Stock of record are to be determined for the purposes of such action by the Company, or (ii) the
            date on which such dissolution, liquidation or winding-up is expected to become effective or occur, and the date as of which it is expected that holders of Common Stock of record shall be entitled to exchange their Common Stock for securities
            or other property deliverable upon such dissolution, liquidation or winding-up.&#160; Failure to give such notice, or any defect therein, shall not affect the legality or validity of such action by the Company, dissolution, liquidation or
            winding-up.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">Section 14.11&#160;&#160; <u>Stockholder Rights Plans</u></font><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">.&#160; </font><font style="font-size: 10pt;">If the Company has a stockholder rights plan in effect upon conversion of the Notes, each share of Common Stock, if any, issued
          upon such conversion shall be entitled to receive the appropriate number of rights, if any, and the certificates representing the Common Stock issued upon such conversion shall bear such legends, if any, in each case as may be provided by the
          terms of any such stockholder rights plan, as the same may be amended from time to time.&#160; However, if, prior to any conversion of Notes, the rights have separated from the shares of Common Stock in accordance with the provisions of the applicable
          stockholder rights plan, the Conversion Rate shall be adjusted at the time of separation as if the Company distributed to all or substantially all holders of the Common Stock Distributed Property as provided in <font style="font-family: 'Times New Roman';"><u>Section 14.04(c)</u></font>, subject to readjustment in the event of the expiration, termination or redemption of such rights.</font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">82</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">Section 14.12&#160;&#160; <u>Exchange in Lieu of Conversion</u></font><font style="font-size: 10pt;">.</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(a)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">When


            a Holder surrenders its Notes for conversion, the Company may, at its election (an &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Exchange Election</font>&#8221;), cause the surrender, on or prior to the Trading Day immediately
            following the Conversion Date, of such Notes to one or more financial institutions designated by the Company (each, a &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Designated Financial Institution</font>&#8221;) for exchange in
            lieu of conversion.&#160; In order to accept any Notes surrendered for conversion, the Designated Financial Institution(s) must agree to timely pay or deliver, as the case may be, in exchange for such Notes, the cash, shares of Common Stock or
            combination thereof that would otherwise be due upon conversion pursuant to <font style="font-family: 'Times New Roman';"><u>Section 14.02</u></font> or such other amount agreed to by the Holder and the Designated Financial Institution(s) (the
            &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Conversion Consideration</font>&#8221;).&#160; If the Company makes an Exchange Election, the Company shall, by the close of business on the Trading Day following the relevant Conversion
            Date, notify in writing the Trustee, the Conversion Agent (if other than the Trustee) and the Holder surrendering Notes for conversion that the Company has made the Exchange Election, and the Company shall promptly notify the Designated
            Financial Institution(s) of the relevant deadline for delivery of the Conversion Consideration and the type of Conversion Consideration to be paid and/or delivered, as the case may be.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(b)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">Any


            Notes delivered to the Designated Financial Institution(s) shall remain outstanding, subject to the applicable procedures of the Depositary.&#160; If the Designated Financial Institution(s) agree(s) to accept any Notes for exchange but do(es) not
            timely pay and/or deliver, as the case may be, the related Conversion Consideration, or if such Designated Financial Institution(s) do(es) not accept the Notes for exchange, the Company shall pay and/or deliver, as the case may be, the relevant
            Conversion Consideration, as, and at the time, required pursuant to this Indenture as if the Company had not made the Exchange Election.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(c)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">The


            Company&#8217;s designation of any Designated Financial Institution(s) to which the Notes may be submitted for exchange does not require such Designated Financial Institution(s) to accept any Notes.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">ARTICLE 15</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><a name="z_Toc62469753"></a>REPURCHASE OF NOTES AT OPTION OF HOLDERS</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">Section


            15.01&#160;&#160; </font><u>[Intentionally Omitted]</u></font><font style="font-size: 10pt;">.</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">Section


            15.02&#160;&#160; </font><u>Repurchase at Option of Holders Upon a Fundamental Change</u></font><font style="font-size: 10pt;">.&#160; (a) If a Fundamental Change (other than an Exempted Fundamental Change pursuant to <font style="font-family: 'Times New Roman';"><u>Section 15.02(f)</u></font>) occurs at any time, each Holder shall have the right, at such Holder&#8217;s option, to require the Company to repurchase for cash all of such Holder&#8217;s Notes, or any portion of the principal amount thereof
          properly surrendered and not validly withdrawn pursuant to <font style="font-family: 'Times New Roman';"><u>Section 15.03</u></font> that is equal to $1,000 or an integral multiple of $1,000, on the date (the &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Fundamental Change Repurchase Date</font>&#8221;) specified by the Company that is not less than 20 Business Days or more than 35 Business Days following the date of the Fundamental Change Company Notice at a
          repurchase price equal to 100% of the principal amount thereof, <font style="font-family: 'Times New Roman'; font-style: italic;">plus</font> accrued and unpaid interest thereon to, but excluding, the Fundamental Change Repurchase Date (the &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Fundamental Change Repurchase Price</font>&#8221;), unless the Fundamental Change Repurchase Date falls after a Regular Record Date but on or prior to the Interest Payment Date to which such
          Regular Record Date relates, in which case the Company shall instead pay the full amount of accrued and unpaid interest to Holders of record as of such Regular Record Date, and the Fundamental Change Repurchase Price shall be equal to 100% of the
          principal amount of Notes to be repurchased pursuant to this <font style="font-family: 'Times New Roman';"><u>Article 15</u></font>.</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">83</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(b)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">Repurchases


            of Notes under this <font style="font-family: 'Times New Roman';"><u>Section 15.02</u></font> shall be made, at the option of the Holder thereof, upon:</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; margin-left: 36pt; text-indent: 27pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(i)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160; &#160; &#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">delivery to the Paying Agent by a Holder of a duly completed notice (the &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Fundamental Change Repurchase Notice</font>&#8221;) in the form set forth in Attachment 2
            to the Form of Note attached hereto as Exhibit A, if the Notes are Physical Notes, or in compliance with the Depositary&#8217;s procedures for surrendering interests in Global Notes, if the Notes are Global Notes, in each case, on or before the close
            of business on the Business Day immediately preceding the Fundamental Change Repurchase Date; and</font></font></div>
      <div style="font-size: 10pt; margin-left: 36pt; text-indent: 27pt;">&#160;</div>
      <div style="text-align: left; margin-left: 36pt; text-indent: 27pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(ii)</font><font style="font-size: 10pt;">&#160;&#160; &#160; &#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">delivery of the Notes, if the Notes are Physical Notes, to the Paying Agent at any time after delivery of the Fundamental Change Repurchase Notice (together with all necessary endorsements for transfer) at the Corporate
            Trust Office of the Paying Agent, or book-entry transfer of the Notes, if the Notes are Global Notes, in compliance with the procedures of the Depositary, in each case, such delivery or transfer being a condition to receipt by the Holder of the
            Fundamental Change Repurchase Price therefor.</font></font></div>
      <div style="font-size: 10pt; margin-left: 36pt; text-indent: 27pt;">&#160;</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; margin-left: 36pt; text-indent: 27pt;">The Fundamental Change Repurchase Notice in respect of any Physical Notes to be repurchased shall state:</div>
      <div style="font-size: 10pt; margin-left: 36pt; text-indent: 27pt;">&#160;</div>
      <div style="text-align: left; margin-left: 36pt; text-indent: 27pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(iii)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160; &#160; &#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">the certificate numbers of the Notes to be delivered for repurchase;</font></font></div>
      <div style="font-size: 10pt; margin-left: 36pt; text-indent: 27pt;">&#160;</div>
      <div style="text-align: left; margin-left: 36pt; text-indent: 27pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(iv)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">the portion of the principal amount of Notes to be repurchased, which must be $1,000 or an integral multiple thereof; and</font></font></div>
      <div style="font-size: 10pt; margin-left: 36pt; text-indent: 27pt;">&#160;</div>
      <div style="text-align: left; margin-left: 36pt; text-indent: 27pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(v)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">that the Notes are to be repurchased by the Company pursuant to the applicable provisions of the Notes and this Indenture.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">If the Notes are Global Notes, to exercise the Fundamental Change repurchase right, Holders must surrender their Notes in accordance with applicable
        Depositary procedures.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Notwithstanding anything herein to the contrary, any Holder delivering to the Paying Agent the Fundamental Change Repurchase Notice contemplated by
        this <font style="font-family: 'Times New Roman';"><u>Section 15.02</u></font> shall have the right to withdraw, in whole or in part, such Fundamental Change Repurchase Notice at any time prior to the close of business on the Business Day
        immediately preceding the Fundamental Change Repurchase Date by delivery of a written notice of withdrawal to the Paying Agent in accordance with <font style="font-family: 'Times New Roman';"><u>Section 15.03</u></font>.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">The Paying Agent shall promptly notify the Company of the receipt by it of any Fundamental Change Repurchase Notice or written notice of withdrawal
        thereof.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(c)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">On


            or before the 20th Business Day after the occurrence of the effective date of a Fundamental Change, subject to <font style="font-family: 'Times New Roman';"><u>Section 15.02(f)</u></font>, the Company shall provide to all Holders and the
            Trustee, the Conversion Agent and the Paying Agent (in the case of a Paying Agent other than the Trustee) a notice (the &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Fundamental Change Company Notice</font>&#8221;) of the
            occurrence of the effective date of the Fundamental Change and of the repurchase right at the option of the Holders arising as a result thereof.&#160; In the case of Physical Notes, such notice shall be by first class mail or, in the case of Global
            Notes, such notice shall be delivered in accordance with the applicable procedures of the Depositary.&#160; Each Fundamental Change Company Notice shall specify:</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">84</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: left; margin-left: 36pt; text-indent: 27pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(i)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">the events causing the Fundamental Change;</font></font></div>
      <div style="font-size: 10pt; margin-left: 36pt; text-indent: 27pt;">&#160;</div>
      <div style="text-align: left; margin-left: 36pt; text-indent: 27pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(ii)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">the effective date of the Fundamental Change;</font></font></div>
      <div style="font-size: 10pt; margin-left: 36pt; text-indent: 27pt;">&#160;</div>
      <div style="text-align: left; margin-left: 36pt; text-indent: 27pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(iii)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">the last date on which a Holder may exercise the repurchase right pursuant to this <font style="font-family: 'Times New Roman';"><u>Article 15</u></font>;</font></font></div>
      <div style="font-size: 10pt; margin-left: 36pt; text-indent: 27pt;">&#160;</div>
      <div style="text-align: left; margin-left: 36pt; text-indent: 27pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(iv)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">the Fundamental Change Repurchase Price;</font></font></div>
      <div style="font-size: 10pt; margin-left: 36pt; text-indent: 27pt;">&#160;</div>
      <div style="text-align: left; margin-left: 36pt; text-indent: 27pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(v)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">the Fundamental Change Repurchase Date;</font></font></div>
      <div style="font-size: 10pt; margin-left: 36pt; text-indent: 27pt;">&#160;</div>
      <div style="text-align: left; margin-left: 36pt; text-indent: 27pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(vi)</font><font style="font-size: 10pt;">&#160;&#160; &#160; &#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">the name and address of the Paying Agent and the Conversion Agent, if applicable;</font></font></div>
      <div style="font-size: 10pt; margin-left: 36pt; text-indent: 27pt;">&#160;</div>
      <div style="text-align: left; margin-left: 36pt; text-indent: 27pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(vii)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">if applicable, the Conversion Rate and any adjustments to the Conversion Rate as a result of the Fundamental Change (or related Make-Whole Fundamental Change);</font></font></div>
      <div style="font-size: 10pt; margin-left: 36pt; text-indent: 27pt;">&#160;</div>
      <div style="text-align: left; margin-left: 36pt; text-indent: 27pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(viii)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">that the Notes with respect to which a Fundamental Change Repurchase Notice has been delivered by a Holder may be converted only if the Holder withdraws the Fundamental Change Repurchase Notice in accordance with the terms
            of this Indenture; and</font></font></div>
      <div style="font-size: 10pt; margin-left: 36pt; text-indent: 27pt;">&#160;</div>
      <div style="text-align: left; margin-left: 36pt; text-indent: 27pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(ix)</font><font style="font-size: 10pt;">&#160; &#160; &#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">the procedures that Holders must follow to require the Company to repurchase their Notes.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">No failure of the Company to give the foregoing notices and no defect therein shall limit the Holders&#8217; repurchase rights or affect the validity of the
        proceedings for the repurchase of the Notes pursuant to this <font style="font-family: 'Times New Roman';"><u>Section 15.02</u></font>.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">At the Company&#8217;s request, given at least two Business Days prior to the date the Fundamental Change Company Notice is to be sent (or such shorter
        period as may be agreed to by the Trustee), the Trustee shall give such notice in the Company&#8217;s name and at the Company&#8217;s expense; <font style="font-family: 'Times New Roman'; font-style: italic;">provided</font>, <font style="font-family: 'Times New Roman'; font-style: italic;">however</font>, that, in all cases, the text of such Fundamental Change Company Notice shall be prepared by the Company.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(d)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">Notwithstanding


            anything to the contrary in this <font style="font-family: 'Times New Roman';"><u>Article 15</u></font>, the Company shall not be required to repurchase or make an offer to repurchase, the Notes upon a Fundamental Change if a third party makes
            such an offer in the same manner, at the same time and otherwise in compliance with the requirements for an offer made by the Company as set forth in this <font style="font-family: 'Times New Roman';"><u>Article 15</u></font> and such third
            party purchases all Notes properly surrendered and not validly withdrawn under its offer in the same manner, at the same time and otherwise in compliance with the requirements for an offer made by the Company as set forth above.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">85</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(e)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">Notwithstanding


            the foregoing, no Notes may be repurchased by the Company on any date at the option of the Holders upon a Fundamental Change if the principal amount of the Notes has been accelerated, and such acceleration has not been rescinded, on or prior to
            such date (except in the case of an acceleration resulting from a Default by the Company in the payment of the Fundamental Change Repurchase Price with respect to such Notes).&#160; The Paying Agent will promptly return to the respective Holders
            thereof any Physical Notes held by it during the acceleration of the Notes (except in the case of an acceleration resulting from a Default by the Company in the payment of the Fundamental Change Repurchase Price with respect to such Notes), or
            any instructions for book-entry transfer of the Notes in compliance with the applicable procedures of the Depositary shall be deemed to have been cancelled, and, upon such return or cancellation, as the case may be, the Fundamental Change
            Repurchase Notice with respect thereto shall be deemed to have been withdrawn.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(f)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><font style="font-family: 'Times New Roman';">Notwithstanding anything to the contrary in this <u>Section 15.02</u></font>, the Company shall not be required to send a <font style="font-family: 'Times New Roman';">Fundamental Change Company
              Notice, or offer to repurchase or repurchase any Notes, as set forth in this <u>Article 15</u></font>, in connection with a Fundamental Change occurring pursuant to clause (b)(A) or (B) (or pursuant to clause (a) that also constitutes a
            Fundamental Change occurring pursuant to clause (b)(A) or (B)) of the definition thereof, if: (i) such Fundamental Change constitutes a Merger Event pursuant to <font style="font-family: 'Times New Roman';"><u>Section 14.07</u></font> whose
            Reference Property consists entirely of cash in U.S. dollars; (ii) immediately <font style="font-family: 'Times New Roman';">after such Fundamental Change, the Notes become convertible (pursuant to <u>Section 14.07</u> and, if applicable, <u>Section


                14.03</u></font>) into consideration that consists solely of U.S. dollars in an amount per $1,000 principal amount of Notes that equals or exceeds the Fundamental Change Repurchase Price per $1,000 principal amount of Notes (calculated
            assuming that the same includes the maximum amount of accrued but unpaid interest payable as part of the Fundamental Change Repurchase Price for such Fundamental Change)<font style="font-family: 'Times New Roman';">; and (iii) the Company
              timely sends the notice relating to such Fundamental Change required pursuant to <u>Section 14.01(b)(iii)</u>. Any Fundamental Change with respect to which, in accordance with the provisions described in this <u>Section 15.02(f)</u></font>,
            the Company is not required to offer to repurchase any Notes is referred to as herein as an &#8220;Exempted Fundamental Change.&#8221;</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">Section


            15.03&#160;&#160; </font><u>Withdrawal of Fundamental Change Repurchase Notice</u></font><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">.&#160; </font><font style="font-size: 10pt;">(a) A Fundamental Change Repurchase
          Notice may be withdrawn (in whole or in part) in respect of Physical Notes by means of a written notice of withdrawal delivered to the Corporate Trust Office of the Paying Agent in accordance with this <font style="font-family: 'Times New Roman';"><u>Section 15.03</u></font> at any time prior to the close of business on the Business Day immediately preceding the Fundamental Change Repurchase Date, specifying:</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; margin-left: 36pt; text-indent: 27pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(i)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">the principal amount of the Notes with respect to which such notice of withdrawal is being submitted, which must be $1,000 or an integral multiple thereof,</font></font></div>
      <div style="font-size: 10pt; margin-left: 36pt; text-indent: 27pt;">&#160;</div>
      <div style="text-align: left; margin-left: 36pt; text-indent: 27pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(ii)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">the certificate number of the Note in respect of which such notice of withdrawal is being submitted, and</font></font></div>
      <div style="font-size: 10pt; margin-left: 36pt; text-indent: 27pt;">&#160;</div>
      <div style="text-align: left; margin-left: 36pt; text-indent: 27pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(iii)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">the principal amount, if any, of such Note that remains subject to the original Fundamental Change Repurchase Notice, which portion must be in principal amounts of $1,000 or an integral multiple of $1,000;</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">86</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">If the Notes are Global Notes, Holders may withdraw their Notes subject to repurchase at any time prior to the close of business on the Business Day
        immediately preceding the Fundamental Change Repurchase Date in accordance with applicable procedures of the Depositary.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">Section


            15.04 &#160; </font><u>Deposit of Fundamental Change Repurchase Price</u></font><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">.&#160; </font><font style="font-size: 10pt;">(a) The Company will deposit with the
          Trustee (or other Paying Agent appointed by the Company, or if the Company is acting as its own Paying Agent, set aside, segregate and hold in trust as provided in <font style="font-family: 'Times New Roman';"><u>Section 4.04</u></font>) on or
          prior to 11:00 a.m., New York City time, on the Fundamental Change Repurchase Date an amount of money sufficient to repurchase all of the Notes to be repurchased at the appropriate Fundamental Change Repurchase Price.&#160; Subject to receipt of funds
          and/or Notes by the Trustee (or other Paying Agent appointed by the Company), payment for Notes surrendered for repurchase (and not validly withdrawn prior to the close of business on the Business Day immediately preceding the Fundamental Change
          Repurchase Date) will be made on the later of (i) the Fundamental Change Repurchase Date (<font style="font-family: 'Times New Roman'; font-style: italic;">provided </font>the Holder has satisfied the conditions in <font style="font-family: 'Times New Roman';"><u>Section 15.02</u></font>) and (ii) the time of book-entry transfer or the delivery of such Note to the Trustee (or other Paying Agent appointed by the Company) by the Holder thereof in the manner required by <font style="font-family: 'Times New Roman';"><u>Section 15.02</u></font> by mailing checks for the amount payable to the Holders of such Notes entitled thereto as they shall appear in the Note Register; <font style="font-family: 'Times New Roman'; font-style: italic;">provided</font>, <font style="font-family: 'Times New Roman'; font-style: italic;">however</font>, that payments to the Depositary shall be made by wire transfer of immediately available funds to the account of the
          Depositary or its nominee.&#160; The Trustee shall, promptly after such payment and upon written demand by the Company, return to the Company any funds in excess of the Fundamental Change Repurchase Price.</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(b)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">If


            by 11:00 a.m. New York City time, on the Fundamental Change Repurchase Date, the Trustee (or other Paying Agent appointed by the Company) holds money sufficient to pay the Fundamental Change Repurchase Price (and, to the extent not included in
            the Fundamental Change Repurchase Price, accrued and unpaid interest, if applicable) of the Notes to be repurchased on such Fundamental Change Repurchase Date, then, with respect to the Notes that have been properly surrendered for repurchase
            and have not been validly withdrawn, (i) such Notes will cease to be outstanding, (ii) interest will cease to accrue on such Notes (whether or not book-entry transfer of the Notes has been made or whether or not the Notes have been delivered to
            the Trustee or Paying Agent) and (iii) all other rights of the Holders of such Notes will terminate (other than the right to receive the Fundamental Change Repurchase Price and, to the extent not included in the Fundamental Change Repurchase
            Price, accrued and unpaid interest, if applicable).</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(c)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">Upon


            surrender of a Note that is to be repurchased in part pursuant to <font style="font-family: 'Times New Roman';"><u>Section 15.02</u></font>, the Company shall execute and the Trustee shall authenticate and deliver to the Holder a new Note in
            an authorized denomination equal in principal amount to the unrepurchased portion of the Note surrendered.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">Section


            15.05&#160;&#160; </font><u>Covenant to Comply with Applicable Laws Upon Repurchase of Notes</u></font><font style="font-size: 10pt;">.&#160; In connection with any repurchase offer upon a Fundamental Change pursuant to this <font style="font-family: 'Times New Roman';"><u>Article 15</u></font>, the Company will, if required:</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">87</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(a)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">comply


            with the tender offer rules under the Exchange Act that may then be applicable;</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(b)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">file


            a Schedule TO or any other required schedule under the Exchange Act; and</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(c)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">otherwise


            comply in all material respects with all federal and state securities laws in connection with any offer by the Company to repurchase the Notes;</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">in each case, so as to permit the rights and obligations under this <font style="font-family: 'Times New Roman';"><u>Article 15</u></font> to be exercised in the time
        and in the manner specified in this <font style="font-family: 'Times New Roman';"><u>Article 15</u></font>.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">To the extent that, as a result of a change in law occurring after the first date on which the Notes are issued, the provisions of any securities laws
        or regulations conflict with the provisions of this Indenture relating to the Company&#8217;s obligations to repurchase the Notes upon a Fundamental Change, the Company shall comply with the applicable securities laws and regulations and shall not be
        deemed to have breached its obligations under such provisions of this Indenture by virtue of such conflict.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">ARTICLE 16</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><a name="z_Toc33751379"></a><a name="z_Toc62469759"></a>OPTIONAL REDEMPTION</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">Section


            16.01&#160;&#160; </font><u>Optional Redemption</u></font><font style="font-size: 10pt;">.&#160; No sinking fund is provided for the Notes. The Notes shall not be redeemable by the Company prior to March 6, 2028.&#160; On or after March 6, 2028, the Company may
          redeem (an &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Optional Redemption</font>&#8221;) for cash all or any portion of the Notes (subject to the Partial Redemption Limitation), at the Redemption Price, at the Company&#8217;s option,
          if (a) the Notes are Freely Tradable as of the date the Company sends the related Notice of Redemption and all accrued and unpaid Additional Interest, if any, has been paid in full as of the first Interest Payment Date occurring on or before the
          date the Company sends such Notice of Redemption; and (b) the Last Reported Sale Price of the Common Stock has been at least 130% of the Conversion Price then in effect for at least 20 Trading Days (whether or not consecutive), including the
          Trading Day immediately preceding the date on which the Company provides the Notice of Redemption in accordance with <font style="font-family: 'Times New Roman';"><u>Section 16.02</u></font>, during any 30 consecutive Trading Day period ending
          on, and including, the Trading Day immediately preceding the date on which the Company provides the Notice of Redemption (a &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Redemption Notice Date</font>&#8221;) in accordance with <font style="font-family: 'Times New Roman';"><u>Section 16.02</u></font>. The Trustee shall have no liability or responsibility for determining whether the conditions to redemption have been met.</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">Section


            16.02 &#160; </font><u>Notice of Optional Redemption; Selection of Notes</u></font><font style="font-size: 10pt;">.&#160; (a) In case the Company exercises its Optional Redemption right to redeem all or, as the case may be, any part of the Notes
          pursuant to <font style="font-family: 'Times New Roman';"><u>Section 16.01</u></font>, it shall fix a date for redemption (each, a &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Redemption Date</font>&#8221;) and it or, at its
          written request set forth in an Officers&#8217; Certificate received by the Trustee not less than five (5) days prior to the date the Redemption Notice is to be sent to Holders (or such shorter period of time as may be acceptable to the Trustee), the
          Trustee, in the name of and at the expense of the Company, shall deliver or cause to be delivered a notice of such Optional Redemption (a &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Notice of Redemption</font>&#8221;) not less
          than 45 nor more than 65 Scheduled Trading Days prior to the Redemption Date to the Trustee, the Paying Agent (if other than the Trustee) and each Holder of Notes to be redeemed as a whole or in part; <font style="font-family: 'Times New Roman'; font-style: italic;">provided</font>, <font style="font-family: 'Times New Roman'; font-style: italic;">however</font>, that, if the Company shall give such notice, it shall also give written notice of the Redemption Date to the Trustee and
          the Paying Agent (if other than the Trustee); <font style="font-family: 'Times New Roman'; font-style: italic;">provided further</font><font style="font-family: 'Times New Roman';"> that if, in accordance with the provisions described in Section
            14.02(a)(iii), the Company elects to settle all conversions of Notes </font>with a Conversion Date that occurs on or after the date the Company sends a Notice of Redemption pursuant to Section 14.01(b)(v) and before the related Redemption Date
          by Physical Settlement, then the Company may instead elect to choose a Redemption Date that is a Business Day not less than 10 calendar days nor more than 65 Scheduled Trading Days after the date the Company sends such Notice of Redemption.&#160; The
          Redemption Date must be a Business Day and the Company may not specify a Redemption Date that falls on or after the 41st Scheduled Trading Day immediately preceding the Maturity Date. The Trustee is permitted to accept the Company&#8217;s direction
          regarding redemptions, notwithstanding anything to the contrary in this Indenture, and the Trustee shall have no liability for any action taken at the Company&#8217;s direction.</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">88</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(b)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">The


            Notice of Redemption, if delivered in the manner herein provided, shall be conclusively presumed to have been duly given, whether or not the Holder receives such notice.&#160; In any case, failure to give such Notice of Redemption or any defect in
            the Notice of Redemption to the Holder of any Note designated for redemption as a whole or in part shall not affect the validity of the proceedings for the redemption of any other Note.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(c)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">Each


            Notice of Redemption shall specify:</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; margin-left: 36pt; text-indent: 27pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(i)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">the Redemption Date;</font></font></div>
      <div style="font-size: 10pt; margin-left: 36pt; text-indent: 27pt;">&#160;</div>
      <div style="text-align: left; margin-left: 36pt; text-indent: 27pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(ii)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">the Redemption Price;</font></font></div>
      <div style="font-size: 10pt; margin-left: 36pt; text-indent: 27pt;">&#160;</div>
      <div style="text-align: left; margin-left: 36pt; text-indent: 27pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(iii)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">that on the Redemption Date, the Redemption Price will become due and payable upon each Note to be redeemed, and that interest thereon, if any, shall cease to accrue on and after the Redemption Date;</font></font></div>
      <div style="font-size: 10pt; margin-left: 36pt; text-indent: 27pt;">&#160;</div>
      <div style="text-align: left; margin-left: 36pt; text-indent: 27pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(iv)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">the place or places where such Notes are to be surrendered for payment of the Redemption Price;</font></font></div>
      <div style="font-size: 10pt; margin-left: 36pt; text-indent: 27pt;">&#160;</div>
      <div style="text-align: left; margin-left: 36pt; text-indent: 27pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(v)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">that Holders may surrender their Notes for conversion at any time prior to the close of business on the second Business Day immediately preceding the Redemption Date;</font></font></div>
      <div style="font-size: 10pt; margin-left: 36pt; text-indent: 27pt;">&#160;</div>
      <div style="text-align: left; margin-left: 36pt; text-indent: 27pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(vi)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">the procedures a converting Holder must follow to convert its Notes and the Settlement Method and Specified Dollar Amount, if applicable;</font></font></div>
      <div style="font-size: 10pt; margin-left: 36pt; text-indent: 27pt;">&#160;</div>
      <div style="text-align: left; margin-left: 36pt; text-indent: 27pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(vii)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">the Conversion Rate and, if applicable, the number of Additional Shares added to the Conversion Rate in accordance with <font style="font-family: 'Times New Roman';"><u>Section 14.03</u></font>;</font></font></div>
      <div style="font-size: 10pt; margin-left: 36pt; text-indent: 27pt;">&#160;</div>
      <div style="text-align: left; margin-left: 36pt; text-indent: 27pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(viii)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">the CUSIP, ISIN or other similar numbers, if any, assigned to such Notes; and</font></font></div>
      <div style="font-size: 10pt; margin-left: 36pt; text-indent: 27pt;">&#160;</div>
      <div style="text-align: left; margin-left: 36pt; text-indent: 27pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(ix)</font><font style="font-size: 10pt;">&#160;&#160; &#160; &#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">in case any Note is to be redeemed in part only, the portion of the principal amount thereof to be redeemed and on and after the Redemption Date, upon surrender of such Note, a new Note in principal amount equal to the
            unredeemed portion thereof shall be issued.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">89</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">A Notice of Redemption shall be irrevocable.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(d)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">If


            the Company elects to redeem fewer than all of the outstanding Notes pursuant to <font style="font-family: 'Times New Roman';"><u>Section 16.01</u></font>, at least $100,000,000 aggregate principal amount of Notes must be outstanding and not
            subject to Optional Redemption pursuant to the relevant Notice of Redemption as of the Optional Redemption Notice Date (such requirement, the &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Partial Redemption Limitation</font>&#8221;).


            If fewer than all of the outstanding Notes are to be redeemed and the Notes to be redeemed are Global Notes, the Notes to be redeemed shall be selected by the Depositary in accordance with the applicable procedures of the Depositary.&#160; If fewer
            than all of the outstanding Notes are to be redeemed and the Notes to be redeemed are not Global Notes, the Notes to be redeemed will be selected by the Trustee by a method that is similar to the selection procedures the Depositary would have
            applied if the Notes had been Global Notes, or by such other method as the Trustee shall deem fair and appropriate.&#160; If any Note selected for partial redemption is submitted for conversion in part after such selection, the portion of the Note
            submitted for conversion shall be deemed (so far as may be possible) to be the portion selected for redemption, subject, in the case of Notes represented by a Global Note, to the Depositary&#8217;s applicable procedures.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">Section


            16.03&#160;&#160; </font><u>Payment of Notes Called for Redemption</u></font><font style="font-size: 10pt;">.&#160; (a) If any Notice of Redemption has been given in respect of the Notes in accordance with <font style="font-family: 'Times New Roman';"><u>Section


              16.02</u></font>, the Notes shall become due and payable on the Redemption Date at the place or places stated in the Notice of Redemption and at the applicable Redemption Price.&#160; On presentation and surrender of the Notes at the place or
          places stated in the Notice of Redemption, the Notes shall be paid and redeemed by the Company at the applicable Redemption Price.</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(b)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">Prior


            to 11:00 a.m. New York City time on the Redemption Date, the Company shall deposit with the Paying Agent or, if the Company or a Subsidiary of the Company is acting as the Paying Agent, shall segregate and hold in trust as provided in <font style="font-family: 'Times New Roman';"><u>Section 7.05</u></font> an amount of cash (in immediately available funds if deposited on the Redemption Date), sufficient to pay the Redemption Price of all of the Notes to be redeemed on such
            Redemption Date.&#160; Subject to receipt of funds by the Paying Agent, payment for the Notes to be redeemed shall be made on the Redemption Date for such Notes.&#160; The Paying Agent shall, promptly after such payment and upon written demand by the
            Company, return to the Company any funds in excess of the Redemption Price.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">Section 16.04 &#160; </font></font><u>Restrictions on Redemption</u></font><font style="font-size: 10pt;">.&#160; The Company may not redeem any Notes on any date
          if the principal amount of the Notes has been accelerated in accordance with the terms of this Indenture, and such acceleration has not been rescinded, on or prior to the Redemption Date (except in the case of an acceleration resulting from a
          Default by the Company in the payment of the Redemption Price with respect to such Notes).</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">90</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">ARTICLE 17</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><a name="z_Toc62469764"></a>MISCELLANEOUS PROVISIONS</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">Section 17.01 &#160; <u>Provisions Binding on Company&#8217;s Successors</u></font><font style="font-size: 10pt;">.&#160; All the covenants, stipulations, promises and agreements of the Company contained in this Indenture shall bind its successors and assigns whether so expressed or not.</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">Section 17.02 &#160; <u>Official Acts by Successor Corporation</u></font><font style="font-size: 10pt;">.&#160; Any act or proceeding by any provision of this Indenture authorized or required to be done or performed by any board, committee or Officer of the Company shall and may be done and performed with like force and effect
          by the like board, committee or officer of any corporation or other entity that shall at the time be the lawful sole successor of the Company.</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">Section 17.03 &#160; <u>Addresses for Notices, Etc</u></font><font style="font-size: 10pt;">.&#160; Any notice or demand that by any provision of this Indenture is required or permitted to be given or served by the Trustee or by the Holders on the Company shall be deemed to have been sufficiently given or made, for
          all purposes if given or served by overnight courier or by being deposited postage prepaid by registered or certified mail in a post office letter box addressed (until another address is filed by the Company with the Trustee) to BridgeBio Pharma,
          Inc., 421 Kipling Street, Palo Alto, CA 94301, Attention:&#160; General Counsel.&#160; Any notice, direction, request or demand hereunder to or upon the Trustee shall be deemed to have been sufficiently given or made, for all purposes, if given or served
          by being deposited postage prepaid by registered or certified mail in a post office letter box addressed to the Corporate Trust Office or sent electronically in PDF format to an email address specified by the Trustee.</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">The Trustee, by notice to the Company, may designate additional or different addresses for subsequent notices or communications.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Any notice or communication delivered or to be delivered to a Holder of Physical Notes shall be mailed to it by first class mail, postage prepaid, at
        its address as it appears on the Note Register and shall be sufficiently given to it if so mailed within the time prescribed.&#160; Any notice or communication delivered or to be delivered to a Holder of Global Notes shall be delivered in accordance
        with the applicable procedures of the Depositary and shall be sufficiently given to it if so delivered within the time prescribed.&#160; Notwithstanding any other provision of this Indenture or any Note, where this Indenture or any Note provides for
        notice of any event (including any Fundamental Change Company Notice) to a Holder of a Global Note (whether by mail or otherwise), such notice shall be sufficiently given if given to the Depositary (or its designee) pursuant to the standing
        instructions from the Depositary or its designee, including by electronic mail in accordance with the Depositary&#8217;s applicable procedures.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Failure to mail or deliver a notice or communication to a Holder or any defect in it shall not affect its sufficiency with respect to other Holders.&#160;
        If a notice or communication is mailed or delivered, as the case may be, in the manner provided above, it is duly given, whether or not the addressee receives it.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">91</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">In case by reason of the suspension of regular mail service or by reason of any other cause it shall be impracticable to give such notice to Holders by
        mail, then such notification as shall be made with the approval of the Trustee shall constitute a sufficient notification for every purpose hereunder.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">Section 17.04&#160;&#160; <u>Governing Law; Jurisdiction</u></font><font style="font-size: 10pt;">.&#160; THIS INDENTURE AND EACH NOTE, AND ANY CLAIM, CONTROVERSY OR DISPUTE ARISING UNDER OR RELATED TO THIS INDENTURE AND EACH NOTE, SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF NEW YORK.</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">The Company irrevocably consents and agrees, for the benefit of the Holders from time to time of the Notes and the Trustee, that any legal action, suit
        or proceeding against it with respect to obligations, liabilities or any other matter arising out of or in connection with this Indenture or the Notes may be brought in the courts of the State of New York or the courts of the United States located
        in the Borough of Manhattan, New York City, New York and, until amounts due and to become due in respect of the Notes have been paid, hereby irrevocably consents and submits to the non-exclusive jurisdiction of each such court<font style="font-family: 'Times New Roman'; font-style: italic;"> in personam</font>, generally and unconditionally with respect to any action, suit or proceeding for itself in respect of its properties, assets and revenues.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">The Company irrevocably and unconditionally waives, to the fullest extent permitted by law, any objection which it may now or hereafter have to the
        laying of venue of any of the aforesaid actions, suits or proceedings arising out of or in connection with this Indenture brought in the courts of the State of New York or the courts of the United States located in the Borough of Manhattan, New
        York City, New York and hereby further irrevocably and unconditionally waives and agrees not to plead or claim in any such court that any such action, suit or proceeding brought in any such court has been brought in an inconvenient forum.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">Section 17.05&#160;&#160; <u>Evidence of Compliance with Conditions
            Precedent; Certificates and Opinions of Counsel to Trustee</u></font><font style="font-size: 10pt;">.&#160; Upon any application or demand by the Company to the Trustee to take any action under any of the provisions of this Indenture, the Company
          shall furnish to the Trustee an Officer&#8217;s Certificate and Opinion of Counsel stating that such action is permitted by the terms of this Indenture and that all conditions precedent to such action have been complied with.</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Each Officer&#8217;s Certificate and Opinion of Counsel provided for, by or on behalf of the Company in this Indenture and delivered to the Trustee with
        respect to compliance with this Indenture (other than the Officer&#8217;s Certificates provided for in <font style="font-family: 'Times New Roman';"><u>Section 4.08</u></font>) shall include (a) a statement that the person signing such certificate is
        familiar with the requested action and this Indenture; (b) a brief statement as to the nature and scope of the examination or investigation upon which the statement contained in such certificate is based; (c) a statement that, in the judgment of
        such person, he or she has made such examination or investigation as is necessary to enable him or her to express an informed judgment as to whether or not such action is permitted by this Indenture; and (d) a statement as to whether or not, in the
        judgment of such person, such action is permitted by this Indenture and that all conditions precedent to such action have been complied with; <font style="font-family: 'Times New Roman'; font-style: italic;">provided </font>that no Opinion of
        Counsel shall be required to be delivered in connection with (1) the original issuance of Notes on the date hereof under this Indenture, (2) the mandatory exchange of the restricted CUSIP of the Restricted Securities to an unrestricted CUSIP
        pursuant to the applicable procedures of the Depositary upon the Notes becoming Freely Tradable, or (3) a request by the Company that the Trustee deliver a notice to Holders under the Indenture where the Trustee receives an Officer&#8217;s Certificate
        with respect to such notice.&#160; With respect to matters of fact, an Opinion of Counsel may rely on an Officer&#8217;s Certificate or certificates of public officials.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">92</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Notwithstanding anything to the contrary in this <font style="font-family: 'Times New Roman';"><u>Section 17.05</u></font>, if any provision in this
        Indenture specifically provides that the Trustee shall or may receive an Opinion of Counsel in connection with any action to be taken by the Trustee or the Company hereunder, the Trustee shall be entitled to such Opinion of Counsel.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">Section 17.06 &#160; <u>Legal Holidays</u></font><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">.&#160; </font><font style="font-size: 10pt;">In any case where any Interest Payment Date, any Fundamental Change Repurchase Date, any Redemption Date or the Maturity Date
          is not a Business Day, then any action to be taken on such date need not be taken on such date, but may be taken on the next succeeding Business Day with the same force and effect as if taken on such date, and no interest shall accrue in respect
          of the delay; <font style="font-family: 'Times New Roman'; font-style: italic;">provided</font>, <font style="font-family: 'Times New Roman'; font-style: italic;">however</font>, for purposes of this <font style="font-family: 'Times New Roman';"><u>Section 17.06</u></font>, a day on which the applicable place of payment is authorized or required by law or executive order to close or be closed will be deemed not to be a Business Day.</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">Section 17.07 &#160; </font><u>No Security Interest Created</u></font><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">.&#160; </font><font style="font-size: 10pt;">Nothing in this Indenture or in
          the Notes, expressed or implied, shall be construed to constitute a security interest under the Uniform Commercial Code or similar legislation, as now or hereafter enacted and in effect, in any jurisdiction.</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">Section 17.08 &#160; </font><u>Benefits of Indenture</u></font><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">.&#160; </font><font style="font-size: 10pt;">Nothing in this Indenture or in the
          Notes, expressed or implied, shall give to any Person, other than the Holders, the parties hereto, any Paying Agent, any Conversion Agent, any authenticating agent, any Note Registrar and their successors hereunder, any benefit or any legal or
          equitable right, remedy or claim under this Indenture.</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">Section 17.09 &#160; </font><u>Table of Contents, Headings, Etc.</u></font><font style="font-size: 10pt;">&#160; The table of contents and the titles and headings of the articles and sections of this Indenture have been inserted
          for convenience of reference only, are not to be considered a part hereof, and shall in no way modify or restrict any of the terms or provisions hereof.</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">Section 17.10 &#160; </font><u>Authenticating Agent</u></font><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">.&#160; </font><font style="font-size: 10pt;">The Trustee may appoint an
          authenticating agent that shall be authorized to act on its behalf and subject to its direction in the authentication and delivery of Notes in connection with the original issuance thereof and transfers and exchanges of Notes hereunder, including
          under <font style="font-family: 'Times New Roman';"><u>Section 2.04</u></font>, <font style="font-family: 'Times New Roman';"><u>Section 2.05</u></font>, <font style="font-family: 'Times New Roman';"><u>Section 2.06</u></font>, <font style="font-family: 'Times New Roman';"><u>Section 2.07</u></font>, <font style="font-family: 'Times New Roman';"><u>Section 10.04</u></font> and <font style="font-family: 'Times New Roman';"><u>Section 15.04</u></font> as fully to all
          intents and purposes as though the authenticating agent had been expressly authorized by this Indenture and those Sections to authenticate and deliver Notes.&#160; For all purposes of this Indenture, the authentication and delivery of Notes by the
          authenticating agent shall be deemed to be authentication and delivery of such Notes &#8220;by the Trustee&#8221; and a certificate of authentication executed on behalf of the Trustee by an authenticating agent shall be deemed to satisfy any requirement
          hereunder or in the Notes for the Trustee&#8217;s certificate of authentication.&#160; Such authenticating agent shall at all times be a Person eligible to serve as trustee hereunder pursuant to <font style="font-family: 'Times New Roman';"><u>Section 7.08</u></font>.</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">93</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Any corporation or other entity into which any authenticating agent may be merged or converted or with which it may be consolidated, or any corporation
        or other entity resulting from any merger, consolidation or conversion to which any authenticating agent shall be a party, or any corporation or other entity succeeding to all or substantially all the corporate trust business of any authenticating
        agent, shall be the successor of the authenticating agent hereunder, if such successor corporation or other entity is otherwise eligible under this <font style="font-family: 'Times New Roman';"><u>Section 17.10</u></font>, without the execution or
        filing of any paper or any further act on the part of the parties hereto or the authenticating agent or such successor corporation or other entity.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Any authenticating agent may at any time resign by giving written notice of resignation to the Trustee and to the Company.&#160; The Trustee may at any time
        terminate the agency of any authenticating agent by giving written notice of termination to such authenticating agent and to the Company.&#160; Upon receiving such a notice of resignation or upon such a termination, or in case at any time any
        authenticating agent shall cease to be eligible under this Section, the Trustee may appoint a successor authenticating agent (which may be the Trustee), shall give written notice of such appointment to the Company and shall deliver notice of such
        appointment to all Holders.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">The Company agrees to pay to the authenticating agent from time to time reasonable compensation for its services although the Company may terminate the
        authenticating agent, if it determines such agent&#8217;s fees to be unreasonable.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">The provisions of <font style="font-family: 'Times New Roman';"><u>Section 7.02</u></font>, <font style="font-family: 'Times New Roman';"><u>Section
            7.03</u></font>, <font style="font-family: 'Times New Roman';"><u>Section 7.04</u></font>, <font style="font-family: 'Times New Roman';"><u>Section 8.03</u></font> and this <font style="font-family: 'Times New Roman';"><u>Section 17.10</u></font>
        shall be applicable to any authenticating agent.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">If an authenticating agent is appointed pursuant to this <font style="font-family: 'Times New Roman';"><u>Section 17.10</u></font>, the Notes may have
        endorsed thereon, in addition to the Trustee&#8217;s certificate of authentication, an alternative certificate of authentication in the following form:</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">________________________________,</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">as Authenticating Agent, certifies that this is one of the Notes described in the within-named Indenture.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">By:</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Authorized Officer</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">Section 17.11 &#160; </font><u>Execution in Counterparts</u></font><font style="font-size: 10pt;">.&#160; This Indenture may be executed in any number of counterparts, each of which shall be an original, but such counterparts shall
          together constitute but one and the same instrument.&#160; The exchange of copies of this Indenture and of signature pages by facsimile, PDF or other electronic transmission shall constitute effective execution and delivery of this Indenture as to the
          parties hereto and may be used in lieu of the original Indenture for all purposes.&#160; Signatures of the parties hereto transmitted by facsimile, PDF or other electronic transmission shall constitute effective execution and delivery of this
          Indenture as to the other parties hereto shall be deemed to be their original signatures for all purposes. All notices, approvals, consents, requests and any communications hereunder must be in writing (provided that any communication sent to the
          Trustee hereunder must be in the form of a document that is signed manually or by way of a digital signature provided by DocuSign (or such other digital signature provider as specified in writing to the Trustee by the authorized representative),
          in English.&#160; The Company agrees to assume all risks arising out of the use of using digital signatures and electronic methods to submit communications to the Trustee, including without limitation the risk of the Trustee acting on unauthorized
          instructions, and the risk of interception and misuse by third parties.</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">94</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">Section 17.12 &#160; </font><u>Severability</u></font><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">.&#160; </font><font style="font-size: 10pt;">In the event any provision of this Indenture or
          in the Notes shall be invalid, illegal or unenforceable, then (to the extent permitted by law) the validity, legality or enforceability of the remaining provisions shall not in any way be affected or impaired.</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">Section 17.13&#160;&#160; </font></font><u>Waiver of Jury Trial</u></font><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">.&#160; </font><font style="font-size: 10pt;">EACH OF THE COMPANY AND THE TRUSTEE HEREBY IRREVOCABLY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY LEGAL PROCEEDING ARISING OUT OF OR
          RELATING TO THIS INDENTURE, THE NOTES OR THE TRANSACTIONS CONTEMPLATED HEREBY.</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">Section 17.14 &#160; </font></font><u>Force Majeure</u></font><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">.&#160; </font><font style="font-size: 10pt;">In no event shall the Trustee be responsible or liable for any failure or delay in the performance of its obligations hereunder arising out of or caused by, directly or indirectly, forces beyond
          its control, including, without limitation, strikes, work stoppages, accidents, acts of war or terrorism, civil or military disturbances, pandemics, epidemics, recognized public emergencies, quarantine restrictions, nuclear or natural
          catastrophes or acts of God,&#160; interruptions, loss or malfunctions of utilities, communications or computer (software and hardware) services, and hacking, cyber-attacks, or other use or infiltration of the Trustee&#8217;s technological infrastructure
          exceeding authorized access; it being understood that the Trustee shall use reasonable efforts that are consistent with accepted practices in the banking industry to resume performance as soon as practicable under the circumstances.</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">Section 17.15&#160;&#160; </font></font><u>Calculations</u></font><font style="font-size: 10pt;">.&#160; Except as otherwise provided herein, the
          Company shall be responsible for making all calculations called for under the Notes.&#160; These calculations include, but are not limited to, determinations of the Last Reported Sale Prices of the Common Stock, the Trading Price of the Notes for
          purposes of determining whether the Notes are convertible, the Daily VWAPs, the Daily Conversion Values, the Daily Settlement Amounts, accrued interest payable on the Notes (including Additional Interest or Deferred Additional Interest), the
          Redemption Price and the Conversion Rate of the Notes.&#160; The Company shall make all these calculations in good faith and, absent manifest error, the Company&#8217;s calculations shall be final and binding on Holders of Notes.&#160; The Company shall provide
          a schedule of its calculations to each of the Trustee and the Conversion Agent, and each of the Trustee and Conversion Agent is entitled to rely conclusively upon the accuracy of the Company&#8217;s calculations without independent verification.&#160; The
          Trustee will forward the Company&#8217;s calculations to any Holder of Notes upon the request of that Holder at the sole cost and expense of the Company.</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">Section 17.16&#160;&#160; </font></font><u>USA PATRIOT Act</u></font><font style="font-size: 10pt;">.&#160; The parties hereto acknowledge that in
          accordance with Section 326 of the USA PATRIOT Act, the Trustee, like all financial institutions and in order to help fight the funding of terrorism and money laundering, is required to obtain, verify, and record information that identifies each
          person or legal entity that establishes a relationship or opens an account with the Trustee.&#160; The parties to this Indenture agree that they will provide the Trustee with such information as it may request in order for the Trustee to satisfy the
          requirements of the USA PATRIOT Act.</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">95</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Section 17.17.&#160; <font style="font-family: 'Times New Roman';"><u>Withholding Taxes</u></font>. Any applicable withholding taxes (including backup
        withholding) may be withheld from interest and payments upon conversion, repurchase or maturity of the Notes, or if any withholding taxes (including backup withholding) are paid on behalf of a Holder or beneficial owner of Notes, those withholding
        taxes may be set off against payments of cash or Common Stock, if any, payable on the Notes (or, in some circumstances, any payments on the Common Stock) or sales proceeds received by or other funds or assets of the Holder or beneficial owner.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">[<font style="font-family: 'Times New Roman'; font-style: italic;">Remainder of page intentionally left blank</font>]</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">96</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">IN WITNESS WHEREOF</font><font style="font-size: 10pt;">, the parties
          hereto have caused this Indenture to be duly executed as of the date first written above.</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zcd58ab2f8c5b495bba8e6667547b9404">

          <tr>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;">&#160;</td>
            <td colspan="2" rowspan="1" style="width: 5%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-weight: bold;">BRIDGEBIO PHARMA, INC.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;">&#160;</td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt;">&#160;</td>
            <td style="width: 45%; vertical-align: top; font-size: 10pt;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; font-size: 10pt; padding-bottom: 2px;">&#160;</td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt; padding-bottom: 2px;">
              <div style="text-align: left; font-family: 'Times New Roman';">By<font style="font-family: 'Times New Roman';">:</font></div>
            </td>
            <td style="width: 45%; vertical-align: top; font-size: 10pt; border-bottom: 2px solid rgb(0, 0, 0);"><font style="font-family: 'Times New Roman';">/s/Neil Kumar</font></td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;">&#160;</td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">Name:</div>
            </td>
            <td style="width: 45%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">Neil Kumar</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;">&#160;</td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">Title:</div>
            </td>
            <td style="width: 45%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">Chief Executive Officer</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;">&#160;</td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt;">&#160;</td>
            <td style="width: 45%; vertical-align: top; font-size: 10pt;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;">&#160;</td>
            <td colspan="2" rowspan="1" style="width: 5%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION</font><font style="font-size: 10pt;">,</font></div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;">&#160;</td>
            <td colspan="2" rowspan="1" style="width: 5%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">as Trustee</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;">&#160;</td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt;">&#160;</td>
            <td style="width: 45%; vertical-align: top; font-size: 10pt;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;">&#160;</td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">By:</div>
            </td>
            <td style="width: 45%; vertical-align: top; border-bottom: 2px solid black; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">/s/ Joshua A. Hahn</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;">&#160;</td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">Name:</div>
            </td>
            <td style="width: 45%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">Joshua A. Hahn</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;">&#160;</td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">Title: <br>
              </div>
            </td>
            <td style="width: 45%; vertical-align: top; font-size: 10pt;">Vice President</td>
          </tr>

      </table>
      <div style="font-size: 10pt;">
        <div style="font-size: 10pt;">&#160;</div>
        <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">[<font style="font-family: 'Times New Roman'; font-style: italic;">Signature Page to Indenture</font>]</div>
        <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
        </div>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <!--PROfilePageNumberReset%Num%1%A-%%-->
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><a name="EXHIBITA"><!--Anchor--></a><!--Anchor-->EXHIBIT A</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">[FORM OF FACE OF NOTE]</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">[INCLUDE FOLLOWING LEGEND IF A GLOBAL NOTE]</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">[UNLESS THIS CERTIFICATE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY, A NEW YORK CORPORATION (&#8220;DTC&#8221;), TO THE COMPANY
        OR ITS AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE, OR PAYMENT, AND ANY CERTIFICATE ISSUED IS REGISTERED IN THE NAME OF CEDE &amp; CO. OR IN SUCH OTHER NAME AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC (AND ANY PAYMENT HEREUNDER IS MADE
        TO CEDE &amp; CO. OR TO SUCH OTHER ENTITY AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC), ANY TRANSFER, PLEDGE, OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL INASMUCH AS THE REGISTERED OWNER HEREOF, CEDE &amp;
        CO., HAS AN INTEREST HEREIN.]</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">[INCLUDE FOLLOWING LEGEND IF A RESTRICTED SECURITY]</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">[THIS SECURITY AND THE COMMON STOCK, IF ANY, ISSUABLE UPON CONVERSION OF THIS SECURITY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS
        AMENDED (THE &#8220;SECURITIES ACT&#8221;), AND MAY NOT BE OFFERED, SOLD, PLEDGED OR OTHERWISE TRANSFERRED EXCEPT IN ACCORDANCE WITH THE FOLLOWING SENTENCE.&#160; BY ITS ACQUISITION HEREOF OR OF A BENEFICIAL INTEREST HEREIN, THE ACQUIRER:</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; margin-left: 36pt; text-indent: 27pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(1)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';">REPRESENTS THAT IT
            AND ANY ACCOUNT FOR WHICH IT IS ACTING IS A &#8220;QUALIFIED INSTITUTIONAL BUYER&#8221; (WITHIN THE MEANING OF RULE 144A UNDER THE SECURITIES ACT) AND THAT IT EXERCISES SOLE INVESTMENT DISCRETION WITH RESPECT TO EACH SUCH ACCOUNT, AND</font></font></div>
      <div style="font-size: 10pt; margin-left: 36pt; text-indent: 27pt;">&#160;</div>
      <div style="text-align: left; margin-left: 36pt; text-indent: 27pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(2)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';">AGREES FOR THE
            BENEFIT OF BRIDGEBIO PHARMA, INC. (THE &#8220;COMPANY&#8221;) THAT IT WILL NOT OFFER, SELL, PLEDGE OR OTHERWISE TRANSFER THIS SECURITY AND THE COMMON STOCK, IF ANY, ISSUABLE UPON CONVERSION OF THIS SECURITY, IF ANY OR ANY BENEFICIAL INTEREST HEREIN OR
            THEREIN PRIOR TO THE DATE THAT IS THE LATER OF (X) ONE YEAR AFTER THE LAST ORIGINAL ISSUE DATE HEREOF OR SUCH SHORTER PERIOD OF TIME AS PERMITTED BY RULE 144 UNDER THE SECURITIES ACT OR ANY SUCCESSOR PROVISION THERETO AND (Y) SUCH LATER DATE,
            IF ANY, AS MAY BE REQUIRED BY APPLICABLE LAW, EXCEPT:</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; margin-left: 63pt; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(A)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';">TO THE COMPANY OR ANY
            SUBSIDIARY THEREOF, OR</font></font></div>
      <div style="font-size: 10pt; margin-left: 63pt; text-indent: 36pt;">&#160;</div>
      <div style="text-align: left; margin-left: 63pt; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(B)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';">PURSUANT TO A
            REGISTRATION STATEMENT WHICH HAS BECOME EFFECTIVE UNDER THE SECURITIES ACT, OR</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">A-1</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: left; text-indent: 36pt; margin-left: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(C)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';">TO A QUALIFIED
            INSTITUTIONAL BUYER IN COMPLIANCE WITH RULE 144A UNDER THE SECURITIES ACT, OR</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt; margin-left: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(D)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';">PURSUANT TO AN
            EXEMPTION FROM REGISTRATION PROVIDED BY RULE 144 UNDER THE SECURITIES ACT OR ANY OTHER AVAILABLE EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">PRIOR TO THE REGISTRATION OF ANY TRANSFER IN ACCORDANCE WITH CLAUSE (2)(D) ABOVE, THE COMPANY AND THE TRUSTEE RESERVE THE RIGHT TO REQUIRE THE DELIVERY
        OF SUCH LEGAL OPINIONS, CERTIFICATIONS OR OTHER EVIDENCE AS MAY REASONABLY BE REQUIRED IN ORDER TO DETERMINE THAT THE PROPOSED TRANSFER IS BEING MADE IN COMPLIANCE WITH THE SECURITIES ACT AND APPLICABLE STATE SECURITIES LAWS.&#160; NO REPRESENTATION IS
        MADE AS TO THE AVAILABILITY OF ANY EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt; color: rgb(35, 31, 32); font-family: 'Times New Roman'; font-size: 10pt;">NO AFFILIATE (AS DEFINED IN RULE 144 UNDER THE SECURITIES ACT) OF BRIDGEBIO PHARMA, INC. OR PERSON THAT HAS BEEN AN AFFILIATE
        (AS DEFINED IN RULE 144 UNDER THE SECURITIES ACT) OF BRIDGEBIO PHARMA, INC. DURING THE PRECEDING THREE MONTHS MAY PURCHASE, OTHERWISE ACQUIRE OR HOLD THIS SECURITY OR A BENEFICIAL INTEREST HEREIN.]</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">A-2</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">BridgeBio Pharma, Inc.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">1.75% Convertible Senior Note due 2031</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt;">[Initially]<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">1</sup>&#160;&#160; $[__________]</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">No. [__]</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">CUSIP No. [__________]<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">2</sup></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">BridgeBio Pharma, Inc., a corporation duly organized and validly existing under the laws of the State of Delaware (the &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Company</font>,&#8221; which term includes any successor corporation or other entity under the Indenture referred to on the reverse hereof), for value received hereby promises to pay to [CEDE &amp; CO.]<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">3</sup>
        [__________]<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">4</sup>, or registered assigns, the principal sum [as set forth in the &#8220;Schedule of Exchanges of Notes&#8221; attached hereto]<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">5</sup> [of $[__________]]<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">6</sup>, which amount, taken together with the principal amounts of all
        other outstanding Notes, shall not, unless permitted by the Indenture, exceed $575,000,000 in aggregate at any time , in accordance with the rules and applicable procedures of the Depositary, on March 1, 2031, and interest thereon as set forth
        below.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">This Note shall bear interest at the rate of 1.75% per year from February 28, 2025 or from the most recent date to which interest has been paid or
        provided for to, but excluding, the next scheduled Interest Payment Date until March 1, 2031.&#160; Interest is payable semi-annually in arrears on each March 1 and September 1, commencing on September 1, 2025, to Holders of record at the close of
        business on the preceding February 15 and August 15 (whether or not such day is a Business Day), respectively.&#160; Additional Interest will be payable as set forth in <font style="font-family: 'Times New Roman';"><u>Section 4.06(c)</u></font>, <font style="font-family: 'Times New Roman';"><u>Section 4.06(d)</u></font> and <font style="font-family: 'Times New Roman';"><u>Section 6.03</u></font> of the within-mentioned Indenture, and any reference to interest on, or in respect of, any Note
        therein shall be deemed to include Additional Interest and Deferred Additional Interest if, in such context, Additional Interest or Deferred Additional Interest is, was or would be payable pursuant to any of such <font style="font-family: 'Times New Roman';"><u>Section 4.06(c)</u></font>, <font style="font-family: 'Times New Roman';"><u>Section 4.06(d)</u></font>, <font style="font-family: 'Times New Roman';"><u>Section 4.06(f)</u></font> or <font style="font-family: 'Times New Roman';"><u>Section 6.03</u></font>, and any express mention of the payment of Additional Interest or Deferred Additional Interest in any provision therein shall not be construed as excluding Additional Interest or Deferred Additional Interest in
        those provisions thereof where such express mention is not made.</div>
      <br>
      <div style="font-size: 10pt;">
        <hr noshade="noshade" align="left" style="height: 2px; width: 20%; color: #000000; background-color: #000000; text-align: left; margin-left: 0px; margin-right: auto; border: none;"></div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">1</sup> Include if a global note.</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">2</sup> This Note will be deemed to be identified by CUSIP No. [__________] from and after such time when (i) the Company delivers, pursuant to Section&#160;2.05(c) of
        the within-mentioned Indenture, written notice to the Trustee of the occurrence of the Resale Restriction Termination Date and the removal of the restrictive legend affixed to this Note and (ii) this Note is identified by such CUSIP number in
        accordance with the applicable procedures of the Depositary.</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">3</sup> Include if a global note.</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">4</sup> Include if a physical note.</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">5</sup> Include if a global note.</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">6</sup> Include if a physical note.</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">A-3</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Any Defaulted Amounts shall accrue interest per annum at the rate borne by the Notes, subject to the enforceability thereof under applicable law, from,
        and including, the relevant payment date to, but excluding, the date on which such Defaulted Amounts shall have been paid by the Company, at its election, in accordance with <font style="font-family: 'Times New Roman';"><u>Section 2.03(c)</u></font>
        of the Indenture.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">The Company shall pay or cause the Paying Agent to pay the principal of and interest on this Note, if and so long as such Note is a Global Note, in
        immediately available funds to the Depositary or its nominee, as the case may be, as the registered Holder of such Note.&#160; As provided in and subject to the provisions of the Indenture, the Company shall pay or cause the Paying Agent to pay the
        principal of any Notes (other than Notes that are Global Notes) at the office or agency designated by the Company for that purpose.&#160; The Company has initially designated the Trustee as its Paying Agent and Note Registrar in respect of the Notes and
        its agency in the contiguous United States, as a place where Notes may be presented for payment or for registration of transfer and exchange.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Reference is made to the further provisions of this Note set forth on the reverse hereof, including, without limitation, provisions giving the Holder
        of this Note the right to convert this Note into cash, shares of Common Stock or a combination of cash and shares of Common Stock, as applicable, on the terms and subject to the limitations set forth in the Indenture.&#160; Such further provisions shall
        for all purposes have the same effect as though fully set forth at this place.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">This Note, and any claim, controversy or dispute arising under or related to this Note, shall be construed in accordance with and
        governed by the laws of the State of New York (without regard to the conflicts of laws provisions thereof).</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">In the case of any conflict between this Note and the Indenture, the provisions of the Indenture shall control and govern.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">This Note shall not be valid or become obligatory for any purpose until the certificate of authentication hereon shall have been signed manually by the
        Trustee or a duly authorized authenticating agent under the Indenture.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">[<font style="font-family: 'Times New Roman'; font-style: italic;">Remainder of page intentionally left blank</font>]</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">A-4</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">IN WITNESS WHEREOF</font><font style="font-size: 10pt;">, the Company
          has caused this Note to be duly executed.</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z07ba39bf27cc484a90a366f6f66a4ed4">

          <tr>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;">&#160;</td>
            <td colspan="2" style="vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-weight: bold;">BRIDGEBIO PHARMA, INC.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;">&#160;</td>
            <td style="width: 3%; vertical-align: top; font-size: 10pt;">&#160;</td>
            <td style="width: 47%; vertical-align: top; font-size: 10pt;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; font-size: 10pt; padding-bottom: 2px;">&#160;</td>
            <td style="width: 3%; vertical-align: top; font-size: 10pt; padding-bottom: 2px;">
              <div style="text-align: left; font-family: 'Times New Roman';">By:</div>
            </td>
            <td style="width: 47%; vertical-align: top; font-size: 10pt; border-bottom: 2px solid rgb(0, 0, 0);"><br>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;">&#160;</td>
            <td style="width: 3%; vertical-align: top; font-size: 10pt;">&#160;</td>
            <td style="width: 47%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">Name:</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;">&#160;</td>
            <td style="width: 3%; vertical-align: top; font-size: 10pt;">&#160;</td>
            <td style="width: 47%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">Title:</div>
            </td>
          </tr>

      </table>
      <div style="text-align: left; margin-left: 216pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"> </font><font style="font-size: 10pt;"><br>
        </font></div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Dated:</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">TRUSTEE&#8217;S CERTIFICATE OF AUTHENTICATION</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION,</font><font style="font-size: 10pt;"> as
          Trustee, certifies that this is one of the Notes</font></div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">described in the within-named Indenture.</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zb33919bac447495aafd36b26aac8031f">

          <tr>
            <td style="width: 3%; vertical-align: top; font-size: 10pt; padding-bottom: 2px;">
              <div style="text-align: left; font-family: 'Times New Roman';">By:</div>
            </td>
            <td style="width: 47%; vertical-align: top; font-size: 10pt; border-bottom: 2px solid rgb(0, 0, 0);"><br>
            </td>
            <td style="width: 50%; vertical-align: top; font-size: 10pt; padding-bottom: 2px;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 3%; vertical-align: top; font-size: 10pt;">&#160;</td>
            <td style="width: 47%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">Authorized Signatory</div>
            </td>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;">&#160;</td>
          </tr>

      </table>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">A-5</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">[FORM OF REVERSE OF NOTE]</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">BridgeBio Pharma, Inc.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">1.75% Convertible Senior Note due 2031</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">This Note is one of a duly authorized issue of Notes of the Company, designated as its 1.75% Convertible Senior Notes due 2031 (the &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Notes</font>&#8221;), limited to the aggregate principal amount of $575,000,000 all issued or to be issued under and pursuant to an Indenture dated as of February 28, 2025 (the &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Indenture</font>&#8221;), between the Company and U.S. Bank Trust Company, National Association (the &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Trustee</font>&#8221;), to which
        Indenture and all indentures supplemental thereto reference is hereby made for a description of the rights, limitations of rights, obligations, duties and immunities thereunder of the Trustee, the Company and the Holders of the Notes.&#160; Additional
        Notes may be issued in an unlimited aggregate principal amount, subject to certain conditions specified in the Indenture.&#160; Capitalized terms used in this Note and not defined in this Note shall have the respective meanings set forth in the
        Indenture.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">In case certain Events of Default shall have occurred and be continuing, the principal of, and interest on, all Notes may be declared, by either the
        Trustee or Holders of at least 25% in aggregate principal amount of Notes then outstanding, and upon said declaration shall become, due and payable, in the manner, with the effect and subject to the conditions and certain exceptions set forth in
        the Indenture.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Subject to the terms and conditions of the Indenture, the Company will make all payments and deliveries in respect of the Fundamental Change Repurchase
        Price on the Fundamental Change Repurchase Date and the principal amount on the Maturity Date, as the case may be, to the Holder who surrenders a Note to a Paying Agent to collect such payments in respect of the Note.&#160; The Company will pay cash
        amounts in money of the United States that at the time of payment is legal tender for payment of public and private debts.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">The Indenture contains provisions permitting the Company and the Trustee in certain circumstances, without the consent of the Holders of the Notes, and
        in certain other circumstances, with the consent of the Holders of not less than a majority in aggregate principal amount of the Notes at the time outstanding, evidenced as in the Indenture provided, to execute supplemental indentures modifying the
        terms of the Indenture and the Notes as described therein.&#160; It is also provided in the Indenture that, subject to certain exceptions, the Holders of a majority in aggregate principal amount of the Notes at the time outstanding may on behalf of the
        Holders of all of the Notes waive any past Default or Event of Default under the Indenture and its consequences.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Each Holder shall have the right to receive payment or delivery, as the case may be, of (x) the principal (including the Redemption Price and the
        Fundamental Change Repurchase Price, if applicable) of, (y) accrued and unpaid interest, if any, on, and (z) the consideration due upon conversion of, this Note at the place, at the respective times, at the rate and in the lawful money and/or
        shares of Common Stock, as the case may be, herein prescribed.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">A-6</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">The Notes are issuable in registered form without coupons in denominations of $1,000 principal amount and integral multiples thereof.&#160; At the office or
        agency of the Company referred to on the face hereof, and in the manner and subject to the limitations provided in the Indenture, Notes may be exchanged for a like aggregate principal amount of Notes of other authorized denominations, without
        payment of any service charge but, if required by the Company or Trustee, with payment of a sum sufficient to cover any transfer or similar tax that may be imposed in connection therewith as a result of the name of the Holder of the new Notes
        issued upon such exchange of Notes being different from the name of the Holder of the old Notes surrendered for such exchange.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">The Notes shall be redeemable at the Company&#8217;s option on or after March 6, 2028 and on or before the 41st Scheduled Trading Date immediately preceding
        the Maturity Date in accordance with the terms and subject to the conditions specified in the Indenture.&#160; No sinking fund is provided for the Notes.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Upon the occurrence of a Fundamental Change, the Holder has the right, at such Holder&#8217;s option and subject to the limitations set forth in the
        Indenture, to require the Company to repurchase for cash all of such Holder&#8217;s Notes or any portion thereof (in principal amounts of $1,000 or integral multiples thereof) on the Fundamental Change Repurchase Date at a price equal to the Fundamental
        Change Repurchase Price.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Subject to the provisions of the Indenture, the Holder hereof has the right, at its option, during certain periods and upon the occurrence of certain
        conditions specified in the Indenture, prior to the close of business on the second Scheduled Trading Day immediately preceding the Maturity Date, to convert any Notes or portion thereof that is $1,000 or an integral multiple thereof, into cash,
        shares of Common Stock or a combination of cash and shares of Common Stock, as applicable and subject to the limitations set forth in the Indenture, in each case, at the Conversion Rate specified in the Indenture, as adjusted from time to time as
        provided in the Indenture.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">A-7</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <!--PROfilePageNumberReset%Num%8%A-%%-->
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">ABBREVIATIONS</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">The following abbreviations, when used in the inscription of the face of this Note, shall be construed as though they were written out in full
        according to applicable laws or regulations:</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">TEN COM = as tenants in common</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">UNIF GIFT MIN ACT = Uniform Gifts to Minors Act</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">CUST = Custodian</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">TEN ENT = as tenants by the entireties</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">JT TEN = joint tenants with right of survivorship and not as tenants in common</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Additional abbreviations may also be used though not in the above list.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">A-8</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">SCHEDULE A<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">7</sup></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">SCHEDULE OF EXCHANGES OF NOTES</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">BridgeBio Pharma, Inc.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">1.75% Convertible Senior Notes due 2031</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">The initial principal amount of this Global Note is [__________] DOLLARS ($[__________]).&#160; The following increases or decreases in this Global Note
        have been made:</div>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="za887b46028c0493a9feec664f3abfd97">

          <tr>
            <td style="width: 18%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">
              <div>
                <div style="text-align: center; font-family: 'Times New Roman'; font-weight: bold;">Date of</div>
                <div style="text-align: center; font-family: 'Times New Roman'; font-weight: bold;"> exchange</div>
              </div>
            </td>
            <td colspan="1" style="width: 1%; vertical-align: bottom; font-size: 10pt; padding-bottom: 2px;">&#160;</td>
            <td style="width: 20%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">
              <div>
                <div style="text-align: center; font-family: 'Times New Roman'; font-weight: bold;">Amount of</div>
                <div style="text-align: center; font-family: 'Times New Roman'; font-weight: bold;"> decrease in</div>
                <div style="text-align: center; font-family: 'Times New Roman'; font-weight: bold;"> principal</div>
                <div style="text-align: center; font-family: 'Times New Roman'; font-weight: bold;"> amount of this</div>
                <div style="text-align: center; font-family: 'Times New Roman'; font-weight: bold;"> Global Note</div>
              </div>
            </td>
            <td colspan="1" style="width: 1%; vertical-align: bottom; font-size: 10pt; padding-bottom: 2px;">&#160;</td>
            <td style="width: 19%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">
              <div>
                <div style="text-align: center; font-family: 'Times New Roman'; font-weight: bold;">Amount of</div>
                <div style="text-align: center; font-family: 'Times New Roman'; font-weight: bold;"> increase in</div>
                <div style="text-align: center; font-family: 'Times New Roman'; font-weight: bold;"> principal</div>
                <div style="text-align: center; font-family: 'Times New Roman'; font-weight: bold;"> amount of this</div>
                <div style="text-align: center; font-family: 'Times New Roman'; font-weight: bold;"> Global Note</div>
              </div>
            </td>
            <td colspan="1" style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
            <td style="width: 20%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
              <div>
                <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Principal</div>
                <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> amount of this</div>
                <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> Global Note</div>
                <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">following such</div>
                <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> decrease or</div>
                <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> increase</div>
              </div>
            </td>
            <td colspan="1" style="width: 1%; vertical-align: bottom; font-size: 10pt; padding-bottom: 2px;">&#160;</td>
            <td style="width: 19%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">
              <div>
                <div style="text-align: center; font-family: 'Times New Roman'; font-weight: bold;">Signature of</div>
                <div style="text-align: center; font-family: 'Times New Roman'; font-weight: bold;"> authorized</div>
                <div style="text-align: center; font-family: 'Times New Roman'; font-weight: bold;"> signatory of</div>
                <div style="text-align: center; font-family: 'Times New Roman'; font-weight: bold;"> Trustee or</div>
                <div style="text-align: center; font-family: 'Times New Roman'; font-weight: bold;"> Custodian</div>
              </div>
            </td>
          </tr>
          <tr>
            <td style="width: 18%; vertical-align: top; font-size: 10pt;">&#160;</td>
            <td colspan="1" style="width: 1%; vertical-align: top; font-size: 10pt;">&#160;</td>
            <td style="width: 20%; vertical-align: top; font-size: 10pt;">&#160;</td>
            <td colspan="1" style="width: 1%; vertical-align: top; font-size: 10pt;">&#160;</td>
            <td style="width: 19%; vertical-align: top; font-size: 10pt;">&#160;</td>
            <td colspan="1" style="width: 1%; vertical-align: top; font-size: 10pt;">&#160;</td>
            <td style="width: 20%; vertical-align: top; font-size: 10pt;">&#160;</td>
            <td colspan="1" style="width: 1%; vertical-align: top; font-size: 10pt;">&#160;</td>
            <td style="width: 19%; vertical-align: top; font-size: 10pt;">&#160;</td>
          </tr>

      </table>
      <div style="font-size: 10pt;"><br>
      </div>
      <hr noshade="noshade" align="left" style="height: 2px; width: 20%; color: #000000; background-color: #000000; text-align: left; margin-left: 0px; margin-right: auto; border: none;">
      <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman';">7</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';">Include if a global note.</font></font></div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
      </div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">Schedule A-1</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <!--PROfilePageNumberReset%Num%8%%%-->
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">ATTACHMENT 1</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">[FORM OF NOTICE OF CONVERSION]</div>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z86a92e0c6c6f4060a89f0372ea456f6b">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">To:</td>
            <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">U.S. Bank Trust Company, National Association</div>
            </td>
          </tr>

      </table>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; margin-left: 36pt;">60 Livingston Ave</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; margin-left: 36pt;">Saint Paul, MN 55107</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; margin-left: 36pt;">Attention:&#160; BridgeBio Pharma, Inc. Administrator</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">The undersigned registered owner of this Note hereby exercises the option to convert this Note, or the portion hereof (that is $1,000 principal amount
        or an integral multiple thereof) below designated, into cash, shares of Common Stock or a combination of cash and shares of Common Stock, as applicable, in accordance with the terms of the Indenture referred to in this Note, and directs that any
        cash payable and any shares of Common Stock issuable and deliverable upon such conversion, together with any cash for any fractional share, and any Notes representing any unconverted principal amount hereof, be issued and delivered to the
        registered Holder hereof unless a different name has been indicated below.&#160; If any shares of Common Stock or any portion of this Note not converted are to be issued in the name of a Person other than the undersigned, the undersigned will pay all
        documentary, stamp or similar issue or transfer taxes, if any in accordance with Section 14.02(d) and Section 14.02(e) of the Indenture.&#160; Any amount required to be paid to the undersigned on account of interest accompanies this Note.&#160; Capitalized
        terms used herein but not defined shall have the meanings ascribed to such terms in the Indenture.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Dated:</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">Signature(s)</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Signature Guarantee</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Signature(s) must be guaranteed by an eligible Guarantor Institution (banks, stock brokers, savings and loan associations and credit unions) with membership in an
        approved signature guarantee medallion program pursuant to Securities and Exchange Commission Rule 17Ad-15 if shares of Common Stock are to be issued, or Notes are to be delivered, other than to and in the name of the registered holder.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Fill in for registration of shares if to be issued, and Notes if to be delivered, other than to and in the name of the registered holder:</div>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zc270a4abcf4f4eab8a72346e1fc583f6">

          <tr>
            <td rowspan="1" style="width: 35%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);"><br>
            </td>
            <td rowspan="1" style="width: 65%; vertical-align: top; font-size: 10pt; padding-bottom: 2px;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 35%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">(Name)</div>
            </td>
            <td style="width: 65%; vertical-align: top; font-size: 10pt;">&#160;</td>
          </tr>
          <tr>
            <td rowspan="1" style="width: 35%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);"><br>
            </td>
            <td rowspan="1" style="width: 65%; vertical-align: top; font-size: 10pt; padding-bottom: 2px;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 35%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">(Street Address)</div>
            </td>
            <td style="width: 65%; vertical-align: top; font-size: 10pt;">&#160;</td>
          </tr>
          <tr>
            <td rowspan="1" style="width: 35%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);"><br>
            </td>
            <td rowspan="1" style="width: 65%; vertical-align: top; font-size: 10pt; padding-bottom: 2px;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 35%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">(City, State and Zip Code)</div>
            </td>
            <td style="width: 65%; vertical-align: top; font-size: 10pt;">&#160;</td>
          </tr>

      </table>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">Attachment 1-1</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zbeeb6ee74a094a39930a0083e9cc296c">

          <tr>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">Please print name and address</div>
            </td>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;">&#160;</td>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">Principal amount to be converted (if less than all):&#160; $,000</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;">&#160;</td>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">NOTICE:&#160; The above signature(s) of the Holder(s) hereof must correspond with the name as written upon the face of the Note in every particular without alteration or enlargement or
                any change whatever.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;">&#160;</td>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">Social Security or Other Taxpayer Identification Number</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">Attachment 1-2</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">ATTACHMENT 2</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">[FORM OF FUNDAMENTAL CHANGE REPURCHASE NOTICE]</div>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z90357cced32f41a98c8a3d63a4e2c794">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">To:</td>
            <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">U.S. Bank Trust Company, National Association</div>
            </td>
          </tr>

      </table>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; margin-left: 36pt;">60 Livingston Ave</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; margin-left: 36pt;">Saint Paul, MN 55107</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; margin-left: 36pt;">Attention:&#160; BridgeBio Pharma, Inc. Administrator</div>
      <div style="font-size: 10pt; margin-left: 36pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">The undersigned registered owner of this Note hereby acknowledges receipt of a notice from BridgeBio Pharma, Inc. (the &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Company</font>&#8221;) as to the occurrence of a Fundamental Change with respect to the Company and specifying the Fundamental Change Repurchase Date and requests and instructs the Company to pay to the registered
        holder hereof in accordance with Section 15.02 of the Indenture referred to in this Note (1) the entire principal amount of this Note, or the portion thereof (that is $1,000 principal amount or an integral multiple thereof) below designated, and
        (2) if such Fundamental Change Repurchase Date does not fall during the period after a Regular Record Date and on or prior to the corresponding Interest Payment Date, accrued and unpaid interest, if any, thereon to, but excluding, such Fundamental
        Change Repurchase Date.&#160; Capitalized terms used herein but not defined shall have the meanings ascribed to such terms in the Indenture.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">In the case of Physical Notes, the certificate numbers of the Notes to be repurchased are as set forth below:</div>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z05baea2daef54332bb39b82f00844251">

          <tr>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">Dated:</div>
            </td>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">Signature(s)</div>
            </td>
          </tr>
          <tr>
            <td rowspan="1" style="width: 50%; vertical-align: top; font-size: 10pt;">&#160;</td>
            <td rowspan="1" style="width: 50%; vertical-align: top; font-size: 10pt;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;">&#160;</td>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">Social Security or Other Taxpayer Identification Number</div>
            </td>
          </tr>
          <tr>
            <td rowspan="1" style="width: 50%; vertical-align: top; font-size: 10pt;">&#160;</td>
            <td rowspan="1" style="width: 50%; vertical-align: top; font-size: 10pt;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;">&#160;</td>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">Principal amount to be repaid (if less than all):&#160; $,000</div>
            </td>
          </tr>
          <tr>
            <td rowspan="1" style="width: 50%; vertical-align: top; font-size: 10pt;">&#160;</td>
            <td rowspan="1" style="width: 50%; vertical-align: top; font-size: 10pt;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;">&#160;</td>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">NOTICE:&#160; The above signature(s) of the Holder(s) hereof must correspond with the name as written upon the face of the Note in every particular without alteration or enlargement or
                any change whatever.</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">Attachment 2-1</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">ATTACHMENT 3</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">[FORM OF ASSIGNMENT AND TRANSFER]</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">For value received hereby sell(s), assign(s) and transfer(s) unto (Please insert social security or Taxpayer Identification Number of assignee) the
        within Note, and hereby irrevocably constitutes and appoints attorney to transfer the said Note on the books of the Company, with full power of substitution in the premises.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">In connection with any transfer of the within Note occurring prior to the Resale Restriction Termination Date, as defined in the Indenture governing
        such Note, the undersigned confirms that such Note is being transferred:</div>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z11db8df3150b41e288f04f39c89f243d">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Segoe UI Symbol',sans-serif; font-size: 10pt;">&#9744;</td>
            <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">To BridgeBio Pharma, Inc. or a subsidiary thereof; or</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z69d66aff53e049aa8bcec54405a57e63">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#9744;</td>
            <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">Pursuant to a registration statement that has become or been declared effective under the Securities Act of 1933, as amended; or</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zb0c26369345f4dafb22d9d858480621f">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Segoe UI Symbol',sans-serif; font-size: 10pt;">&#9744;</td>
            <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">Pursuant to and in compliance with Rule 144A under the Securities Act of 1933, as amended; or</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z0f48fa625f4042059b556a0add872d86">

          <tr>
            <td style="width: 36pt; vertical-align: top; font-family: 'Segoe UI Symbol',sans-serif; font-size: 10pt;">&#9744;</td>
            <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">Pursuant to and in compliance with Rule 144 under the Securities Act of 1933, as amended, or any other available exemption from the registration requirements of the Securities Act of 1933, as
                amended.</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zfb13fb1d8fc94a83aca51215308b30a1">

          <tr>
            <td style="width: 4%; vertical-align: top; padding-bottom: 2px;">
              <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman';">Dated:</font><font style="font-size: 10pt;"><br>
                </font></div>
            </td>
            <td style="width: 36%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 60%; vertical-align: top; font-size: 10pt; padding-bottom: 2px;">&#160;</td>
          </tr>
          <tr>
            <td colspan="2" style="vertical-align: top; font-size: 10pt;"><br>
            </td>
            <td style="width: 60%; vertical-align: top; font-size: 10pt;">&#160;</td>
          </tr>
          <tr>
            <td colspan="2" style="vertical-align: top; font-size: 10pt; border-bottom: 2px solid rgb(0, 0, 0);" rowspan="1"><br>
            </td>
            <td style="width: 60%; vertical-align: top; font-size: 10pt; padding-bottom: 2px;" rowspan="1">&#160;</td>
          </tr>
          <tr>
            <td colspan="2" style="vertical-align: top; font-size: 10pt;" rowspan="1"><br>
            </td>
            <td style="width: 60%; vertical-align: top; font-size: 10pt;" rowspan="1">&#160;</td>
          </tr>
          <tr>
            <td colspan="2" style="vertical-align: top; font-size: 10pt; border-bottom: 2px solid rgb(0, 0, 0);"><br>
            </td>
            <td style="width: 60%; vertical-align: top; font-size: 10pt; padding-bottom: 2px;">&#160;</td>
          </tr>
          <tr>
            <td colspan="2" style="vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Signature(s)</div>
            </td>
            <td style="width: 60%; vertical-align: top; font-size: 10pt;">&#160;</td>
          </tr>
          <tr>
            <td colspan="2" style="vertical-align: top; font-size: 10pt; border-bottom: 2px solid rgb(0, 0, 0);"><br>
            </td>
            <td style="width: 60%; vertical-align: top; font-size: 10pt; padding-bottom: 2px;">&#160;</td>
          </tr>
          <tr>
            <td colspan="2" style="vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Signature Guarantee</div>
            </td>
            <td style="width: 60%; vertical-align: top; font-size: 10pt;">&#160;</td>
          </tr>

      </table>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Signature(s) must be guaranteed by an eligible Guarantor Institution (banks, stock brokers, savings and loan associations and credit unions) with
        membership in an approved signature guarantee medallion program pursuant to Securities and Exchange Commission Rule 17Ad-15 if Notes are to be delivered, other than to and in the name of the registered holder.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">NOTICE:&#160; The signature on the assignment must correspond with the name as written upon the face of the Note in every particular without alteration or
        enlargement or any change whatever.</div>
      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
      </div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">Attachment 3-1</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="font-size: 10pt;"><br>
      </div>
    </div>
    <div>
      <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>3
<FILENAME>ef20044715_ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc.
         Document created using Broadridge PROfile 25.1.1.5279
         Copyright 1995 - 2025 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">

  <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
  <div style="text-align: right;"><font style="font-weight: bold;"> Exhibit 99.1</font><br>
    </div>
  <div><font style="font-weight: bold;"> </font><br>

    <div style="font-weight: bold;">BridgeBio Initiates Long Term Debt Management Strategy and Announces Proposed Offering of Convertible Senior Notes to Refinance Senior Secured Debt</div>
    <div>&#160;</div>
    <div style="font-style: italic;">- Long term debt management strategy will strengthen the balance sheet without increasing total liabilities</div>
    <div>&#160;</div>
    <div style="font-style: italic;">- Refinancing term debt facility lowers interest expense, eliminates near-term amortization payments, and significantly extends debt maturity</div>
    <div>&#160;</div>
    <div>PALO ALTO, Calif. &#8211; February 24, 2025 &#8211; BridgeBio Pharma, Inc. (Nasdaq: BBIO) (the &#8220;Company,&#8221; &#8220;we&#8221; or &#8220;BridgeBio&#8221;) announced today that it intends to offer, subject to
      market conditions and other factors, $500 million aggregate principal amount of convertible senior notes due 2031 (the &#8220;notes&#8221;) in a private offering (the &#8220;offering&#8221;) to qualified institutional buyers pursuant to Rule 144A under the Securities Act of
      1933, as amended (the &#8220;Securities Act&#8221;). In connection with the offering, the Company expects to grant the initial purchasers an option to purchase up to an additional $75 million aggregate principal amount of notes.</div>
    <div>&#160;</div>
    <div>The Company intends to use a portion of the net proceeds from the offering to repay all outstanding borrowings under and terminate its Financing Agreement, dated as of
      January 17, 2024, with the lenders party thereto and Blue Owl Corporation, as administrative agent, as amended (the &#8220;Financing Agreement&#8221;), and pay any fees related thereto. The termination of the Financing Agreement, which accounted for
      approximately $51.5 million of cash paid for interest in 2024 and contains various restrictive covenants, will provide the Company with reduced pro forma interest expense and greater operational flexibility. The Company intends to use up to $50
      million of any remaining net proceeds from the offering to repurchase shares of its common stock from certain purchasers of the notes in privately negotiated transactions effected through one or more of the initial purchasers or an affiliate thereof
      concurrently with the pricing of the notes (such transactions, the &#8220;share repurchases&#8221;), together, if necessary, with cash on hand.&#160; The Company expects to use any remaining net proceeds from the offering for general corporate purposes.</div>
    <div>&#160;</div>
    <div>The Company expects the purchase price per share of its common stock in the share repurchases to equal the last reported sale price per share of its common stock on the
      Nasdaq Global Select Market as of the date of the pricing of the notes. The share repurchases could increase (or reduce the size of any decrease in) the market price of the Company&#8217;s common stock prior to, concurrently with or shortly after the
      pricing of the notes, and could result in a higher effective conversion price for the notes.&#160; The Company cannot predict the magnitude of such market activity or the overall effect it will have on the market price of the notes and/or the market price
      of the Company&#8217;s common stock.</div>
    <div>&#160;</div>
    <div>The final terms of the notes, including the initial conversion rate, interest rate and certain other terms, will be determined at the time of pricing. The notes will bear
      interest semi-annually and will mature on March 1, 2031, unless earlier converted, redeemed or repurchased. Prior to December 2, 2030, the notes will be convertible only upon satisfaction of certain conditions and during certain periods. Thereafter,
      the notes will be convertible at any time until the close of business on the second scheduled trading day immediately preceding the maturity date. The notes will be convertible at the option of the holders, subject to certain conditions and during
      certain periods, into cash, shares of the Company&#8217;s common stock or a combination of cash and shares of the Company&#8217;s common stock, with the form of consideration determined at the Company&#8217;s election.</div>
    <div>&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div>The Company may not redeem the notes prior to March 6, 2028. On or after March 6, 2028 and on or before the 41st scheduled trading day immediately before the maturity date
      of the notes, the Company may redeem for cash all or any portion of the notes, at its option at any time, and from time to time, if the last reported sale price per share of the Company&#8217;s common stock exceeds 130% of the conversion price for a
      specified period of time and certain other conditions are satisfied. The redemption price will be equal to 100% of the principal amount of the notes being redeemed, plus accrued and unpaid interest to, but excluding, the redemption date. Holders of
      the notes will have the right to require the Company to repurchase all or a portion of their notes at 100% of their principal amount, plus any accrued and unpaid interest, upon the occurrence of certain events.</div>
    <div>&#160;</div>
    <div>When issued, the notes will be the Company&#8217;s senior unsecured obligations and will rank senior in right of payment to any of the Company&#8217;s unsecured indebtedness that is
      expressly subordinated in right of payment to the notes; equal in right of payment to any of the Company&#8217;s unsecured indebtedness that is not so subordinated; <a name="z_Hlk191208909"></a>effectively junior in right of payment to any of the
      Company&#8217;s secured indebtedness and obligations, to the extent of the value of the assets securing such indebtedness; and structurally junior to all indebtedness and other liabilities (including trade payables) of the Company&#8217;s subsidiaries.</div>
    <div>&#160;</div>
    <div>The notes and the shares of common stock issuable upon conversion of the notes, if any, are not being registered under the Securities Act, or the securities laws of any
      other jurisdiction. The notes and the shares of common stock issuable upon conversion of the notes, if any, may not be offered or sold in the United States except in transactions exempt from, or not subject to, the registration requirements of the
      Securities Act and any applicable state securities laws.</div>
    <div>&#160;</div>
    <div>This press release does not constitute an offer to sell or a solicitation of an offer to buy the securities described herein, nor shall there be any sale of these
      securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of such jurisdiction.</div>
    <div>&#160;</div>
    <div style="font-weight: bold;">About BridgeBio</div>
    <div>&#160;</div>
    <div><a name="z_Hlk189834665"></a>BridgeBio is a new type of biopharmaceutical company founded to discover, create, test, and deliver transformative medicines to treat patients
      who suffer from genetic diseases. BridgeBio&#8217;s pipeline of development programs ranges from early science to advanced clinical trials. BridgeBio was founded in 2015 and its team of experienced drug discoverers, developers and innovators are committed
      to applying advances in genetic medicine to help patients as quickly as possible.</div>
    <div>&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="font-weight: bold;">Forward-Looking Statements</div>
    <div>&#160;</div>
    <div><a name="z_Hlk189834733"></a>This press release contains forward-looking statements. Statements in this press release may include statements that are not historical facts
      and are considered forward-looking within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), which are usually identified by the use of words such as
      &#8220;anticipates,&#8221; &#8220;believes,&#8221; &#8220;continues,&#8221; &#8220;estimates,&#8221; &#8220;expects,&#8221; &#8220;hopes,&#8221; &#8220;intends,&#8221; &#8220;may,&#8221; &#8220;plans,&#8221; &#8220;projects,&#8221; &#8220;remains,&#8221; &#8220;seeks,&#8221; &#8220;should,&#8221; &#8220;will,&#8221; and variations of such words or similar expressions. We intend these forward-looking statements to
      be covered by the safe harbor provisions for forward-looking statements contained in Section 27A of the Securities Act and Section 21E of the Exchange Act. These forward-looking statements, including statements relating to whether we will offer and
      issue the notes, the terms of the notes, the anticipated use of the net proceeds from the offering and the expectations regarding the effect of the share repurchases, reflect our current views about our plans, intentions, expectations and strategies,
      which are based on the information currently available to us and on assumptions we have made.</div>
    <div>&#160;</div>
    <div>Although we believe that our plans, intentions, expectations and strategies as reflected in or suggested by those forward-looking statements are reasonable, we can give no
      assurance that the plans, intentions, expectations or strategies will be attained or achieved. Furthermore, actual results may differ materially from those described in the forward-looking statements and will be affected by a number of risks,
      uncertainties and assumptions, including, but not limited to, those risks set forth in the Risk Factors section of our Annual Report on Form 10-K for the year ended December 31, 2024 and our other filings with the U.S. Securities and Exchange
      Commission. Moreover, we operate in a very competitive and rapidly changing environment in which new risks emerge from time to time. These forward-looking statements are based upon the current expectations and beliefs of our management as of the date
      of this press release, and are subject to certain risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Except as required by applicable law, we assume no obligation to
      update publicly any forward-looking statements, whether as a result of new information, future events or otherwise.</div>
    <div>&#160;</div>
    <div style="font-weight: bold;">Contact:</div>
    <div>&#160;</div>
    <div><a name="z_Hlk189834777"></a>Bubba Murarka, EVP Communications</div>
    <div>contact@bridgebio.com</div>
    <div>(650)-789-8220</div>
    <div>Source: BridgeBio Pharma, Inc.</div>
    <div> <br>
    </div>
    <div> <br>
    </div>
    <div>
      <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"> </div>
  </div>

</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>4
<FILENAME>ef20044715_ex99-2.htm
<DESCRIPTION>EXHIBIT 99.2
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc.
         Document created using Broadridge PROfile 25.1.1.5279
         Copyright 1995 - 2025 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <div>
      <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
      <div>
        <div style="text-align: right; font-weight: bold;">Exhibit 99.2</div>
        <div><br>
        </div>
        <div style="font-weight: bold;">BridgeBio Prices Offering of $500 Million Convertible Senior Notes due 2031 to Refinance Senior Secured Debt</div>
        <div style="font-weight: bold;"> <br>
        </div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z0274a15dcdba48e994851e508fcd9400">

            <tr>
              <td style="width: 18pt; vertical-align: top;">-</td>
              <td style="width: auto; vertical-align: top;">
                <div style="font-style: italic;">Refinancing term debt facility lowers interest expense, eliminates near-term amortization payments, and significantly extends debt maturity</div>
              </td>
            </tr>

        </table>
        <div> <br>
        </div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z4a8c60b4e5204935b9a72bdf377f7969">

            <tr>
              <td style="width: 18pt; vertical-align: top;">-</td>
              <td style="width: auto; vertical-align: top;">
                <div style="font-style: italic;">Offering priced at 1.75% interest rate and 45% conversion premium</div>
              </td>
            </tr>

        </table>
        <div> <br>
        </div>
        <div>PALO ALTO, Calif. &#8211; February 25, 2025 &#8211; BridgeBio Pharma, Inc. (Nasdaq: BBIO) (the &#8220;Company,&#8221; &#8220;we&#8221; or &#8220;BridgeBio&#8221;) announced today the pricing of $500 million aggregate
          principal amount of 1.75% convertible senior notes due 2031 (the &#8220;notes&#8221;) in a private offering (the &#8220;offering&#8221;) to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;). In
          connection with the offering, the Company granted the initial purchasers an option to purchase up to an additional $75 million aggregate principal amount of notes. The sale of the notes is expected to close on February 28, 2025, subject to
          customary closing conditions.</div>
        <div> <br>
        </div>
        <div>The Company estimates that the net proceeds from the sale of the notes will be approximately $489.5 million (or approximately $563.0 million if the initial purchasers
          exercise their option to purchase additional notes in full), after deducting the initial purchasers&#8217; discounts and estimated offering expenses payable by the Company. The Company intends to use a portion of the net proceeds from the offering to
          repay all outstanding borrowings under and terminate its Financing Agreement, dated as of January 17, 2024, with the lenders party thereto and Blue Owl Corporation, as administrative agent, as amended (the &#8220;Financing Agreement&#8221;), and pay any fees
          related thereto. The termination of the Financing Agreement, which accounted for approximately $51.5 million of cash paid for interest in 2024 and contains various restrictive covenants, will provide the Company with reduced pro forma interest
          expense and greater operational flexibility.</div>
        <div> <br>
        </div>
        <div>The Company intends to use approximately $48.3 million of the remaining net proceeds from the offering to repurchase 1,405,411 shares of its common stock from certain
          purchasers of the notes in privately negotiated transactions effected through one of the initial purchasers or an affiliate thereof and entered into concurrently with the pricing of the notes (such transactions, the &#8220;share repurchases&#8221;). The
          agreed to purchase price per share of the Company&#8217;s common stock in the share repurchases is equal to the last reported sale price of the Company&#8217;s common stock of $34.35 per share on the Nasdaq Global Select Market on February 25, 2025. The
          share repurchases could increase (or reduce the size of any decrease in) the market price of the Company&#8217;s common stock, and could have resulted in a higher effective conversion price for the notes. The Company expects to use the remaining net
          proceeds from the offering for general corporate purposes.</div>
        <div> <br>
        </div>
        <div>The notes will bear interest at a rate of 1.75% per year, payable semi-annually in arrears on March 1 and September 1 of each year, beginning September 1, 2025. The
          notes will mature on March 1, 2031, unless earlier converted, redeemed or repurchased. Prior to December 2, 2030, the notes will be convertible only upon satisfaction of certain conditions and during certain periods. Thereafter, the notes will be
          convertible at any time until the close of business on the second scheduled trading day immediately preceding the maturity date. The notes will be convertible at the option of the holders, subject to certain conditions and during certain periods,
          into cash, shares of the Company&#8217;s common stock or a combination of cash and shares of the Company&#8217;s common stock, with the form of consideration determined at the Company&#8217;s election.</div>
        <div><br>
        </div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
          <div style="page-break-after: always;" class="BRPFPageBreak">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        </div>
        <div>The conversion rate will initially be 20.0773 shares of the Company&#8217;s common stock per $1,000 principal amount of notes (equivalent to an initial conversion price of
          approximately $49.81 per share of the Company&#8217;s common stock). The initial conversion price of the notes represents a premium of approximately 45.0% over the last reported sale price of the Company&#8217;s common stock of $34.35 per share on February
          25, 2025.</div>
        <div> <br>
        </div>
        <div>The Company may not redeem the notes prior to March 6, 2028. On or after March 6, 2028 and on or before the 41st scheduled trading day immediately before the maturity
          date of the notes, the Company may redeem for cash all or any portion of the notes, at its option at any time, and from time to time, if (i) the last reported sale price per share of the Company&#8217;s common stock has been at least 130% of the
          conversion price then in effect for at least 20 trading days (whether or not consecutive), including the trading day immediately preceding the date on which the Company provides notice of redemption, during any 30 consecutive trading day period
          ending on, and including, the trading day immediately preceding the date on which the Company provides notice of redemption and (ii) certain other conditions are satisfied. The redemption price will be equal to 100% of the principal amount of the
          notes being redeemed, plus accrued and unpaid interest to, but excluding, the redemption date.</div>
        <div> <br>
        </div>
        <div>Holders of the notes will have the right to require the Company to repurchase all or a portion of their notes at 100% of their principal amount, plus any accrued and
          unpaid interest, upon the occurrence of certain events.</div>
        <div> <br>
        </div>
        <div>When issued, the notes will be the Company&#8217;s senior unsecured obligations and will rank senior in right of payment to any of the Company&#8217;s unsecured indebtedness that
          is expressly subordinated in right of payment to the notes; equal in right of payment to any of the Company&#8217;s unsecured indebtedness that is not so subordinated; effectively junior in right of payment to any of the Company&#8217;s secured indebtedness
          and obligations to the extent of the value of the assets securing such indebtedness; and structurally junior to all indebtedness and other liabilities (including trade payables) of the Company&#8217;s subsidiaries.</div>
        <div> <br>
        </div>
        <div>The notes and the shares of common stock issuable upon conversion of the notes, if any, are not being registered under the Securities Act, or the securities laws of any
          other jurisdiction. The notes and the shares of common stock issuable upon conversion of the notes, if any, may not be offered or sold in the United States except in transactions exempt from, or not subject to, the registration requirements of
          the Securities Act and any applicable state securities laws.</div>
        <div> <br>
        </div>
        <div>This press release does not constitute an offer to sell or a solicitation of an offer to buy the securities described herein, nor shall there be any sale of these
          securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of such jurisdiction.</div>
        <div><br>
        </div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
          <div style="page-break-after: always;" class="BRPFPageBreak">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        </div>
        <div style="font-weight: bold;">About BridgeBio</div>
        <div style="font-weight: bold;"> <br>
        </div>
        <div>BridgeBio is a new type of biopharmaceutical company founded to discover, create, test, and deliver transformative medicines to treat patients who suffer from genetic
          diseases. BridgeBio&#8217;s pipeline of development programs ranges from early science to advanced clinical trials. BridgeBio was founded in 2015 and its team of experienced drug discoverers, developers and innovators are committed to applying advances
          in genetic medicine to help patients as quickly as possible.</div>
        <div> <br>
        </div>
        <div style="font-weight: bold;">Forward-Looking Statements</div>
        <div style="font-weight: bold;"> <br>
        </div>
        <div>This press release contains forward-looking statements. Statements in this press release may include statements that are not historical facts and are considered
          forward-looking within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), which are usually identified by the use of words such as &#8220;anticipates,&#8221; &#8220;believes,&#8221;
          &#8220;continues,&#8221; &#8220;estimates,&#8221; &#8220;expects,&#8221; &#8220;hopes,&#8221; &#8220;intends,&#8221; &#8220;may,&#8221; &#8220;plans,&#8221; &#8220;projects,&#8221; &#8220;remains,&#8221; &#8220;seeks,&#8221; &#8220;should,&#8221; &#8220;will,&#8221; and variations of such words or similar expressions. We intend these forward-looking statements to be covered by the safe
          harbor provisions for forward-looking statements contained in Section 27A of the Securities Act and Section 21E of the Exchange Act. These forward-looking statements, including statements relating to whether we will issue the notes, the
          anticipated use of the net proceeds from the offering and the expectations regarding the effect of the share repurchases, reflect our current views about our plans, intentions, expectations and strategies, which are based on the information
          currently available to us and on assumptions we have made.</div>
        <div> <br>
        </div>
        <div>Although we believe that our plans, intentions, expectations and strategies as reflected in or suggested by those forward-looking statements are reasonable, we can give
          no assurance that the plans, intentions, expectations or strategies will be attained or achieved. Furthermore, actual results may differ materially from those described in the forward-looking statements and will be affected by a number of risks,
          uncertainties and assumptions, including, but not limited to, those risks set forth in the Risk Factors section of our Annual Report on Form 10-K for the year ended December 31, 2024 and our other filings with the U.S. Securities and Exchange
          Commission. Moreover, we operate in a very competitive and rapidly changing environment in which new risks emerge from time to time. These forward-looking statements are based upon the current expectations and beliefs of our management as of the
          date of this press release, and are subject to certain risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Except as required by applicable law, we assume no
          obligation to update publicly any forward-looking statements, whether as a result of new information, future events or otherwise.</div>
        <div style="font-weight: bold;"><br>
          Contact:</div>
        <div style="font-weight: bold;"> <br>
        </div>
        <div>Bubba Murarka, EVP Communications</div>
        <div>contact@bridgebio.com</div>
        <div>(650)-789-8220</div>
        <div><br>
        </div>
        <div>Source: BridgeBio Pharma, Inc.</div>
        <div><br>
        </div>
        <div><br>
        </div>
        <div>
          <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
      </div>
    </div>

  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>5
<FILENAME>bbio-20250224.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 25.1.1.5279 Broadridge-->
<xs:schema targetNamespace="http://bridgebio.com/20250224" elementFormDefault="qualified" xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:bbio="http://bridgebio.com/20250224" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:us-types="http://fasb.org/us-types/2024" xmlns:srt-types="http://fasb.org/srt-types/2024">
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xlink:type="simple" xlink:href="bbio-20250224_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="bbio-20250224_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:roleType roleURI="http://bridgebio.com/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
        <link:definition>000100 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:import namespace="http://fasb.org/us-gaap/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/dei/2024" schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/country/2024" schemaLocation="https://xbrl.sec.gov/country/2024/country-2024.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/currency/2024" schemaLocation="https://xbrl.sec.gov/currency/2024/currency-2024.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/exch/2024" schemaLocation="https://xbrl.sec.gov/exch/2024/exch-2024.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/naics/2024" schemaLocation="https://xbrl.sec.gov/naics/2024/naics-2024.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/sic/2024" schemaLocation="https://xbrl.sec.gov/sic/2024/sic-2024.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/stpr/2024" schemaLocation="https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd" />
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
  <xs:import namespace="http://www.xbrl.org/2004/ref" schemaLocation="http://www.xbrl.org/2004/ref-2004-08-10.xsd" />
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
  <xs:import namespace="http://fasb.org/us-types/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd" />
  <xs:import namespace="http://fasb.org/srt/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd" />
  <xs:import namespace="http://fasb.org/srt-types/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd" />
  <xs:import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/cyd/2024" schemaLocation="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd" />
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>6
<FILENAME>bbio-20250224_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 25.1.1.5279 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" />
  <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="CoverAbstract" xlink:title="CoverAbstract" />
    <link:label xlink:type="resource" xlink:label="dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_CoverAbstract" xml:lang="en-US" id="dei_CoverAbstract">Cover [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CoverAbstract" xlink:to="dei_CoverAbstract" xlink:title="label: CoverAbstract to dei_CoverAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="DocumentType" xlink:title="DocumentType" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentType" xml:lang="en-US" id="dei_DocumentType">Document Type</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentType" xlink:to="dei_DocumentType" xlink:title="label: DocumentType to dei_DocumentType" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="WrittenCommunications" xlink:title="WrittenCommunications" />
    <link:label xlink:type="resource" xlink:label="dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_WrittenCommunications" xml:lang="en-US" id="dei_WrittenCommunications">Written Communications</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WrittenCommunications" xlink:to="dei_WrittenCommunications" xlink:title="label: WrittenCommunications to dei_WrittenCommunications" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="SolicitingMaterial" xlink:title="SolicitingMaterial" />
    <link:label xlink:type="resource" xlink:label="dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_SolicitingMaterial" xml:lang="en-US" id="dei_SolicitingMaterial">Soliciting Material</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SolicitingMaterial" xlink:to="dei_SolicitingMaterial" xlink:title="label: SolicitingMaterial to dei_SolicitingMaterial" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="PreCommencementTenderOffer" xlink:title="PreCommencementTenderOffer" />
    <link:label xlink:type="resource" xlink:label="dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_PreCommencementTenderOffer" xml:lang="en-US" id="dei_PreCommencementTenderOffer">Pre-commencement Tender Offer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer" xlink:title="label: PreCommencementTenderOffer to dei_PreCommencementTenderOffer" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="PreCommencementIssuerTenderOffer" xlink:title="PreCommencementIssuerTenderOffer" />
    <link:label xlink:type="resource" xlink:label="dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_PreCommencementIssuerTenderOffer" xml:lang="en-US" id="dei_PreCommencementIssuerTenderOffer">Pre-commencement Issuer Tender Offer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer" xlink:title="label: PreCommencementIssuerTenderOffer to dei_PreCommencementIssuerTenderOffer" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="AmendmentFlag" xlink:title="AmendmentFlag" />
    <link:label xlink:type="resource" xlink:label="dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_AmendmentFlag" xml:lang="en-US" id="dei_AmendmentFlag">Amendment Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AmendmentFlag" xlink:to="dei_AmendmentFlag" xlink:title="label: AmendmentFlag to dei_AmendmentFlag" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="DocumentFiscalYearFocus" xlink:title="DocumentFiscalYearFocus" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentFiscalYearFocus" xml:lang="en-US" id="dei_DocumentFiscalYearFocus">Document Fiscal Year Focus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus" xlink:title="label: DocumentFiscalYearFocus to dei_DocumentFiscalYearFocus" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="DocumentFiscalPeriodFocus" xlink:title="DocumentFiscalPeriodFocus" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentFiscalPeriodFocus" xml:lang="en-US" id="dei_DocumentFiscalPeriodFocus">Document Fiscal Period Focus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus" xlink:title="label: DocumentFiscalPeriodFocus to dei_DocumentFiscalPeriodFocus" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="DocumentPeriodEndDate" xlink:title="DocumentPeriodEndDate" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentPeriodEndDate" xml:lang="en-US" id="dei_DocumentPeriodEndDate">Document Period End Date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate" xlink:title="label: DocumentPeriodEndDate to dei_DocumentPeriodEndDate" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="EntityRegistrantName" xlink:title="EntityRegistrantName" />
    <link:label xlink:type="resource" xlink:label="dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityRegistrantName" xml:lang="en-US" id="dei_EntityRegistrantName">Entity Registrant Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityRegistrantName" xlink:to="dei_EntityRegistrantName" xlink:title="label: EntityRegistrantName to dei_EntityRegistrantName" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="EntityCentralIndexKey" xlink:title="EntityCentralIndexKey" />
    <link:label xlink:type="resource" xlink:label="dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityCentralIndexKey" xml:lang="en-US" id="dei_EntityCentralIndexKey">Entity Central Index Key</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey" xlink:title="label: EntityCentralIndexKey to dei_EntityCentralIndexKey" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="EntityFileNumber" xlink:title="EntityFileNumber" />
    <link:label xlink:type="resource" xlink:label="dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityFileNumber" xml:lang="en-US" id="dei_EntityFileNumber">Entity File Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityFileNumber" xlink:to="dei_EntityFileNumber" xlink:title="label: EntityFileNumber to dei_EntityFileNumber" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="EntityTaxIdentificationNumber" xlink:title="EntityTaxIdentificationNumber" />
    <link:label xlink:type="resource" xlink:label="dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityTaxIdentificationNumber" xml:lang="en-US" id="dei_EntityTaxIdentificationNumber">Entity Tax Identification Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber" xlink:title="label: EntityTaxIdentificationNumber to dei_EntityTaxIdentificationNumber" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="EntityIncorporationStateCountryCode" xlink:title="EntityIncorporationStateCountryCode" />
    <link:label xlink:type="resource" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityIncorporationStateCountryCode" xml:lang="en-US" id="dei_EntityIncorporationStateCountryCode">Entity Incorporation, State or Country Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode" xlink:title="label: EntityIncorporationStateCountryCode to dei_EntityIncorporationStateCountryCode" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="EntityEmergingGrowthCompany" xlink:title="EntityEmergingGrowthCompany" />
    <link:label xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityEmergingGrowthCompany" xml:lang="en-US" id="dei_EntityEmergingGrowthCompany">Entity Emerging Growth Company</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany" xlink:title="label: EntityEmergingGrowthCompany to dei_EntityEmergingGrowthCompany" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="EntityAddressAddressLine1" xlink:title="EntityAddressAddressLine1" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine1" xml:lang="en-US" id="dei_EntityAddressAddressLine1">Entity Address, Address Line One</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1" xlink:title="label: EntityAddressAddressLine1 to dei_EntityAddressAddressLine1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="EntityAddressAddressLine2" xlink:title="EntityAddressAddressLine2" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine2" xml:lang="en-US" id="dei_EntityAddressAddressLine2">Entity Address, Address Line Two</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2" xlink:title="label: EntityAddressAddressLine2 to dei_EntityAddressAddressLine2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine3" xlink:label="EntityAddressAddressLine3" xlink:title="EntityAddressAddressLine3" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine3" xml:lang="en-US" id="dei_EntityAddressAddressLine3">Entity Address, Address Line Three</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3" xlink:title="label: EntityAddressAddressLine3 to dei_EntityAddressAddressLine3" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="EntityAddressCityOrTown" xlink:title="EntityAddressCityOrTown" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressCityOrTown" xml:lang="en-US" id="dei_EntityAddressCityOrTown">Entity Address, City or Town</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown" xlink:title="label: EntityAddressCityOrTown to dei_EntityAddressCityOrTown" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="EntityAddressStateOrProvince" xlink:title="EntityAddressStateOrProvince" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressStateOrProvince" xml:lang="en-US" id="dei_EntityAddressStateOrProvince">Entity Address, State or Province</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince" xlink:title="label: EntityAddressStateOrProvince to dei_EntityAddressStateOrProvince" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry" xlink:label="EntityAddressCountry" xlink:title="EntityAddressCountry" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressCountry" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressCountry" xml:lang="en-US" id="dei_EntityAddressCountry">Entity Address, Country</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressCountry" xlink:to="dei_EntityAddressCountry" xlink:title="label: EntityAddressCountry to dei_EntityAddressCountry" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="EntityAddressPostalZipCode" xlink:title="EntityAddressPostalZipCode" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressPostalZipCode" xml:lang="en-US" id="dei_EntityAddressPostalZipCode">Entity Address, Postal Zip Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode" xlink:title="label: EntityAddressPostalZipCode to dei_EntityAddressPostalZipCode" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="CityAreaCode" xlink:title="CityAreaCode" />
    <link:label xlink:type="resource" xlink:label="dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_CityAreaCode" xml:lang="en-US" id="dei_CityAreaCode">City Area Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CityAreaCode" xlink:to="dei_CityAreaCode" xlink:title="label: CityAreaCode to dei_CityAreaCode" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="LocalPhoneNumber" xlink:title="LocalPhoneNumber" />
    <link:label xlink:type="resource" xlink:label="dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_LocalPhoneNumber" xml:lang="en-US" id="dei_LocalPhoneNumber">Local Phone Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber" xlink:title="label: LocalPhoneNumber to dei_LocalPhoneNumber" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="Security12bTitle" xlink:title="Security12bTitle" />
    <link:label xlink:type="resource" xlink:label="dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_Security12bTitle" xml:lang="en-US" id="dei_Security12bTitle">Title of 12(b) Security</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Security12bTitle" xlink:to="dei_Security12bTitle" xlink:title="label: Security12bTitle to dei_Security12bTitle" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_NoTradingSymbolFlag" xlink:label="NoTradingSymbolFlag" xlink:title="NoTradingSymbolFlag" />
    <link:label xlink:type="resource" xlink:label="dei_NoTradingSymbolFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_NoTradingSymbolFlag" xml:lang="en-US" id="dei_NoTradingSymbolFlag">No Trading Symbol Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag" xlink:title="label: NoTradingSymbolFlag to dei_NoTradingSymbolFlag" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="TradingSymbol" xlink:title="TradingSymbol" />
    <link:label xlink:type="resource" xlink:label="dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_TradingSymbol" xml:lang="en-US" id="dei_TradingSymbol">Trading Symbol</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TradingSymbol" xlink:to="dei_TradingSymbol" xlink:title="label: TradingSymbol to dei_TradingSymbol" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="SecurityExchangeName" xlink:title="SecurityExchangeName" />
    <link:label xlink:type="resource" xlink:label="dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_SecurityExchangeName" xml:lang="en-US" id="dei_SecurityExchangeName">Security Exchange Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SecurityExchangeName" xlink:to="dei_SecurityExchangeName" xlink:title="label: SecurityExchangeName to dei_SecurityExchangeName" />
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>7
<FILENAME>bbio-20250224_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 25.1.1.5279 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" />
  <link:roleRef roleURI="http://bridgebio.com/role/DocumentAndEntityInformation" xlink:type="simple" xlink:href="bbio-20250224.xsd#DocumentAndEntityInformation" />
  <link:presentationLink xlink:type="extended" xlink:role="http://bridgebio.com/role/DocumentAndEntityInformation">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="CoverAbstract" xlink:title="CoverAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="DocumentType" xlink:title="DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentType" xlink:title="presentation: CoverAbstract to DocumentType" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="AmendmentFlag" xlink:title="AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="AmendmentFlag" xlink:title="presentation: CoverAbstract to AmendmentFlag" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="DocumentPeriodEndDate" xlink:title="DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentPeriodEndDate" xlink:title="presentation: CoverAbstract to DocumentPeriodEndDate" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="DocumentFiscalYearFocus" xlink:title="DocumentFiscalYearFocus" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentFiscalYearFocus" xlink:title="presentation: CoverAbstract to DocumentFiscalYearFocus" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="DocumentFiscalPeriodFocus" xlink:title="DocumentFiscalPeriodFocus" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentFiscalPeriodFocus" xlink:title="presentation: CoverAbstract to DocumentFiscalPeriodFocus" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="EntityFileNumber" xlink:title="EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityFileNumber" xlink:title="presentation: CoverAbstract to EntityFileNumber" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="EntityRegistrantName" xlink:title="EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityRegistrantName" xlink:title="presentation: CoverAbstract to EntityRegistrantName" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="EntityCentralIndexKey" xlink:title="EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityCentralIndexKey" xlink:title="presentation: CoverAbstract to EntityCentralIndexKey" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="EntityIncorporationStateCountryCode" xlink:title="EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityIncorporationStateCountryCode" xlink:title="presentation: CoverAbstract to EntityIncorporationStateCountryCode" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="EntityTaxIdentificationNumber" xlink:title="EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityTaxIdentificationNumber" xlink:title="presentation: CoverAbstract to EntityTaxIdentificationNumber" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="EntityAddressAddressLine1" xlink:title="EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressAddressLine1" xlink:title="presentation: CoverAbstract to EntityAddressAddressLine1" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="EntityAddressAddressLine2" xlink:title="EntityAddressAddressLine2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressAddressLine2" xlink:title="presentation: CoverAbstract to EntityAddressAddressLine2" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine3" xlink:label="EntityAddressAddressLine3" xlink:title="EntityAddressAddressLine3" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressAddressLine3" xlink:title="presentation: CoverAbstract to EntityAddressAddressLine3" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="EntityAddressCityOrTown" xlink:title="EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressCityOrTown" xlink:title="presentation: CoverAbstract to EntityAddressCityOrTown" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="EntityAddressStateOrProvince" xlink:title="EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressStateOrProvince" xlink:title="presentation: CoverAbstract to EntityAddressStateOrProvince" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry" xlink:label="EntityAddressCountry" xlink:title="EntityAddressCountry" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressCountry" xlink:title="presentation: CoverAbstract to EntityAddressCountry" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="EntityAddressPostalZipCode" xlink:title="EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressPostalZipCode" xlink:title="presentation: CoverAbstract to EntityAddressPostalZipCode" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="CityAreaCode" xlink:title="CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="CityAreaCode" xlink:title="presentation: CoverAbstract to CityAreaCode" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="LocalPhoneNumber" xlink:title="LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="LocalPhoneNumber" xlink:title="presentation: CoverAbstract to LocalPhoneNumber" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="Security12bTitle" xlink:title="Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="Security12bTitle" xlink:title="presentation: CoverAbstract to Security12bTitle" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="TradingSymbol" xlink:title="TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="TradingSymbol" xlink:title="presentation: CoverAbstract to TradingSymbol" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_NoTradingSymbolFlag" xlink:label="NoTradingSymbolFlag" xlink:title="NoTradingSymbolFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="NoTradingSymbolFlag" xlink:title="presentation: CoverAbstract to NoTradingSymbolFlag" order="21.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="SecurityExchangeName" xlink:title="SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="SecurityExchangeName" xlink:title="presentation: CoverAbstract to SecurityExchangeName" order="22.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="EntityEmergingGrowthCompany" xlink:title="EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityEmergingGrowthCompany" xlink:title="presentation: CoverAbstract to EntityEmergingGrowthCompany" order="23.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="WrittenCommunications" xlink:title="WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="WrittenCommunications" xlink:title="presentation: CoverAbstract to WrittenCommunications" order="24.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="SolicitingMaterial" xlink:title="SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="SolicitingMaterial" xlink:title="presentation: CoverAbstract to SolicitingMaterial" order="25.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="PreCommencementTenderOffer" xlink:title="PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="PreCommencementTenderOffer" xlink:title="presentation: CoverAbstract to PreCommencementTenderOffer" order="26.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="PreCommencementIssuerTenderOffer" xlink:title="PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="PreCommencementIssuerTenderOffer" xlink:title="presentation: CoverAbstract to PreCommencementIssuerTenderOffer" order="27.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>image00006.jpg
<TEXT>
begin 644 image00006.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1"  C +8# 2(  A$! Q$!_\0
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M@"@##/AK/_,9UO\ \"__ *U9GQ,\+7'BCP+<:387 34(S%/:RS\@S1.KKO\
M8E<$^^:[.B@#FM'UW4]0AABN/#M]I][\HG%PT9AC_O;75CO'7&!GIG%><7_P
M\O=>\0>-KV2R-C?27]MJ&BWDX1T=X857#KDG864@JPZ'(Y%>V44 >0^)]=U^
MXM#-?V5WHMW'H-Q<0VWFALWZN@ 5D)#]MHZD.<CK7J%S'=7&FO%#.+2[=,>:
M$#^6QZD \'VSGMG-69(XW*ET5BIW D9P?6I: .?\-^&X/#SS1:9*Z:?+^\:V
M<;L3$Y:0.><MU8<C/(P2<]!110!S7B+PAI_B*ZCGU"XU6)XD\M19ZC/:J1G/
M(C< GGJ>:X?4=#\%Z?+?+<:AXL:.PXO)X=5U"6*W.T-AF5S@X()ZX!&<5Z[7
MC7BFUU/PW+XG\6>"K^UOM*$DLNMZ%>\1N\:@2M$_5'V@94Y!Z^@H L:IH/@W
M2]832KN_\7M?M;FZ6*#4M1F)A4X+C8Q& 2/SK4T/P-X5US3;?4M(U?7KNQN%
MW131>(+PAO\ R)UR,8ZYZUG75Q<ZC\9/#]SI;):2W'A::51=0E_+#31$ J&'
M(R,C/;'O5G3[B'X9Z*VB66_4#8V5QK=_/+A#(#+E]H' ))? Z *!WS0!K_\
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KW5?+$87Y0O3&/3VHHH 2UACMK:*&WC2*&)?+CC08557@ #L !1110!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>image00007.jpg
<TEXT>
begin 644 image00007.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1"  C + # 2(  A$! Q$!_\0
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M#5Y"=KQQD]E; 9'&YMO=3F@#T?0M.T36([KR(=:@EM9O(FBN;RYC='VJV/\
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,4WMZG Y-7J** /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>image00008.jpg
<TEXT>
begin 644 image00008.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1"  C ( # 2(  A$! Q$!_\0
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.,R,/=B3^9QU-%% '_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>image00009.jpg
<TEXT>
begin 644 image00009.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1"  B -8# 2(  A$! Q$!_\0
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**** "BBB@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>image00010.jpg
<TEXT>
begin 644 image00010.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1"  C -8# 2(  A$! Q$!_\0
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MO;P:O>222N 20H\WLH))Z #DBLN]T/X?V.@:EK-Y_P ))#9Z;((;SS-0U /
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HT_P]HVFW#W.G:586MP^2TD%NB,2>O('?O6K110 4444 %%%% '__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>image00011.jpg
<TEXT>
begin 644 image00011.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1"  Q /L# 2(  A$! Q$!_\0
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M!&?4(#]36+=Z+K<EU,\0FV,[%<:],G&>/E$)"_3)Q0!V<DJ1([RNJ(@W,S'
M '4DURQ\=:;_ &4VK+:ZB^C!=ZWZ6^8G7LRC.\J>S;<=\XYK.^)FEZK>?"#7
MM.T]9'U1]/=!&LS3-)Q\RAB 6)7(Y'.>E:GAC6]$U'P/IUY:7-LVEO:H@7((
M4;0#&5_O#[NWKGC% #;SQS86NM:GI9LM4EN=-A2XN?)MMX2-L[6&#EL[6X )
MX/%;VDZI9:QIEOJ&F7$=S97$8EBF0_*ZGH:\;\3KX@;XB>/F\)3(NH1Z/I[&
M 1@R2INFW+&QX63;G:2I&2,BM;3=:TRQ\(> ]%\!7#1Z=JURMFDQ.9H8DC>2
M;.>DOR%3Z%B>PH ]:W"C-<;X(UFYN=<\5Z'?2M/)HMY''%._5X98ED0-ZE=S
M+GN .^2>8N+Z;2?B2MM=ZO?/X7U*\413M<MBWU!5/^B;]W$;CYL?WUV=\4 >
MM44#I10 53UC4K71]*O-1U"00V=I"T\TA_A1023^0JY7%^.&DU74[#0+>TCO
MHB/MM_ TH0-"IQ&AR#PTF#CN(VH ZJWO[:XL(KV*9#:RQ"99<X4H1D-GTQS6
M!_PG.E?V=_:8COCI! *:@+9C#("< KCYMI)X;&T]<XYKR:,:L?@GXZ\#0+(=
M=\/QO:QPJ^]WLW DBY ^;,1*=.=M>OZ'J>C:AX.L+VVFMWT>:U0)CE-I4#9C
MU_AV]<\=: .BW#-1PW$4R%X9$D0,R%E((# X(^H((^HJOJ4-Y-;@:?=16TV<
MEY(?-!'IC<.??-<WX'L]7B@D:]U""2W%[>;HELC$S$SR<AMYP#UZ=#CWH Z6
M^U*WLI+>.5B9KA_+AB7EG.,G ] ,DGL*Q)/&^E)<2C9?/:QW'V-KV.V9H/.W
M[-FX>C?*3C:#QG-8L<LDOQWEBN"WDVWAU7M@>F9+DB5A[_NXA^5<?J9OO MG
M=^)/"UY'K/@RXO2][HEQR]O(\^V0V[]<^8V?+/?..30!Z-J7CS1]-U:_T^Z3
M4//T^);BZ:.SDD6&)LXD)4'Y?E;D>A]*Z/3[ZVU&Q@O+">.XM+A!)%-&VY74
MC((/I7ETEE>ZC\8/&=IIU]!9R3:)91-*\'G%<M,,A=P&0#WR.E=/HD$?@QO"
MGA+38O,T\VTT0FE?,@,2J<X QR6.>E '8YI-_/0_E7(_$N._;0XY=#O9K?68
M)TELX$D*I>.IW&"09Y1@"">-H^;. :G^'>IP:UX6M]1AN+F:2X=WN$N&.^WF
MW'?"5/W=C97;VQWZT 7;SQ-9P:C/86T5U?WMNJO<16<>\PAAE=QR "1R%SDC
MG&*C;QAHO]AQZK%=&:VDF^RQI$A,KS[MOE!/O;]P(*D C!S@"N3^#Z/::AXY
ML-1^751X@N+IPQ^9X)0IAD'JI4;1_ND=JY:QT*S\177C S:E-IEGJ'B5)-$O
M8&"E;V*##RQYX8,R.OHV"!SS0!Z]H?B"TU>:Z@BBNK:ZM AG@NH3&\>[.WKP
M0<'D$CWJU<:G;VVH6UG<%HY+G(A9AA9& )* _P![ )QZ XZ&O/?"OB'Q#87'
MB?2/$T.GWNLZ-91W::C;#RX[R)A(4$BX_=N"C9 XY)'J5^*U_-/\(X-9MT$6
MH)+IU[;JISME,\.%'UW%?<&@#TZB@=** "L[5-$TW5GC;5-/LKTQ',9N(%D*
M>N,CBM&B@#/N=&TZZBABNK"TFB@QY220JPCQ_=!''X5)+IMG-=07,UI;27$
MQ%*T2EXQ_LG&15RB@#,T/2(M'LWMK>661&GFN"TI!.Z61I&Z <;F.*T\444
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MHO?VMFT-X[;VFCT"Y5RQZMD0]??K7JE% '"#XK^$?^?K4O\ P47G_P :IO\
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MK&>R9G@8,1M9E*$XS@_*2.<]:O4 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
&444 ?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45973478788944">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Feb. 24, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Feb. 24,  2025<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-38959<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">BridgeBio Pharma, Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001743881<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">84-1850815<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">3160 Porter Dr.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 250<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Palo Alto<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">94304<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">650<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">391-9740<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.001 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BBIO<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>16
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M<6A4"H[<8R6,<6*T_C6"R0_L?@!02P,$%     @ >8%<6APX9>H_ 0  / (
M  \   !X;"]W;W)K8F]O:RYX;6R-4<MNPD ,_)75?D 34(M41+B4/I"J%I6*
M^Y)UB,4^(J\#+5]?)U%4I%YZ\GILC6=F%^=(QWV,1_7E74B%KIF;>9:EL@9O
MTDUL(,BDBN0-2TN'+#4$QJ8:@+W+IGD^R[S!H)>+D6M#V743&4K&& 3L@!W"
M.?W.NU:=,.$>'?)WH?NW ZT\!O1X 5OH7*M4Q_-+)+S$P,9M2XK.%7HR#'9
MC.4?>-N)_#3[U"-L]A]&A!1ZE@MAA92XW^CYC6@\@2P/7<OQ"1T#K0S#,\6V
MP7#H:,1%=F6CSV&L0XAS^D^,L:JPA%4L6P^!AQP)7"<PI!J;I%4P'@H]KB@3
MK'H,+"&I=1BH9+=S*J?7=G#-(O<J0YJC#&AM!^&C6@L5!K!O<B )+LF5&U)=
MZ7FFMW>3>TFH=>Y!L/?P&HT=S8\?M_P!4$L#!!0    ( 'F!7%HD'INBK0
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M;V-0<F]P<R]A<' N>&UL4$L! A0#%     @ >8%<6II0R\?N    *P(  !$
M             ( !KP   &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @
M>8%<6IE<G",0!@  G"<  !,              ( !S $  'AL+W1H96UE+W1H
M96UE,2YX;6Q02P$"% ,4    " !Y@5Q:?S!>4F4$   V$0  &
M    @($-"   >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%     @
M>8%<6I^@&_"Q @  X@P   T              ( !J P  'AL+W-T>6QE<RYX
M;6Q02P$"% ,4    " !Y@5Q:EXJ[',     3 @  "P              @ &$
M#P  7W)E;',O+G)E;'-02P$"% ,4    " !Y@5Q:'#AEZC\!   \ @  #P
M            @ %M$   >&PO=V]R:V)O;VLN>&UL4$L! A0#%     @ >8%<
M6B0>FZ*M    ^ $  !H              ( !V1$  'AL+U]R96QS+W=O<FMB
M;V]K+GAM;"YR96QS4$L! A0#%     @ >8%<6F60>9(9 0  SP,  !,
M         ( !OA(  %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&      D "0 ^
) @  "!0

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.0.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="ef20044715_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000100 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://bridgebio.com/role/DocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>bbio-20250224.xsd</File>
    <File>bbio-20250224_lab.xml</File>
    <File>bbio-20250224_pre.xml</File>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="ef20044715_8k.htm">ef20044715_8k.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>22
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "ef20044715_8k.htm": {
   "nsprefix": "bbio",
   "nsuri": "http://bridgebio.com/20250224",
   "dts": {
    "schema": {
     "local": [
      "bbio-20250224.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2004/ref-2004-08-10.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd",
      "https://xbrl.sec.gov/country/2024/country-2024.xsd",
      "https://xbrl.sec.gov/currency/2024/currency-2024.xsd",
      "https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/exch/2024/exch-2024.xsd",
      "https://xbrl.sec.gov/naics/2024/naics-2024.xsd",
      "https://xbrl.sec.gov/sic/2024/sic-2024.xsd",
      "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "bbio-20250224_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "bbio-20250224_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "ef20044715_8k.htm"
     ]
    }
   },
   "keyStandard": 23,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2024": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 29,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2024": 23
   },
   "report": {
    "R1": {
     "role": "http://bridgebio.com/role/DocumentAndEntityInformation",
     "longName": "000100 - Document - Document and Entity Information",
     "shortName": "Document and Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c20250224to20250224",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20044715_8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c20250224to20250224",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20044715_8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://bridgebio.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://bridgebio.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://bridgebio.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://bridgebio.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://bridgebio.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://bridgebio.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://bridgebio.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://bridgebio.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://bridgebio.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://bridgebio.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://bridgebio.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://bridgebio.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://bridgebio.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://bridgebio.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://bridgebio.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://bridgebio.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://bridgebio.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://bridgebio.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://bridgebio.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://bridgebio.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://bridgebio.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://bridgebio.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://bridgebio.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://bridgebio.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://bridgebio.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://bridgebio.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://bridgebio.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://bridgebio.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>23
<FILENAME>0001140361-25-006524-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001140361-25-006524-xbrl.zip
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MB#+5Z"*[WPA["B3Q#LM.#1@2D1&IJ<EZ4T+1/TN+H6G;M R$L/^;C^7Y;C(
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MN&MTA -7<H,1!]4)]44U<H$QC>KO0&[3V>@'#2T0-+1 \)XLH!?U3 L$3Q:
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MJF%XJM:44*-J=;12%7+/;<*0>-Y^O$VF--8D-<;D8F@Q>&*ZR-<HJ0U53\I
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MS ']\VZW!M)R"(\3(+G[(P QX_%)$HB[7\6] 6G7"T;V<.@%O;[C#D<];PC
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M8>.JPF9JCZJSP2UL&=K*V4Q0O72&9YY-^3T9&+F81#Q)@'+C>Z+L#.PDV!S
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M;;^82/H],<[)NN3RI*'C_\PP-595_[\)EJ<(ENXF6MZ--MN+FO1E=*@L7*7
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M,7FM[O;3+ LQS^:6+6YVSX;7*?PJ&V96!&QP7';TZ(I;;DK^1G4G#SN;B@7
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M;"!HMAKKD^&I#(]_]PCIF<LM09Q3.@Q0J:\/1!R-I,2\!%O<#@?A:%SHT)7
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MH]?YGN;LCZ1(18@/(3^+6H$Y\P-!NG#G22J7A\6*D@FM![86<=S*9N[?\>:
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MY!,!0\!@=*4\Z396;A"H,5-X;9:E=Z'JKHL(+J0#A@-VKLC?:1)/E?*@0 %
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M^*_$L=]!GDF$06G)TIVLKAAHD8K> IT4-^D=HM\Y3@IEKC.JDUXK,_?:1:.
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M8U[RN\6YZ)>@>U0LW"321$4NX,E%@5574]CF5_AX_E8[$H7AF"3GETYM%\
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M!MI3L!S8.3OJD <.HHP:B^(QEK]Q/2(D0()TS4QII/CD9C.-^>YV;9_X-D^
M@Q7>XA#+)T]Q,">FH'H$B]I-?E&W@V"EJ]]-&5]<<4!:S2H;P!NNI#D+M5-
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M8IP:GA'GAB'D\=0F;RES2N%V3'ZGW.8!G)4PJ;^>#SBR> ^3M]W*>/VP\%M
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MDEDM-B-Y'?%)F%PFC3CI-:I!7-_.2JM_]?_/WKOVMI%DV:+?#W#^ W$P!Y"
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MO\,5?NUC7H-820ZSY6@?Y11=TZG%G&+NQO/B(I]3@P=SZ9AG/02" Q<O/SG
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M5T"B&#G$KPG-643+3IXJ'=09)P,G)8@2@I8D4B/6E3;TBML3GNG?/9;!19@
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MNC^>DS\Z%C,A_9_DAMP?N?O<$X$#%3U.Y"[YY\"#0*X-G(J35MI\"1Q<S@4
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MHS8Y=B*)A)H!]K!R.^T?13TI/?T"PJJ!0G'9IE154ZX$F?RY"Q"P!H]C@@X
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M&JKN?=<XH!UHN"8089%L>6!ST81\OUP46(GU(^P7A/0_-AVYZRG2P([ K<7
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M[0,S/(!Z"*VS#1_S#,"X,<#!7IFBCYM*/K#X>/)IS 7Y.&X=GYY@^]\ ><W
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M6GO<?7K%PO@:2,B^,,E7N7N(ZXS+$2X2)W!)]6W)A5[TJ]!LL0BN+'DD.N.
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M<Z-LVXD'.CS^]K* A5L68,&:@C$\&OC 6R#2";W^6>D<#"D^>G?7-!^Y.5_
M1A2TFGTU4ZSG',B!@6O=\7?'&9%!#K>/=55AW]>YEH$V'G2?]]<8UZ%\O/7E
M'B>;H6]WV5<Q@?I*1C JILT2AXOJMX )Y)X_,'5"4NL/"MUDJJC8PEY$[%W"
M<+-A5#V3>CUG*"P)CXAF8^@!7!.1I7!&Q@D5RC8S0241=S7FP?HEXJTQ@<Y%
MMJ.V5. 9-/FF1K:.!H6.B6XF.]2W2]@M'GE>P]*9)(=$=/LH'(8;\+L.AQ!_
M=2<8P/W:MCO6?4TY]2^&=.K_>0D2Z\7H+>6;SL;8+EV T&/:\'VY-,1*01JS
MCU-Z5S%(]6XBW4GM1H6[,:T@=J%! SE6*/*.(J*N[IIWDGLWA?N'6PR3-%03
MQ,@!ZJ00K.3LR>0R)"P$.?-%-4@"%NC=5]A>9_ZB#^ V5PWX6NKW:\%*23>C
M!!-Z\.,=FLMRY0OFFE5#-W>I>E$XI.Q@:UH\]N="R<QH7(_3S?A"V6;0]/ P
M2Q&A]5T1$H.9V KN\JEP010ENC_6TND(?_AYO9SF<$WWG3?N:2_@8=R])Y>0
MU<//'I/1FHZ.3./Y[8S.XS"O>0SO4:^9.&V]7.7E-%#_TRDDVC!;G[(S#]\6
M*3": *7/3.7?J2RZY!JLG9MEY"$O>;+L?M%?QEO&3O@R.<L&VH,95:_6%J:>
MD=HAKP.U#K?N@PUDF^__/J_&;A[#M0X7>ENX47#.+!%'PXF.G:7^,#R3PC"O
ML(8(IHEJD*KPN,@YC\S>@:Q5TDLL)%P4>;:PPD.$TO)4J,N,&SR+A",5G[AH
M JW'4. 1>$5AE?C'A#(^):A!1A;RP>@#$.C2"XG M4.929;Z=&].O!]Z3[XP
M_I;Z_23*@Q&6H7O?M1^ =;S@U[*#(/.92,3P2 IM@I K):C\R4[;::=F@TF)
MM17>--@V8=<#&FP$E;K FY6<5 2JM>>'Q5^IODD8Z:$;F EI[7\KGBC.K(Q"
M3N_N4O1?(+O)E./T=EU!GN*/"=DH_%3JO7'[TQL#1L1[:&@9%KL1'=V)/O9?
MMS3P[.2A-'#7+O(AZJ6S1?H)W-XIF\:W94,( \#U=/S@=\L@S22.8"(KAMDM
M9X>V9;#IKE)89>U#5N53C'[F[:3/.0=V,*TBBQ</#21D3&MR:S7Z5,O,3L+G
M];@IIR684$FT5LIYYG77NXV=/5_V?!9^<!F.A_$'BJ1CU=2P?J0<53T?91+P
M8!@2RQ7 :E,<Z7W3WP%5NRNVY'IA&7F.CIT]XV\PNPBOHI7"4AR?J"Z-*%I6
M@XC2FB2@"YW7U+_H'!J:=)_#J.R$&'>#_#'Z--[/PQI7V,:-[W1155-69.!D
MBI_;9M-,#D6G$-&VT"_+#DL9/;+,C&IQ* >6U82+\(+XT/3UKJ_04&,I@Y)8
MH:2RX$O"W'"Q1QZC)$G<8-_E/5O.>6<;MUOB:\92"78BPL_G,.NK-2?2*]-2
MFW$U;%(*- ^."_XIQDHAOD&CZWQZQ;T_(@4<RH3P;C#\TE&V+.Y0#I(,]KV9
MS7%=+\TDRE-Y$O&.QHH=!2NWXM8"0Z_<J@;+R8@.N N7-H0G"S;3,C*:8KAP
MLV!W_9QIX#SGL8^A#70X'P.ET%33CZR7_)I"EL$BX3BOW%O]44"7*9EP7^,V
MS1E82%[[QDOW\)O"YFJT+NEQ;RP6'95&9=AQE\#DF)HFGES?<T0<9-;QV0&Z
M5)^*J\HCD-_0N>86]<]KC$+%2?H;N+$IV*@AW=(JVI$T':"G?DRQ/*TQ'P:;
MC.20_"8OX[),U3E?;E J_7YX0T<4)(2IQ;K0 8S )%0\A:)H[#27QJ;ISF7!
M%@.D](\2O;YY10)'1B!!!<[1XU$M^%IZK2)^-(V7E<&)9%#?: \2:?N0,:)L
MWHK LE2&DH++T(O@<; (:K?*O\;L2QX[6SE[5HM1+.IETTWJ>/VXW!FQHLE+
MVTD3@6'-4I)E%J;@C/%%%8^2S",.C>$H]N-%1VBP)=$:8RJZF_,T-VW<HFG6
M1<Q.H8D3Z20#&42FE2-&9<G;U9RD5'^+Z5#$@7'';<WN%+P/+BMRLX/$.3K5
MA 2G;CM8S)A"]&\M7*$Z8/KH SQO=)#N6Y%LGYB^5WO!]#UFT1P&\4DI\M?S
M\R_OWO_]$$!]KVX-ZOLQJ ;O#?U*==]42>\LA9J2#F7&39G3&$L?V)R!DEH5
MG]$;R6,&$*_JDHM)PT#W(/99;0DT!]8+>,BL/CM]R*S^0(+._%[2 +N]?T&N
MA]07@[,Q8IY-=;_:*VA:K.D$]Q#/8>]3.MM)%Q)\+G\9,FK&/1>Y:O?9CH2U
M[WX] @\AYS96BB@VWOMXQ&K;43&N@7R&<P$;>3A%* ?I/2ES=;O3Q"[OPE!Z
M2TMK03JO#R1</A39FU9(DN,CRQ+5;N2%WGC0WG+F7_R)9GY(HO2!9CXT2&'0
M%. E1Z6MUNL/$#VN5O."030<[>R3MN_T) QX7UMMF\-<%T-26P^T+L*SH M*
MWW L$#;+RU9$J2;,(VC":-<4$QUL_G#2%=5%+&!P3!_WBLKS_-OAI5E?'29P
M_0WS\TA\!XMBHRYWKW#L!$D<4K&@7:*2V;)9R%O#@L/$*BUQ+)_D7'+HRL/Y
MOZWF^41;0<(BADI%F)(F%Z>@'29H%S([!UORA<26TY :^E(%+S>M*7(19CZY
M*)9%#;@P5#AH?3MPLH]?WL)>!!.P4ITTG,8A_9=O3AFB+;PGR9U6(8I;T=!L
M!,(SG,5E9I!Y4W6N84*!Q#>;U)VQ#J3M]8]/8OBC;\)Y==+7?S,K_R" %F'<
M:=0/BQCJ+-WG%@(>%5O',U%VSP:MKP%F.ZBFY37U0V"W1=3)1WT9X);,]-H:
M[2!J8>H> E+9(:>"/'&W'M+_( 3++M/,ENHQNSLQL%:>&<2KH>O/G)MUP7_,
M(9F,>$\H3V2;GC63]Z'W/ 1"FE=WWJ*PMU/,Y GZ^[ 2,J(AH"*(ESNB<)F@
M8>UR%!6QTY/_?=/B7'<!>SZ*T'HCO*$(5S*$"'V'<&;%Z 0=$1Y36 C1UJ<I
M,)K/=SE_@A4?[ZZ(T<R8\$NE+XD/0J9@?7QB&%BCLZLH5ZU^S_9:1_)#M:U:
M-=P+PH=ZW[D\DV_9,Q6^.5%2,OE+PK,Q-F-PUR90=+A6U+M[$$'C2S?SD$7+
M5V$,=Y"N^1V#2E-%K*=#]EW]G[4[I&=,'T/JA?^!G>TII[V*T3A76([M[7C/
MI36(-B_V^!>FTY)ZF<5A8DH]D4(Q;B7)-5A5!KT9=^H7H=0;WS:@*@PE+RS#
M5<.^1- %>NMGLZ$.HB493H6BDDELT]@[.^0LNN F_[IA?(.&%[Y\D,U)3%7*
MR2]KQ<A)DU3'3>G*6 $*8L>O69?)?.VAS6#H8MCCAV+879\(AXF)TR;TA)U/
MM'?%";A$SU!(?P9NSD+H+8).^*#_/5!Y!<1N@Q^2BGK*_30PFRIL]H];V^-$
MC?C0H?P>V/X2ZF&<-O$7CS^,_0$D:D54-"L24(:?KCSE2+,>"TL@?*/X(U\8
M9A6]74!"JX*3':BJ@KNOL!=4E;WHTXO<^>&UPKJ$]PVD+->3H"V3+Z>6'X>>
MU;6=D_QU-"O;PTH_?(FC@VS3,9\9*>"V6 !VK[X&3?'2V<YE-#S*.FB'+&:C
M9DA*!+[V;#:F6#JT&QTR)':E4"/6&WD,>&)9(C[0:A26SV ;"1;==5&)3<@F
M-HR?A_! 63I?FIY@'6+T$?S?004*U*[JZWAM&E9V[11&]R515[BAJJ]-+I%/
MIQZ+E\JPWE'*A0H3=O=ZC^R1'J8C4=SOIR)P0>E59&&@T\U-O4E_&!QP'',X
M#O :_W*:N6-_4]<:*YS9676KY[)<L(#Z(;%L+WG)>5 M9(,J<M9;CX:3$6=R
M4)AOB\F=P->+Y05U04$&)4BQ B?-VABR'I/( 4KT=1OD]'VQFWER+Q8<:X8Z
M O=Z6;?K(II4]_NRPT,61G&*6Z:DZU34-&%H6K%S%.KIC6W-DIXBHBSK27);
M,K=]%KY?I5B3W"@,>H30+QEIF4]_K]8U] YUP96)G+DWP+ND*&4%;+.]V2AB
M- '( B&B8:Y'_[6NW!KP64*9(7X'JMF1DH*^CA0B1#CEH)+ISW]\WNGYD'FG
M_B33)1M]I9^H-4M.KK5PIF]+BI@\]=C]JD):%>85]VQ>8^EV0]<=#<:Z]ID+
M7>JB$5O6<9(C2J8RL20OS,#4[IB\[SG$W <6=I2\)[79\HK?UGZK4D&+R4=1
M4R#\B_Z"YTWD%'$C@M!H=*K!.E<P O[2"\IN3Z'+QC35]/J --*0E,;BOB\X
M.,>3#/]T3;37A93N>I_9.Z><N8N_S4:;%8AP:-#=V+2ZW-2L\EIG)NB\Z7LI
M57PV;#AMZ^[$34EP=/$CXMIAT6-]:[Y<:A)YK^#.<4_$"YY**WC+G'FM9K-R
MFE]!$@Y0.R;%*>E)=U##LWJ![*!G,JST &_HZCI!>1(*[]GWA^XNFF!(1L(;
M2Z-5WEC5NGT6'KH<=:Q8Y)[M1F6VF 0V'(APFYB]T?L 8S)!S$6@JY^/73-W
MOGLO-@$XQIL6(,XY_5HW01+ED!)#OU1?+01"F^QU';'XA5W:E"*98]H"OH7A
MM-\$#"6$S] 2QC'NN >'E:@XP\FG::Z2$YQJFXL309+J::5KN<V)Q/\0W)<7
M/]Y]&92N\'TU>EO,<]Q@GTB2!84<B\BKN7UD*+:"+^CL#C)M :]6CNS:W'U[
M.\1U+,/1;7(R!@(94E@EJ44..Q9OPG(U<J9B;P+FXRCU*P'IA/$527@?)WU9
MXJ;X \Q),R>,S\)9JF(*,5>U!*5ZH(&SFJT^USS!3" 2AKGE7!-Y,U*FY=?2
M-ES\4=23TK?G4S0:$E'S8_C[H4.*;AD9N737B'4:#7XUT1V10+#:P^6A.#9T
M<>S)0W'L![3RGI[LIY?W)=GSS[]]_/C+^:_G[[^<_3)Z]_ZM^\=OG\X/H9<7
M>AJ^HYEWB+/PU;!BQJ87Y)WO$?DGYUO>B#S%+(&?&_R _-*/T%3],_Z[$L>P
M-G8&Z:.@?;>3 &.\MT+\<,.0$/,-NV4PCC;AET19=]4Q?) =HD/U/\$419F+
M?#$N+]8E:DYS^39S3L,,L^DPF^#M /?/<G)]Z"UI][ 9D8-] <0',],T:R9R
M1H369VU%U#(G%_?&[AAC:$$$/$JUR-J\_2W[%4]/'QH6][DZ\NET=+'.G3/O
MS'B0<(VY[M1]/O19N(?M@4V!AO-/,\3%_1MB6.@I$NVK8IDS13F2!#26)2"R
M==)31%S1^F<393? Z:JQJ02_HU7UK:CC@-=<^=#G>W9?N2H6 OTG!J@./>ZT
M8O+!? JT^P5T%"'MNT>(:9<MPRR8KW>1._^TQ!("FLA#G\*+>[9ENT1W(>@0
M<H(@,$Z[-AL93T=I6)?$S%H7+/+0(H4NQA2?G/]98Q+X8UT!U/PZX.$<&FQP
M^C2FE:..%0_CG".M/"U394.A!E.;NTJPK;#4@<_JJ=B:<^IN_]A_)L:(RWNV
MR(DQ K4$HH-I6S[3-*31*H"0^_')Z[?(,:LJY+@#\$^GK\'+L,3''YRAP\ZD
M7PL7)[OUN%X<^OR6]_4<FKASWNU,J<X'V7 4,!-&44^QX+4MLI'7WX$D#/\%
MU,B((5-;(9MJ-*\(LD7<D@OGC"!<]^8'W:&OA=_OZUI0M&_$*1JQ /UIXZ^O
M]\\(N_T%U;0.99-18_K$W-<6.Q$I0!WXO,SOZX;9E,%"TG*1D;4M)9C0\KM*
M$]48:@.H4KA>ZRQ2KOM;.1U]MH*M9R)8V=&S@VQS/@'UI[RE\#V?@EY$P"$+
M?AS</:T;!@_J62T@;\T&X$] Q+089$4-M<?K&OG*QR!9!>T/P3H:?2[:EBH)
MSA]J+ZLIBRXH"\[;:@Z"V&<(5D)6@6)>,HM;JO3A=:;@9JD[O%9CDHT8IN[Q
MZ7A^XU=9GD'N1N$0H _I_$8=EL[#,]X'B2^DV>,(B_6(,4!44=#02I\Y[AP[
M"G8?,*?[=/^]ZG_A8OS3Q% ^%./W T#[31)Y,6]'F#D,.SC+!DN5X^N(]>WW
MJEQZ *\D'3VP)M1;)LUT6__4NJA,%U9I31),\/GNG*RK58U*,_E%711>>[YI
MRY5VD:(M8N"_@.,4'D4J[_:] L5W+AFQY#M\=$$H(0!9@H*B,T]8"0P*O=<]
M;T2/0A8OH %3<PO*!A3&9-Q**J. (*?%>EEB?VGR#!8-IF]E,W#;PGXPCSV#
M9)838T,3:83;TT6>]C2XR(#34NTV<,;$,PEMR!Z"PP :S,D]1 D$1#PI\=TD
M/&Q8QLQ# (KR,P_KWG?_]_8 FB<G=P&@02-[M^B9?XI=EY5^)##DVT/RQ;%Z
M&<@@)[:2\%[=L+?,9AMC(KDC)6N:IO10OQ\V2_\=!?^Q+\BL IP8\TJSX":+
MM"R/M7OYL<?TQOHY.72!B$@U:)) F$E%/'"[53P$TJ40@[+4XG&VR;CMA(C:
M%09EA^%[$5%H!8UTUE1-I+&-T!I<4Q&"NR^HU(5=ZC8&V61=4^05S/)3;SKB
M":6[J*8LRD9WM^_.#Q)F+,T:/Z 6Y*0RLK9'*5526//J--FKY'>F(6//X*)O
M]@!XVT=NH2ZFZTDG==C?2?_M$O:@\MU! M_0AD.CD63M#SVC."0:;A_S-:JI
M33%J+<."*K>MMA3"@"D&*\J*]L12PRKAW" (DWOH$S8D0.WN-E@UBV;M5^@T
M!N?FK32Q_DGF9TCHVG#S4ZB^G2 /.EV*H4<0H7(XN(\*DXV<C))R#XN4?XI2
MV) XN7WOMT_%M&"P\,>ZG"@*X>?U<IJSO_&&YO.3]Z?YHX8T!9Q .. (GP_.
M7N1G\D*(6[Y2SK3')8>=:FRFF\S(=M?5^N(R.%[A"42$>V:=6$ZY*3@P8'6=
M%K,2<DGH[9J\T:&OQ?N)X5-3 6LG,/_Y=4YH+NB51]CEY!IC-]1,5_Y^7@J9
M9<*A#GDZVHW<Z:'/X) 0ON%F4&T\N%M+D,]-D.>1-3_\BN>0 +,];"*>BU#.
M=0#EQM.33DH8]QC[ P%/F1IO#7IKV81LC$-+?+MD[?.]L#RYJ[ZZ([[M'UBS
M4@5A;)]C#>=8M!F%5D(^A4DGL1IRB!'3YD":]Y#9?A:*RW1*4KL7UC:E4)BX
M<M-';E:@"BM3LB6W%JA2M)26'#918X/RVX;JG"G!;7B[P>H<?^':_+.$B7BH
MS>_'SBFA8(6K?EF$@I[#%@'YT*NHMD[BC\[WA/-Q#; AQ'AS&"0J'3)S/=N-
MS_]WK255F\W*28G\N[-0-\/>%T7.L0;3LE@Y7^L,]6^VH ?<C285#$"!UJR\
M*L)*APAO(9M1'*4=<4D%V:M"&H]C]VMFI!K793$C(DG@B#,^X2;[PR_Q#P^5
M NZL<H[X %:5;8PT%<S&?+[SXV52G^#>9#X?Z&(98:Y@(95N&$JB:O,(:E1D
M,O6T/9O0/9>*OT-@Z(>PK9_3!+@Q[ZGT[K.BJWY4 IJ3W%=[%U /W/ L]B$\
M,]YR:NB&B& ,,S$ELV=AAJ13ST5;0ON'\ZP,$X1])YZ-K[[".\EO3?^X.C]8
MOHUP.7%88CV@0"8C77L-J03Q>4GQ"]]6RM29DA1-F8C:&>=)0'LDWBD,P%Q;
M_!HO1(*C)=(N.F0>1B5VAQJXX#= '%]J!WW2!(=EWIVF#4X8!1GWW"L:2%$
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M5L;RPA8W]R^L%Q <Z]M\CXS1/\DKHUT47<<0[N0B\'RJZ45[2W?%:CV?>BW
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MG3\@5"=9?FP7KVJ<;B@BX+OQSQ0U\!<*!)W_RVGF8K $]R3VSH#3<E&[WRX
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M&?M4FN4*%YW#(#0I@-$\;MO;[:@%]NL5X;.E3UV.WYD;PFP-7EO OBJ6Z:7
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MWM,NW4E<7^$%0\I"$\7YR<_?%<QNE>IPFRV&<>/X&\*;L)7$,O>H525_YG7
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M+.MADP*U4WXPM7!U\9#!(8RH[?P.9<,2L>.)@_?C"]YZD&OC[8WB,[]KZ-S
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M$)02+@55)T9D=QFG%8!X^P+$D$F)_&G+9><TUZ+V!6U\DSO?Q)[C9L]FV0:
M$L!=NT*>!A$.$#W:#TZ-G&XCGRQ0_N\CMZQQG,+KQ:(<$9R%B]EF$=*E@D8]
MWAHB4\E_<4Q-B#-BKN VB-FQ?%Y,]AH?X/'[51QBM(G9C:_8I05N_B9GGR[N
M@JON?W0[0,!<W+6(;11OTY>)*/AZ-,3Q5%T5)58- WM5K- B2-YTJV"C)2VF
MTYFX;!8%9Y\11@UBX<DGZ?Y8,<@Z_)S&@E[R>%5+R4?D^0:((S/PN-T500$
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M)]#)QDP33T4XA%MQ@")&]V8=9U4QC8JP #H;9:APSC8\GS_:Z_N!VGW!'Z?
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MBBR9LJ4PHO'5N1&R+)U^J\Q,IU%19%:[+8H#!P^=BG5O77HTT&181)R25?L
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M7-8"\<>L.;O$3J5I5!UE!TX4@:ZD9RW!$Q\2'9V8Q<4FD\!=_BBPH/FFE(0
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MWX%4#35<2Y*X:+\6H6@WW151,A@U5,F<UYOJM]-O60R9U"]9&(E".%$L*IC
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M$$7N22HFHZ_M"IQ3V7^8\\!)2!)=A%_)D:X=^RD<A.\:VW'CL1UGF$P^-SP
M:D[;HW2I6K1MC%;!6B*2LS$)>Z"MZD"8/IDMF-*]Y\HOWY1(*)G"?*0N!VT7
MMIG;C-Q#R75#2L.S@;ZA1*YHCB&Z851>'B*^RSMBN+#RSJ^9^$V>!T1()3-/
MF$SA'6TYBD[+5@NO5[?4J.BDH28QU\ :, H/6'Z*<P--KG<[.$_6Z/K,B$$N
M@X+(LO!\K[*+Y?ZQ4VM^*R^*J =\ZI4KYM%V)DY%!3=2MD8;JK 0-;J(?,&
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M0^A<'^<K:)ICOG\<20;>=+S>9^5U=*Z#O,[EHQ$;L[^'N@)'QEM1URT7W+S
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MP-<'C'([[<%F<+I#%(R6:TS^U,G?Y6WR]RNK@07Q\H<;3CP?Z2)7Y:8@K*S
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MS:/I=:ZP5!*^UN;OU3H\R']>^9T%20:K]G;4I&265'%XU3R#86&X#[4SWQ
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M6Z/J+(IXVWR#R3OM$($1\1_5H,/K&NAZ5K1TK\)PC.TT37,N^<W7$,%W0R+
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MN;[8\EM<@>\8GC/JXFP8+,JR::AK:95*J=/(K+06265YD#Z9)M!RB[EM%=<
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M'KUOS.8&NZP!99IOQ%DWS(END:=2Z0IN1S=/%P\ !!W"UP<OWKYY^09E[ N
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M[\S[7X&O-?KTDXM']*D^?;+_*/T/"?\!4$L#!!0    ( 'F!7%K,C 69A!$
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MGMN6 C,$;2LN$W1DMS%@HBV= /4TEHC'].?)6/(?G@,=J,YQRL%S\=$XY]F
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M3')R=AU9PX%XW/6:_'*@UR]W2)9@X<DUE^F]1]QIY^W9=CB"QF):%TXX"FC
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ML>'%C_1GC/PA_+'F_P!02P$"% ,4    " !Y@5Q:!A);)U(#  "R#P  $0
M            @ $     8F)I;RTR,#(U,#(R-"YX<V102P$"% ,4    " !Y
M@5Q:0"/#R7H(   P5@  %0              @ &! P  8F)I;RTR,#(U,#(R
M-%]L86(N>&UL4$L! A0#%     @ >8%<6B8#J&3;!0  \SX  !4
M     ( !+@P  &)B:6\M,C R-3 R,C1?<')E+GAM;%!+ 0(4 Q0    ( 'F!
M7%I+9.A&,B,  "K2   1              "  3P2  !E9C(P,#0T-S$U7SAK
M+FAT;5!+ 0(4 Q0    ( 'F!7%K>#]&^2ZT! !2X#0 4              "
M 9TU  !E9C(P,#0T-S$U7V5X-"TQ+FAT;5!+ 0(4 Q0    ( 'F!7%IZ!/H.
M,!   )DP   5              "  1KC 0!E9C(P,#0T-S$U7V5X.3DM,2YH
M=&U02P$"% ,4    " !Y@5Q:S(P%F801  "U.0  %0              @ %]
M\P$ 968R,# T-#<Q-5]E>#DY+3(N:'1M4$L%!@     '  < S $  #0% @
!  $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>ef20044715_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="bbio-20250224.xsd" xlink:type="simple"/>
    <context id="c20250224to20250224">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001743881</identifier>
        </entity>
        <period>
            <startDate>2025-02-24</startDate>
            <endDate>2025-02-24</endDate>
        </period>
    </context>
    <dei:AmendmentFlag
      contextRef="c20250224to20250224"
      id="Fact_d79fb903e3c54fba817e3cdd57c20042">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="c20250224to20250224"
      id="Fact_3bd9188bd5624895b8a8160fb3e468be">0001743881</dei:EntityCentralIndexKey>
    <dei:DocumentType
      contextRef="c20250224to20250224"
      id="Fact_93772f2c96dd42139eafc2d275aab268">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="c20250224to20250224"
      id="Fact_d00554e814454be4a62c596c90c1716e">2025-02-24</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="c20250224to20250224"
      id="Fact_53fbc0836e0e475d803f89efbca8fbbc">BridgeBio Pharma, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="c20250224to20250224"
      id="Fact_fcd34a5c7a7041e1a9be50d4ea6afeeb">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="c20250224to20250224"
      id="Fact_efd8787eef2548fe8b500d06160c8f08">001-38959</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="c20250224to20250224"
      id="Fact_ffdb06dbe5164051a467e90ba686afa7">84-1850815</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="c20250224to20250224"
      id="Fact_3377389d490b4dd7b1d0a2e72ce45dcb">3160 Porter Dr.</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="c20250224to20250224"
      id="Fact_e198d91a1d754c8792901fa89be20b25">Suite 250</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="c20250224to20250224"
      id="Fact_e4ccf16e9790435fb4ffbccefde2caad">Palo Alto</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="c20250224to20250224"
      id="Fact_589d8d7a34ff44688fb4d89d88603a5c">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="c20250224to20250224"
      id="Fact_45ac14447eda4b3792b30bf59698fe8b">94304</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="c20250224to20250224"
      id="Fact_88e7f54ab8bc4954afc5cf3f75421ce7">650</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="c20250224to20250224"
      id="Fact_eba4d5a19df84fec91ca4e40feaf359e">391-9740</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="c20250224to20250224"
      id="Fact_7b0fb11ca36145daa7b9788d7dd70788">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="c20250224to20250224"
      id="Fact_027e19c6dab848fe92d74412b58b0824">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="c20250224to20250224"
      id="Fact_f5d61fd13c4b4afa8fa94cb4c73b7e14">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="c20250224to20250224"
      id="Fact_760f52d7858b471eb58d579b589bc88e">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="c20250224to20250224"
      id="Fact_9522a370899a40b3ac0a71a224a05117">Common Stock, par value $0.001 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="c20250224to20250224"
      id="Fact_a0f583e34e344c77ae1fe9f00cc0c971">BBIO</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="c20250224to20250224"
      id="Fact_af3a50c05b3c4dae85faae4824ced06c">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="c20250224to20250224"
      id="Fact_a0e16efd4cbe43629552af6079645691">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
